"uid","title","source","date_published","format","annotation","url","authors","type","access_notes","includes_research_tools","id"
"24200","What Maritime Pilots Need to Know about COVID-19","Centers for Disease Control and Prevention, National Center for Health Statistics","2020-10-30T00:00:00.000","Text","This web page provides information and answers to questions about COVID-19 and maritime pilots:  As a maritime pilot, how can I protect myself and slow the spread of COVID-19?; What steps should pilots’ associations take?; and Where can I get more information?","https://www.cdc.gov/coronavirus/2019-ncov/community/maritime-pilots.html",,"Fact Sheet","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/maritime-pilots.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/maritime-pilots.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/maritime-pilots.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/maritime-pilots.html","false","24200"
"23884","Coronavirus Disease (COVID-19): Considerations for Retirement Communities and Independent Living Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-30T00:00:00.000","Text","This web page, updated on October 30, 2020, offers considerations for ways in which administrators of retirement communities and independent living facilities can help protect residents, workers, visitors, and communities, and slow the spread of COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/community/retirement/considerations.html?CDC_AA_refVal=https%3A%2F%2Fwww.cdc.gov%2Fcoronavirus%2F2019-ncov%2Fcommunity%2Fretirement%2Fguidance-retirement-response.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/retirement/considerations.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/retirement/considerations.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/retirement/considerations.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/retirement/considerations.html","false","23884"
"24193","COVID-19 Infection Fatality Ratio Estimates from Seroprevalence","Imperial College London","2020-10-29T00:00:00.000","PDF","This 18-page report discusses infection fatality ratio (IFR), a key statistic for estimating the burden of COVID-19 that has been continuously debated throughout the current pandemic. Previous estimates have relied on data early in the epidemic, or have not fully accounted for uncertainty in serological test characteristics and delays from onset of infection to seroconversion, death, and antibody waning. After screening 175 studies, this study identified 10 representative antibody surveys to obtain updated estimates of the infection fatality rate using a modeling framework that addresses the limitations.","https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-34-ifr/","Brazeau, Nicholas; Verity, Robert; Jenks, Sara; Fu, Han; Whittaker, Charles","Report","Direct link to document: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-10-29-COVID19-Report-34.pdfLink to Supplementary data: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-10-29-COVID19-Report-34-supplement.pdfLink to Supplement excluded studies: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-10-29-COVID19-Report-34-Supplement-excluded-studies.xlsx","false","24193"
"23149","Operating Schools During COVID-19: CDC's Considerations","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-10-29T00:00:00.000","Text","The CDC offers these considerations, updated on October 29, 2020, for ways in which schools can help protect students, teachers, administrators, and staff and slow the spread of COVID-19. Schools can determine, in collaboration with state and local health officials to the extent possible, whether and how to implement these considerations while adjusting to meet the unique needs and circumstances of the local community.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/schools.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/schools.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/schools.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/schools.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/schools.html","false","23149"
"3733","Ohio Pandemic Influenza Public Engagement Demonstration Project","Center for Public Health Practice [Ohio State University, College of Public Health]","2009-08-01T00:00:00.000","PDF","This is a report on a project to help state and local level decision-makers manage response and recovery plans concerning mass fatalities as a result of an outbreak of pandemic influenza in Ohio and is product of a series of meetings with stakeholders and representatives of the public.","http://www.cidrap.umn.edu/sites/default/files/public/php/452/452_massfatality_report.pdf",,"Report",,"false","3733"
"22916","Coronavirus Disease (COVID-19) Considerations for Institutions of Higher Education","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-29T00:00:00.000","Text","This web page, updated on October 29, 2020, provides updates on expanded considerations on care for students and staff when becoming ill in an institution of higher learning setting, considerations on ventilation, considerations on food service, and considerations for contact tracing.","https://www.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/considerations.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/considerations.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/considerations.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/considerations.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/considerations.html","false","22916"
"22243","Coronavirus Disease (COVID-19) Staffing Resources: Staffing Resources and Guidance","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-29T00:00:00.000","Text","This web page, updated on October 29, 2020, provides resources for state, tribal, local, and territorial health departments on staffing the public health workforce to coordinate the response to the COVID-19 pandemic and reopening state, tribal, local, and territorial programs. Charts show CDC field team deployments and quarantine station deployments by date, and resources from other organizations are provided.","https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/staffing.html",,"Guideline/Assessment Tool",,"false","22243"
"22201","Coronavirus Disease (COVID-19) FAQs for Wildland Firefighters","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-29T00:00:00.000","Text","This web page, updated on October 29, 2020, provides answers to frequently asked questions about wildland firefighters and COVID-19. Topics include how to prevent infection and spread, prioritization of testing, and precautions wildland firefighters should take.","https://www.cdc.gov/coronavirus/2019-ncov/community/wildland-firefighters-faq.html",,"Fact Sheet","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/wildland-firefighters-faq.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/wildland-firefighters-faq.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/wildland-firefighters-faq.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/wildland-firefighters-faq.html","false","22201"
"5034","Cultural Competency Program for Disaster Preparedness and Crisis Response","Office of Minority Health [U.S. Department of Health and Human Services]","2009-06-30T00:00:00.000","Video or Multimedia","This course provides the knowledge, skills, and awareness to best serve all individuals, regardless of cultural or linguistic background, during every phase of a disaster. It is for EMT/First Responders, Emergency Managers, Psychologists and Psychiatrists, Social Workers, Dentists, and any disaster or emergency response personnel interested in learning more about culturally and linguistically appropriate services.","https://www.thinkculturalhealth.hhs.gov/education/disaster-personnel",,"Instructional/Training Material",,"false","5034"
"21130","Implementation of Mitigation Strategies for Communities with Local COVID-19 Transmission","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-29T00:00:00.000","PDF","This web page, updated on October 29, 2020, describes the goals, guiding principles, and strategies for community mitigation to reduce or prevent local COVID-19 transmission. Community mitigation activities are actions that people and communities can take to slow the spread of a new virus with pandemic potential.","https://www.cdc.gov/coronavirus/2019-ncov/community/community-mitigation.html",,"Guideline/Assessment Tool","This page is available in Chinese, Korean, Spanish, and Vietnamese. Link to Mitigation Strategies for Santa Clara, CA: https://www.cdc.gov/coronavirus/2019-ncov/downloads/Santa-Clara_Community_Mitigation.pdfLink to Mitigation Strategies for Seattle, WA: https://www.cdc.gov/coronavirus/2019-ncov/downloads/Seattle_Community_Mitigation.pdfLink to Mitigation Strategies for New Rochelle, NY: https://www.cdc.gov/coronavirus/2019-ncov/downloads/New-Rochelle_Community_Mitigation.pdf Link to Mitigation Strategies for Florida: https://www.cdc.gov/coronavirus/2019-ncov/downloads/FL_Community_Mitigation.pdfLink to Mitigation Strategies for Massachusetts: https://www.cdc.gov/coronavirus/2019-ncov/downloads/MA_Community_Mitigation.pdf","false","21130"
"21039","Considerations for Communities of Faith","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-29T00:00:00.000","Text","This interim guidance, updated on October 29, 2020, offers the general considerations to help communities of faith discern how best to practice their beliefs while keeping their staff and congregations safe during the COVID-19 pandemic.","https://www.cdc.gov/coronavirus/2019-ncov/community/faith-based.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/faith-based.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/faith-based.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/faith-based.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/faith-based.html","false","21039"
"21012","Polling Locations and Voters: Interim Guidance to Prevent Spread of Coronavirus Disease 2019 (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-29T00:00:00.000","Text","This guidance, updated on October 29, 2020, provides expanded guidance on changes to operations, procedures, and facilities for polling locations; added reminders to maintain accessibility; and added recommendations for voters.","https://www.cdc.gov/coronavirus/2019-ncov/community/election-polling-locations.html",,"Guideline/Assessment Tool","Link to Toolkit for Reducing the Spread of COVID-19 During Elections: https://www.cdc.gov/coronavirus/2019-ncov/community/election-polling-locations/elections-toolkit.htmlLink to guidance in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/election-polling-locations.htmlLink to guidance in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/election-polling-locations.htmlLink to guidance in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/election-polling-locations.htmlLink to guidance in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/election-polling-locations.html","false","21012"
"24191","Ransomware Activity Targeting the Healthcare and Public Health Sector","U.S. Department of Homeland Security","2020-10-28T00:00:00.000","Text","This joint cybersecurity advisory was coauthored by the Cybersecurity and Infrastructure Security Agency (CISA), the Federal Bureau of Investigation (FBI), and the Department of Health and Human Services (HHS). It describes the tactics, techniques, and procedures (TTPs) used by cybercriminals against targets in the Healthcare and Public Health Sector (HPH) to infect systems with Ryuk ransomware for financial gain.","https://us-cert.cisa.gov/ncas/alerts/aa20-302a",,"Guideline/Assessment Tool","Link to advisory in a PDF file: https://us-cert.cisa.gov/sites/default/files/publications/AA20-302A_Ransomware%20_Activity_Targeting_the_Healthcare_and_Public_Health_Sector.pdf","false","24191"
"24187","Innovating on Campus: Supporting Mental Health of Students of Color During COVID-19 and Beyond","Harvard University, Harvard T.H. Chan School of Public Health","2020-10-27T00:00:00.000","Video or Multimedia","This one-hour, two-minute presentation discusses what higher education leaders, staff, and faculty should do to help young people of color successfully navigate today’s campus climate, social distancing protocols, and remote learning experiences.","https://theforum.sph.harvard.edu/events/innovating-on-campus/","Martin, Phillip; Krislov, Marvin; Kumar, Meeta; Chavous, Tabbye; Kim, Josephine","Instructional/Training Material",,"false","24187"
"24164","Common Investigation Protocol for Investigating Suspected SARS-CoV-2 Reinfection","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-27T00:00:00.000","Text","This protocol is designed to support a common public health investigation into suspected SARS-CoV-2 reinfection cases across jurisdictions. Confirming SARS-CoV-2 reinfection requires advanced laboratory diagnostic support built upon advanced planning to implement this protocol, or a locally adapted version, with referral of specimens to supporting laboratory networks.","https://www.cdc.gov/coronavirus/2019-ncov/php/reinfection.html",,"Guideline/Assessment Tool","Link to Investigative Criteria for Suspected Cases of SARS-CoV-2 Reinfection (ICR): https://www.cdc.gov/coronavirus/2019-ncov/php/invest-criteria.html","false","24164"
"24154","SARS-CoV-2 Viral Culturing at CDC","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-27T00:00:00.000","Text","This web page for laboratories provides information about how the CDC is using SARS-CoV-2 in various ways, including: To test serum collected from people who have recovered from COVID-19 to look for antibody that might block viral infections; and to determine when people shed live virus during the disease. This information has shaped CDC’s guidance on when to discontinue transmission-based precautions for patients.","https://www.cdc.gov/coronavirus/2019-ncov/lab/grows-virus-cell-culture.html",,"Web Page",,"false","24154"
"20872","Interim Clinical Guidance for Management of Patients with Confirmed Coronavirus Disease (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-27T00:00:00.000","Text","This interim guidance, updated on October 27, 2020, is for clinicians caring for patients with confirmed infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19).","https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-guidance-management-patients.html",,"Guideline/Assessment Tool",,"false","20872"
"24165","Fact Sheet for Healthcare Providers: MassARRAY SARS-CoV-2 Panel","U.S. Food and Drug Administration","2020-10-26T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MassARRAY SARS-CoV-2 Panel. The MassARRAY SARS-CoV-2 Panel is  authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/143332/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/143333/downloadLink to Letter of Authorization: https://www.fda.gov/media/143331/downloadLink to Instructions for Use: https://www.fda.gov/media/143334/download","false","24165"
"24148","Key Aspects Regarding the Introduction and Prioritisation of COVID-19 Vaccination in the EU/EEA and the UK","European Union, European Centre for Disease Prevention and Control","2020-10-26T00:00:00.000","PDF","This 12-page document provides an overview of the key aspects related to the initial phases following the introduction of one or more COVID-19 vaccines in the European Union and European Economic Area (EU/EEA) and the United Kingdom (UK). These components are those usually adopted when a new vaccine is available on the market and integrated into national vaccination schedules.","https://www.ecdc.europa.eu/en/publications-data/key-aspects-regarding-introduction-and-prioritisation-covid-19-vaccination",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/Key-aspects-regarding-introduction-and-prioritisation-of-COVID-19-vaccination.pdf","false","24148"
"24120","Coronavirus Disease 2019 (COVID-19) Community Mitigation (Non-U.S. Settings)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-26T00:00:00.000","Video or Multimedia","This web page, updated on October 26, 2020, provides guidance, documents, posters, and videos about community mitigation measures for COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/non-us-community-mitigation.html",,"Guideline/Assessment Tool","Some materials are available in several languages.","false","24120"
"24152","Strategies for Optimizing the Supply of Disposable Medical Gloves","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-25T00:00:00.000","Text","This web page offers a series of strategies or options to optimize supplies of disposable medical gloves in healthcare settings when there is limited supply. These considerations are intended for use by federal, state, and local public health officials; leaders in occupational health services and infection prevention and control programs; and other leaders in healthcare settings who are responsible for developing and implementing policies and procedures for preventing pathogen transmission in healthcare settings.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/gloves.html",,"Guideline/Assessment Tool",,"false","24152"
"23995","Flowchart for Management of HCWs (Health Care Workers) with Exposure to a Person with COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-25T00:00:00.000","Text","This web page, updated on October 25, 2020, provides a flowchart for management of health care workers with exposure in the last 14 days to a person with COVID-19, for both high- and low-risk exposure.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/flowchart-for-management-HCWs.html",,"Guideline/Assessment Tool",,"false","23995"
"22892","CDC’s Diagnostic Multiplex Assay for Flu and COVID-19 at Public Health Laboratories and Supplies","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-25T00:00:00.000","Text","This web page, updated on October 25, 2020, provides information about the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay, which is a real-time reverse-transcriptase polymerase chain reaction (RT-PCR) test that detects and differentiates RNA from SARS-CoV-2, influenza A virus, and influenza B virus in upper or lower respiratory specimens. The Food and Drug Administration (FDA) granted an Emergency Use Authorization (EUA) for this test on July 2, 2020.","https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex.html",,"Web Page","Link to Research Use Only CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay Real-Time RT-PCR Primers and Probes: https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex-primer-probes.html","false","22892"
"22110","How to Report COVID-19 Laboratory Data","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-25T00:00:00.000","Text","This web page, updated on October 25, 2020, outlines reporting requirements for laboratories for collecting and sending COVID-19/SARS-CoV-2 laboratory testing data. It also details how to report using standard terminology.","https://www.cdc.gov/coronavirus/2019-ncov/lab/reporting-lab-data.html",,"Guideline/Assessment Tool",,"false","22110"
"24162","Guidance Related to Childcare During COVID-19","American Academy of Pediatrics","2020-10-23T00:00:00.000","Text","The aim of the strategies provided within this guidance is to reduce risk of COVID-19 exposure and spread of infection to staff, children, and families involved with early care and education programs. The guidance also explores primary prevention such as immunizations, well child care, and special considerations for children with special health care needs.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/guidance-related-to-childcare-during-covid-19/",,"Guideline/Assessment Tool",,"false","24162"
"24161","Interim Guidance on Supporting the Emotional and Behavioral Health Needs of Children, Adolescents, and Families During the COVID-19 Pandemic","American Academy of Pediatrics","2020-10-23T00:00:00.000","Text","This web page details how the COVID-19 pandemic has underscored the need to continue to integrate emotional and behavioral health as part of standard care, and how pediatricians, professionals, families, and agencies can partner together to support the emotional and behavioral health of the nation’s children, adolescents, and families during this public health crisis.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/interim-guidance-on-supporting-the-emotional-and-behavioral-health-needs-of-children-adolescents-and-families-during-the-covid-19-pandemic/",,"Guideline/Assessment Tool",,"false","24161"
"24153","Fact Sheet for Healthcare Providers: Sampinute™ COVID-19 Antigen MIA","U.S. Food and Drug Administration","2020-10-23T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Sampinute™ COVID-19 Antigen Magnetic Immunoassay (MIA). The Sampinute™ COVID-19 Antigen MIA is authorized for use using nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.","https://www.fda.gov/media/143268/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/143269/downloadLink to Letter of Authorization: https://www.fda.gov/media/143267/downloadLink to Instructions for Use: https://www.fda.gov/media/143270/download","false","24153"
"24145","National Wastewater Surveillance System (NWSS): A New Public Health Tool to Understand COVID-19 Spread in a Community","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-23T00:00:00.000","Text","This web page provides information about the National Wastewater Surveillance System (NWSS), initiated in response to the COVID-19 pandemic. The data generated by NWSS will help public health officials to better understand the extent of COVID-19 infections in communities.","https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance.html",,"Fact Sheet","Link to Developing a Wastewater Surveillance Sampling Strategy: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance/developing-a-wastewater-surveillance-sampling-strategy.htmlLink to Wastewater Surveillance Testing Methods: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance/testing-methods.htmlLink to Wastewater Surveillance Data Reporting and Analytics: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance/data-reporting-analytics.htmlLink to Targeted Wastewater Surveillance at Facilities, Institutions, and Workplaces: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance/wastewater-workplaces.htmlLink to Public Health Interpretation and Use of Wastewater Surveillance Data: https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance/public-health-interpretation.html","false","24145"
"24140","Increased Transmission of COVID-19 in the EU/EEA and the UK: Thirteenth Update","European Union, European Centre for Disease Prevention and Control","2020-10-23T00:00:00.000","PDF","This 14-page update assesses the risk for the general population and vulnerable individuals in relation to the increase in COVID-19 notification rates in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK). There has been a considerable further increase in COVID-19 infections, and the current situation represents a major threat to public health.","https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-increased-transmission-thirteenth-update",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/RRA-COVID-19-EU-EEA-UK-thirteenth-update-23-Oct-2020.pdf","false","24140"
"23779","Guide to Global Digital Tools for COVID-19 Response","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-23T00:00:00.000","Text","This guide, updated on October 23, 2020, compares the District Health Information Software (DHIS2), the Surveillance, Outbreak Response Management and Analysis System (SORMAS), Go.Data, Open Data Kit (ODK), Epi Info, CommCare, KoboToolbox, Excel, and paper.  Each has been deployed in various countries for contact tracing, investigations, and/or, in the case of DHIS2 and SORMAS, national surveillance.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/compare-digital-tools.html",,"Guideline/Assessment Tool",,"false","23779"
"23608","How to Mitigate COVID-19 Transmission in Densely Populated Areas Globally","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-23T00:00:00.000","Text","This web page, updated on October 23, 2020, provides suggestions for community mitigation measures in densely populated, international, low-resource settings, and describes implementation considerations associated with each measure. Community mitigation activities are actions that people and communities can take to prevent or reduce local COVID-19 transmission.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/global-urban-areas.html",,"Guideline/Assessment Tool",,"false","23608"
"23570","Considerations for Use of SARS-CoV-2 Antigen Testing in Nursing Homes","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-23T00:00:00.000","Text","This web page, updated on October 23, 2020, provides a summary of considerations for use of SARS-CoV-2 (the virus that causes COVID-19) antigen testing in nursing homes and is intended for nursing home providers and state and local public health departments.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-homes-antigen-testing.html",,"Guideline/Assessment Tool","Link to testing algorithm: https://www.cdc.gov/coronavirus/2019-ncov/downloads/hcp/nursing-home-testing-algorithm-508.pdf","false","23570"
"23313","Operational Considerations for Adapting a Contact Tracing Program to Respond to the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-23T00:00:00.000","Text","This web page, updated on October 23, 2020, outlines considerations for modifying contact tracing protocols during the COVID-19 pandemic to maximize efficient use of limited resources. It is for CDC country offices, ministries of health, sub-national public health authorities, and other implementing partners in non-U.S. settings.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/operational-considerations-contact-tracing.html",,"Guideline/Assessment Tool",,"false","23313"
"22273","Evaluation and Management Considerations for Neonates At Risk for COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-23T00:00:00.000","Text","This guidance, updated on October 23, 2020, is intended to inform healthcare providers about the diagnosis, evaluation, infection prevention and control practices, and disposition of neonates (≤28 days old) with confirmed or suspected COVID-19 or known COVID-19 exposure, including birth to a mother with confirmed or suspected COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/caring-for-newborns.html",,"Guideline/Assessment Tool",,"false","22273"
"21642","Assessment Tool for Laboratories Implementing SARS-CoV-2 Testing","World Health Organization","2020-10-23T00:00:00.000","PDF","This tool, updated on October 23, 2020, has been designed to assess the capacity of laboratories that have implemented or intend to implement testing for SARS-CoV-2, the virus that causes novel coronavirus disease 2019 (COVID-19). The tool is a shortened version of the 2012 laboratory assessment tool that is widely used to assess national laboratory systems and the capacity of laboratories.","https://www.who.int/publications/i/item/assessment-tool-for-laboratories-implementing-covid-19-virus-testing",,"Guideline/Assessment Tool","Direct link to user guide: https://apps.who.int/iris/rest/bitstreams/1310603/retrieveDirect link to tool: https://apps.who.int/iris/rest/bitstreams/1310611/retrieve","false","21642"
"24138","COVID-19 Case Investigation and Contact Tracing among Refugee, Immigrant, and Migrant (RIM) Populations: Important Considerations for Health Departments","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-22T00:00:00.000","Text","This web page discusses why refugee, immigrant, and migrant populations are at increased risk for COVID-19, and provides guidance, including how health departments can conduct effective case investigation and contact tracing among refugee, immigrant, and migrant populations, and how to overcome language barriers.","https://www.cdc.gov/coronavirus/2019-ncov/php/rim-considerations.html",,"Guideline/Assessment Tool",,"false","24138"
"3188","Learning to Live in a World with the H1N1 Pandemic","Center for Strategic and International Studies","2009-06-30T00:00:00.000","Video or Multimedia","Dr. Harvey Fineberg, president of the Institute of Medicine and Dr. Anthony Fauci, director of the National Institute of Allergy and Infectious Diseases talk about the H1N1 flu outbreak and policy decisions to combat and mitigate the outbreak.","https://www.csis.org/events/learning-live-world-h1n1-pandemic","Fauci, Anthony S.","Conference/Meeting Material",,"false","3188"
"24137","Leveraging Existing Resources to Meet the Challenges Faced by People Who Use Drugs or Who Have Substance Use Disorders During the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-22T00:00:00.000","Video or Multimedia","The COVID-19 pandemic has presented challenges in healthcare for those who may be at greater risk for adverse health outcomes such as people who use drugs or people who have a substance use disorder. To better facilitate provision of care, the CDC organized this one-hour Clinician Outreach and Communication Activities (COCA) call to highlight existing resources and exceptions for clinicians who prescribe medications for opioid use disorder, increase awareness of existing community-based linkage to care resources, and discuss the outpatient telemedicine experience from a front-line provider perspective.","https://emergency.cdc.gov/coca/calls/2020/callinfo_102220.asp","Gandotra, Neerj; Rooks-Peck, Cherie; Ryan, Shawn","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/PWUD-COCA_10.22.2020_FINAL.pdf","false","24137"
"23352","Case Investigation and Contact Tracing in Non-Healthcare Workplaces: Information for Employers","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-22T00:00:00.000","Text","This web page, updated on October 22, 2020, provides tips and considerations for how employers can partner with state, tribal, local, or territorial (STLT) health departments and work with their employees on COVID-19 case investigation and contact tracing, which may lower the need for business closures to prevent the spread of the disease.","https://www.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces.html","false","23352"
"22057","Letter of Authorization: Emergency Use Authorization (EUA) of Remdesivir (GS-5734™)","U.S. Food and Drug Administration","2020-10-22T00:00:00.000","PDF","The Food and Drug Administration (FDA) updated this Emergency Use Authorization (EUA) on October 1, 2020, to permit the emergency use of the unapproved product remdesivir for treatment of suspected or laboratory confirmed coronavirus disease 2019 (COVID-19) in adults and children hospitalized with severe disease. The FDA approved remdesivir for the treatment of COVID-19 requiring hospitalization on October 22, 2020.","https://www.fda.gov/media/137564/download",,"Guideline/Assessment Tool","Link to updated information (October 22, 2020): https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-covid-19Link to Fact Sheet for Healthcare Providers: https://www.fda.gov/media/137566/downloadLink to Fact Sheet for Patients and Parents/Caregivers: https://www.fda.gov/media/137565/downloadLink to Frequently Asked Questions on the Emergency Use Authorization for Remdesivir for Certain Hospitalized COVID-19 Patients: https://www.fda.gov/media/137574/downloadLink to FDA Broadens Emergency Use Authorization for Veklury (remdesivir) to Include All Hospitalized Patients for Treatment of COVID-19 (August 28, 2020): https://www.fda.gov/news-events/press-announcements/covid-19-update-fda-broadens-emergency-use-authorization-veklury-remdesivir-include-all-hospitalized","false","22057"
"3179","Influenza Vaccine Use by Adults in the U.S.","RAND Corporation","2009-06-29T00:00:00.000","PDF","This report contains data on influenza vaccine use by adults 65 or older, those with high-risk health conditions, health care workers, or those with close contact with high-risk individuals.","https://www.rand.org/content/dam/rand/pubs/occasional_papers/2009/RAND_OP270.1.pdf","Lurie, Nicole","Report",,"false","3179"
"21170","Considerations in the Investigation of Cases and Clusters of COVID-19","World Health Organization","2020-10-22T00:00:00.000","PDF","This five-page document, updated on October 22, 2020, offers operational guidance to Member States for the rapid investigation of suspected COVID-19 cases after an alert or signal. It is to be used by local, regional, or national health authorities as considerations for investigating cases of COVID-19. A table serves as operational guidance for time-sensitive (within first few days of notification) priority actions after the signal of a COVID-19 case/cluster.","https://www.who.int/publications/i/item/considerations-in-the-investigation-of-cases-and-clusters-of-covid-19",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1313227/retrieve","false","21170"
"24176","Mental Health Interventions in Shelters: Lessons from Hurricane Harvey","Natural Hazards Center [University of Colorado at Boulder]","2020-10-21T00:00:00.000","Text","After Hurricane Harvey hit Houston in 2017, a team of psychiatrists and therapists from Baylor College of Medicine arrived at the George R. Brown Convention Center to help deliver mental health care to those displaced, although information and supplies were limited. The experiences and information gathered can provide useful lessons in how to better prepare shelters to provide mental health services.","https://hazards.colorado.edu/news/research-counts/mental-health-interventions-in-shelters-lessons-from-hurricane-harvey","Truong, Thanh Truy; Shah, Asim; Goodman, Wayne; Banu, Sophia; Salloum, Alison","Report",,"false","24176"
"24174","130,000 – 210,000 Avoidable COVID-19 Deaths – and Counting – in the U.S","National Center for Disaster Preparedness [Columbia University, Earth Institute]","2020-10-21T00:00:00.000","PDF","This 13-page report looks at the staggering and disproportionate nature of COVID-19 fatalities in the United States, which now ranks first in the world in the total number of fatalities, to estimate how many deaths were “avoidable.” It estimates that at least 130,000 deaths and perhaps as many as 210,000 could have been avoided with earlier policy interventions and more robust federal coordination and leadership.","https://ncdp.columbia.edu/custom-content/uploads/2020/10/Avoidable-COVID-19-Deaths-US-NCDP.pdf","Redlener, Irwin; Sachs, Jeffrey; Hansen, Sean; Hupert, Nathaniel","Report",,"false","24174"
"24170","Telehealth for Community-Based Organizations Webinar Series","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-10-21T00:00:00.000","Video or Multimedia","The ASPR At-Risk Individuals Program led this three-part webinar series on implementing telehealth services to address the access and functional needs of at-risk individuals, in partnership with the Department of Housing and Urban Development, during COVID-19 pandemic.","https://www.phe.gov/emergency/events/COVID19/atrisk/CBO-series/Pages/default.aspx",,"Instructional/Training Material",,"false","24170"
"24147","NETEC COVID-19 Webinar Series: Containing the Spread of COVID-19 on Inpatient Psychiatric Units","National Emerging Special Pathogens Training and Education Center","2020-10-21T00:00:00.000","Video or Multimedia","This 57-minute webinar discusses effective leadership strategies that will allow for successful management of COVID-19 on inpatient psychiatric units, how to develop policies and procedures that will lead to efficient identification and isolation of cases, and how to identify necessary modifications to unit programming that must be made to prevent the spread of infection.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1358","Tennill, Trish; Lopez, Leonardo","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/75d455f777383d3b0a352353b88464f0.pdfLink to recording on YouTube: https://youtu.be/lSEFMwMja4o","false","24147"
"24142","Pandemic’s Effect on the Widening Gap in Mortality Rate Between the U.S. and Peer Countries","Henry J. Kaiser Family Foundation","2020-10-21T00:00:00.000","Text","This report compares where COVID-19 falls as a leading cause of death in the U.S. versus peer countries (Organisation for Economic Co-operation and Development [OECD] member nations with above median GDP and above median GDP per capita). It finds that COVID-19 mortality rates are the third leading cause of death in the U.S., and that the U.S. nears the top of the list of countries most affected by COVID-19 on a per capita basis, surpassed only by Belgium and the United Kingdom.","https://www.healthsystemtracker.org/brief/the-pandemics-effect-on-the-widening-gap-in-mortality-rate-between-the-u-s-and-peer-countries/","Ramirez, Giorlando; Amin, Krutika; Cox, Cynthia","Report",,"false","24142"
"24132","COVID-19 Employer Information for Paratransit Operators","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page provides guidance for paratransit operators about how they can protect their staff and others, and slow the spread of COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/paratransit-employers.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/organizations/paratransit-employers.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/organizations/paratransit-employers.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/organizations/paratransit-employers.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/organizations/paratransit-employers.htmlLink to page on What Paratransit Operators Need to Know about COVID-19: https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/paratransit-employees.html","false","24132"
"24070","Considerations for Monitoring and Evaluation of Mitigation Strategies Implemented in Institutions of Higher Education","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, provides example evaluation questions, indicators, and data sources to help institutions of higher education, their administrators, public health agencies, and evaluation professionals to monitor and evaluate the implementation and impact of COVID-19 mitigation strategies in institutions of higher education on transmission of SARS-CoV-2, the virus that causes COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/php/monitoring-evaluation-ihe.html",,"Guideline/Assessment Tool",,"false","24070"
"23903","Interim Guidance for Case Investigation and Contact Tracing in Institutions of Higher Education (IHEs)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, provides COVID-19 guidance for institutions of higher education on topics that include federal, state, and local legal considerations; roles and responsibilities; ways IHEs can prepare; when a COVID-19 case is suspected or confirmed; and assisting the health department with contact tracing.","https://www.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/contact-tracing.html",,"Guideline/Assessment Tool",,"false","23903"
"23792","Considerations for Monitoring and Evaluation of Mitigation Strategies Implemented in K-12 Schools","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This resource, updated on October 21, 2020, provides example evaluation questions, indicators, and data sources to help state and local public health and education agencies, school and district administrators, and evaluation professionals monitor and evaluate the implementation and impact of COVID-19 mitigation strategies implemented in K-12 schools on the transmission of SARS-CoV-2, the virus that causes COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/php/monitoring-evaluation-k-12.html",,"Guideline/Assessment Tool",,"false","23792"
"23791","Contact Tracing Workflow in a Non-US Setting","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This workflow and additional information, updated on October 21, 2020, are intended to be professionally generated as a job aid for distribution via CDC country offices to local Ministries of Health or National Public Health Institutes with the intent to be given to facilities with frontline healthcare workers doing COVID-19 contact tracing, case investigations, community outreach, or in other ways working with potential contacts.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/contact-tracing-workflow.html",,"Guideline/Assessment Tool",,"false","23791"
"23787","Health Departments: Contact Tracing for COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, provides information for health departments about contact tracing for COVID-19, and a summary of COVID-19-specific practices.","https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/contact-tracing.html",,"Guideline/Assessment Tool",,"false","23787"
"23609","Strategies for Protecting K-12 School Staff from COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","The information on this page, updated on October 21, 2020, provides an expanded focus on the health and safety of K-12 school staff during the COVID-19 pandemic. The strategies also provide workplace safety and health information for administrators related to protecting teachers, substitute teachers, paraprofessionals, janitorial/maintenance staff, office staff, school nutrition staff, school nurses/health professionals, school bus drivers and bus aides, coaching staff and athletic trainers, and music, choir, and performing arts teachers.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-staff.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-staff.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-staff.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-staff.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-staff.html","false","23609"
"23599","Prioritizing Non-Healthcare Worksite Assessments for Coronavirus Disease 2019 (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, is intended to assist state, tribal, local, and territorial health departments in making decisions about how to allocate limited resources to respond to worksites that report COVID-19-related concerns, complaints, or clusters. In general, COVID-19 clusters in shared housing, detention and correctional facilities, schools, daycares, and youth programs should be considered high priority.","https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/prioritizing-non-healthcare-assessments.html",,"Guideline/Assessment Tool","A short questionnaire can be customized and used to remotely collect this information from the employer’s human resource, occupational health, safety, or other professional at the worksite. An example is COVID-19 prioritization questions for non-health care worksite assessments by state, tribal, local, and territorial health departments: https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/open-america/Prioritizing-Nonhealthcare-Worksite-Assessments-Checklist.pdf","false","23599"
"23137","Coronavirus Disease (COVID-19) Screening K-12 Students for Symptoms of COVID-19: Limitations and Considerations","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, provides guidance to K-12 schools on COVID-19 symptom screening as part of a school reopening process. The guidance detailed here is intended only for students in K-12 school settings.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/symptom-screening.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/symptom-screening.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/symptom-screening.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/symptom-screening.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/symptom-screening.html","false","23137"
"22878","Investigating and Responding to COVID-19 Cases in Non-Healthcare Work Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","Workplaces can present unique challenges for COVID-19 investigation and public health action. The tools on this web page, updated on October 21, 2020, can be used for responding to individual cases and outbreaks in non-healthcare work settings.","https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/non-healthcare-work-settings.html",,"Guideline/Assessment Tool",,"false","22878"
"22847","Testing, Screening, and Outbreak Response for Institutions of Higher Education (IHEs)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This guidance, updated on October 21, 2020, is meant to help college and university administrators protect students, faculty, and staff from COVID-19 infections and slow the spread of the virus.  This document includes considerations for expanded and widespread testing; provides a tiered approach to testing in the context of an outbreak; gives examples of successful entry and periodic screening strategies; and discusses the likelihood of off-campus transmission.","https://www.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/ihe-testing.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/ihe-testing.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/ihe-testing.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/ihe-testing.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/ihe-testing.html","false","22847"
"22846","Interim Considerations for Testing for K-12 School Administrators and Public Health Officials","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","These interim considerations, updated on October 21, 2020, are for COVID-19 testing in school settings and are intended for K-12 school administrators working in collaboration with their state, tribal, local, and territorial (STLT) public health officials.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/k-12-testing.html","false","22846"
"22618","Overview of Testing for SARS-CoV-2 (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020,  is intended to provide guidance on the appropriate use of testing for SARS-CoV-2 (COVID-19) and does not address decisions regarding payment for or insurance coverage of such testing.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/testing-overview.html",,"Guideline/Assessment Tool",,"false","22618"
"22492","COVID-19 Contact Tracing Communications Toolkit for Health Departments","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, provides communication resources for health departments' COVID-19 contact tracing, under these topics: Main Message, Talking Points, Sample Public Service Announcements, Sample Social Media Posts, and Questions and Answers.","https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing-comms.html",,"Guideline/Assessment Tool","Link to page in Spanish: https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing-comms-sp.html","false","22492"
"22173","Identify Strategies to Reduce Spread of COVID-19: Sample Training Plan","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, provides training resources in these topic areas: Background on COVID-19; COVID-19 disease-specific information; Prevent spread of COVID-19; and Training catalog.","https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/strategies-to-reduce-spread.html",,"Instructional/Training Material",,"false","22173"
"21915","Case Investigation and Contact Tracing: Part of a Multi-Pronged Approach to Fight the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated on October 21, 2020, highlights basic principles of case investigation and contact tracing to stop COVID-19 transmission; detailed guidance for health departments is available.","https://www.cdc.gov/coronavirus/2019-ncov/php/principles-contact-tracing.html",,"Guideline/Assessment Tool",,"false","21915"
"21811","Interim Operational Considerations for Public Health Management of Healthcare Workers Exposed to or Infected with COVID-19: Non-US Healthcare Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","These operational considerations, updated on October 21, 2020, are intended to be used by healthcare facilities and public health authorities in non-U.S. healthcare settings, particularly focusing on low- and middle-income countries, assisting with the management of healthcare workers exposed to a person with confirmed or suspected COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/public-health-management-hcw-exposed.html",,"Guideline/Assessment Tool","Link to page in French: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/public-health-management-hcw-exposed-fr.htmlLink to page in Portuguese: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/profissionais-saude.htmlLink to page in Spanish: https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/gestion-de-trabajadores-sanitarios-expuestos.html","false","21811"
"21498","Coronavirus Disease 2019 (COVID-19) Public Health Guidance for Community-Related Exposure","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","These public health recommendations for community-related exposure to COVID-19 have been updated on October 21, 2020, to accommodate new scientific evidence, evolving epidemiology, and the need to simplify risk assessment.","https://www.cdc.gov/coronavirus/2019-ncov/php/public-health-recommendations.html",,"Guideline/Assessment Tool",,"false","21498"
"21342","Interim Guidance on Management of Coronavirus Disease 2019 (COVID-19) in Correctional and Detention Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-21T00:00:00.000","Text","This web page, updated October 21, 2020, provides interim guidance specific for correctional facilities and detention centers during the outbreak of COVID-19, to ensure continuation of essential public services and protection of the health and safety of incarcerated and detained persons, staff, and visitors.","https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.html",,"Guideline/Assessment Tool","Link to Resources for Correctional and Detention Facilities: https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/index.htmlLink to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/correction-detention/guidance-correctional-detention.html","false","21342"
"24204","Diagnostics, Therapeutics, Vaccine Readiness, and Other Health Products for COVID-19","World Health Organization","2020-10-20T00:00:00.000","PDF","This 28-page tool has been designed to assess present and surge capacities for the treatment of COVID-19 in health facilities, with a focus on the availability of diagnostics, therapeutics and other health products, vaccine readiness, availability of beds, and space capacities. This tool forms part of a wider suite of health service capacity assessment tools, the harmonized health service capacity assessments in the context of the COVID-19 pandemic.","https://www.who.int/publications/i/item/WHO-2019-nCoV-HCF_assessment-Products-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1313573/retrieve","false","24204"
"24203","Ensuring a Safe Environment for Patients and Staff in COVID-19 Health-Care Facilities","World Health Organization","2020-10-20T00:00:00.000","PDF","This 49-page tool has been designed to assess the structural capacities of hospitals to allow safe COVID-19 case management, maintain the delivery of essential services, and enable surge capacity planning. This tool forms part of a wider suite of health service capacity assessment tools, the harmonized health service capacity assessments in the context of the COVID-19 pandemic.","https://www.who.int/publications/i/item/WHO-2019-nCoV-HCF_assessment-Safe_environment-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1313577/retrieve","false","24203"
"24202","Infection Prevention and Control Health-Care Facility Response for COVID-19","World Health Organization","2020-10-20T00:00:00.000","PDF","This 32-page tool has been designed to assess infection prevention and control capacities to respond to COVID-19 in health facilities. This tool forms part of a wider suite of health service capacity assessment tools, the harmonized health service capacity assessments in the context of the COVID-19 pandemic.","https://www.who.int/publications/i/item/WHO-2019-nCoV-HCF_assessment-IPC-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1313569/retrieve","false","24202"
"24201","Continuity of Essential Health Services: Facility Assessment Tool","World Health Organization","2020-10-20T00:00:00.000","PDF","This 37-page tool has been designed to help identify health systems bottlenecks in order to monitor and track the continuity of essential health services. It forms part of a wider suite of health service capacity assessment tools, the health service capacity assessments in the context of the COVID-19 pandemic.","https://www.who.int/publications/i/item/WHO-2019-nCoV-HCF_assessment-EHS-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1313565/retrieve","false","24201"
"24199","Legal Challenges to State COVID-19 Orders","Association of State and Territorial Health Officials","2020-10-20T00:00:00.000","PDF","This seven-page report examines the legal challenges being made against COVID-19 orders and looks at some of the early litigation results and emerging issues.","https://www.astho.org/generickey/GenericKeyDetails.aspx?contentid=22924&folderid=5156&catid=7203",,"Report","Direct link to document: https://www.astho.org/ASTHOReports/Legal-Challenges-to-State-COVID-19-Orders/10-20-20/","false","24199"
"24188","Innovating in the Workplace: Supporting Mental Health of Young People of Color During COVID-19 and Beyond","Harvard University, Harvard T.H. Chan School of Public Health","2020-10-20T00:00:00.000","Video or Multimedia","This one-hour, six-minute event explores mental health factors employers should consider, along with solutions and strategies for promoting mental health in today’s landscape, and creating a supportive workplace for young people of color.","https://theforum.sph.harvard.edu/events/innovating-in-the-workplace/","Martin, Phillip; Akutagawa, Linda; Hooper-Campbell, Damien; Steinberg, Joan; Vinson, Sarah","Instructional/Training Material",,"false","24188"
"24173","UK Pandemic Preparedness","United Kingdom Department of Health","2020-10-20T00:00:00.000","Text","This document sets out how the United Kingdom (UK) prepares for and responds to an infectious disease pandemic, particularly a potential outbreak of pandemic influenza; and how exercises carried out as part of pandemic preparedness have informed the UK’s COVID-19 response.","https://www.gov.uk/government/publications/uk-pandemic-preparedness",,"Report",,"false","24173"
"24146","Letter of Authorization: binx health At-Home Nasal Swab COVID-19 Sample Collection Kit","U.S. Food and Drug Administration","2020-10-20T00:00:00.000","PDF","This seven-page letter authorizes the emergency use of the binx health At-Home Nasal Swab COVID-19 Sample Collection Kit. The kit is for use by individuals for self-collection of nasal swab specimens at home, when determined by a healthcare provider to be appropriate based on the results of an online COVID-19 questionnaire and for use only with an in vitro diagnostic (IVD) molecular test for the detection of SARS-CoV-2 RNA that is indicated for use with the binx health At-Home Nasal Swab COVID-19 Sample Collection Kit.","https://www.fda.gov/media/143183/download",,"Guideline/Assessment Tool","Link to EUA summary: https://www.fda.gov/media/143185/downloadLink to Instructions for Use: https://www.fda.gov/media/143186/download","false","24146"
"24139","Interim Guidance for Case Investigation and Contact Tracing in K-12 Schools","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-20T00:00:00.000","Text","This web page aims to highlight potential collaboration between health officials and K-12 school administrators to facilitate effective COVID-19 case investigation and contact tracing. Topics are Overview; Background; Federal, state, and local legal considerations; Roles and responsibilities; Ways schools can prepare; When a COVID-19 case is suspected or confirmed; and Assisting the health department with contact tracing.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/contact-tracing.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/contact-tracing.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/contact-tracing.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/contact-tracing.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/contact-tracing.html","false","24139"
"24133","SARS-CoV-2 Testing Strategy: Considerations for Non-Healthcare Workplaces","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-20T00:00:00.000","Text","The purpose of this web page is to provide employers with strategies for consideration of incorporating testing for SARS-CoV-2, the virus that causes COVID-19, into a workplace COVID-19 preparedness, response, and control plan.","https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/organizations/testing-non-healthcare-workplaces.html","false","24133"
"24128","Distributing a COVID-19 Vaccine Across the U.S.: A Look at Key Issues","Henry J. Kaiser Family Foundation","2020-10-20T00:00:00.000","Text","This issue brief details the key issues and challenges of distributing a COVID-19 vaccine in the U.S., including Funding for Vaccine Distribution; Supply, Logistics, and Monitoring; Federal, State, and Local Authority Over Vaccination Requirements; Insurance Coverage and Out-of-Pocket Costs; Addressing Racial and Ethnic Disparities; and Communication and Trust.","https://www.kff.org/report-section/distributing-a-covid-19-vaccine-across-the-u-s-a-look-at-key-issues-issue-brief/","Michaud, Josh; Kates, Jennifer","Report",,"false","24128"
"24119","Fact Sheet for Healthcare Personnel: Zoe-Ann Decontamination System for Decontaminating Compatible N95 Respirators","U.S. Food and Drug Administration","2020-10-20T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of decontaminated, compatible N95 respirators. These compatible N95 respirators have been decontaminated using the Zoe-Ann Decontamination System.","https://www.fda.gov/media/143150/download",,"Guideline/Assessment Tool","Link to Letter of Authorization: https://www.fda.gov/media/143149/downloadLink to Instructions for Healthcare Personnel: https://www.fda.gov/media/143151/downloadLink to Instructions for Healthcare Facilities: https://www.fda.gov/media/143152/download","false","24119"
"23344","Cleaning, Disinfection, and Hand Hygiene in Schools: A Toolkit for School Administrators","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-20T00:00:00.000","Text","This guidance, updated on October 20, 2020, is intended to aid school administrators as they consider how to protect the health, safety, and well-being of students, teachers, other school staff, families, and communities, and prepare for educating students this fall. It details the Importance of cleaning, disinfection, and hand hygiene.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/clean-disinfect-hygiene.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/clean-disinfect-hygiene.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/clean-disinfect-hygiene.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/clean-disinfect-hygiene.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/clean-disinfect-hygiene.html","false","23344"
"22633","Testing Strategy for Coronavirus (COVID-19) in High-Density Critical Infrastructure Workplaces after a COVID-19 Case Is Identified","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-20T00:00:00.000","Text","This web page, updated on October 20, 2020, presents different COVID-19 testing strategy options for exposed co-workers when public health organizations and employers determine COVID-19 testing is needed to help support existing disease control measures. Such strategies can aid in identifying infectious individuals with the goal of reducing transmission of SARS-CoV-2 in the workplace.","https://www.cdc.gov/coronavirus/2019-ncov/community/worker-safety-support/hd-testing.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/worker-safety-support/hd-testing.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/worker-safety-support/hd-testing.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/worker-safety-support/hd-testing.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/worker-safety-support/hd-testing.html","false","22633"
"21785","Occupational Safety and Health Administration (OSHA): Emergency Temporary Standards (ETS) and COVID-19","Congressional Research Service [Library of Congress]","2020-10-20T00:00:00.000","PDF","The Occupational Safety and Health Administration (OSHA) does not currently have a specific standard that protects healthcare or other workers from airborne or aerosol transmission of disease or diseases transmitted by airborne droplets. This 31-page report, updated on October 20, 2020, describes how some in Congress, and some groups representing healthcare and other workers, are calling on OSHA to promulgate an emergency temporary standard (ETS) to protect workers from exposure to SARS-Cov-2, the virus that causes coronavirus disease 2019 (COVID-19).","https://crsreports.congress.gov/product/pdf/R/R46288","Szymendera, Scott","Report",,"false","21785"
"24123","Trends in Overall and Non-COVID-19 Hospital Admissions","Henry J. Kaiser Family Foundation","2020-10-19T00:00:00.000","Text","This report analyzed trends in total hospital admissions, and then separately analyzed non-COVID-19 admissions by patient sex, age, and region. It calculated actual admissions as a share of total predicted admissions in 2020 based on trends from past years.","https://www.kff.org/health-costs/issue-brief/trends-in-overall-and-non-covid-19-hospital-admissions/","Heist, Tyler; Schwartz, Karyn; Butler, Sam","Report",,"false","24123"
"24122","Updated Advice on Hospital Antibiotic Management and Antimicrobial Stewardship in the Context of the COVID-19 Pandemic","Health Improvement Scotland","2020-10-19T00:00:00.000","PDF","This two-page document provides recommendations that have been agreed upon by infections specialists from across Scotland to support National Health Service boards with local clinical practice and to maintain antimicrobial stewardship during the COVID-19 pandemic.","https://www.sapg.scot/media/5449/advice-on-hospital-ams-covid-19-october-2020.pdf",,"Guideline/Assessment Tool",,"false","24122"
"24121","Advice on Management of People with Respiratory Infections Presenting in the Community During the COVID-19 Pandemic","Health Improvement Scotland","2020-10-19T00:00:00.000","PDF","As the COVID-19 pandemic continues, it is critical that local antibiotic treatment guidelines are followed and that unnecessary antibiotic use is minimized. This one-page document provides guidelines for antibiotic treatment.","https://www.sapg.scot/media/5448/advice-on-community-respiratory-infections-covid-19-october-2020.pdf",,"Guideline/Assessment Tool",,"false","24121"
"24118","Confronting Urgent Threats to Human Health and Society: COVID-19 and Climate Change (NAM Annual Meeting)","National Academy of Medicine","2020-10-19T00:00:00.000","Video or Multimedia","This web page provides recordings and presentation slides from the 2020 National Academy of Medicine Annual Meeting, which focused on the state of the COVID-19 pandemic: virus emergence, the impact of the pandemic, and U.S. and global preparedness and response; climate change and human health: navigating environmental, societal, and individual impacts; and responding to global crises: future directions in science and policymaking to address complex threats to society.","https://nam.edu/event/confronting-urgent-threats-to-human-health-society-covid-19-and-climate-change/","Gates, Bill; Fauci, Anthony S.; Gupta, Sanjay; Ihekweazu, Chikwe; Lurie, Nicole","Conference/Meeting Material",,"false","24118"
"23076","Duration of Isolation and Precautions for Adults with COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-19T00:00:00.000","Text","Accumulating evidence supports ending isolation and precautions for persons with COVID-19 using a symptom-based strategy. This guidance, updated on October 19, 2020, incorporates recent evidence to inform the duration of isolation and precautions recommended to prevent transmission of SARS-CoV-2 to others, while limiting unnecessary prolonged isolation and unnecessary use of laboratory testing resources.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/duration-isolation.html",,"Guideline/Assessment Tool",,"false","23076"
"8372","Incorporation of GIS (Geographic Information Systems) Technologies in Emergency Preparedness and Response","National Center for Disaster Preparedness [Columbia University, Earth Institute]","2009-06-26T00:00:00.000","PDF","This 32-page document discusses how geographic information systems (GIS) can enable public health agency staff to visualize spatial information in new ways, so that they can become better planners and problem solvers, particularly in the areas of disaster preparedness and response. It covers online GIS data resources, constraints to using GIS in public health, best practices, competencies needed for using GIS, and public health research incorporating GIS technologies.","https://academiccommons.columbia.edu/doi/10.7916/D8FF41QW","Chandler, Thomas","Report","Direct link to document: https://academiccommons.columbia.edu/doi/10.7916/D8W384MW/download","false","8372"
"22868","Interim Considerations for Health Departments for SARS-CoV-2 Testing in Homeless Shelters and Encampments","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-19T00:00:00.000","Text","The information on this web page, updated on October 19, 2020, is meant to assist health departments and homeless service providers in making decisions on the appropriate use of COVID-19 testing, including testing asymptomatic individuals with recent known or suspected exposure to SARS-CoV-2 to control transmission.","https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/testing.html","false","22868"
"22569","COVID-19 Infection Prevention and Control for Primary Care, Including General Practitioner Practices, Dental Clinics and Pharmacy Settings: First Update","European Union, European Centre for Disease Prevention and Control","2020-10-19T00:00:00.000","PDF","This 12-page document, updated on October 19, 2020, provides guidance on infection prevention and control to healthcare providers, general practitioner offices, primary care clinics, dental offices/clinics, and pharmacies in the European Union/European Economic Area in order to prevent COVID-19 infection.","https://www.ecdc.europa.eu/en/publications-data/covid-19-infection-prevention-and-control-primary-care",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-infection-prevention-primary-care-dental-clinics-pharmacy-october-2020.pdfLink to related infographic: https://www.ecdc.europa.eu/en/publications-data/infographic-infection-prevention-and-control-primary-care","false","22569"
"24134","Frequently Asked Questions: Right of Reference to the CDC Influenza SARS-CoV-2 (Flu SC2) Performance Data for Manufacturers and Test Developers","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-18T00:00:00.000","Text","This web page for laboratories provides answers to frequently asked questions about the CDC Influenza SARS-CoV-2 (Flu SC2) performance data for manufacturers and test developers.","https://www.cdc.gov/coronavirus/2019-ncov/lab/multiplex-faq.html",,"Fact Sheet",,"false","24134"
"24103","Resources for Laboratories Working on Coronavirus (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-18T00:00:00.000","Text","This web page provides resources for laboratories working on (COVID-19), including about diagnostic tests, using antibody tests, and pooling procedures.","https://www.cdc.gov/coronavirus/2019-ncov/lab/resources.html",,"Guideline/Assessment Tool",,"false","24103"
"24166","Testing Guidance for Clinicians When SARS-CoV-2 and Influenza Viruses are Co-circulating","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-16T00:00:00.000","Text","This web page provides an algorithm for clinicians regarding outpatient clinic or emergency department patients with acute respiratory illness symptoms (with or without fever) when SARS-CoV-2 and flu viruses are co-circulating.","https://www.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-clinicians.htm",,"Guideline/Assessment Tool","Link to page in Spanish: https://espanol.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-clinicians.htmLink to Testing Guidance for Outpatient Clinic or Emergency Department Patients with Acute Respiratory Illness Symptoms (With or Without Fever) Not Requiring Hospital Admission:  https://www.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-outpatient.htmLink to page in Spanish: https://espanol.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-outpatient.htmLink to Testing Guidance Patients with Acute Respiratory Illness Symptoms Requiring Hospital Admission (With or Without Fever): https://www.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-clinicians-hospitaized.htmLink to page in Spanish: https://espanol.cdc.gov/flu/professionals/diagnosis/testing-guidance-for-clinicians-hospitaized.htm","false","24166"
"24160","Disasters and Religion App","National Disaster Interfaiths Network","2020-10-16T00:00:00.000","Video or Multimedia","This app helps disaster responders better serve America’s diverse religious communities and build partnerships with religious leaders, with easily accessible religious literacy and competency information on 27 unique religions. It was created by the National Disaster Interfaiths Network (NDIN), New York Disaster Interfaith Services (NYDIS), and the University of Southern California Center for Religion and Civic Culture (CRCC).","https://www.disastersandreligionsapp.org/",,"Guideline/Assessment Tool","Link to app from the App Store: https://apps.apple.com/us/app/disasters-and-religions/id1513405416Link to app from Google Play: https://play.google.com/store/apps/details?id=com.crcc&hl=en_US&gl=US","false","24160"
"24108","NETEC COVID-19 Webinar Series: Pediatric Perspectives During a Pandemic","National Emerging Special Pathogens Training and Education Center","2020-10-16T00:00:00.000","Video or Multimedia","This 54-minute webinar describes the epidemiology of acute COVID-19, including post-infectious manifestations and the unique aspects of caring for children during a pandemic. It also discusses the features of multi-system inflammatory syndrome in children (MIS-C) and how to devise a diagnostic and acute management plan and integrate potential post-recovery complications into the development of follow-up plans for a child with MIS-C.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1329","Grindle, Amanda; Shayne, Andi; Jaggio, Preeti; Oster, Matthew","Instructional/Training Material","Link to video on YouTube: https://youtu.be/mseYyxUrMk4Link to presentation slides: https://repository.netecweb.org/files/original/840a5b3eb0d83e90f0f487520d270e08.pdf","false","24108"
"3189","Emergency Alert System (EAS) and All-Hazard Warnings","Congressional Research Service [Library of Congress]","2009-06-26T00:00:00.000","PDF","This 14-page document describes the organization and administration of the Emergency Alert System, NOAA Weather Radio, All-Hazard Warning Technology, and the Commercial Mobile Alert System. It also summarizes two 2009 Congressional initiatives concerning emergency preparedness.","https://www.hsdl.org/?view&did=35463","Moore, Linda K.","Report",,"false","3189"
"12235","Hurricane Suiter Emergency Support Function 6, Mass Care and Emergency Assistance After Action Report","Florida Division of Emergency Management","2009-06-24T00:00:00.000","PDF","This 18-page document is the after action report for a hurricane exercise from May 28-June 3, 2009. Hurricane Suiter was one of the most intense and demanding hurricane exercises ever conducted in the state. The mass care portion of the exercise was one of the largest and most complex ever conducted in the nation.","http://nationalmasscarestrategy.org/wp-content/uploads/2016/02/Florida-Hurricane-Exercise-2009-ESF-6-AAR-final-version.pdf",,"Report",,"false","12235"
"24094","COVID-19 Case Investigation and Contact Tracing in Non-Healthcare Workplaces: How Employers Can Assist Health Departments","World Health Organization","2020-10-16T00:00:00.000","Text","Health departments are responsible for leading case investigations, contact tracing, and outbreak investigations. When a COVID-19 case is identified that impacts a workplace, the health department may ask the employer for help. This web page provides tips to ensure employers and their employees are prepared to assist if contacted by the health department.","https://www.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces/FS-Employers.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces/FS-Employers.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces/FS-Employers.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces/FS-Employers.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/contact-tracing-nonhealthcare-workplaces/FS-Employers.html","false","24094"
"24069","Operational Considerations for Influenza Surveillance in the WHO European Region During COVID-19: Interim Guidance","European Union, European Centre for Disease Prevention and Control","2020-10-16T00:00:00.000","PDF","This 11-page document outlines operational considerations for how to support the continuity of national influenza surveillance systems and public health laboratories for the epidemiological and virological surveillance for influenza in the 2020–2021 season during the ongoing COVID-19 pandemic. It also describes how these systems might be used to contribute to COVID-19 surveillance.","https://www.ecdc.europa.eu/en/publications-data/operational-considerations-influenza-surveillance-european-region-during-covid-19",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/Joint-influenza-interim-guidance.pdf","false","24069"
"24068","Guidance for Discharge and Ending of Isolation of People with COVID-19","European Union, European Centre for Disease Prevention and Control","2020-10-16T00:00:00.000","PDF","This seven-page document provides guidance for planning the discharge and ending of isolation of COVID-19 patients. It is provided in the context of all European Union/European Economic Area (EU/EEA) countries and the United Kingdom continuing to experience varying degrees of community transmission of SARS-CoV-2.","https://www.ecdc.europa.eu/en/publications-data/guidance-discharge-and-ending-isolation-people-covid-19",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/Guidance-for-discharge-and-ending-of-isolation-of-people-with-COVID-19.pdf","false","24068"
"23368","Interim Guidance for Implementing Home Care of People Not Requiring Hospitalization for Coronavirus Disease 2019 (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-16T00:00:00.000","Text","This interim guidance, updated on October 16, 2020, is for staff at local and state health departments, infection prevention and control professionals, and healthcare personnel who are coordinating the home care and isolation of people with confirmed or suspected COVID-19 infection, including persons under investigation.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care.html",,"Guideline/Assessment Tool","Link to page in Spanish: https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-home-care-es.html","false","23368"
"22881","Information for Laboratories about Coronavirus (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-16T00:00:00.000","Text","This web page, updated on October 16, 2020, provides COVID-19 resources for laboratories, including about diagnostics tests, CDC lab work, publications, and alerts and advisories.","https://www.cdc.gov/coronavirus/2019-nCoV/lab/index.html",,"Guideline/Assessment Tool",,"false","22881"
"22674","Testing Guidelines for Nursing Homes: Interim SARS-CoV-2 Testing Guidelines for Nursing Home Residents and Healthcare Personnel","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-16T00:00:00.000","Text","This web page, updated on October 16, 2020, is intended to provide guidance on the appropriate use of COVID-19 testing among nursing home residents and does not dictate the determination of payment decisions or insurance coverage of such testing, except as may be otherwise referenced (or prescribed) by another entity or federal or state agency.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-homes-testing.html",,"Guideline/Assessment Tool",,"false","22674"
"21162","Coronavirus Disease 2019 (COVID-19): Schools and Childcare Programs: Plan, Prepare, and Respond","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-16T00:00:00.000","Text","This web page, updated on October 16, 2020, provides guidance for school and program administrators, parents, and caregivers, with sections on Reopening: Decision-Making Indicators, Printable Posters and Graphics, and additional resources.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/index.htmlLink to Considerations for School Closure: https://www.cdc.gov/coronavirus/2019-ncov/downloads/considerations-for-school-closure.pdf Link to Interim Guidance for Administrators of U.S. K-12 Schools and Childcare Programs, including a decision tree: https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/guidance-for-schools.htmlLink to Supplemental Guidance For Child Care Programs That Remain Open: https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/guidance-for-childcare.htmlLink to COVID-19 Stakeholder Call: Camps and Youth Programs: https://www.youtube.com/watch?v=8l5Kw7IfIoM&feature=youtu.beLink to COVID-19 Stakeholder Call: Schools and Childcare Programs: https://www.youtube.com/watch?v=o9YXxl-79Zs&feature=youtu.be","false","21162"
"21104","Colleges, Universities, and Higher Learning: Plan, Prepare, and Respond","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-16T00:00:00.000","Text","This web page, updated on October 16, 2020, provides COVID-19 guidance resources for administrators, faculty, and staff of institutes of higher education, including when to quarantine.","https://www.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/index.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/index.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/index.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/index.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/colleges-universities/index.html","false","21104"
"24127","Supply Shortages Impacting COVID-19 and Non-COVID Testing","American Society for Microbiology","2020-10-15T00:00:00.000","Text","ASM has partnered with the Association of Supply Chain Management to develop a survey to collect testing supplies status for COVID-19 tests, as well as other microbiological tests, to highlight, and ultimately alleviate, these supply chain issues. This web page will provide the survey findings each week on the most recent shortages of medium, reagents, collection devices, and consumables that are significantly impacting day-to-day testing for both COVID-19 and other infectious diseases, along with week-over-week longitudinal changes.","https://asm.org/Articles/2020/September/Clinical-Microbiology-Supply-Shortage-Collecti-1",,"Report",,"false","24127"
"24109","SARS-CoV-2 mRNA Vaccine Development Enabled by Prototype Pathogen Preparedness","National Institutes of Health","2020-10-15T00:00:00.000","Video or Multimedia","With a new infectious disease threat at hand, scientists at the NIH swiftly developed a vaccine candidate against the novel coronavirus that causes COVID-19. The pre-clinical effort for a fast, reliable, and universal vaccine was driven in part by the speaker in this one-hour presentation.","https://videocast.nih.gov/watch=38864","Corbett, Kizzmekia","Instructional/Training Material",,"false","24109"
"24091","Letter of Authorization: EmpowerDX At-Home COVID-19 PCR Test Kit","U.S. Food and Drug Administration","2020-10-15T00:00:00.000","PDF","This seven-page letter authorizes the emergency use of the EmpowerDX At-Home COVID-19 PCR Test Kit for use by individuals to self-collect nasal swabs at home, when determined by a healthcare provider to be appropriate based on the results of an online COVID-19 questionnaire, and for use only with in vitro diagnostic (IVD) molecular tests for the detection of SARS-CoV-2 RNA that are indicated for use with the EmpowerDX At-Home COVID-19 PCR Test Kit.","https://www.fda.gov/media/143063/download",,"Guideline/Assessment Tool","Link to EUA Summary: https://www.fda.gov/media/143064/downloadLink to Instructions for Use: https://www.fda.gov/media/143065/download","false","24091"
"24079","COVID-19 and the U.S. Criminal Justice System","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-10-15T00:00:00.000","PDF","This 33-page report summarizes the current state and future projections of the COVID-19 pandemic in the United States, details the impact that the pandemic has already had on the U.S. criminal justice system, and provides evidence-based recommendations on how to reduce COVID-19 risks to people in the system.","https://www.centerforhealthsecurity.org/our-work/publications/covid-19-and-the-us-criminal-justice-system","Watson, Crystal; Warmbrod, Kelsey; Vahey, Rachel; Cicero, Anita; Inglesby, Thomas V.","Report","Direct link to document: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/20201015-covid-19-criminal-justice-system.pdfLink to webinar for report launch: https://youtu.be/YaQQ8pNznUg","false","24079"
"24077","Impact of the COVID-19 Pandemic on Outpatient Care: Visits Return to Prepandemic Levels, but Not for All Providers and Patients","Commonwealth Fund","2020-10-15T00:00:00.000","Text","This report details how visits for outpatient care, which had fallen nearly 60 percent in April, have returned in the past month to the levels prior to the COVID-19 pandemic. While outpatient visits overall have rebounded, there is a lot of variation among providers.","https://www.commonwealthfund.org/publications/2020/oct/impact-covid-19-pandemic-outpatient-care-visits-return-prepandemic-levels","Mehrotra, Ateev; Chernew, Michael; Linetsky, David; Hatch, Hilary; Cutler, David","Report",,"false","24077"
"3182","Communicate Better to Protect Your Community in a Crisis!","University at Albany Center for Public Health Preparedness [State University of New York]","2009-06-24T00:00:00.000","Video or Multimedia","This hour-long presentation explains how to effectively communicate with the public before, during, and after an emergency.","https://ualbanycphp.org/GRS/eventpast.cfm?id=112",,"Instructional/Training Material",,"false","3182"
"24074","Living with COVID-19: A Dynamic Review of the Evidence Around Ongoing COVID-19 Symptoms (Often Called Long COVID)","National Institute for Health Research","2020-10-15T00:00:00.000","Text","This rapid and dynamic review draws on the lived experience of COVID-19 patients and expert consensus, as well as published evidence, to better understand the impact of ongoing effects of COVID-19, how health and social care services should respond, and what future research questions might be.","https://evidence.nihr.ac.uk/themedreview/living-with-covid19/",,"Report",,"false","24074"
"24067","COVID-19 Response Assistance Field Team Observations","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-10-15T00:00:00.000","Text","ASPR’s COVID-19 Response Assistance Field Team (CRAFT) has spent the last several months traveling the country engaging with local communities and supporting their COVID-19 response efforts in a variety of areas (e.g., K-12 schools and institutes of higher education, critical infrastructure businesses, and outreach to at-risk populations). This TRACIE (Technical Resources, Assistance Center, and Information Exchange) landing page provides links to CRAFT Resource Collections.","https://asprtracie.hhs.gov/craft",,"Bibliography/Resource List",,"false","24067"
"24055","External Quality Assessment (EQA) of Performance of Laboratories Participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net), 2019","European Union, European Centre for Disease Prevention and Control","2020-10-15T00:00:00.000","PDF","This 26-page report provides an analysis of the external quality assessment (EQA) for the antimicrobial susceptibility testing (AST) performance of laboratories participating in the European Antimicrobial Resistance Surveillance Network (EARS-Net) in 2019.","https://www.ecdc.europa.eu/en/publications-data/antibiotic-resistance-external-quality-assessment-laboratories-earsnet",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/antibiotic-resistance-external-quality-assessment-lab-peformance-EARS-Net-2019.pdf","false","24055"
"24093","Fact Sheet for Healthcare Providers: LumiraDx SARS-CoV-2 RNA STAR Complete","U.S. Food and Drug Administration","2020-10-14T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the LumiraDx SARS-CoV-2 RNA STAR Complete. The LumiraDx SARS-CoV-2 RNA STAR Complete is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/143060/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/143061/downloadLink to Letter of Authorization: https://www.fda.gov/media/143059/downloadLink to Instructions for Use: https://www.fda.gov/media/143062/download","false","24093"
"24092","Letter of Authorization: OMNIgene·ORAL OM-505 and OME-505 (OMNIgene·ORAL) Saliva Collection Devices","U.S. Food and Drug Administration","2020-10-14T00:00:00.000","PDF","This six-page letter authorizes the emergency use of the OMNIgene·ORAL OM-505 and OME-505 (OMNIgene·ORAL) saliva collection devices, which are intended for use by individuals to collect, stabilize, and maintain during transport, saliva specimens suspected of containing SARS-CoV-2 ribonucleic acid (RNA).","https://www.fda.gov/media/143056/download",,"Guideline/Assessment Tool","Link to EUA Summary: https://www.fda.gov/media/143057/downloadLink to Instructions for Use: https://www.fda.gov/media/143058/downloadThis link is no longer available. 10/26/2020.","false","24092"
"24064","Global Tuberculosis Report 2020","World Health Organization","2020-10-14T00:00:00.000","PDF","This 232-page annual report provides a comprehensive and up-to-date assessment of the tuberculosis (TB) epidemic, and of progress in prevention, diagnosis, and treatment of the disease, at global, regional and country levels. In recognition of the enormous health, social, and economic impacts of the COVID-19 pandemic, the report includes a provisional assessment of how the pandemic will affect the TB epidemic, people with TB, and progress toward global TB targets.","https://www.who.int/publications/i/item/global-tuberculosis-report-2020","Baddeley, Annabel; Bartens, Marie-Christine; Dean, Anna; Dias, Hannah; Falzon, Dennis","Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/336069/9789240013131-eng.pdfLink to executive summary: https://www.who.int/tb/publications/global_report/TB20_Exec_Sum_20201014.pdfLink to technical appendix: https://www.who.int/tb/publications/global_report/TB20_Technical_Appendix_20201014.pdf","false","24064"
"24054","Disaster Recovery: COVID-19 Pandemic Intensifies Disaster Recovery Challenges for K-12 Schools","U.S. Government Accountability Office","2020-10-14T00:00:00.000","PDF","This 14-page report summarizes a study that examined how the COVID-19 pandemic has affected schools recovering from recent natural disasters; the support the U.S. Department of Education has provided to help schools recover from recent natural disasters and how the COVID-19 pandemic has affected schools’ use of these resources; and how recovery efforts from recent natural disasters were affected by the COVID-19 pandemic.","https://www.gao.gov/products/GAO-21-62R","Nowicki, Jacqueline","Report","Direct link to document: https://www.gao.gov/assets/720/710136.pdf","false","24054"
"24051","10 Things Healthcare Professionals Need to Know About U.S. COVID-19 Vaccination Plans","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-14T00:00:00.000","Text","With the possibility of one or more COVID-19 vaccines becoming available before the end of the year, this web page lists 10 things healthcare professionals need to know about where those plans currently stand.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/vaccination.html",,"Fact Sheet",,"false","24051"
"24050","Guidance for SARS-CoV-2 Point-of-Care Testing","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-14T00:00:00.000","Text","This web page provides guidance on the regulatory requirements for SARS-CoV-2 point-of-care (POC) testing, using POC tests safely, and information on reporting POC test results. POC tests, such as some rapid tests for diagnosing an infectious disease, provide results within minutes of the test being administered, allowing for rapid decisions about patient care. POC tests can also extend testing to communities and populations that cannot readily access care.","https://www.cdc.gov/coronavirus/2019-ncov/lab/point-of-care-testing.html",,"Guideline/Assessment Tool",,"false","24050"
"23737","Sharing and Shifting Tasks to Maintain Essential Healthcare During COVID-19 in Low Resource, Non-US Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-14T00:00:00.000","Text","These considerations, updated on October 14, 2020, are intended for countries where access to basic essential health services is constrained due to the COVID-19 pandemic, that have an underlying health workforce shortage, and that are considering implementation of a task shifting or sharing approach to strengthen and expand the health workforce for the delivery of COVID-19 care and other essential health services.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/task-sharing.html",,"Guideline/Assessment Tool",,"false","23737"
"24071","Online Presentation and Q&A on the Words into Action Guidelines on Disaster Displacement","United Nations Office for Disaster Risk Reduction","2020-10-13T00:00:00.000","Video or Multimedia","In this one-hour, seven-minute presentation, experts answer questions on the key issues related to disaster displacement and the tools available to address displacement risk in disaster risk reduction strategies, focusing particularly on the Words into Action Guidelines on Disaster Displacement.","https://www.youtube.com/watch?v=Xepj-dtGjLU&feature=youtu.be","Desai, Bina; Cappellan, Pauline; Kumar, Animesh; Solberg, Atle; Llosa, Silvia","Instructional/Training Material",,"false","24071"
"24048","Survey on Race and Health","Henry J. Kaiser Family Foundation","2020-10-13T00:00:00.000","Text","This survey, a joint project between the Kaiser Family Foundation and ESPN’s The Undefeated, explores the public’s views and experiences on the topics of health care, racial discrimination, and the coronavirus pandemic, with a special focus on Black adults, a group that has borne a disproportionate burden of COVID-19 cases and deaths.","https://www.kff.org/racial-equity-and-health-policy/report/kff-the-undefeated-survey-on-race-and-health/","Hamel, Liz; Lopes, Lunna; Munana, Cailey; Artiga, Samantha; Brodie, Mollyann","Report","Link to full report on the survey: http://files.kff.org/attachment/TOPLINE-KFF-The-Undefeated-Survey-on-Race-and-Health.pdf","false","24048"
"24044","Good Participatory Practices for COVID-19 Research and Response","World Health Organization","2020-10-13T00:00:00.000","Video or Multimedia","This one-hour, 26-minute webinar highlights approaches to good participatory practices, tips, and tools for COVID-19 research and response, providing practical examples of how these methods work to engage and empower communities through their involvement.","https://www.youtube.com/watch?v=f9SGiIxNUq8&feature=youtu.be","Mumba, Noni; Davies, Alun; Tam, Way Jia","Instructional/Training Material",,"false","24044"
"24043","Coronavirus Disease (COVID-19) Additional Tools and Resources","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-13T00:00:00.000","Text","This web page provides COVID-19 tools and resources intended for use by healthcare workers in non-U.S. healthcare settings.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/tools-resources.html",,"Guideline/Assessment Tool",,"false","24043"
"24042","Enforcement Policy for Modifications to FDA-Cleared Molecular Influenza and RSV Tests During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency","U.S. Food and Drug Administration","2020-10-13T00:00:00.000","PDF","This nine-page guidance was issued to provide a policy to help expand access to certain FDA-cleared molecular assays intended for detection and identification of influenza (flu) viruses, including those molecular influenza assays that also detect and identify respiratory syncytial viruses (RSV), during the influenza season and for the duration of the COVID-19 public health emergency.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/enforcement-policy-modifications-fda-cleared-molecular-influenza-and-rsv-tests-during-coronavirus",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/142933/download","false","24042"
"24040","Human Cost of Disasters: An Overview of the Last 20 Years (2000-2019)","United Nations Office for Disaster Risk Reduction","2020-10-13T00:00:00.000","PDF","This 17-page report confirms how extreme weather events have come to dominate the disaster landscape in the 21st century. It focuses primarily on the staggering rise in climate-related disasters over the last 20 years, and is also a commentary on the need to strengthen disaster risk governance for the entire range of natural hazards and man-made hazards, including related environmental, technological, and biological hazards and risks.","https://www.undrr.org/publication/human-cost-disasters-overview-last-20-years-2000-2019",,"Report","Direct link to document: https://www.undrr.org/media/48008/download","false","24040"
"22093","Emergency Global Supply Chain System (COVID 19) Catalogue","World Health Organization","2020-10-13T00:00:00.000","PDF","This four-page catalog, updated on October 13, 2020, lists all medical devices, including personal protective equipment, medical equipment, medical consumables, single use devices, and laboratory and test-related devices, that may be requested through the COVID-19 Supply Portal.","https://www.who.int/publications/i/item/emergency-global-supply-chain-system-(covid-19)-catalogue",,"Guideline/Assessment Tool","Direct link to document: https://www.who.int/docs/default-source/coronaviruse/20200822-catalogue-v13.pdf?sfvrsn=7ab2ed1b_3&download=true","false","22093"
"3476","2009 Influenza Pandemic","Congressional Research Service [Library of Congress]","2009-06-23T00:00:00.000","PDF","This 19-page document discusses the extent of the H1N1 pandemic influenza and U.S. international preparations as of June 2009, as well as considerations for the future.","https://www.hsdl.org/?view&did=35229","Salaam-Blyther, Tiaji","Report",,"false","3476"
"21916","Elastomeric Respirators: Strategies During Conventional and Surge Demand Situations","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-13T00:00:00.000","Text","This web page, updated on October 13, 2020, offers guidance for the use of reusable elastomeric particulate respirators to provide respiratory protection to healthcare practitioners (HCP) against pathogens as a component of a formally developed and implemented written respiratory protection program. It is based on what is currently known about the transmission and severity of coronavirus disease 2019 (COVID-19).","https://www.cdc.gov/coronavirus/2019-ncov/hcp/elastomeric-respirators-strategy/index.html",,"Guideline/Assessment Tool",,"false","21916"
"24060","Convalescent Plasma or Hyperimmune Immunoglobulin for People with COVID‐19: A Living Systematic Review","Cochrane Library","2020-10-12T00:00:00.000","PDF","The goal of this 425-page study was to continually assess, as more evidence becomes available, whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe in treatment of people with COVID‐19.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub3/full","Chai, Khai Li; Valk, Sarah; Piechotta, Vanessa; Kimber, Catherine; Mousef, Ina","Report","Direct link to document: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub3/epdf/fullLink to resource in Arabic: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub3/full/fa#CD013600-abs-0003Link to resource in French: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub3/full/fr#CD013600-abs-0007Link to resource in Portuguese: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub3/full/pt#CD013600-abs-0005Link to resource in Spanish: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub3/full/es#CD013600-abs-0009","false","24060"
"23064","Clinical Guidance: Family Presence Policies for Pediatric Inpatient Settings During the COVID-19 Pandemic","American Academy of Pediatrics","2020-10-12T00:00:00.000","Text","This web page, updated on October 12, 2020, provides answers to frequently asked questions during the COVID-19 pandemic about family presence policies, which are are critical components of family-centered care for all children and are particularly important for children with special health care needs, including those with disabilities, medical complexity, and serious illness.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/family-presence-policies-for-pediatric-inpatient-settings-during-the-covid-19-pandemic/",,"Fact Sheet",,"false","23064"
"21375","Handbook for Public Health Capacity-Building at Ground Crossings and Cross-Border Collaboration","World Health Organization","2020-10-12T00:00:00.000","PDF","This 68-page handbook, updated on October 12, 2020, follows a comprehensive approach to health system strengthening at borders in order to support International Health Regulations (IHR) national focal points and other national agencies in developing and implementing evidence-based action plans for IHR capacity development at ground crossings. The approach includes the movement of travelers and baggage, cargo, containers, conveyances, goods, and postal parcels across ground crossings, as well as the interaction with adjacent border communities.","https://www.who.int/publications/i/item/handbook-for-public-health-capacity-building-at-ground-crossings-and-cross-border-collaboration",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1272765/retrieveLink to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/331534/9789240009172-rus.pdf","false","21375"
"24030","Countering Stigmatization in the Humanitarian Response to COVID-19","InterAction","2020-10-10T00:00:00.000","PDF","This 16-page report highlights key findings and recommendations outlined in a webinar and roundtable event hosted by the InterAction Protection Working Group in July 2020 to discuss how stigma is impacting humanitarian responses during the COVID-19 pandemic, best practices, key challenges, and ways forward.","https://www.interaction.org/wp-content/uploads/2020/10/Countering-Stigmatization-in-the-Humanitarian-Response-to-COVID19-1.pdf",,"Report","Link to additional information: https://www.interaction.org/blog/countering-stigmatization-in-the-humanitarian-response-to-covid-19-2/","false","24030"
"24052","Fact Sheet for Healthcare Providers: AdviseDx SARS-CoV-2 IgM","U.S. Food and Drug Administration","2020-10-09T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the AdviseDx SARS-CoV-2 IgM assay. The AdviseDx SARS-CoV-2 IgM assay is authorized for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum, serum separator tube, and plasma (dipotassium EDTA, tripotassium EDTA, lithium heparin, lithium heparin separator tube, sodium heparin).","https://www.fda.gov/media/142938/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142939/downloadLink to Letter of Authorization: https://www.fda.gov/media/142937/downloadLink to Instructions for Use: Architect: https://www.fda.gov/media/142940/downloadLink to Instructions for Use: Alinity i: https://www.fda.gov/media/142941/download","false","24052"
"24006","Strategies for Optimizing the Supply of Isolation Gowns","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page offers a series of strategies or options to optimize supplies of isolation gowns in healthcare settings when there is limited supply. It includes considerations for returning to conventional capacity practices.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/isolation-gowns.html",,"Guideline/Assessment Tool",,"false","24006"
"24005","Contact Tracing by Community Health Workers in Low-Resource, Non-U.S. Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page provides information on how community health workers can support contact tracing efforts related to COVID-19 in low resource and resource-limited non-U.S. settings. The considerations provided can be adapted to follow national or local guidelines and account for local context.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/contact-tracing-by-health-workers.html",,"Guideline/Assessment Tool",,"false","24005"
"24001","Strategic Considerations in Preparing for Deployment of COVID-19 Vaccine and Vaccination in the WHO European Region","World Health Organization, Regional Office for Europe","2020-10-09T00:00:00.000","PDF","This 11-page document outlines the key strategic considerations for ministries of health, their agencies, national immunization technical advisory groups/committees, and relevant public and private sector authorities in the WHO European Region in preparing for deployment of COVID-19 vaccine and vaccination in their countries. The objective is to allow Member States to identify and address any critical gaps for effective deployment of COVID-19 vaccines.","https://apps.who.int/iris/handle/10665/335940",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/335940/WHO-EURO2020-1148-40894-55356-eng.pdf?sequence=1&isAllowed=yLink to resource in Russian: https://apps.who.int/iris/handle/10665/335941","false","24001"
"23998","National Action Plan for Combating Antibiotic-Resistant Bacteria, 2020-2025","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","PDF","This 47-page document presents coordinated, strategic actions to change the course of antimicrobial resistance in the next five years. The new plan includes CDC activities to combat antibiotic-resistant infections in healthcare, food and farms, animals, communities, and the environment, both at home and abroad.","https://www.cdc.gov/drugresistance/us-activities/national-action-plan.html",,"Report","Link to additional information: https://aspe.hhs.gov/pdf-report/carb-plan-2020-2025Direct link to document: https://aspe.hhs.gov/system/files/pdf/264126/CARB-National-Action-Plan-2020-2025.pdf","false","23998"
"23256","Coronavirus Disease (COVID-19) Toolkit for Correctional and Detention Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page, updated on October 9, 2020, provides COVID-19 guidance and tools to help administrators of correctional and detention facilities make decisions and protect and communicate with staff, people who are incarcerated, and their communities.","https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/correctional-and-detention-facilities.html",,"Guideline/Assessment Tool",,"false","23256"
"23022","Coronavirus Disease (COVID-19): Correctional and Detention Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page, updated on October 9, 2020, provides guidance for correctional and detention facilities to plan, prepare, and respond to the COVID-19 pandemic. It also provides communication resources and posters.","https://www.cdc.gov/coronavirus/2019-ncov/community/correction-detention/index.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/correction-detention/index.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/correction-detention/index.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/correction-detention/index.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/correction-detention/index.html","false","23022"
"22550","Wildfire Smoke and COVID-19: Frequently Asked Questions and Resources for Air Resource Advisors and Other Environmental Health Professionals","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page, updated on October 9, 2020, provides Air Resource Advisors and other environmental health professionals with key messages about wildfire smoke and COVID-19. It also provides resources that can be given to communities affected by wildfire smoke during community spread of SARS-CoV-2, the virus that causes COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/php/smoke-faq.html",,"Fact Sheet","Link to page in Spanish: https://www.cdc.gov/coronavirus/2019-ncov/php/smoke-faq-sp.html","false","22550"
"22275","CDC’s Diagnostic Test for COVID-19 Only and Supplies","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page, updated on October 9, 2020, describes how to order the CDC 2019 Novel Coronavirus (2019-nCoV) Real-Time Reverse Transcriptase (RT)-PCR Diagnostic Panel and supplies. In addition to this test, CDC has developed a diagnostic test that can be used to detect SARS-CoV-2, influenza A, and influenza B viruses at the same time. This test is called the CDC Influenza SARS-CoV-2 (Flu SC2) Multiplex Assay.","https://www.cdc.gov/coronavirus/2019-ncov/lab/virus-requests.html",,"Guideline/Assessment Tool",,"false","22275"
"21930","Clinical Care Guidance for Healthcare Professionals about Coronavirus (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-09T00:00:00.000","Text","This web page, updated on October 9, 2020, provides clinical care guidance for healthcare professionals about COVID-19, including for home care, ending home isolation, and by patient type.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care.html",,"Guideline/Assessment Tool",,"false","21930"
"24101","Addressing the COVID-19 Crisis: An Open Forum Webinar Series for Pharmacists","American Pharmacists Association","2020-10-08T00:00:00.000","Video or Multimedia","This one-hour open forum provides the latest information on COVID-19 followed by a group discussion on what’s working, what’s challenging, and what resources are available to assist pharmacists as frontline responders and essential healthcare providers.","https://www.youtube.com/watch?v=pJOGJfhVCkk&feature=youtu.be","Hogue, Michael; Patel, Anita; Hannan, Claire; Bernstein, Ilisa; Rothholz, Mitchel","Instructional/Training Material","Link to presentation slides: https://www.pharmacist.com/sites/default/files/audience/Week27PresentationCOVID19WebinarSeries.pdf","false","24101"
"24072","Systematic Racism, Health Disparities, and COVID-19: Leading through Complex Trauma","Association of State and Territorial Health Officials","2020-10-08T00:00:00.000","Video or Multimedia","Speakers in this one-hour, three-minute webinar discuss systemic racism, health disparities, COVID-19, and the unprecedented social and economic stress impacting individuals, families, and communities across cultures, generations, genders, and racial groups. They cite tools for supporting individuals as they develop healing and resiliency around complex trauma.","https://www.youtube.com/watch?v=CHg6gLZZGD4&feature=youtu.be","Henderson-Smith, Linda; Guroff, Elizabeth; Roeschlein, Amelia","Instructional/Training Material",,"false","24072"
"24022","ADA (Americans with Disabilities Act) National Network Learning Session: American Red Cross Disaster Response During the COVID-19 Pandemic","ADA [Americans with Disabilities Act] National Network","2020-10-08T00:00:00.000","Video or Multimedia","This one-hour, seven-minute webinar covers several aspects of disaster response from the perspective of the American Red Cross during the COVID-19 pandemic, including preparation and guidance development for disaster response, the strategy for non-congregate sheltering, and the challenges of this strategy. Worker safety and workforce care protocols are also shared.","https://www.adapresentations.org/webinar.php?id=169","Casey-Lockyer, Mary","Instructional/Training Material","Link to recording: https://us02web.zoom.us/rec/share/IoW3bTywqBQbViWCWckRdHkuetAgN8Vo2vVyKPS7Uplz9j_O-vXH1gEu7rfAAT9R.XTEHDsJffU989Xc8Link to presentation slides: http://adapresentations.org/doc/10_08_20/American%20Red%20Cross%20Disaster%20Response%20During%20the%20COVID-19%20Pandemic.pdfLink to transcript: http://adapresentations.org/doc/10_08_20/Transcript%2010-08-20.pdf","false","24022"
"24020","Review Process For Vaccines to Prevent COVID-19: A Discussion","Center for Infectious Disease Research and Policy [University of Minnesota]","2020-10-08T00:00:00.000","Video or Multimedia","This one-hour, two-minute video features a discussion with the current Food and Drug Administration (FDA) Commissioner and a former FDA Commissioner regarding the review process for vaccines to prevent COVID-19.","https://www.youtube.com/watch?v=C75_eMnNvlc&feature=youtu.be","Osterholm, Michael; Hahn, Stephen; Hamburg, Margaret A.","Instructional/Training Material",,"false","24020"
"24010","Letter of Authorization: SDNA-1000 Saliva Collection Device","U.S. Food and Drug Administration","2020-10-08T00:00:00.000","PDF","This six-page document provides the Emergency Use Authorization (EUA) for the SDNA-1000 Saliva Collection Device (SDNA-1000), which is intended for use by individuals to collect, stabilize, and maintain during transport, unprocessed saliva specimens suspected of containing SARS-CoV-2 ribonucleic acid (RNA).","https://www.fda.gov/media/142906/download",,"Guideline/Assessment Tool","Link to EUA Summary: https://www.fda.gov/media/142907/download","false","24010"
"24009","Fact Sheet for Healthcare Providers: Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2","U.S. Food and Drug Administration","2020-10-08T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2. The Maverick SARS-CoV-2 Multi-Antigen Serology Panel v2 is authorized for the detection of antibodies to SARS-CoV-2 in human dipotassium EDTA venous whole blood, dipotassium EDTA plasma, and serum.","https://www.fda.gov/media/142913/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142914/downloadLink to Letter of Authorization: https://www.fda.gov/media/142912/downloadLink to Instructions for Use: https://www.fda.gov/media/142915/download","false","24009"
"24008","Fact Sheet for Healthcare Providers: ACCESS SARS‐CoV‐2 IgM","U.S. Food and Drug Administration","2020-10-08T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Access SARS‐CoV‐2 IgM. The Access SARS‐CoV‐2 IgM is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma.","https://www.fda.gov/media/142909/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142910/downloadLink to Letter of Authorization: https://www.fda.gov/media/142908/downloadLink to Instructions for Use: https://www.fda.gov/media/142911/download","false","24008"
"24007","Fact Sheet for Healthcare Providers: CareStart™ COVID-19 Antigen","U.S. Food and Drug Administration","2020-10-08T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CareStart™ COVID-19 Antigen test. The CareStart™ COVID-19 Antigen test is authorized for use using nasopharyngeal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first five days of the onset of symptoms.","https://www.fda.gov/media/142917/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142918/downloadLink to Letter of Authorization: https://www.fda.gov/media/142916/downloadLink to Instructions for Use: https://www.fda.gov/media/142919/download","false","24007"
"23992","Recommendations for Influenza Prevention and Treatment in Children: An Update for Pediatric Providers","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-10-08T00:00:00.000","Video or Multimedia","During this one-hour, nine-minute Clinician Outreach and Communication Activity (COCA) call, subject matter experts from the American Academy of Pediatrics (AAP) and CDC discuss strategies primary care providers and medical subspecialists can use to improve flu prevention and control in children this season. They discuss the importance of vaccinating, testing, and treating influenza during the COVID-19 pandemic, and review recommendations about influenza antiviral use in children.","https://emergency.cdc.gov/coca/calls/2020/callinfo_100820.asp","Dawood, Fatimah; Kimball, Anne; Munoz, Flor","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/FINAL_Peds_COVID_Flu_COCA_Final-Combined.pdf","false","23992"
"23718","CDC’s Interim Guidance for General Population Disaster Shelters During the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-08T00:00:00.000","Text","This interim guidance for general population disaster shelters, updated on October 8, 2020, is based on current information about the transmission and severity of coronavirus disease 2019 (COVID-19). Because conditions vary from community to community, disaster shelter managers should look to their state and local health officials for information specific to their location.","https://www.cdc.gov/coronavirus/2019-ncov/php/eh-practitioners/general-population-disaster-shelters.html",,"Guideline/Assessment Tool",,"false","23718"
"20875","Interim Guidelines for Collecting, Handling, and Testing Clinical Specimens for COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-08T00:00:00.000","Text","These COVID-19 guidelines for laboratories, updated on October 8, 2020, add clarification on language for the collection of specimens, and include the addition of saliva language.","https://www.cdc.gov/coronavirus/2019-nCoV/lab/guidelines-clinical-specimens.html",,"Guideline/Assessment Tool",,"false","20875"
"24053","Coronavirus Disease 2019 (COVID-19) Clinical Decision Algorithm to Guide Care Advice Messages","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-07T00:00:00.000","Text","This web page provides healthcare workers with a clinical decision algorithm to guide care advice messages regarding COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/phone-guide/clinical-decision-algorithm.html",,"Guideline/Assessment Tool",,"false","24053"
"24032","Interim Guidance on the Use of Rapid Antigen Detection Tests for the Identification of SARS-CoV-2 Infection","Government of Canada","2020-10-07T00:00:00.000","Text","This web page provides interim guidance on the use of rapid antigen detection tests (RADT) for SARS-CoV-2 in the context of the public health system. These guidelines were developed in collaboration with provincial and territorial public health authorities and will be updated periodically as the science evolves.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/use-rapid-antigen-detection-tests.html",,"Guideline/Assessment Tool",,"false","24032"
"24026","Ethics Grand Rounds: Vaccine Trials for COVID-19","National Institutes of Health","2020-10-07T00:00:00.000","Video or Multimedia","Speakers in this 58-minute presentation discuss vaccines for COVID-19, current clinical trials, and the ethical issues that they raise. An issue is if one vaccine is proven effective, should all other clinical trials be stopped?","https://videocast.nih.gov/watch=38781","Erbelding, Emily; Millum, Joseph; Goodman, Steve","Instructional/Training Material",,"false","24026"
"24025","Human Antibody Responses to SARS-CoViD-2","National Institutes of Health","2020-10-07T00:00:00.000","Video or Multimedia","The speaker in this one-hour, four-minute presentation, the 5th Annual William E. Paul Lecture, discusses the development of antibody responses, focusing on neutralizing antibody responses to SARS-CoViD-2. At the start of the COVID-19 pandemic, a group of 148 individuals who had recovered from SARS-CoV-2 infection were recruited to Rockefeller University to give blood for analysis. This lecture summarizes features of the humoral immune response in these individuals and their neutralizing properties in vitro and in animal models.","https://videocast.nih.gov/watch=38684","Nussenzweig, Michel","Instructional/Training Material",,"false","24025"
"24019","Strengthening Disability Inclusion in Humanitarian Action","Overseas Development Institute","2020-10-07T00:00:00.000","Video or Multimedia","This one-hour, 33-minute presentation discusses disability-inclusive practices and approaches being used in humanitarian action, and what more needs to be done to ensure the rhetoric around disability-inclusive humanitarian preparedness and response is being translated into action.","https://www.odi.org/events/17332-strengthening-disability-inclusion-humanitarian-action","Fenton, Wendy; Uja, Sulayman AbdulMumuni; Abdalla, Alradi; Al Sheikh Ahmed, Sherin; Bula, Simione","Instructional/Training Material",,"false","24019"
"24017","Preparing the Whole Community: Including Individuals Experiencing Homelessness in Disaster Planning","Natural Hazards Center [University of Colorado at Boulder]","2020-10-07T00:00:00.000","Text","This report details how collaboration between emergency management officials and homeless service providers can ensure that individuals experiencing homelessness are included in planning for disasters, sheltering, response, and recovery.","https://hazards.colorado.edu/news/research-counts/preparing-the-whole-community-including-individuals-experiencing-homelessness-in-disaster-planning","Gin, June","Report",,"false","24017"
"24015","Virtual Launch of the Capitol Hill Steering Committee on Pandemic Preparedness and Health Security","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-10-07T00:00:00.000","Video or Multimedia","This one-hour launch of the Capitol Hill Steering Committee on Pandemic Preparedness and Health Security features a discussion about how the committee will provide an educational forum to discuss new topics, technologies, and ideas that could improve domestic health security now and in the future.","https://www.youtube.com/watch?v=VHu-eRQqyFo&feature=youtu.be","Inglesby, Thomas V.; Baldwin, Tammy; Burr, Richard; Casey, Bob; Hyde-Smith, Cindy","Instructional/Training Material",,"false","24015"
"24011","Fact Sheet for Healthcare Providers: ePlex® Respiratory Pathogen Panel 2","U.S. Food and Drug Administration","2020-10-07T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ePlex® Respiratory Pathogen Panel 2. The ePlex® Respiratory Pathogen Panel 2 is authorized for use with nasopharyngeal swab specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider.","https://www.fda.gov/media/142903/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142904/downloadLink to Letter of Authorization: https://www.fda.gov/media/142902/downloadLink to Instructions for Use: https://www.fda.gov/media/142905/download","false","24011"
"24000","Diagnostics Allocations Frequently Asked Questions","World Health Organization","2020-10-07T00:00:00.000","PDF","This three-page fact sheet provides answers to frequently asked questions about COVID-19 diagnostic supply allocations, including how the allocation principles are developed.","https://www.who.int/publications/m/item/diagnostics-allocations-frequently-asked-questions",,"Fact Sheet","Direct link to document: https://www.who.int/docs/default-source/coronaviruse/dx-allocation-faqs-for-website-v3.pdf?sfvrsn=467fcb6a_2&download=true","false","24000"
"23991","Recommendations on Providing Clear Instructions to Patients Who Self-Collect an Anterior Nares (Nasal) Sample in a Health Care Setting for SARS-CoV-2 Testing","U.S. Food and Drug Administration","2020-10-07T00:00:00.000","Text","The U.S. Food and Drug Administration (FDA) provides these recommendations that health care providers give clear, step-by-step instructions to patients who, in a health care setting, are self-collecting anterior nares (nasal) samples for SARS-CoV-2 testing. Without proper instructions, patients may not collect an adequate sample for testing, which may decrease the sensitivity of the test.","https://www.fda.gov/medical-devices/letters-health-care-providers/recommendations-providing-clear-instructions-patients-who-self-collect-anterior-nares-nasal-sample",,"Guideline/Assessment Tool",,"false","23991"
"24023","Lower Flu Vaccination Rates Among Black, Hispanic, and Low-Income Seniors Suggest Challenges for COVID-19 Vaccination Efforts","Henry J. Kaiser Family Foundation","2020-10-06T00:00:00.000","Text","This analysis explores variation in the rate of flu vaccination among adults ages 65 and older covered by Medicare, and reasons cited for not getting vaccinated, based on data from the 2018 Medicare Current Beneficiary Survey. Findings include that flu vaccination rates are lower among older Black and Hispanic adults than older white adults.","https://www.kff.org/medicare/issue-brief/lower-flu-vaccination-rates-among-black-hispanic-and-low-income-seniors-suggest-challenges-for-covid-19-vaccination-efforts/","Cubanski, Juliette; Neuman, Tricia; Damico, Anthony","Report",,"false","24023"
"23986","Fact Sheet for Healthcare Providers: UCLA SwabSeq COVID-19 Diagnostic Platform","U.S. Food and Drug Administration","2020-10-06T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the UCLA SwabSeq COVID-19 Diagnostic Platform. The UCLA SwabSeq COVID19 Diagnostic Platform is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142803/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142804/downloadLink to Letter of Authorization: https://www.fda.gov/media/142802/downloadLink to EUA Summary: https://www.fda.gov/media/142805/download","false","23986"
"23985","Fact Sheet for Healthcare Providers: ZEUS ELISA SARS-CoV-2 IgG Test System","U.S. Food and Drug Administration","2020-10-06T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ZEUS ELISA SARS-CoV-2 IgG Test System. The ZEUS ELISA SARS-CoV-2 IgG Test System is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (dipotassium EDTA, lithium heparin and sodium citrate).","https://www.fda.gov/media/142807/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142808/downloadLink to Letter of Authorization: https://www.fda.gov/media/142806/downloadLink to Instructions for Use: https://www.fda.gov/media/142809/download","false","23985"
"23983","Infection Prevention and Control and Preparedness for COVID-19 in Healthcare Settings: Fifth Update","European Union, European Centre for Disease Prevention and Control","2020-10-06T00:00:00.000","PDF","This 20-page document aims to provide guidance to healthcare facilities and healthcare providers in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) on preparedness and infection prevention and control (IPC) measures for the management of possible and confirmed cases of COVID-19 in healthcare settings, including long-term care facilities (LTCFs). It also addresses the management of clinical diagnostic specimens at laboratories in the EU/EEA.","https://www.ecdc.europa.eu/sites/default/files/documents/Infection-prevention-and-control-in-healthcare-settings-COVID-19_5th_update.pdf",,"Report",,"false","23983"
"23981","Interim Final Rule (IFC), CMS-3401-IFC; Requirements and Enforcement Process for Reporting of COVID-19 Data Elements for Hospitals and Critical Access Hospitals","Centers for Medicare & Medicaid Services","2020-10-06T00:00:00.000","PDF","The Centers for Medicare & Medicaid Services (CMS) has released new regulatory requirements in this 12-page memorandum for all hospitals and critical access hospitals to report COVID-19 data elements in accordance with a frequency and in a standardized format as specified by the Secretary during the public health emergency for COVID-19.","https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/interim-final-rule-ifc-cms-3401-ifc-requirements-and-enforcement-process-reporting-covid-19-data",,"Guideline/Assessment Tool","Direct link to document: https://www.cms.gov/files/document/qso-21-03-hospitalscahs.pdf-0","false","23981"
"23974","Emergency Use Authorization for Vaccines to Prevent COVID-19","U.S. Food and Drug Administration","2020-10-06T00:00:00.000","PDF","The Food and Drug Administration (FDA) has issued this 18-page guidance to provide sponsors of requests for Emergency Use Authorization (EUA) for COVID-19 vaccines with recommendations regarding the data and information needed to support the issuance of an EUA for an investigational vaccine to prevent COVID-19 for the duration of the COVID-19 public health emergency.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/emergency-use-authorization-vaccines-prevent-covid-19",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/142749/download","false","23974"
"23649","Frequently Asked Questions: Interfacility Transport of the Critically Ill Neonatal or Pediatric Patient with Suspected or Confirmed COVID-19","American Academy of Pediatrics","2020-10-06T00:00:00.000","Text","This web page, updated on October 6, 2020, provides answers to frequently asked questions about interfacility transport of pediatric patients and the importance of providing the best medical care while reducing the risk to transport team members and minimizing the use of personal protective equipment (PPE) where possible during the COVID-19 pandemic.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/frequently-asked-questions-interfacility-transport-of-the-critically-ill-neonatal-or-pediatric-patient-with-suspected-or-confirmed-covid-19/",,"Fact Sheet",,"false","23649"
"23036","COVID-19 Guidance for Hospital Reporting and FAQs for Hospitals, Hospital Laboratory, and Acute Care Facility Data Reporting","U.S. Department of Health and Human Services","2020-10-06T00:00:00.000","PDF","This 15-page document, updated on October 6, 2020, details the federal government’s COVID-19 data needs, explains the division of reporting responsibility between hospitals and states, and provides clear, flexible options for the timely delivery of daily data reports on COVID-19 testing, capacity, and utilization. The objective is to allow states and hospitals either to leverage existing data reporting capabilities or, where those capabilities are insufficient, to provide guidance in how to build upon existing capabilities.","https://www.hhs.gov/sites/default/files/covid-19-faqs-hospitals-hospital-laboratory-acute-care-facility-data-reporting.pdf",,"Guideline/Assessment Tool","Link to Disaster Lit record for Centers for Medicare & Medicare Services Interim Guidance (October 6, 2020): https://disasterinfo.nlm.nih.gov/search/id:23981.","false","23036"
"22638","Issue Brief: Reports of Increases in Opioid-Related Overdose and Other Concerns During COVID Pandemic","American Medical Association","2020-10-06T00:00:00.000","PDF","This 17-page report, updated on October 6, 2020, lists the steps states must take to save lives, reduce harm, and get people the treatment they need as the opioid epidemic continues during the COVID-19 pandemic. It also notes the concerns stemming from a growing number of national, state, and local media reports suggesting swells in opioid-related mortality—particularly from illicitly manufactured fentanyl and fentanyl analogs.","https://www.ama-assn.org/system/files/2020-10/issue-brief-increases-in-opioid-related-overdose.pdf",,"Report",,"false","22638"
"22167","Guidance on Newborn Screening During COVID-19","American Academy of Pediatrics","2020-10-06T00:00:00.000","Text","The American Academy of Pediatrics (AAP) strongly supports the continued provision of health care for children during the COVID-19 pandemic unless community circumstances related to the pandemic require necessary adjustments. This page, updated on October 6, 2020, provides guidance on several types of screening during the pandemic.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/guidance-on-newborn-screening-during-covid-19/",,"Guideline/Assessment Tool",,"false","22167"
"23987","Fact Sheet for Healthcare Providers: AQ-TOP COVID-19 Rapid Detection Kit PLUS","U.S. Food and Drug Administration","2020-10-05T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the AQ-TOP COVID-19 Rapid Detection Kit PLUS. The AQ-TOP COVID-19 Rapid Detection Kit PLUS is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142798/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142799/downloadLink to Letter of Authorization: https://www.fda.gov/media/142797/downloadLink to Instructions for Use: https://www.fda.gov/media/142800/download","false","23987"
"23976","Scientific Brief: SARS-CoV-2 and Potential Airborne Transmission","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-10-05T00:00:00.000","Text","The principal mode by which people are infected with SARS-CoV-2 (the virus that causes COVID-19) is through exposure to respiratory droplets carrying infectious virus. This web page details potential airborne transmission of respiratory viruses, and how SARs-CoV-2 is spread.","https://www.cdc.gov/coronavirus/2019-ncov/more/scientific-brief-sars-cov-2.html",,"Report",,"false","23976"
"23966","Impact of COVID-19 on Mental, Neurological and Substance Use Services","World Health Organization","2020-10-05T00:00:00.000","PDF","This 48-page report of a survey completed by 130 countries during the period June-August 2020 provides information about the extent of disruption to mental, neurological, and substance use services due to COVID-19; the types of services that have been disrupted; and how countries are adapting to overcome these challenges.","https://www.who.int/publications/i/item/978924012455",,"Report","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1310579/retrieve","false","23966"
"22821","Potential FEMA Emergency Sheltering Options During the COVID-19 Pandemic","Congressional Research Service [Library of Congress]","2020-10-05T00:00:00.000","PDF","The ongoing COVID-19 pandemic may complicate efforts to provide sheltering in typical congregate settings. This three-page report, updated on October 5, 2020, discusses potential emergency sheltering models previously used by the Federal Emergency Management Agency (FEMA) and challenges posed by COVID-19, as well as policy considerations.","https://crsreports.congress.gov/product/pdf/IN/IN11440","Webster, Elizabeth; Lee, Erica","Report",,"false","22821"
"24078","Water, Sanitation and Hygiene Innovation Catalog: Second Edition","Enhancing Learning and Research for Humanitarian Assistance","2020-10-02T00:00:00.000","PDF","This 60-page document is an updated collection of some of the most promising solutions in water, sanitation, and hygiene (WASH). It offers easier navigation, updated evidence on a range of innovations, plus a number of newly added innovation projects.","https://www.elrha.org/researchdatabase/wash-innovation-catalogue/",,"Guideline/Assessment Tool","Direct link to document: https://www.elrha.org/wp-content/uploads/2020/10/HIF-WASH-innovation-catalogue-second-edition-2020-WEB_spreads.pdf","false","24078"
"24076","September 9-10, 2020, Virtual Public Meeting: Antimicrobial Resistance and COVID-19","Office of the Assistant Secretary for Health [U.S. Department of Health and Human Services]","2020-10-02T00:00:00.000","Video or Multimedia","This two-day virtual meeting focused on the impact of COVID-19 and its effect on antimicrobial resistance (AMR). Topics included presentations on the COVID-19 mortality rate due to secondary acquired infections, antibiotic stewardship practices during a pandemic, disruptions in the agricultural industry due to COVID-19, and the intersection of AMR and emergency preparedness.","https://www.hhs.gov/ash/advisory-committees/paccarb/meetings/upcoming-meetings/september-9-2020-virtual-public-meeting.html","Srinivasan, Arjun; Heil, Emily; Yu, Kalvin; O'Leary, Sean; Clancy, Cornelius","Conference/Meeting Material","This web page provides links to the meeting agenda, recordings, documents, and presentations.","false","24076"
"24058","Infection Prevention and Control Recommendations for Medical Evacuation by Aircraft of Patients with Suspected or Confirmed COVID-19 from Remote and Isolated Communities in Canada’s North","Public Health Agency of Canada","2020-10-02T00:00:00.000","Text","The purpose of this web page is to provide infection prevention and control guidance for the medical evacuation of patients with suspected or confirmed COVID-19 by air, based on current PHAC COVID-19 guidance and the PHAC Routine Practices and Additional Precautions guidance.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/medical-evacuation-aircraft-patients-suspected-confirmed-covid-19-remote-isolated-communities-canada-north.html",,"Guideline/Assessment Tool",,"false","24058"
"24057","Child Protection Minimum Standards Implementation Toolkit","Alliance for Child Protection in Humanitarian Action","2020-10-02T00:00:00.000","Text","This web page provides links to the documents in this toolkit, which contains essential information on how to promote and implement the Child Protection Minimum Standards in diverse humanitarian settings from refugee contexts to infectious disease outbreaks and beyond.","https://alliancecpha.org/en/child-protection-online-library/child-protection-minimum-standards-implementation-toolkit",,"Guideline/Assessment Tool",,"false","24057"
"3211","Gulf Coast Disaster Recovery","U.S. Government Accountability Office","2009-06-19T00:00:00.000","PDF","This 49-page document describes how Louisiana and Mississippi allocated their shares of Community Development Block Grant funds, the administration challenges associated with the housing recovery programs, and the human capital challenges the States encountered.","https://www.gao.gov/new.items/d09541.pdf",,"Report",,"false","3211"
"23973","Temporary Enforcement Guidance: Tight-Fitting Powered Air Purifying Respirators (PAPRs) Used During the Coronavirus Disease 2019 (COVID-19) Pandemic","Occupational Safety and Health Administration [U.S. Department of Labor]","2020-10-02T00:00:00.000","Text","This web page details temporary guidance for enforcing initial and annual fit-testing requirements related to tight-fitting powered air-purifying respirators. The new enforcement discretion policy permits the use of National Institute for Occupational Safety and Health (NIOSH)-approved tight-fitting powered air-purifying respirators for protection against the coronavirus when initial and/or annual fit testing is infeasible due to respirator and fit-testing supply shortages. The guidance applies to healthcare personnel and other workers in high or very high exposure risk activities.","https://www.osha.gov/memos/2020-10-02/temporary-enforcement-guidance-tight-fitting-powered-air-purifying-respirators",,"Guideline/Assessment Tool",,"false","23973"
"23965","Got Masks? PPE Compliance and Fatigue in First Responder Realms","National Emerging Special Pathogens Training and Education Center","2020-10-02T00:00:00.000","Video or Multimedia","This 56-minute webinar discusses the importance of personal protective equipment (PPE) in the First Responder Environment, techniques to deal with PPE fatigue, and how to improve compliance. The presenters answer questions from participants, including about PPE requirements in the office, ambulance, and firehouse.","https://repository.netecweb.org/exhibits/show/exercise-templates/item/1319","Grindle, Amanda; Kumar, Lekshmi; Carr, Michael; Tysor, Ben; Miles, Wade","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/b9423bf471c704e2f8d2afdbfc9ab758.pdf","false","23965"
"23959","Fact Sheet for Healthcare Providers: BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ)","U.S. Food and Drug Administration","2020-10-02T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BioFire Respiratory Panel 2.1-EZ (RP2.1-EZ). The BioFire RP2.1-EZ is authorized for use with nasopharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142694/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142695/downloadLink to Letter of Authorization: https://www.fda.gov/media/142693/downloadLink to Instructions for Use: https://www.fda.gov/media/142696/download","false","23959"
"23958","Fact Sheet for Healthcare Providers: OmniPATH COVID-19 Total Antibody ELISA Test","U.S. Food and Drug Administration","2020-10-02T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the OmniPATH COVID-19 Total Antibody ELISA Test. The OmniPATH COVID-19 Total Antibody ELISA Test is authorized for the detection of total antibodies (including IgM/IgG/IgA) to SARS-CoV-2 in human serum.","https://www.fda.gov/media/142698/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142699/downloadLink to Letter of Authorization: https://www.fda.gov/media/142697/downloadLink to Instructions for Use: https://www.fda.gov/media/142700/download","false","23958"
"23957","Fact Sheet for Healthcare Providers: Sofia 2 Flu + SARS Antigen FIA","U.S. Food and Drug Administration","2020-10-02T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Sofia 2 Flu + SARS Antigen FIA. The Sofia 2 Flu + SARS Antigen FIA is authorized for use with certain respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider within the first five days of the onset of symptoms.","https://www.fda.gov/media/142702/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142703/downloadLink to Letter of Authorization: https://www.fda.gov/media/142701/downloadLink to Instructions for Use: https://www.fda.gov/media/142704/download","false","23957"
"23937","Hybrid Hearing with Secretary of Health and Human Services Alex M. Azar II","U.S. House of Representatives, Committee on Oversight and Reform","2020-10-02T00:00:00.000","Video or Multimedia","This two-hour, 53-minute Congressional hearing of the House Select Subcommittee on the Coronavirus Crisis features Secretary Alex Azar, who responds to questions about the Department of Health and Human Services’ response to the coronavirus pandemic.","https://coronavirus.house.gov/subcommittee-activity/hearings/hybrid-hearing-secretary-health-and-human-services-alex-m-azar-ii","Clyburn, James; Azar, Alex","Hearing/Testimony",,"false","23937"
"23689","Framework for Equitable Allocation of COVID-19 Vaccine","National Academies Press","2020-10-02T00:00:00.000","Text","This 216-page report, finalized on October 2, 2020, offers an overarching framework for COVID-19 vaccine allocation to assist policymakers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.","https://www.nap.edu/catalog/25917/framework-for-equitable-allocation-of-covid-19-vaccine",,"Report","Link to Discussion Draft: https://www.nap.edu/resource/25917/25914.pdfLink to report webinar: https://www.nationalacademies.org/event/10-02-2020/final-report-public-release-webinar-framework-for-equitable-allocation-of-covid-19-vaccine","false","23689"
"24198","“Whoever Finds the Vaccine Must Share It:” Strengthening Human Rights and Transparency Around Covid-19 Vaccines","Human Rights Watch","2020-10-01T00:00:00.000","PDF","This 83-page document summarizes research examining the rights implications surrounding COVID-19 vaccine availability and affordability. It drew on more than six months of reporting on the pandemic’s impacts on different populations, including health workers.","https://www.hrw.org/sites/default/files/media_2020/10/globalvaccine1020_web.pdf","Kashyap, Aruna; Wurth, Margaret","Report",,"false","24198"
"24197","COVID-19: What Physicians Need to Know Webinar Series","American Medical Association","2020-10-01T00:00:00.000","Video or Multimedia","Each installment of this webinar series aims to gain fact-based insights from the nation’s highest-ranking subject matter experts working to protect the health of the public, particularly during the COVID-19 pandemic.","https://www.ama-assn.org/delivering-care/public-health/covid-19-what-physicians-need-know-webinar-series",,"Instructional/Training Material",,"false","24197"
"24196","Guide to Investigating Outbreak Origins: Nature Versus the Laboratory","James Martin Center for Nonproliferation Studies, Monterey Institute of International Studies","2020-10-01T00:00:00.000","PDF","COVID-19 has exposed key gaps in the global community’s ability to assess infectious disease outbreaks of international concern, in particular the ability to differentiate between natural and laboratory sources of infection. The purpose of this 34-page paper is to outline a readily adoptable, stepwise methodology to guide the investigation of corresponding outbreak origins, building upon traditional epidemiological principles.","https://nonproliferation.org/op-49-a-guide-to-investigating-outbreak-origins/","Pitch, Richard; Pomper, Miles; Luster, Jill; Lentzos, Filippa","Report","Direct link to document: https://nonproliferation.org/wp-content/uploads/2020/10/Investigating-Outbreaks.pdf","false","24196"
"24195","Vaccine Allocation Planner for COVID-19","Ariadne Labs","2020-10-01T00:00:00.000","Text","This vaccine allocation planner will help state and county decision-makers by estimating the size of their highest priority populations in every county of the U.S., the number of vaccine doses that may be available to each state, and the percent vaccine coverage achievable under various scenarios. It was jointly developed by Ariadne Labs, a joint center for health systems innovation at Brigham and Women’s Hospital and Harvard T.H. Chan School of Public Health, and the Surgo Foundation.","https://vaccineallocation.ariadnelabs.net/",,"Guideline/Assessment Tool",,"false","24195"
"24194","Healthcare Operations During the COVID-19 Pandemic","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-10-01T00:00:00.000","PDF","The U.S. Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Technical Resources, Assistance Center, and Information Exchange (TRACIE) presents a speaker series focused on how the COVID-19 pandemic brought healthcare and public health, emergency medical services, and emergency and management together to adjust healthcare operations. Links to each presentation are on this one-page fact sheet.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-healthcare-operations-during-covid-19-pandemic-webinar-series.pdf",,"Fact Sheet",,"false","24194"
"24192","Enforcement Policy for Non-Invasive Remote Monitoring Devices Used to Support Patient Monitoring During the Coronavirus Disease 2019 (COVID-19) Public Health Emergency (Revised)","U.S. Food and Drug Administration","2020-10-01T00:00:00.000","PDF","The FDA is issuing this 12-page guidance to provide a policy to help expand the availability and capability of non-invasive remote monitoring devices to facilitate patient monitoring while reducing patient and healthcare provider contact and exposure to COVID-19 for the duration of the COVID-19 public health emergency.","https://www.fda.gov/media/136290/download",,"Guideline/Assessment Tool",,"false","24192"
"24190","Framework for Equitable Allocation of COVID-19 Vaccine","National Academies Press","2020-10-01T00:00:00.000","Text","This 216-page report offers an overarching framework for vaccine allocation to assist policy makers in the domestic and global health communities. Built on widely accepted foundational principles and recognizing the distinctive characteristics of COVID-19, this report's recommendations address the commitments needed to implement equitable allocation policies for COVID-19 vaccine.","https://www.nap.edu/catalog/25917/framework-for-equitable-allocation-of-covid-19-vaccine",,"Report",,"false","24190"
"24189","Indian Health Service COVID-19 Pandemic Vaccine Draft Plan","Indian Health Service (IHS) [U.S. Department of Health and Human Services]","2020-10-01T00:00:00.000","PDF","This 24-page plan details how the Indian Health Service (IHS) health care system will prepare for and operationalize a COVID-19 vaccine when it becomes available. This draft plan includes an overview of the IHS Vaccine Task Force and is divided into seven sections.  Each section includes key IHS activities, assumptions, and specific actions for the Vaccine Task Force, Areas, and the IHS National Supply Service Center.","https://www.ihs.gov/sites/coronavirus/themes/responsive2017/display_objects/documents/IHS_COVID-19_Pandemic_Vaccine_Plan.pdf",,"Guideline/Assessment Tool",,"false","24189"
"24182","Assessment of Risks of SARS-CoV-2 Transmission During Air Travel and Non-Pharmaceutical Interventions to Reduce Risk","Harvard University, Harvard T.H. Chan School of Public Health","2020-10-01T00:00:00.000","PDF","This 187-page document summarizes the emerging scientific literature on the effectiveness of selected non-pharmaceutical interventions (NPI) used to control transmission of the novel coronavirus SARS-CoV-2 on board aircraft. Based on modeling of aircraft ventilation systems and current evidence about this novel coronavirus, the report presents recommendations regarding risk mitigation for airlines, airline passengers, and crew members.","https://cdn1.sph.harvard.edu/wp-content/uploads/sites/2443/2020/10/HSPH-APHI-Phase-One-Report.pdf",,"Report","Link to Phase One Report Highlights: https://cdn1.sph.harvard.edu/wp-content/uploads/sites/2443/2020/10/Phase-One-Report-Highlights-1.pdf","false","24182"
"24181","COVID-19 and the Experiences of Populations at Greater Risk  Description and Top-Line Summary Data — Wave 1, Summer 2020","RAND Corporation","2020-10-01T00:00:00.000","PDF","This 63-page report presents the results of the first of four waves of COVID-19 and the Experiences of Populations at Greater Risk Survey, fielded during summer 2020, with particular focus on populations deemed at risk or underserved, including people of color and those from low- to moderate-income backgrounds.","https://www.rand.org/pubs/research_reports/RRA764-1.html","Carman, Katherine Grace; Chandra, Anita; Bugliari, Delia; Nelson, Christopher; Miller, Carolyn","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/research_reports/RRA700/RRA764-1/RAND_RRA764-1.pdf","false","24181"
"24180","COVID-19 and the Cost of Vaccine Nationalism","RAND Corporation","2020-10-01T00:00:00.000","PDF","This 75-page report examines how the management of the COVID-19 crisis may be affected by vaccine nationalism and what the associated economic cost would be of inequitable access to vaccines across countries.","https://www.rand.org/pubs/research_reports/RRA769-1.html","Hafner, Marco; Yerushalmi, Erez; Fays, Clement; Dufresne, Eliane; Van Stolk, Christian","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/research_reports/RRA700/RRA769-1/RAND_RRA769-1.pdf","false","24180"
"24178","2020 American Heart Association Guidelines for CPR and ECC (Emergency Cardiovascular Care)","American Heart Association","2020-10-01T00:00:00.000","PDF","This web page provides several documents related to the 2020 American Heart Association Guidelines for CPR and ECC. The highlights document is available for download in 17 languages.","https://cpr.heart.org/en/resuscitation-science/cpr-and-ecc-guidelines",,"Guideline/Assessment Tool",,"false","24178"
"24172","Economics of Vaccine Development and Supply: Responding to COVID-19 and Preparing for the Next Threat","Agency for Healthcare Research and Quality  [U.S. Department of Health and Human Services]","2020-10-01T00:00:00.000","PDF","This seven-page brief summarizes key points from a meeting convened by Academy Health in August 2020. Research and policy experts reviewed existing research on vaccine development, manufacturing, and distribution, including financing mechanisms to help ensure access to vaccines in developing countries.","https://academyhealth.org/sites/default/files/ah_ri_economics_of_vaccines_brief_final.pdf","Cassil, Alwyn","Report",,"false","24172"
"24169","COVID-19 Homeless System Response: Alternative Approaches to Winter Sheltering During COVID-19","U.S. Department of Housing and Urban Development","2020-10-01T00:00:00.000","PDF","Due to the current community spread of COVID-19, local facilities that are normally available to prevent death from exposure for people experiencing homelessness are now more limited. This three-page document provides a framework for a graduated approach to sheltering from life-threatening temperatures and regular seasonal weather.","https://files.hudexchange.info/resources/documents/COVID-19-Homeless-System-Response-Alternative-Approaches-to-Winter-Sheltering-During-COVID-19.pdf",,"Guideline/Assessment Tool",,"false","24169"
"24168","COVID-19 Homeless System Response: COVID-19 Preparedness Checklist for Shelter Facilities","U.S. Department of Housing and Urban Development","2020-10-01T00:00:00.000","PDF","This three-page document provides a series of preparedness checklists designed to help homeless shelter providers implement strategies for mitigating the spread of COVID-19 in winter facilities.","https://files.hudexchange.info/resources/documents/COVID-19-Homeless-System-Response-COVID-19-Preparedness-Checklist-for-Shelter-Facilities.pdf",,"Guideline/Assessment Tool",,"false","24168"
"24157","GLASS Guide for National Surveillance Systems for Monitoring Antimicrobial Consumption in Hospitals","World Health Organization","2020-10-01T00:00:00.000","PDF","This 88-page document proposes an approach for monitoring antimicrobial consumption in hospitals, based largely on the WHO methodology used for monitoring  antimicrobial  consumption on a national level. It is part of the Global Antimicrobial Resistance and Use Surveillance System (GLASS).","https://apps.who.int/iris/handle/10665/336182","Schweickert, Birgitta; Muller, Arno; Ivanovska, Verica","Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/336182/9789240000421-eng.pdf?sequence=1&isAllowed=y","false","24157"
"24156","GLASS Manual on the Management of Antimicrobial Consumption Data","World Health Organization","2020-10-01T00:00:00.000","PDF","This 80-page manual summarizes the WHO methodology for a global program on surveillance of antimicrobial consumption (AMC), a component of the Global Antimicrobial Resistance and Use Surveillance System (GLASS). It is intended to guide countries on how to use the GLASS-AMC Microsoft Excel template to prepare the national AMC surveillance data according to the WHO methodology; and produce national AMC data files to foster AMC data analysis at national level.","https://apps.who.int/iris/handle/10665/336216",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/336216/9789240010192-eng.pdf?sequence=1&isAllowed=y","false","24156"
"24155","GLASS Methodology for Surveillance of National Antimicrobial Consumption","World Health Organization","2020-10-01T00:00:00.000","PDF","This 68-page document details the methodology for monitoring the use of antimicrobials, both in terms of strengthening the surveillance and optimizing the use of antimicrobials. It is part of the Global Antimicrobial Resistance and Use Surveillance System (GLASS), and discusses data collection and management.","https://apps.who.int/iris/handle/10665/336215",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/336215/9789240012639-eng.pdf?sequence=1&isAllowed=y","false","24155"
"24151","Airborne Transmission of SARS-CoV-2: Proceedings of a Workshop - In Brief","National Academies Press","2020-10-01T00:00:00.000","Text","This 18-page document summarizes an Environmental Health Matters Initiative (EHMI) workshop, held on August 26-27, 2020, that delved into the rapidly evolving science on the spread of the SAR-CoV-2 virus, as part of a larger body of COVID-19 related work at the National Academies. It featured experts in aerosol science and atmospheric chemistry, building engineering, epidemiology, environmental health, infectious disease, pulmonary medicine, public health, and virology to explore the evidence on airborne transmission of SARS-CoV-2.","https://www.nap.edu/catalog/25958/airborne-transmission-of-sars-cov-2-proceedings-of-a-workshop",,"Conference/Meeting Material","Link to Disaster Lit record for related video: https://disasterinfo.nlm.nih.gov/search/id:23613","false","24151"
"24150","Dispersion Modeling Systems Relevant to Homeland Security Preparedness and Response","U.S. Environmental Protection Agency","2020-10-01T00:00:00.000","PDF","The purpose of this 119-page report is to provide a comprehensive database of dispersion models that are currently available while also briefly explaining the fundamental concepts of atmospheric transport and dispersion. It can act as a comprehensive guide to relay risk, sampling, and model choices to decision-makers. The dispersion model background information and model summaries are intended to provide a quick reference for those new to air dispersion modeling or for those seeking to expand their knowledge base.","https://cfpub.epa.gov/si/si_public_record_Report.cfm?dirEntryId=349940&Lab=CESER","Pirhalla, Michael","Report","Direct link to document: https://cfpub.epa.gov/si/si_public_file_download.cfm?p_download_id=541378&Lab=CESER","false","24150"
"24125","In Vivo Exposures for Prolonged Exposure Therapy During a Pandemic","National Center for PTSD [Post-Traumatic Stress Disorder] [U.S. Department of Veterans Affairs]","2020-10-01T00:00:00.000","Text","This web page describes Prolonged Exposure (PE), an evidence-based treatment for PTSD, and how conducting PE during the coronavirus (COVID-19) pandemic may require creativity to identify in vivo exposures that are meaningful and effective for patients while also compliant with shelter-in-place, physical distancing, and other safety recommendations.","https://www.ptsd.va.gov/covid/COVID_pe_invivo.asp","Cuccurullo, Lisa; Joyce, Jennifer","Guideline/Assessment Tool",,"false","24125"
"24124","Impact of the COVID-19 Pandemic on Parental Stress and Young Children’s Development During Physical Distancing","Natural Hazards Center [University of Colorado at Boulder]","2020-10-01T00:00:00.000","Text","This study investigated the potential parental stress risk factors of the parents of young children during the COVID-19 pandemic, with consideration of socioeconomic and ethnic backgrounds.","https://hazards.colorado.edu/quick-response-report/impact-of-the-covid-19-pandemic-on-parental-stress-and-young-childrens-development-during-physical-distancing","Zhang, Chenyi; Qiu, Wei","Report",,"false","24124"
"24115","Decarcerating Correctional Facilities During COVID-19: Advancing Health, Equity, and Safety","National Academies Press","2020-10-01T00:00:00.000","Text","This 124-page document offers guidance on efforts to decarcerate, or reduce the incarcerated population, as a response to COIVD-19 pandemic. It examines best practices for implementing decarceration as a response to the pandemic and the conditions that support safe and successful reentry of those decarcerated.","https://www.nap.edu/catalog/25945/decarcerating-correctional-facilities-during-covid-19-advancing-health-equity-and",,"Guideline/Assessment Tool","Link to related video: https://www.nationalacademies.org/event/10-20-2020/decarcerating-correctional-facilities-during-covid-19-advancing-health-equity-and-safety-report-release-webinar","false","24115"
"24114","Health System Considerations: When Influenza Meets COVID-19","World Health Organization, Regional Office for Europe","2020-10-01T00:00:00.000","PDF","This 30-page document provides preparedness and response measures to take when COVID-19, influenza, and acute respiratory infections coincide in the WHO European Region. It is divided into seven sections: Prevention and health system preparedness; Risk communication and community engagement; Immunization; Surveillance; Clinical management of clusters and cases; Needs of special settings and groups; and Public health and social measures, including infection prevention and control.","https://apps.who.int/iris/handle/10665/336165",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/336165/WHO-EURO-2020-1248-40998-55644-eng.pdf?sequence=1&isAllowed=y","false","24114"
"24106","Preserving the Scientific Integrity of Getting to COVID-19 Vaccines","Johns Hopkins University","2020-10-01T00:00:00.000","Video or Multimedia","This six-part virtual vaccine symposium, held on October 6, 2020 and co-sponsored with the University of Washington, brings together leading voices in the field to explore complex issues regarding COVID-19 vaccines, from development to allocation. Topics include the Science and Structure of the U.S. Government’s COVID-19 Vaccine Trial Program, and Protecting Scientific Integrity in the Design and Conduct of COVID-19 Vaccine Efficacy Trials.","https://coronavirus.jhu.edu/live/events/covid-19-vaccine-symposium","Cauce, Ana Mari; Daniels, Ronald; Fauci, Anthony S.; Slaoui, Moncef; Jerome, Keith","Instructional/Training Material",,"false","24106"
"24105","Gulf Research Program Annual Report 2019","National Academies Press","2020-10-01T00:00:00.000","Text","This 22-page document is the sixth annual report of the Gulf Research Program (GRP) to summarize how funds were used. These annual reports review accomplishments, highlight activities, and, over time, will assess metrics to determine how the program is progressing in accomplishing its goals. The program seeks to enhance oil system safety and the protection of human health and the environment in the Gulf of Mexico region and other areas along the U.S. outer continental shelf with offshore oil and gas operations.","https://www.nap.edu/catalog/25959/gulf-research-program-annual-report-2019",,"Report",,"false","24105"
"24100","COVID-19 Digital Classroom: Course Series","Community Health Academy","2020-10-01T00:00:00.000","Video or Multimedia","This course series is part of the COVID-19 Digital Classroom initiative. These courses are primarily designed for community-based health workers who practice in low- and middle-income countries. They cover a range of topics on COVID-19, including basic information on the virus and how to mitigate its public health effects.","https://communityhealthacademy.course.tc/catalog/track/covid-19-digital-classroom-course-series",,"Instructional/Training Material","Site requires free registration.Link to course series in Arabic: https://communityhealthacademy.course.tc/catalog/track/covid-19-digital-classroom-course-series-arabic","false","24100"
"24099","Flu Prevention During the COVID-19 Pandemic","Child Care Aware of America","2020-10-01T00:00:00.000","PDF","This three-page document provides guidance about preventing flu during the COVID-19 pandemic, including recommendations for child care programs.","https://www.childcareaware.org/wp-content/uploads/2020/10/FluSeason-IssueBrief-10022020.pdf",,"Guideline/Assessment Tool","Link to document in Spanish: https://www.childcareaware.org/wp-content/uploads/2020/10/FluSeason-IssueBrief-Spanish-10092020.pdf","false","24099"
"24096","Capitol Hill Steering Committee on Pandemic Preparedness and Health Security","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-10-01T00:00:00.000","Video or Multimedia","This web page provides information about the Capitol Hill Steering Committee on Pandemic Preparedness and Health Security, an educational forum to discuss new topics, technologies, and ideas that can improve domestic health security now and in the future. The page provides links to monthly events focused on lessons learned from responses to natural, man-made, and other complex health emergencies, such as the COVID-19 pandemic, and how to better mitigate and respond to future health crises.","https://www.centerforhealthsecurity.org/our-work/CapitolHillSteeringCommittee/index.html",,"Instructional/Training Material",,"false","24096"
"24089","HHS/ASPR: Addressing the Needs of Older Adults in Disasters","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-10-01T00:00:00.000","Video or Multimedia","This course provides information, resources, tools, and strategies to help users assess and address the needs of older adults in common disaster situations, including natural disasters and infectious disease outbreaks. It is designed to improve public health and emergency medical responders’ capability to address the access and functional needs of community-dwelling older adults in disasters.","https://www.train.org/main/course/1093802/",,"Instructional/Training Material","Site requires free registration.","false","24089"
"24073","COVID-19 Transmission in U.S. Child Care Programs","Child Care Aware of America","2020-10-01T00:00:00.000","PDF","This 25-page report provides information about a survey conducted by Yale University of more than 55,000 child care providers from May and June 2020 in the United States that helps provide some answers to the safety of child care workers during the COVID-19 pandemic.","https://www.childcareaware.org/covid-19-in-child-care/","Gilliam, Walter; Malik, Amyn; Shafiq, Mehr; Klotz, Madeline; Reyes, Chin","Report","Direct link to document: https://pediatrics.aappublications.org/content/pediatrics/early/2020/10/12/peds.2020-031971.full.pdfLink to executive summary: https://www.childcareaware.org/wp-content/uploads/2020/10/yale-exec-summary-final.pdf","false","24073"
"24065","Ethics and Vector-Borne Diseases: WHO Guidance","World Health Organization","2020-10-01T00:00:00.000","PDF","This 74-page document details several aspects of vector-borne diseases, including malaria, dengue, and Zika, that raise significant ethical issues. The primary audience for this guidance is persons working directly in vector-borne disease prevention and control, including program managers, researchers, and field workers. The goal is to help readers recognize aspects of their work that raise significant ethical challenges and to respond to these challenges in accordance with internationally accepted values and norms.","https://apps.who.int/iris/bitstream/handle/10665/336075/9789240012738-eng.pdf",,"Guideline/Assessment Tool",,"false","24065"
"24059","XXII World Congress Special Session: COVID-19 and OSH (Occupational Safety and Health)","International Labour Organization","2020-10-01T00:00:00.000","Video or Multimedia","This web page provides recordings from the XXII World Congress Special Session: COVID-19 and OSH, held on October 5-6, 2020, with topics that included Innovations in Addressing COVID-19, and The Changing World of Work and COVID-19.","https://www.safety2021canada.com/session-recordings/",,"Conference/Meeting Material",,"false","24059"
"24056","Risk Assessment and Testing Protocols for Reducing SARS-CoV-2 Transmission in K-12 Schools","Rockefeller Foundation","2020-10-01T00:00:00.000","PDF","This 18-page document aims to aid discussion around whether and how to reopen schools by helping school administrators to assess the risk of SARS-CoV-2 in their schools, and identifying key considerations in developing a screening program to regularly test students and staff for the virus to support schools to open in-person more safely.","https://www.rockefellerfoundation.org/report/risk-assessment-and-testing-considerations-for-reducing-sars-cov-2-transmission-in-k-12-schools/","Rivers, Caitlin; Silcox, Christina; Potter, Christina; Franklin, Michelle; Ray, Rebecca","Report","Direct link to document: https://www.rockefellerfoundation.org/wp-content/uploads/2020/10/Risk-Assessment-and-Testing-Protocols-for-Reducing-SARS-CoV-2-Transmission-in-K-12-Schools_Final-10-14-2020.pdf","false","24056"
"24046","Flight Plan to Recovery: Preparing Airports for the Return of the Traveling Public","National Academies Press","2020-10-01T00:00:00.000","Text","This 83-page report summarizes presentations from airport industry leaders who discussed current and ongoing practices to get passenger confidence back to aid in airport recovery during a virtual Airport Cooperative Research Program Insight Event on May 28, 2020. Specific topics presented the aviation industry with challenges that are mutually shared by all partners, including safety, public confidence, and financial sustainability.","https://www.nap.edu/catalog/25954/flight-plan-to-recovery-preparing-airports-for-the-return-of-the-traveling-public",,"Conference/Meeting Material",,"false","24046"
"24029","Impact of COVID-19 on School Re-Opening","National Association of County and City Health Officials","2020-10-01T00:00:00.000","Video or Multimedia","This one-hour, 24-minute webinar discusses the impact of COVID-19 on school re-opening. Representatives from the Centers for Disease Control and Prevention (CDC), National Association of School Nurses, and Harris County Public Health provide insight on how COVID-19 is impacting the virtual and in-person return to school, share CDC guidance and recommendations, and provide insight on local issues and practices.","https://www.naccho.org/blog/articles/webinar-recording-the-impact-of-covid-19-on-school-re-opening","Massetti, Greta; Mendonca, Linda; Rivera, Maria","Instructional/Training Material","Link to recording: https://naccho.zoom.us/rec/play/3F0C7eLWrFfa49B_lWJvyBN9ZI14lJ441HLgoi26xNR-OOUB8AZJpm37-S6985ikRJ8QSUx7eCd5XoSy.TbCoqyHIrx-U4wfsLink to presentation slides: https://www.naccho.org/uploads/downloadable-resources/Impact-of-COVID19-on-School-ReOpening_Slides.pdf","false","24029"
"24021","Listening to Californians with Low Incomes: Health Care Access, Experiences, and Concerns Since the COVID-19 Pandemic","California Health Care Foundation","2020-10-01T00:00:00.000","PDF","This 37-page report discusses the results of a statewide survey of California’s residents age 18 to 64 who had received health care since March 2019, with an oversampling of residents with low incomes. The survey, conducted in the summer of 2020, asked respondents about their health care concerns, experiences, and access before and during the COVID-19 pandemic, as well as about their experiences with racial discrimination and the impact of the pandemic on employment and insurance coverage.","https://www.chcf.org/wp-content/uploads/2020/10/ListeningCaliforniansLowIncomes.pdf","Joynt, Jen; Catterson, Rebecca; Rabinowitz, Lucy","Report","Link to web page with additional information: https://www.chcf.org/publication/listening-californians-low-incomes/","false","24021"
"24012","Improving Pandemic Preparedness: Lessons From COVID-19","Council on Foreign Relations","2020-10-01T00:00:00.000","PDF","This 158-page report assesses the global response to COVID-19, and frames pandemic disease as a stark threat to global and national security that neither the United States nor the world can afford to ignore again. It argues that future pandemic threats are inevitable and possibly imminent; policymakers should prepare for them and identify what has gone wrong in the U.S. and multilateral response.","https://www.cfr.org/report/pandemic-preparedness-lessons-COVID-19/","Burwell, Sylvia Matthews; Townsend, Frances Fragos; Bollyky, Thomas; Patrick, Stewart","Report","Direct link to document: https://www.cfr.org/report/pandemic-preparedness-lessons-COVID-19/pdf/TFR_Pandemic_Preparedness.pdf","false","24012"
"24004","Responding to Non-Communicable Diseases During and Beyond the COVID-19 Pandemic","World Health Organization","2020-10-01T00:00:00.000","PDF","This 20-page document provides an initial review of emerging information (as July 2, 2020) on the relations among COVID-19, non-communicable diseases (NCDs), and NCD risk factors. It demonstrates that  people living with NCDs are at higher risk of severe COVID-19-related illness and death and that there are limited data for estimating risk. It was published with the United Nations Development Programme, and the UN Interagency Task Force on NCDs.","https://apps.who.int/iris/handle/10665/334143",,"Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334143/WHO-2019-nCoV-Non-communicable_diseases-Evidence-2020.1-eng.pdf?sequence=1&isAllowed=yLink to document in Arabic: https://apps.who.int/iris/bitstream/handle/10665/334143/WHO-2019-nCoV-Non-communicable_diseases-Evidence-2020.1-ara.pdf?sequence=17&isAllowed=yLink to document in Chinese: https://apps.who.int/iris/bitstream/handle/10665/334143/WHO-2019-nCoV-Non-communicable_diseases-Evidence-2020.1-chi.pdf?sequence=5&isAllowed=yLink to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/334143/WHO-2019-nCoV-Non-communicable_diseases-Evidence-2020.1-rus.pdf?sequence=26&isAllowed=y","false","24004"
"24003","WHO Guidance for Climate Resilient and Environmentally Sustainable Health Care Facilities","World Health Organization","2020-10-01T00:00:00.000","PDF","The aim of this 92-page guidance is to enhance the capacity of health care facilities to protect and improve the health of their target communities in an unstable and changing climate; and to empower health care facilities to be environmentally sustainable, by optimizing the use of resources and minimizing the release of waste into the environment.","https://apps.who.int/iris/handle/10665/335909","Corvalan, Carlos; Sena, Aderita; Prats, Elena; Campbell-Lendrum, Diarmid","Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/335909/9789240012226-eng.pdf?sequence=1&isAllowed=y","false","24003"
"24002","Pandemic Influenza Preparedness Framework","World Health Organization","2020-10-01T00:00:00.000","PDF","This 32-page issue of the Pandemic Influenza Preparedness progress report was developed as the world continues to respond to the coronavirus disease 2019 (COVID-19) pandemic. Despite the many challenges brought on by this global crisis, much was nonetheless achieved to continue the work to prepare for the next influenza pandemic, and readers will be able to learn about some of the happenings on the ground in a new section entitled “Stories from the field.”","https://apps.who.int/iris/handle/10665/335937",,"Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/335937/9789240012653-eng.pdf?sequence=1&isAllowed=y","false","24002"
"23999","PPE (Personal Protective Equipment) Preservation Planning Toolkit","U.S. Department of Health and Human Services","2020-10-01T00:00:00.000","PDF","This two-page toolkit from the COVID-19 Healthcare Resilience Working Group provides links to documents that are designed to aid any personal protective equipment (PPE)-using organization to plan and implement preservation strategies. It assists users to understand types of preservation strategies their organizations may implement, and provides estimates of positive impacts of using those strategies in increasing the duration of a specified PPE supply.","https://files.asprtracie.hhs.gov/documents/ppepp-toolkit-fact-sheet-hrwg.pdf",,"Guideline/Assessment Tool",,"false","23999"
"23989","FDA Briefing Document: Vaccines and Related Biological Products Advisory Committee Meeting","U.S. Food and Drug Administration","2020-10-01T00:00:00.000","PDF","This 38-page document is a briefing paper for a meeting to be held on October 22, 2020, to discuss studies that should be conducted, pre- and/or post-licensure, to evaluate the safety and efficacy of COVID-19 vaccine candidates, including in special populations (e.g., pediatric populations and pregnant women), and to further evaluate the immunogenicity and duration of effectiveness of these vaccines. The committee will also be asked to discuss the need for post-marketing safety studies following approval of a Biologics License Application (BLA) for a COVID-19 vaccine.","https://www.fda.gov/media/142723/download",,"Report",,"false","23989"
"23988","""Greatest Need Was to Be Listened To:” The Importance of Mental Health and Psychosocial Support During COVID-19","International Federation of Red Cross and Red Crescent Societies","2020-10-01T00:00:00.000","PDF","This 24-page joint report, sponsored by the International Committee of the Red Cross (ICRC), International Fede­ration of Red Cross and Red Crescent Societies (IFRC), Danish Red Cross, Lebanese Red Cross, and Swedish Red Cross, collates seven case studies from mental health and psychosocial support (MHPSS) activities around the world to highlight how Red Cross and Red Crescent volunteers are treating the hidden wounds of the COVID-19 pandemic among the world’s most vulnerable communities.","https://pscentre.org/?resource=the-greatest-need-was-to-be-listened-to-the-importance-of-mental-health-and-psychosocial-support-during-covid-19","Clomen, Dick; Horn, Rebecca; Osorio, Milena; Powell, Melanie; Rydell, Anne","Report","Direct link to document: https://pscentre.org/wp-content/uploads/2020/10/Covid19_Report_061020.pdf","false","23988"
"23984","Pandemic Fatigue: Reinvigorating the Public to Prevent COVID-19","World Health Organization, Regional Office for Europe","2020-10-01T00:00:00.000","PDF","Across the WHO European Region, Member States are reporting signs of pandemic fatigue in their populations – defined as demotivation to follow recommended protective behaviors, emerging gradually over time and affected by a number of emotions, experiences, and perceptions. This 28-page framework document provides key considerations for the planning and implementation of national and subnational strategies to maintain and reinvigorate public support to prevent COVID-19.","https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/pandemic-fatigue-reinvigorating-the-public-to-prevent-covid-19,-september-2020-produced-by-whoeurope",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/335820/WHO-EURO-2020-1160-40906-55390-eng.pdfLink to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/335823/WHO-EURO-2020-1160-40906-55391-rus.pdf","false","23984"
"23979","COVID-19 Physician FAQs","American College of Obstetricians and Gynecologists","2020-10-01T00:00:00.000","Text","This web page provides links to COVID-19 FAQs for obstetrician-gynecologists. FAQ topics are Ethics, Telehealth, Obstetrics, and Gynecology.","https://www.acog.org/clinical-information/physician-faqs",,"Fact Sheet",,"false","23979"
"23975","Face Masks, Public Policies and Slowing the Spread of COVID-19: Evidence from Canada","National Bureau of Economic Research","2020-10-01T00:00:00.000","PDF","This 68-page report estimates the impact of mask mandates and other non-pharmaceutical interventions (NPI) on COVID-19 case growth in Canada, including regulations on businesses and gatherings, school closures, travel and self-isolation, and long-term care homes. Counterfactual policy simulations suggest that mandating indoor masks nationwide in early July could have reduced the weekly number of new cases in Canada by 25 to 40 percent in mid-August, which translates into 700 to 1,100 fewer cases per week.","https://www.nber.org/papers/w27891","Karaivanov, Alexander; Lu, Shih En; Chen, Cong; Pamplona, Stephanie","Report","Direct link to document: https://www.nber.org/system/files/working_papers/w27891/w27891.pdf","false","23975"
"23960","Fact Sheet for Healthcare Providers: UMass Molecular Virology Laboratory 2019-nCoV rRT-PCR Dx Panel","U.S. Food and Drug Administration","2020-10-01T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the UMass Molecular Virology Laboratory 2019-nCoV rRT-PCR Dx Panel that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142690/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142691/downloadLink to Letter of Authorization: https://www.fda.gov/media/142689/downloadLink to EUA Summary: https://www.fda.gov/media/142692/download","false","23960"
"23956","COVID-19 Diagnostics","Infectious Diseases Society of America","2020-10-01T00:00:00.000","Text","This collection of COVID-19 diagnostic resources, developed with the Centers for Disease Control and Prevention (CDC), is designed for clinicians, clinical microbiologists, and other laboratory science professionals. Resources are provided for Antibody Testing, Rapid Testing, and RT-PCR Testing.","https://www.idsociety.org/covid-19-real-time-learning-network/diagnostics/",,"Guideline/Assessment Tool",,"false","23956"
"23954","COVID-19 Infection Prevention","Infectious Diseases Society of America","2020-10-01T00:00:00.000","Text","This web page, developed with the Centers for Disease Control and Prevention (CDC), reviews research and guidance on the use of masks, face coverings, and eye protection, as well as strategies that include physical distancing and isolation during the COVID-19 pandemic. It covers Eye Protection, Isolation and Infection Control, Masks and Face Coverings for the Public, Personal Protective Equipment in Medical Settings, and Physical Distancing.","https://www.idsociety.org/covid-19-real-time-learning-network/infection-prevention/",,"Guideline/Assessment Tool",,"false","23954"
"23951","epitweetr Tool","European Union, European Centre for Disease Prevention and Control","2020-10-01T00:00:00.000","Text","The R-based tool epitweetr allows users to automatically monitor trends of tweets by time, place and topic, with the aim of detecting public health threats early through signals, such as an unusual increase in the number of tweets. It was designed to support public health experts with the early detection of threats from infectious diseases but can be extended to all hazards and other fields of study by modifying the topics and keywords.","https://www.ecdc.europa.eu/en/publications-data/epitweetr-tool",,"Guideline/Assessment Tool","Materials are available in a zip file.Link to Early Detection of Public Health Threats from Twitter Data manual: https://www.ecdc.europa.eu/sites/default/files/documents/epitweetr_user_manual.pdfLink to User Documentation: https://www.ecdc.europa.eu/sites/default/files/documents/epitweetr_vignette.pdf","false","23951"
"23917","Fact Sheet for Healthcare Providers: iC SARS-CoV2 Test","U.S. Food and Drug Administration","2020-10-01T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the iC SARS-CoV2 Test. The iC SARS-CoV2 Test is authorized for use with upper respiratory tract specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142594/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142595/downloadLink to Letter of Authorization: https://www.fda.gov/media/142593/downloadLink to EUA Summary: https://www.fda.gov/media/142596/download","false","23917"
"23916","Fact Sheet for Healthcare Providers: Access IL-6","U.S. Food and Drug Administration","2020-10-01T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Access IL-6. The Access IL-6 is authorized for use in human serum and plasma specimens collected from patients with confirmed coronavirus disease-2019 (COVID-19) to assist in identifying severe inflammatory response to aid in determining the risk of intubation with mechanical ventilation, in conjunction with clinical findings and the results of other laboratory testing.","https://www.fda.gov/media/142598/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142599/downloadLink to Letter of Authorization: https://www.fda.gov/media/142597/downloadLink to Instructions for Use: https://www.fda.gov/media/142600/download","false","23916"
"22226","Toolkit on State Actions to Mitigate COVID-19 Prevalence in Nursing Homes","Centers for Medicare & Medicaid Services","2020-10-01T00:00:00.000","PDF","This 186-page toolkit, updated in October 2020, catalogs the many innovative solutions designed at the state level to protect the nation’s vulnerable nursing home residents during the coronavirus disease 2019 (COVID-19) pandemic.","https://www.cms.gov/files/document/covid-toolkit-states-mitigate-covid-19-nursing-homes.pdf",,"Guideline/Assessment Tool",,"false","22226"
"19265","Core Commitments for Children in Humanitarian Action (2020)","United Nations Children's Fund","2020-10-01T00:00:00.000","PDF","The Core Commitments for Children (CCCs) promote equality, transparency, responsibility and a results-oriented approach to enable predictable and timely collective humanitarian action. Initially developed in 1998, and revised in 2010 and again in 2020, the CCCs are grounded in global humanitarian norms and standards and set commitments and benchmarks against which UNICEF holds itself accountable for the coverage, quality and equity of its humanitarian action and advocacy.","https://www.unicef.org/emergencies/core-commitments-children",,"Report","Direct link to document: https://www.unicef.org/media/84086/file/Core%20Commitments%20for%20Children%20(English).pdfLink to Disaster Lit record for Core Commitments for Children in Humanitarian Action (2010): https://disasterinfo.nlm.nih.gov/search/id:14594","false","19265"
"14438","Antigenic and Genetic Characteristics of Zoonotic Influenza Viruses and Candidate Vaccine Viruses Developed for Potential Use in Human Vaccines","World Health Organization","2020-10-01T00:00:00.000","Text","This web page, updated in October 2020, provides the most current information about zoonotic influenza virus activity and virus characterization, and describes the current status of the development of candidate vaccine viruses for pandemic preparedness purposes. It is meant to provide guidance for national authorities and vaccine companies on the selection of candidate viruses for use in vaccine development. Summaries on this page begin in August 2006 and are added periodically.","https://www.who.int/influenza/vaccines/virus/characteristics_virus_vaccines/en/",,"Web Page",,"false","14438"
"24075","What to Do If a Child Becomes Sick at Child Care or Reports a New COVID-19 Diagnosis","Child Care Aware of America","2020-09-30T00:00:00.000","PDF","This one-page flowchart details what to do if a child in child care displays an illness consistent with COVID-19, or if parents, guardians, or caregivers report a child to have recent contact with a person with COVID-19.","https://www.childcareaware.org/wp-content/uploads/2020/10/WhatToDo-COVID19InChildCare-Flowchart.pdf",,"Guideline/Assessment Tool","Link to flowchart in Spanish: https://www.childcareaware.org/wp-content/uploads/2020/10/WhatToDo-COVID19InChildCare-Flowchart-Spanish.pdf","false","24075"
"23982","Indian Country COVID-19 Response and Update","U.S. House of Representatives, Committee on Appropriations","2020-09-30T00:00:00.000","Video or Multimedia","Witnesses at this one-hour, 18-minute Congressional hearing discuss how agencies have implemented the appropriate COVID-19 response funding for the Indian Health Service, and tribal and urban Indian health organizations; the new and continuing challenges in addressing the pandemic; and how the federal government can help tribal nations, Indian health facilities, and Bureau of Indian Education-funded schools.","https://appropriations.house.gov/events/hearings/indian-country-covid-19-response-and-update-hearing","McCollum, Betty; Allis, Kevin; Angus-Hornbuckle, Carolyn; Crevier, Francys","Hearing/Testimony",,"false","23982"
"23944","Considerations for the Use of Real-World Evidence to Assess the Effectiveness of Preventive Vaccines","U.S. Food and Drug Administration","2020-09-30T00:00:00.000","Video or Multimedia","This two-day workshop, held on September 17-18, 2020, was organized to exchange information with stakeholders from industry, academia, and government about the scientific, clinical, and regulatory challenges and opportunities in using real-world evidence to assess the effectiveness of preventive vaccines. It included a discussion of emerging infectious diseases (e.g., coronavirus, Ebola, influenza pandemics) and other scenarios (e.g., maternal immunization to prevent disease in infants through the use of licensed/recommended vaccines) in which traditional clinical trials could be impractical or ethically unacceptable.","https://www.fda.gov/vaccines-blood-biologics/workshops-meetings-conferences-biologics/considerations-use-real-world-evidence-assess-effectiveness-preventive-vaccines-09172020-09182020","Gruber, Marion; Roberts, Jeff; Forshee, Rich; Cavaleri, Marco; Izurieta, Hector","Conference/Meeting Material","Scroll down this page for recordings and agenda.","false","23944"
"23939","Study of the COVID-19 Outbreak and Response in Connecticut Long-Term Care Facilities","Mathematica","2020-09-30T00:00:00.000","PDF","This 157-page report assesses the COVID-19 outbreak in long-term care (LTC) facilities in Connecticut. It recommends ways to help the state and LTC facilities prevent future infectious disease outbreaks, and identifies immediate and achievable steps the state and LTC industry can take to prepare for a second wave of COVID-19.","https://www.mathematica.org/our-publications-and-findings/publications/fr-a-study-of-the-covid-19-outbreak-and-response-in-connecticut-long-term-care-facilities","Rowan, Patricia; Gupta, Reena; Lester, Rebecca; Levere, Michael; Liao, Kristie","Report",,"false","23939"
"23936","Guidance Related to the Emergency Preparedness Testing Exercise Requirements-Coronavirus Disease (COVID-19)","Centers for Medicare & Medicaid Services","2020-09-30T00:00:00.000","PDF","This nine-page worksheet presents guidance for surveyors, as well as providers and suppliers, with relevant scenarios on meeting the emergency preparedness testing requirements in light of many of the response activities associated with the COVID-19 Public Health Emergency (PHE). CMS regulations for emergency preparedness require specific testing exercises be conducted to validate a facility’s emergency program.","https://www.cms.gov/files/document/qso-20-41-all.pdf",,"Guideline/Assessment Tool",,"false","23936"
"23935","Ransomware Guide","U.S. Department of Homeland Security","2020-09-30T00:00:00.000","PDF","This 16-page guide details practices that organizations should continuously engage in to help manage the risk posed by ransomware and other cyber threats. It provides actionable best practices for ransomware prevention, as well as a ransomware response checklist that can serve as a ransomware-specific addendum to organization cyber incident response plans.","https://www.cisa.gov/publication/ransomware-guide",,"Guideline/Assessment Tool","Direct link to document: https://www.cisa.gov/sites/default/files/publications/CISA_MS-ISAC_Ransomware%20Guide_S508C.pdf","false","23935"
"23918","Fact Sheet for Healthcare Providers: Alimetrix SARS-CoV-2 RT-PCR Assay","U.S. Food and Drug Administration","2020-09-30T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Alimetrix SARS-CoV-2 RT-PCR Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142590/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142591/downloadLink to Letter of Authorization: https://www.fda.gov/media/142589/downloadLink to EUA Summary: https://www.fda.gov/media/142592/download","false","23918"
"23906","Fact Sheet for Healthcare Providers: Aeon Global Health SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-09-30T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Aeon Global Health SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142533/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142534/downloadLink to Letter of Authorization: https://www.fda.gov/media/142532/downloadLink to EUA Summary: https://www.fda.gov/media/142535/download","false","23906"
"23410","Guidance on the Use of Personal Protective Equipment (PPE) for Pediatric Care in Ambulatory Care Settings During the SARS-CoV-2 Pandemic","American Academy of Pediatrics","2020-09-30T00:00:00.000","Text","This web page, updated on September 30, 2020, provides guidance for mitigating the risk of infection for all who work or receive care in pediatric ambulatory settings, including the appropriate use of personal protective equipment (PPE) along with consistent and effective infection prevention and control practices.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/guidance-on-the-use-of-personal-protective-equipment-ppe-for-pediatric-care-in-ambulatory-care-settings-during-the-sars-cov-2-pandemic/",,"Guideline/Assessment Tool",,"false","23410"
"23409","COVID-19 Testing Guidance","American Academy of Pediatrics","2020-09-30T00:00:00.000","Text","This guidance, updated on September 30, 2020, was developed to help pediatric practices determine when to test for severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2) infection in their patient population.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-testing-guidance/",,"Guideline/Assessment Tool",,"false","23409"
"21017","COVID-19 Guidance for Schools Kindergarten to Grade 12","Public Health Agency of Canada","2020-09-30T00:00:00.000","Text","This guidance, updated on September 30, 2020, provides information for both public and private institutions providing K-12 education programs in the classroom setting. It takes into consideration the diverse needs of population groups based on vulnerability, ethnicity/culture, disability, developmental status, and other socioeconomic and demographic factors.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/guidance-schools-childcare-programs.html",,"Guideline/Assessment Tool",,"false","21017"
"24031","Guidance on the Use of Influenza Vaccine in the Presence of COVID-19","Government of Canada","2020-09-29T00:00:00.000","Text","The guidance on this web page is designed to support provincial and territorial vaccine programs and primary care providers in offering influenza vaccine during the COVID-19 pandemic. Topics include delivery and administration of influenza vaccine during COVID-19 pandemic, and who should receive the influenza vaccine during COVID-19 pandemic.","https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-use-influenza-vaccine-covid-19.html",,"Guideline/Assessment Tool",,"false","24031"
"23952","EU Laboratory Capability Monitoring System (EULabCap), 2018","European Union, European Centre for Disease Prevention and Control","2020-09-29T00:00:00.000","PDF","This 44-page, fifth consecutive report of the European Union Laboratory Capability (EULabCap) monitoring program presents European Union/European Economic Area (EU/EEA) laboratory capabilities and capacities in 2018, and the trends of previous survey results over the period 2013–2018.","https://www.ecdc.europa.eu/en/publications-data/eu-laboratory-capability-monitoring-system-eulabcap-2018","Leitmeyer, Katrin; Struelens, Marc","Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/EULabCap-survey-2018.pdf","false","23952"
"23923","Preventing Global Catastrophic Biological Risks","Nuclear Threat Initiative","2020-09-29T00:00:00.000","PDF","This 32-page report summarizes the exercise scenario and discussion from a scenario-based tabletop exercise designed to identify gaps in global capabilities to prevent and respond to high-consequence biological events, which was held in February 2020. It includes recommendations from the organizers.","https://www.nti.org/analysis/reports/preventing-global-catastrophic-biological-risks/","Cameron, Beth; Eckles, Jacob; Jordan, Jacob; Yassif, Jaime","Instructional/Training Material","Direct link to document: https://media.nti.org/documents/NTI_BIO_TTX_RPT_FINAL.pdfLink to the exercise website, which includes videos: https://www.nti.org/about/projects/global-catastrophic-biological-risks/preventing-global-catastrophic-biological-risks-tabletop-exercise-2020-munich-security-conference/","false","23923"
"23912","Fact Sheet for Healthcare Providers: SARS-CoV-2 Mass Array Test","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the SARS-CoV-2 Mass Array Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142546/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142547/downloadLink to Letter of Authorization: https://www.fda.gov/media/142545/downloadLink to EUA Summary: https://www.fda.gov/media/142548/download","false","23912"
"23911","Fact Sheet for Healthcare Providers: Akron Children’s Hospital SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Akron Children’s Hospital SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142541/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142542/downloadLink to Letter of Authorization: https://www.fda.gov/media/142540/downloadLink to EUA Summary: https://www.fda.gov/media/142543/download","false","23911"
"23910","Fact Sheet for Healthcare Providers: CentoSure SARS-CoV-2 RT-PCR Assay","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CentoSure SARS-CoV-2 RT-PCR Assay. The CentoSure SARS-CoV-2 RT-PCR Assay is authorized for use with dry oropharyngeal swab specimens from individuals without symptoms or other reasons to suspect COVID-19.","https://www.fda.gov/media/142537/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142538/downloadLink to Letter of Authorization: https://www.fda.gov/media/142536/downloadLink to EUA Summary: https://www.fda.gov/media/142539/download","false","23910"
"23909","Fact Sheet for Healthcare Providers: Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit. The Nirmidas COVID-19 (SARS-CoV-2) IgM/IgG Antibody Detection Kit is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (dipotassium EDTA and lithium heparin) specimens.","https://www.fda.gov/media/142559/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142560/downloadLink to Letter of Authorization: https://www.fda.gov/media/142558/downloadLink to Instructions for Use: https://www.fda.gov/media/142561/download","false","23909"
"23908","Fact Sheet for Healthcare Providers: FREND COVID-19 total Ab","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the FREND COVID-19 total Ab. The FREND COVID-19 total Ab is authorized for the qualitative detection of total antibodies to SARS-CoV-2 in human dipotassium EDTA plasma.","https://www.fda.gov/media/142555/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142556/downloadLink to Letter of Authorization: https://www.fda.gov/media/142554/downloadLink to Instructions for Use: https://www.fda.gov/media/142557/download","false","23908"
"23907","Fact Sheet for Healthcare Providers: LIAISON SARS-CoV-2 IgM","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the LIAISON SARS-CoV-2 IgM. The LIAISON SARS-CoV-2 IgM is authorized for the detection of IgM antibodies to SARS-CoV-2 in human serum and plasma (sodium heparin, lithium heparin, and dipotassium EDTA).","https://www.fda.gov/media/142550/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142551/downloadLink to Letter of Authorization: https://www.fda.gov/media/142549/downloadLink to Instructions for Use: https://www.fda.gov/media/142552/download","false","23907"
"23891","Strengthening Health Security Across the Globe: Progress and Impact of U.S. Government Investments in the Global Health Security Agenda","U.S. Department of State","2020-09-29T00:00:00.000","PDF","This 28-page document is the fourth Global Health Security Agenda (GHSA) annual report. It details the progress and impact of investments made by the United States in the GHSA to protect against infectious disease threats and their subsequent adverse effects on global health, security, and the economy.","https://www.state.gov/wp-content/uploads/2020/09/GHSA_ProgressImpactFY19_final.pdf",,"Report",,"false","23891"
"22775","Webinar Series - Respirators and Other Personal Protective Equipment (PPE) for Health Care Personnel Use During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-09-29T00:00:00.000","Text","This web page provides information about a webinar series, starting on September 29, 2020, discussing the importation of respirators during the COVID-19 pandemic, and the Food and Drug Administration's collaboration with the Centers for Disease Control and Prevention on the sampling and testing of international respirators in support of the FDA's respirator Emergency Use Authorizations.","https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/webinar-series-respirators-and-other-personal-protective-equipment-ppe-health-care-personnel-use",,"Instructional/Training Material",,"false","22775"
"23934","COVID-19: Management of Staff and Exposed Patients and Residents in Health and Social Care Settings","United Kingdom Department of Health","2020-09-28T00:00:00.000","Text","This guidance provides advice on the management of staff and patients or residents in health and social care settings according to COVID-19 exposures, symptoms, and test results. It includes guidance for staff with symptoms of COVID-19, and staff return to work criteria.","https://www.gov.uk/government/publications/covid-19-management-of-exposed-healthcare-workers-and-patients-in-hospital-settings",,"Guideline/Assessment Tool",,"false","23934"
"23933","COVID-19: How to Work Safely in Care Homes","United Kingdom Department of Health","2020-09-28T00:00:00.000","Video or Multimedia","These print and video guidance materials for those working in care homes provide information on how to work safely during this period of sustained transmission of COVID-19, including information about personal protective equipment and case studies.","https://www.gov.uk/government/publications/covid-19-how-to-work-safely-in-care-homes",,"Guideline/Assessment Tool","Link to Case Scenarios for Health Care Workers: https://www.gov.uk/government/publications/covid-19-how-to-work-safely-in-care-homes/case-scenarios-for-health-care-workers","false","23933"
"23899","National Public Health Framework for the Prevention and Control of Vector-Borne Diseases in Humans","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-28T00:00:00.000","PDF","Five federal departments and the Environmental Protection Agency contributed to developing this 16-page national framework for vector-borne disease prevention and control, which includes federal activities necessary to detect, prevent, and control vector-borne diseases in humans in the United States.","https://www.cdc.gov/ncezid/dvbd/framework.html",,"Report","Direct link to document: https://www.cdc.gov/ncezid/dvbd/pdf/Brochure_National_Framework_VBDs-P.pdf","false","23899"
"23696","COVID-19 Target Product Profiles for Priority Diagnostics to Support Response to the COVID-19 Pandemic v.0.1","World Health Organization","2020-09-28T00:00:00.000","PDF","The World Health Organization has published this 38-page final version of Target Product Profiles (TPP), updated on September 28, 2020, for priority COVID-19 diagnostics. These TPPs describe the desirable and minimally acceptable profiles for four tests.","https://www.who.int/publications/m/item/covid-19-target-product-profiles-for-priority-diagnostics-to-support-response-to-the-covid-19-pandemic-v.0.1",,"Guideline/Assessment Tool","Direct link to document: https://www.who.int/docs/default-source/blue-print/who-rd-blueprint-diagnostics-tpp-final-v1-0-28-09-jc-ppc-final-cmp.pdf?sfvrsn=af73a99a_2&download=true","false","23696"
"24047","Housing and Shelter During a Pandemic Webinar Series","Naval Postgraduate School, Center for Homeland Security and Defense","2020-09-25T00:00:00.000","Video or Multimedia","This web page provides information and links for a webinar series discussing the challenges and emerging model practices for housing, sheltering, and congregate population management during the COVID-19 pandemic.","https://www.chds.us/c/item/17353",,"Instructional/Training Material",,"false","24047"
"24038","Risk Mitigation Tool for Child and Youth Settings Operating During the COVID-19 Pandemic","Government of Canada","2020-09-25T00:00:00.000","Text","This tool will assist school boards and operators of child and youth settings in considering risks to children/youth, staff, and volunteers during the coronavirus disease (COVID-19) pandemic, and provide examples of strategies that may be implemented to mitigate potential risks.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/covid-19-risk-mitigation-tool-child-youth-settings-operating-during-pandemic.html",,"Guideline/Assessment Tool",,"false","24038"
"23953","Pertussis: Annual Epidemiological Report for 2018","European Union, European Centre for Disease Prevention and Control","2020-09-25T00:00:00.000","PDF","This eight-page report provides information about pertussis cases in 2018, when there were 35,627 cases of pertussis reported by 30 European Union/European Economic Area (EU/EEA) countries. Five countries - Germany, the Netherlands, Norway, Spain, and the United Kingdom (UK) - accounted for 72 percent of all notified cases.","https://www.ecdc.europa.eu/en/publications-data/pertussis-annual-epidemiological-report-2018",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2018_pertussis.pdf","false","23953"
"23943","COVID-19: Current State of the Pandemic","National Emerging Special Pathogens Training and Education Center","2020-09-25T00:00:00.000","Video or Multimedia","This 53-minute webinar describes the current COVID-19 pandemic hotspots in the U.S. and globally, including the epidemiology of the current wave of infections. It also discusses country-wide testing needs to mitigate and suppress COVID-19 infections, reviews the evidence regarding possible re-infections of COVID-19, and interprets the data behind the newest therapeutic guidelines for COVID-19.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1318","Tennill, Trish; Klinger, Amanda; Mukherjee, Vikram","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/53cf2eb5e0fc5d60650c7f9024e4e23b.pdf","false","23943"
"23900","COVID-19 Vaccine Planning Information Session for Tribal Communities","National Indian Health Board","2020-09-25T00:00:00.000","Video or Multimedia","The purpose of this one-hour, four-minute webinar is to introduce Tribal leaders to COVID-19 vaccine distribution options and planning considerations. It includes an overview of the federal government’s COVID-19 vaccine planning activities, and highlights considerations for Tribal leaders and health organizations serving Tribal and urban Indian communities making decisions about vaccine distribution.","https://www.youtube.com/watch?v=pCQXZljE4fw&feature=youtu.be","Whicker, Marion; Groom, Amy; Vigario, Jennifer","Instructional/Training Material","Link to Centers for Disease Control and Prevention (CDC) Presentation Vaccine Planning Webinar Slides: https://www.nihb.org/covid-19/wp-content/uploads/2020/09/CDC-Presentation-Vaccine-Planning-Webinar_9_24_Final.pdfLink to Indian Health Service (IHS) Presentation Vaccine Planning Webinar Slides: https://www.nihb.org/covid-19/wp-content/uploads/2020/09/IHS-Presentation-for-NIHB_final_09252020.pdf","false","23900"
"23897","Fact Sheet for Healthcare Providers: MosaiQ COVID-19 Antibody Magazine","U.S. Food and Drug Administration","2020-09-25T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MosaiQ COVID-19 Antibody Magazine. The MosaiQ COVID-19 Antibody Magazine is authorized for the detection of total (IgM and IgG) antibodies to SARS-CoV-2 in human serum and dipotassium (K2) and tripotassium (K3)EDTA plasma.","https://www.fda.gov/media/142484/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142485/downloadLink to Letter of Authorization: https://www.fda.gov/media/142483/downloadLink to Instructions for Use: https://www.fda.gov/media/142486/download","false","23897"
"23896","Fact Sheet for Healthcare Providers: Genetrack SARS-CoV-2 Molecular Assay","U.S. Food and Drug Administration","2020-09-25T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Genetrack SARS-CoV-2 Molecular Assay. The Genetrack SARS-CoV-2 Molecular Assay is authorized for use with anterior nasal swab specimens self-collected at home using the Vo’ COVID-19 Test Home Collection Kit by individuals suspected of COVID-19 when home collection is determined to be appropriate by their healthcare provider.","https://www.fda.gov/media/142480/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142481/downloadLink to Letter of Authorization: https://www.fda.gov/media/142479/downloadLink to EUA Summary: https://www.fda.gov/media/142482/download","false","23896"
"23841","Topic Collection: COVID-19 and Outreach Efforts: Resources for Communication Tools and Social Media Assets in a COVID-19 Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-25T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources to effectively communicate to diverse populations in the COVID-19 environment.","https://asprtracie.hhs.gov/technical-resources/152/covid-19-and-outreach-efforts-resources-for-communication-tools-and-social-media-assets-in-a-covid-19-environment",,"Bibliography/Resource List",,"false","23841"
"23840","Topic Collection: COVID-19 and Minority/Vulnerable Populations: Resources for Outreach and Protection of At-Risk Individuals in a COVID-19 Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-25T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources to engage and protect minority and vulnerable populations in the COVID-19 environment.","https://asprtracie.hhs.gov/technical-resources/148/covid-19-and-minority-vulnerable-populations-resources-for-outreach-and-protection-of-at-risk-individuals-in-a-covid-19-environment",,"Bibliography/Resource List",,"false","23840"
"23839","Topic Collection: COVID-19 and K-12 Schools: Resources for Operating K-12 Schools in a COVID-19 Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-25T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources related to ways K-12 schools across the country are operating in the COVID-19 environment.","https://asprtracie.hhs.gov/technical-resources/151/covid-19-and-k-12-schools-resources-for-operating-k-12-schools-in-a-covid-19-environment",,"Bibliography/Resource List",,"false","23839"
"23838","Topic Collection: COVID-19 and Institutions of Higher Education (IHE): Resources for Operating IHEs in a COVID-19 Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-25T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources related to ways institutions of higher education (IHEs) across the country are operating in the COVID-19 environment.","https://asprtracie.hhs.gov/technical-resources/147/covid-19-and-institutions-of-higher-education-ihe-resources-for-operating-ihes-in-a-covid-19-environment",,"Bibliography/Resource List",,"false","23838"
"23837","Topic Collection: COVID-19 and Critical Infrastructure and Businesses: Resources for Operating Critical Infrastructure in a COVID-19 Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-25T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources related to how critical infrastructure and businesses across the country are operating in the COVID-19 environment.","https://asprtracie.hhs.gov/technical-resources/150/covid-19-and-critical-infrastructure-and-businesses-resources-for-operating-critical-infrastructure-in-a-covid-19-environment",,"Bibliography/Resource List",,"false","23837"
"23836","Topic Collection: COVID-19 and Community and Faith-Based Organizations Resources for Operating in a COVID-19 Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-25T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources related to ways community and faith-based organizations across the country are operating in the COVID-19 environment.","https://asprtracie.hhs.gov/technical-resources/149/covid-19-and-community-and-faith-based-organizations-resources-for-operating-in-a-covid-19-environment",,"Bibliography/Resource List",,"false","23836"
"23833","Modelling the Allocation and Impact of a COVID-19 Vaccine","Imperial College London","2020-09-25T00:00:00.000","PDF","This 21-page report identifies optimal vaccine allocation strategies within and between countries to maximize health (avert deaths) under constraints on dose supply. It extended an existing mathematical model of SARS-CoV-2 transmission across different country settings to model the public health impact of potential vaccines, using a range of target product profiles developed by the World Health Organization.","https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-33-vaccine/","Hogan, Alexandra; Winskill, Peter; Watson, Oliver; Walker, Patrick; Whittaker, Charles","Report","Direct link to document: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-09-25-COVID19-Report-33.pdf","false","23833"
"23978","Digital Contact Tracing and Data Protection Law","Congressional Research Service [Library of Congress]","2020-09-24T00:00:00.000","PDF","This 47-page report discusses how data privacy and security (together, data protection) law applies to a public health authority’s use of digital contact tracing tools, the role of technology in assisting with contact tracing, and potential privacy concerns. Appendix A provides Digital Contact Tracing Apps By State.","https://crsreports.congress.gov/product/pdf/R/R46542","Gaffney, Jonathan; Holmes, Eric; Linebaugh, Chris","Report",,"false","23978"
"23967","Capacity Building for Improved Behavioral Health in Rural America: Resilience in the Wake of COVID-19","Michigan State University","2020-09-24T00:00:00.000","Video or Multimedia","This one-hour, two-minute webinar seeks to summarize challenges with opioid and other substance misuse, emphasizing related problems for rural communities in the wake of COVID-19; highlight opportunities to address these challenges through science-based prevention programming, using illustrations from work on virtual trainings to enhance resilience; and share recent developments in capacity building for science-based prevention programming in rural communities, focusing on the National Behavioral Health Extension Network (NBH E-Net).","https://www.youtube.com/watch?v=iYC-Z9TE8BM&feature=youtu.be","Spoth, Richard; Pliler, Greg; Knutson, Cassandra","Instructional/Training Material",,"false","23967"
"23898","Fact Sheet for Healthcare Providers: Emergency Use of the COViage System During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-09-24T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COViage System (or “COViage”) for use by healthcare providers in the hospital setting for adult patients (18 years of age or older who are admitted to the hospital) with confirmed COVID-19 (based on a positive PCR test result) for the computation of proprietary patient status indices referred to as Respiratory Decompensation Status and Hemodynamic Instability Status as an adjunct to patient monitoring during the COVID-19 outbreak.","https://www.fda.gov/media/142452/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142455/downloadLink to Letter of Authorization: https://www.fda.gov/media/142454/downloadLink to Instructions for Use: https://www.fda.gov/media/142453/download","false","23898"
"23860","Children’s Health and Well-Being During the Coronavirus Pandemic","Henry J. Kaiser Family Foundation","2020-09-24T00:00:00.000","Text","This brief examines how a range of economic and societal disruptions stemming from COVID-19 may affect the health and well-being of children and families. It finds that school openings/closures, social distancing, loss of health coverage, and disruptions in medical care could negatively impact the health and well-being children in the U.S.","https://www.kff.org/coronavirus-covid-19/issue-brief/childrens-health-and-well-being-during-the-coronavirus-pandemic/","Garfield, Rachel; Chidambaram, Priya","Report",,"false","23860"
"23846","Fact Sheet for Healthcare Providers: Emergency Use of the Duke University COVIAGE","U.S. Food and Drug Administration","2020-09-24T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers  of the significant known and potential risks and benefits of the emergency use of COVIAGE. This device is authorized for use by healthcare personnel (HCP) as an extra layer of protection in addition to personal protective equipment (PPE) to prevent HCP exposure to pathogenic biological airborne particulates by providing isolation of hospitalized patients with suspected or confirmed diagnosis of COVID-19, at the time of definitive airway management, when performing airway-related medical procedures, or during certain transport of such patients during the COVID-19 pandemic.","https://www.fda.gov/media/142450/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142451/downloadLink to Letter of Authorization: https://www.fda.gov/media/142447/downloadLink to Instructions for Healthcare Facilities: https://www.fda.gov/media/142448/downloadLink to Instructions for Healthcare Personnel: https://www.fda.gov/media/142449/download","false","23846"
"23845","Fact Sheet for Healthcare Providers: Xpert Xpress SARS-CoV-2/Flu/RSV","U.S. Food and Drug Administration","2020-09-24T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Xpert Xpress SARS-CoV-2/Flu/RSV test. The Xpert Xpress SARS-CoV-2/Flu/RSV test is authorized for use with certain respiratory specimens collected from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider.","https://www.fda.gov/media/142435/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142436/downloadLink to Letter of Authorization: https://www.fda.gov/media/142434/downloadLink to Instructions for Labs: https://www.fda.gov/media/142437/downloadLink to Instructions for Point-of-Care: https://www.fda.gov/media/142438/download","false","23845"
"23842","Biological Event Horizon: No Return or Total Resilience","Bipartisan Commission on Biodefense","2020-09-24T00:00:00.000","Video or Multimedia","This three-hour, 41-minute virtual meeting was held to better understand emerging biological threats and novel science and technology solutions for biodefense. Participants discuss how the ongoing novel coronavirus 2019 (COVID-19) pandemic is revealing major gaps in national readiness to prepare for, respond to, and recover from biological threats.","https://biodefensecommission.org/events/the-biological-event-horizon-no-return-or-total-resilience-2/","Brooks, Susan; DeGette, Diana; Yassif, Jaime; Ramachandran, Sahini; Madhav, Nita","Conference/Meeting Material",,"false","23842"
"23835","COVID-19: Optimizing Healthcare Personal Protective Equipment and Supplies","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-24T00:00:00.000","Video or Multimedia","This one-hour, 32-minute webinar from TRACIE (Technical Resources, Assistance Center, and Information Exchange) discusses federal authorities and COVID-19, NIOSH activities supporting respirator supply optimization, and healthcare and related applications standards gaps supporting supply optimization.","https://register.gotowebinar.com/recording/6725411770768669448","Hintz, Leslie; Ignacio, Joselito; Hick, John L.; D'Alessandro, Maryann","Instructional/Training Material","Site requires free registration.Link to presentation slides: https://files.asprtracie.hhs.gov/documents/aspr-tracie-optimizing-healthcare-ppe-webinar-ppt-final.pdfLink to Q&A: https://files.asprtracie.hhs.gov/documents/aspr-tracie-covid-19-optimizing-ppe-and-supplies-webinar-q-and-a.pdfThis training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1093722.","false","23835"
"23825","Increased Transmission of COVID-19 in the EU/EEA and the UK – Twelfth Update","European Union, European Centre for Disease Prevention and Control","2020-09-24T00:00:00.000","PDF","This 27-page update analyzes the risk posed to the general population, vulnerable individuals, and healthcare provision by the current increase in COVID-19 case notification rates observed in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK).","https://www.ecdc.europa.eu/en/publications-data/covid-19-risk-assessment-increased-transmission-twelfth-update",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-risk-assessment-increased-transmission-12th-update-september-2020.pdfLink to related infographic: https://www.ecdc.europa.eu/en/publications-data/infographic-increased-transmission-covid-19-eueea-and-uk","false","23825"
"23824","Guidelines for the Implementation of Non-Pharmaceutical Interventions Against COVID-19","European Union, European Centre for Disease Prevention and Control","2020-09-24T00:00:00.000","PDF","The guidelines in this 38-page report detail available options for non-pharmaceutical interventions against COVID-19 in various epidemiologic scenarios, assess the evidence for their effectiveness, and address implementation issues, including potential barriers and facilitators.","https://www.ecdc.europa.eu/en/publications-data/infographic-non-pharmaceutical-measures",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidelines-non-pharmaceutical-interventions-september-2020.pdfLink to related infographic: https://www.ecdc.europa.eu/sites/default/files/images/covid-19-non-pharmaceutical-measures-infographic.png","false","23824"
"21058","List N: EPA’s Registered Antimicrobial Products for Use  Against Novel Coronavirus SARS-CoV-2","U.S. Environmental Protection Agency","2020-09-24T00:00:00.000","Text","This interactive web page, updated on September 24, 2020, provides an expanded list of over 420 EPA-registered disinfectant products that have qualified for use against SARS-CoV-2, the novel coronavirus that causes COVID-19. It has enhanced functionality to allow users to sort these products by surface type and use site.","https://www.epa.gov/pesticide-registration/list-n-advanced-search-page-disinfectants-coronavirus-covid-19",,"Guideline/Assessment Tool","This page includes a link to the list in a PDF document.Link to List N Tool: COVID-19 Disinfectants (mobile app): https://cfpub.epa.gov/giwiz/disinfectants/index.cfmLink to FAQs (English): https://www.epa.gov/coronavirus/frequent-questions-about-disinfectants-and-coronavirus-covid-19Link to Spanish Lista N: Desinfectantes para usar contra SARS-CoV-2: https://espanol.epa.gov/espanol/lista-n-desinfectantes-para-usar-contra-sars-cov-2Link to FAQs in Spanish:  Preguntas frecuentes sobre la Lista N: Desinfectantes para usar contra SARS-CoV-2 https://espanol.epa.gov/espanol/preguntas-frecuentes-sobre-la-lista-n-desinfectantes-para-usar-contra-sars-cov-2Link to Portuguese: Lista N: Desinfetantes para uso contra SARS-CoV-2: https://www.epa.gov/lep/lista-n-desinfetantes-para-uso-contra-sars-cov-2Link to FAQs in Portuguese: Perguntas frequentes sobre desinfetantes e coronavírus (COVID-19): https://www.epa.gov/lep/perguntas-frequentes-sobre-desinfetantes-e-coronavirus-covid-19","false","21058"
"20827","Guidelines for the Implementation of Non-Pharmaceutical Interventions Against COVID-19","European Union, European Centre for Disease Prevention and Control","2020-09-24T00:00:00.000","PDF","This 38-page document, updated on September 24, 2020, provides guidelines that detail available options for non-pharmaceutical interventions against COVID-19 in various epidemiologic scenarios, assess the evidence for their effectiveness, and address implementation issues, including potential barriers and facilitators.","https://www.ecdc.europa.eu/en/publications-data/covid-19-guidelines-non-pharmaceutical-interventions",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-guidelines-non-pharmaceutical-interventions-september-2020.pdf","false","20827"
"24104","PanVax Tool for Pandemic Vaccination Planning","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-23T00:00:00.000","Text","The PanVax tool is a Microsoft Excel-based instrument that guides jurisdictional planning and outreach efforts during preparedness activities. The tool helps local planners understand how their vaccine providers (i.e., pharmacies, clinics, hospitals, employers, schools, points of dispensing) might contribute to the community’s vaccination response during a severe pandemic.","https://www.cdc.gov/flu/pandemic-resources/tools/panvax-tool.htm",,"Guideline/Assessment Tool","Link to manual: https://www.cdc.gov/flu/pandemic-resources/tools/downloads/PanVaxManual_v3.3.pdfLink to Excel file: https://www.cdc.gov/flu/pandemic-resources/tools/downloads/PanVaxPlanningTool_v3.3.xlsxLink to resource in Spanish: https://espanol.cdc.gov/flu/pandemic-resources/tools/panvax-tool.htm","false","24104"
"24035","Interim Guidance: Death Care Services and Handling of Dead Bodies During the Coronavirus Disease (COVID-19) Pandemic","Government of Canada","2020-09-23T00:00:00.000","Text","This guidance is intended for death care providers, including funeral homes, cemeteries and crematorium operators, medical examiners, coroners, medical personnel, and any other personnel community members in remote and isolated communities, who will be handling dead bodies of deceased persons confirmed or suspected to have been infected with COVID-19, or in regions with high levels of community transmission.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/death-care-services-handling-dead-bodies.html",,"Guideline/Assessment Tool",,"false","24035"
"24028","Preparing Health Care Providers for a COVID-19 Vaccine","American Health Law Association","2020-09-23T00:00:00.000","Video or Multimedia","Attorneys advising health care providers and entities, from inside or outside the providers, should take time now to prepare for the legal issues that will ultimately arise once successful development and deployment of an effective COVID-19 vaccine is possible. Even as the COVID-19 pandemic places intense stress on health care providers and legal institutions, it is important to engage with the area of vaccine law to help plan ahead and chart the way out of this crisis. This webinar covers these issues, as well as other relevant, pertinent aspects of vaccine law.","https://educate.americanhealthlaw.org/local/catalog/view/product.php?productid=77","Abramson, Brian Dean; Williamson, Jerry","Instructional/Training Material","Site requires free registration.","false","24028"
"23889","Focusing on Employee Safety While Responding to COVID-19","Alabama Department of Public Health","2020-09-23T00:00:00.000","Video or Multimedia","This one-hour, 30-minute webinar provides information on safety measures employees should consider and practice when conducting drive-through and drive-up screening or vaccination services during the COVID-19 response.","https://www.alabamapublichealth.gov/alphtn/ondemand/2020/09-23.html","Garrett, Carol; Harrison, Kenneth; Persky, Leigh; Poe, William","Instructional/Training Material","Site requires free registration.","false","23889"
"23858","New Behavioral Health Tool for the COVID-19 Era","National Center for Disaster Medicine and Public Health [Uniformed Services University of the Health Sciences]","2020-09-23T00:00:00.000","Video or Multimedia","Presenters in this 56-minute webinar, held in collaboration with the Center for Study in Traumatic Stress (CSTS), discuss the recently published Second Edition of the Curriculum Recommendations for Disaster Health and its application, including for COVID-19.","https://www.youtube.com/watch?v=uP75rgbVQSw&feature=youtu.be","Strauss-Riggs, Kandra ; Flynn, Brian; Morganstein, Joshua; Vance, Mary","Instructional/Training Material","Link to the curriculum: https://www.usuhs.edu/sites/default/files/media/ncdmph/pdf/ncdmph_csts_revised.pdf","false","23858"
"23832","Fact Sheet for Healthcare Providers: Orawell IgM/IgG Rapid Test","U.S. Food and Drug Administration","2020-09-23T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Orawell IgM/IgG Rapid Test. The Orawell IgM/IgG Rapid Test is authorized for the detection of antibodies to SARS-CoV-2 in human serum and acid citrate dextrose (ACD) plasma.","https://www.fda.gov/media/142421/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142424/downloadLink to Letter of Authorization: https://www.fda.gov/media/142423/downloadLink to Instructions for Use: https://www.fda.gov/media/142422/download","false","23832"
"23831","Fact Sheet for Healthcare Providers: Clear Dx SARS-CoV-2 Test","U.S. Food and Drug Administration","2020-09-23T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Clear Dx SARS-CoV-2 Test. The Clear Dx SARS-CoV-2 Test is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142417/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142420/downloadLink to Letter of Authorization: https://www.fda.gov/media/142419/downloadLink to Instructions for Use: https://www.fda.gov/media/142418/download","false","23831"
"23826","Updated Evidence to Support the Emergency Use of COVID-19 Convalescent Plasma","U.S. Food and Drug Administration","2020-09-23T00:00:00.000","PDF","This five-page document describes four lines of evidence that continue to support the emergency use of  COVID-19 Convalescent Plasma at this time, one month after initial issuance of the Emergency Use Authorization: 1) historical data regarding prior experience with the use of convalescent plasma in other outbreak settings; 2) data from animal studies; 3) data that continues to emerge in the published literature from clinical studies performed during the current outbreak; and 4) results obtained from a large expanded access treatment protocol (National Expanded Program).","https://www.fda.gov/media/142386/download",,"Guideline/Assessment Tool",,"false","23826"
"23817","Data for Decision-Making: Responsible Management of Data During COVID-19 and Beyond","U.S. House of Representatives, Committee on Science, Space, and Technology","2020-09-23T00:00:00.000","Video or Multimedia","This one-hour, 17-minute Congressional hearing focuses on how data drives the decision-making at every level of the response to COVID-19, and how ensuring the integrity, transparency, and accuracy of this data is crucial to keeping everyone safe and prepared.","https://science.house.gov/hearings/data-for-decision-making-responsible-management-of-data-during-covid-19-and-beyond","Johnson, Eddie Bernice; Foster, Bill; Lee, Lisa; Maragakis, Lisa; Roy, Avik","Hearing/Testimony",,"false","23817"
"23816","Health Care Lifeline: The Affordable Care Act and the COVID-19 Pandemic","U.S. House of Representatives, Committee on Energy and Commerce","2020-09-23T00:00:00.000","Video or Multimedia","Witnesses in this four-hour, eight-minute Congressional hearing discuss the Affordable Care Act (ACA)’s impact on the status of health coverage amidst COVID-19, and what needs to be done to expand and improve access to quality, affordable health care.","https://energycommerce.house.gov/committee-activity/hearings/hearing-on-health-care-lifeline-the-affordable-care-act-and-the-covid-19","Pallone, Jr., Frank; Aron-Dine, Aviva; Cameron, Dean; Holtz-Eakin, Douglas; Lee, Peter","Hearing/Testimony",,"false","23816"
"23811","COVID-19: An Update on the Federal Response","U.S. Senate, Committee on Health, Education, Labor, and Pensions","2020-09-23T00:00:00.000","Video or Multimedia","Witnesses in this three-hour, 18-minute Congressional hearing discuss the Department of Health and Human Services’ ongoing response to the COVID-19 pandemic, and how each of their agencies and offices are working to prevent, diagnose, and treat the novel coronavirus SARS-CoV-2.","https://www.help.senate.gov/hearings/covid-19-an-update-on-the-federal-response","Fauci, Anthony S.; Redfield, Robert; Giroir, Brett; Hahn, Stephen","Hearing/Testimony",,"false","23811"
"22909","Fact Sheet for Healthcare Providers: Assure COVID-19 IgG/IgM Rapid Test Device-Assure Tech. (Hangzhou Co., Ltd)","U.S. Food and Drug Administration","2020-09-23T00:00:00.000","PDF","This three-page fact sheet, updated on September 23, 2020, informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Assure COVID-19 IgG/IgM Rapid Test Device. The Assure COVID-19 IgG/IgM Rapid Test Device is authorized for the detection of IgG and IgM antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA).","https://www.fda.gov/media/139790/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/139791/downloadLink to Letter of Authorization: https://www.fda.gov/media/139789/downloadLink to Instructions for Use: https://www.fda.gov/media/139792/download","false","22909"
"23819","Fact Sheet for Healthcare Providers: ViroKey SARS-CoV-2 RT-PCR Test v2.0","U.S. Food and Drug Administration","2020-09-22T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ViroKey SARS-CoV-2 RT-PCR Test v2.0. The ViroKey SARS-CoV-2 RT-PCR Test v2.0 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142381/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142382/downloadLink to Letter of Authorization: https://www.fda.gov/media/142380/downloadLink to Instructions for Use: https://www.fda.gov/media/142383/download","false","23819"
"23818","Fact Sheet for Healthcare Providers: Clarifi COVID-19 Test Kit","U.S. Food and Drug Administration","2020-09-22T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Clarifi COVID-19 Test Kit. The Clarifi COVID-19 Test Kit is authorized for use with saliva swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142377/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142378/downloadLink to Letter of Authorization: https://www.fda.gov/media/142376/downloadLink to Instructions for Use: https://www.fda.gov/media/142379/download","false","23818"
"23797","Guidance for Reopening Buildings After Prolonged Shutdown or Reduced Operation","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-22T00:00:00.000","Text","This web page recommends checking for hazards before reopening a building after a prolonged period of building inactivity, and provides guidance about mold, Legionella and Legionnaires’ disease, and lead and copper.","https://www.cdc.gov/coronavirus/2019-ncov/php/building-water-system.html",,"Guideline/Assessment Tool","Link to page in Spanish: https://www.cdc.gov/coronavirus/2019-ncov/php/building-water-system-esp.html","false","23797"
"23793","GLASS Whole-Genome Sequencing for Surveillance of Antimicrobial Resistance","World Health Organization","2020-09-22T00:00:00.000","PDF","This 72-page document from the Global Antimicrobial Resistance and Use Surveillance System (GLASS) addresses the applications of whole-genome sequencing (WGS) for antimicrobial resistance (AMR) surveillance, including the benefits and limitations of current WGS technologies. Local, subnational, national and international case studies are included as examples of use of WGS in AMR surveillance.","https://www.who.int/publications/i/item/9789240011007",,"Report","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1304087/retrieve","false","23793"
"24205","COVID-19 Vaccine Introduction Readiness Assessment Tool","World Health Organization","2020-09-21T00:00:00.000","Text","This readiness assessment tool is a national level tool in an Excel spreadsheet. Data inputs should be entered into the worksheet National Readiness. Suggestions for timing and intervals to implement activities and assess progress are provided in the timeline.","https://www.who.int/publications/i/item/WHO-2019-nCoV-Vaccine-introduction-RA-Tool-2020.1",,"Guideline/Assessment Tool","Direct link to spreadsheet: https://apps.who.int/iris/rest/bitstreams/1312921/retrieve","false","24205"
"24177","Mental Health in a Time of Crisis","CORE Group","2020-09-21T00:00:00.000","Video or Multimedia","This one-hour, 31-minute webinar discusses the importance of mental health, especially in times of crisis like the current COVID-19 pandemic when already scarce resources are often pulled for other priorities. The conversation pays particular attention to the need for mental health services to be highly contextualized and responsive to the needs and perspectives of people with lived experience.","https://coregroup.org/webinar/mental-health-in-a-time-of-crisis/","Fast, Paul Shelter; Farmer, Mychelle; Raviola, Guiseppe; Sunkel, Charlene; Devkota, Matrika","Instructional/Training Material","Site requires free registration.Link to presentation slides: https://coregroup.org/wp-content/uploads/2020/10/Session4_CORE_NCDWebinar_MentalHealth_v1c_FINAL.Oct19.pptx","false","24177"
"24159","Preparing Countries for COVID-19 Vaccine Introduction","World Health Organization","2020-09-21T00:00:00.000","PDF","There are immediate actions that countries can take to prepare for COVID-19 vaccines. This two-page document provides a brief summary of pre-planning actions that all countries can begin working on immediately.","https://apps.who.int/iris/handle/10665/336187",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/336187/WHO-2019-nCoV-Vaccine_introduction-2020.1-eng.pdf?sequence=1&isAllowed=y","false","24159"
"23861","Behavioral Health Care and COVID- 19: The Next Phase","Mental Health Technology Transfer Center Network","2020-09-21T00:00:00.000","Video or Multimedia","As COVID-19 infections reach the six-month and six-million infected mark in the United States, behavioral health organizations are finding themselves having to move beyond rapid infectious disease preparations and on to a ""next phase"" of care. This one-hour webinar explores the ongoing approaches to care and how they are evolving to best meet the needs.","https://mhttcnetwork.org/centers/southeast-mhttc/product/behavioral-health-care-and-covid-19-next-phase","Raney, Lori","Instructional/Training Material","Site requires free registration.","false","23861"
"23822","In Response: Yan et al Preprint Examinations of the Origin of SARS-CoV-2","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-09-21T00:00:00.000","PDF","This 13-page document undertakes a scientific review of a recent report, released as a preprint put forward by the Rule of Law Society, which presents a theory about the origin of SARS-CoV-2 but offers contradictory and inaccurate information that does not support their argument.","https://www.centerforhealthsecurity.org/our-work/publications/in-response-yan-et-al-preprint-examinations-of-the-origin-of-sars-cov-2","Warmbrod, Kelsey; West, Rachel; Connell, Nancy; Gronvall, Gigi","Report","Direct link to document: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200921-in-response-yan.pdf","false","23822"
"23813","WHO SAGE Seasonal Influenza Vaccination Recommendations during the COVID-19 Pandemic","World Health Organization","2020-09-21T00:00:00.000","PDF","This four-page document provides interim recommendations from the WHO Strategic Advisory Group of Experts (SAGE) on Immunization for influenza vaccination during the COVID-19 pandemic. It also provides programmatic considerations for national authorities planning and conducting their influenza vaccination programs, as well as research  considerations to address current knowledge gaps.","https://www.who.int/immunization/policy/position_papers/Interim_SAGE_influenza_vaccination_recommendations.pdf",,"Guideline/Assessment Tool",,"false","23813"
"23801","Fact Sheet for Healthcare Providers: KimForest SARS-CoV-2 Detection Kit v1","U.S. Food and Drug Administration","2020-09-21T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the KimForest SARS-CoV-2 Detection Kit v1. The KimForest SARS-CoV-2 Detection Kit v1 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142361/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142362/downloadLink to Letter of Authorization: https://www.fda.gov/media/142360/downloadLink to Instructions for Use: https://www.fda.gov/media/142363/download","false","23801"
"23799","Reinfection with SARS-CoV-2: Considerations for Public Health Response","European Union, European Centre for Disease Prevention and Control","2020-09-21T00:00:00.000","PDF","The aim of this 14-page Threat Assessment Brief is to elucidate the characteristics and frequency of confirmed SARS-CoV-2 reinfection in the literature, to summarize the findings about SARS-CoV-2 infection and antibody development, and to consider several questions about reinfection and transmission.","https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-reinfection-sars-cov-2",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/Re-infection-and-viral-shedding-threat-assessment-brief.pdf","false","23799"
"23789","COVID-19: Federal Efforts Could Be Strengthened by Timely and Concerted Actions","U.S. Government Accountability Office","2020-09-21T00:00:00.000","PDF","This 371-page report updates the GAO's oversight of federal actions to support public health, individuals, and the economy during the COVID-19 pandemic, and details evolving lessons learned relevant to the nation’s response to pandemics. It provides 16 recommendations for federal agencies.","https://www.gao.gov/products/GAO-20-701",,"Report","Direct link to document: https://www.gao.gov/assets/710/709492.pdf","false","23789"
"21684","PREP Act and COVID-19: Limiting Liability for Medical Countermeasures","Congressional Research Service [Library of Congress]","2020-09-21T00:00:00.000","PDF","The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of Health and Human Services (HHS) to limit legal liability for losses relating to the administration of medical countermeasures such as diagnostics, treatments, and vaccines. This six-page report, updated on September 21, 2020, reviews the structure of the PREP Act and the HHS Declaration to explain the scope of this liability immunity as it applies to COVID-19 countermeasures.","https://crsreports.congress.gov/product/pdf/LSB/LSB10443","Hickey, Kevin","Report",,"false","21684"
"21312","FDA Guidance on Conduct of Clinical Trials of Medical Products During the COVID-19 Public Health Emergency","U.S. Food and Drug Administration","2020-09-21T00:00:00.000","PDF","The Food and Drug Administration (FDA) has issued this 35-page guidance, updated on September 21, 2020, to provide general considerations to assist sponsors in assuring the safety of trial participants in the conduct of clinical trials of medical products, maintaining compliance with good clinical practice (GCP), and minimizing risks to trial integrity during the COVID-19 (coronavirus) pandemic.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/fda-guidance-conduct-clinical-trials-medical-products-during-covid-19-public-health-emergency",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/136238/download","false","21312"
"20662","Interim Laboratory Biosafety Guidelines for Handling and Processing Specimens Associated with Coronavirus Disease 2019 (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-19T00:00:00.000","Text","This web page, updated on September 19, 2020, provides general and specific biosafety guidelines for handling COVID-19 specimens, as well as information about clinical laboratory testing; packing, shipping, and transport; and related resources. Updates include Standard Precautions.","https://www.cdc.gov/coronavirus/2019-nCoV/lab-biosafety-guidelines.html",,"Guideline/Assessment Tool",,"false","20662"
"23919","Maintaining Essential Health Services During COVID-19 in Low-Resource, Non-U.S. Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-18T00:00:00.000","PDF","The purpose of this guidance is to provide ministries of health, public health authorities, and implementing partners with a framework for implementing strategies to reduce preventable illness and death during the COVID-19 pandemic in persons with non-COVID-19 illness and injury, particularly in low-resource settings.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/essential-health-services.html",,"Guideline/Assessment Tool",,"false","23919"
"23856","Adult Social Care: Our COVID-19 Winter Plan 2020 to 2021","United Kingdom Department of Health","2020-09-18T00:00:00.000","Text","This web page sets out the key elements of COVID-19 national support available for the social care sector for winter 2020 to 2021, as well as the main actions to take for local authorities, National Health Service organizations, and social care providers, including in the voluntary and community sector.","https://www.gov.uk/government/publications/adult-social-care-coronavirus-covid-19-winter-plan-2020-to-2021/adult-social-care-our-covid-19-winter-plan-2020-to-2021",,"Report",,"false","23856"
"23790","Fact Sheet for Healthcare Providers: GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT","U.S. Food and Drug Administration","2020-09-18T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT. The GK ACCU-RIGHT SARS-CoV-2 RT-PCR KIT is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142308/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142309/downloadLink to Letter of Authorization: https://www.fda.gov/media/142307/downloadLink to Instructions for Use: https://www.fda.gov/media/142310/download","false","23790"
"23782","Monitoring and Evaluation Checklist for K-12 Schools","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-18T00:00:00.000","Text","As K-12 schools reopen for in-person instruction, it is important to have systems in place for the monitoring and evaluation of COVID-19 mitigation strategies. Monitoring and evaluation provide practical information for making timely decisions, addressing community needs, and identifying best practices to promote the health, safety, and well-being of students, faculty, and staff.","https://www.cdc.gov/coronavirus/2019-ncov/php/monitoring-evaluation-checklist-k-12.html",,"Guideline/Assessment Tool",,"false","23782"
"23780","Large-Scale Geographic Seroprevalence Surveys","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-18T00:00:00.000","Text","CDC is conducting seroprevalence surveys called “large-scale geographic seroprevalence surveys” in locations across the United States. The first seroprevalence surveys began in areas that first reported community transmission of SARS-CoV-2 in the United States; they are now being expanded to more regions. Descriptions of these surveys are provided on this web page.","https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-seroprevalence-surveys.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-seroprevalence-surveys.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-seroprevalence-surveys.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-seroprevalence-surveys.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/cases-updates/geographic-seroprevalence-surveys.html","false","23780"
"23516","Contact Tracing: Frequently Asked Questions; Information for Health Departments","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-18T00:00:00.000","Text","This web page, updated on September 18, 2020, provides answers to frequently asked questions about contact tracing, with topics covering basics, and digital tools and information. It also provides links to additional resources.","https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing-faq.html",,"Fact Sheet",,"false","23516"
"23412","COVID-19 Interim Guidance: Return to Sports","American Academy of Pediatrics","2020-09-18T00:00:00.000","Text","This web page, updated on September 18, 2020, provides new guidance for pediatricians to inform families on how to mitigate risk and prevent the spread of SARS-CoV-2 to others both within sport and within families and the community.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-interim-guidance-return-to-sports/",,"Guideline/Assessment Tool",,"false","23412"
"22168","Breastfeeding Guidance Post Hospital Discharge for Mothers or Infants with Suspected or Confirmed SARS-Co V-2 Infection","American Academy of Pediatrics","2020-09-18T00:00:00.000","Text","This guidance, updated on September 18, 2020, was developed to support pediatricians providing direct care for breastfeeding families after discharge from the newborn hospital stay during the COVID-19 pandemic. Post-discharge guidance and education are essential to support families, ensure the health of mothers and infants, and ensure mothers are able to reach their breastfeeding goals.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/breastfeeding-guidance-post-hospital-discharge/",,"Guideline/Assessment Tool",,"false","22168"
"24045","Public Health Webinar Series on Blood Disorders: Update on COVID-19 and Thrombosis Risk","Centers for Disease Control and Prevention","2020-09-17T00:00:00.000","Video or Multimedia","Participants in this one-hour webinar will learn to summarize the evidence from peer-reviewed publications of COVID-19-associated venous thromboembolism (VTE); describe proposed mechanisms by which COVID-19 may increase the risk for VTE; and recount the latest guidelines for preventing VTE in patients who are hospitalized for COVID-19.","https://www.youtube.com/watch?v=79Wvkr3YlWI&feature=youtu.be","Garcia, David; Sanfilippo, Kristen; Cukor, Adam","Instructional/Training Material",,"false","24045"
"23890","Advancing the Response to COVID-19: Sharing Promising Programs and Practices for Racial and Ethnic Minority Communities","U.S. Department of Health and Human Services","2020-09-17T00:00:00.000","Video or Multimedia","The Health and Human Services Office of Minority Health (OMH) hosted this virtual symposium to highlight state, tribal, territorial, and community-based efforts to address COVID-19 among racial and ethnic minority and American Indian and Alaska Native populations. It featured national, state, tribal and local experts leading efforts developed for public health leaders at all levels and community organizations confronting the pandemic.","https://www.minorityhealth.hhs.gov/omh/Content.aspx?ID=17502&lvl=2&lvlid=12&","Azar, Alex; Collins, Felicia; Giroir, Brett; Liburd, Leandris; Adams, Jerome","Conference/Meeting Material",,"false","23890"
"23773","REMOVE: Guidance on Removing Hazardous Substances","United Kingdom Department of Health","2020-09-17T00:00:00.000","Text","This web page provides guidance that is designed to help people respond safely to incidents involving hazardous substances, including acid attacks.","https://www.gov.uk/government/publications/remove-guidance-on-removing-hazardous-substances",,"Guideline/Assessment Tool",,"false","23773"
"23762","Testing and Treatment of 2020-2021 Seasonal Influenza During the COVID-19 Pandemic","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-09-17T00:00:00.000","Video or Multimedia","Speakers in this one-hour, 18-minute Clinician Outreach and Communication Activity (COCA) call provide an overview of CDC’s recommendations for health care providers regarding influenza diagnostics and the use of antiviral medications for the 2020-2021 influenza season, including considerations during the ongoing COVID-19 pandemic.","https://emergency.cdc.gov/coca/calls/2020/callinfo_091720.asp","Campbell, Angela; Uyeki, Timothy","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/COCA-Call-Slides_091720_Final.pdf","false","23762"
"23759","Age Groups that Sustain Resurging COVID-19 Epidemics in the United States","Imperial College London","2020-09-17T00:00:00.000","PDF","This 32-page report discusses how adults aged 20-49 are a main driver of the COVID-19 epidemic in the United States; yet, in areas with resurging epidemics, opening schools will lead to more COVID-19-attributable deaths, so more targeted interventions in the 20-49 age group could bring epidemics under control, avert deaths, and facilitate the safe reopening of schools.","https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-32-us/","Monod, Melodie; Blenkinsop, Alexandra; Xi, Xiaoyue; Hebert, Daniel; Bershan, Sivan","Report","Direct link to document: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/2020-09-17-COVID19-Report-32.pdf","false","23759"
"23750","Baseline Projections of COVID-19 in the EU/EEA and the UK: Update","European Union, European Centre for Disease Prevention and Control","2020-09-17T00:00:00.000","PDF","This 34-page report provides updated 30-day projections that illustrate potential future trends in COVID-19 transmission in the European Union/European Economic Area (EU/EEA) countries and the United Kingdom. They are presented with the inherent model assumptions and uncertainties.","https://www.ecdc.europa.eu/en/publications-data/baseline-projections-covid-19-eueea-and-uk-update",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/ECDC-30-day-projections-Sept-2020.pdf","false","23750"
"16615","Emergency Preparedness and Response Operations","Centers for Medicare & Medicaid Services","2020-09-17T00:00:00.000","Text","This web page, updated on September 17, 2020, provides information about emergency response and recovery programs at the Centers for Medicare and Medicaid Services (CMS). It describes CMS actions on recent disasters and emergencies, and provides information about emergency preparedness, response, and recovery.","https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/EPRO-Home",,"Web Page",,"false","16615"
"24144","Personal Protective Equipment for SARS-CoV-2","American Industrial Hygiene Association","2020-09-16T00:00:00.000","PDF","This five-page document about types of personal protective equipment is for workers who may be expected to be in contact with known or potentially contagious clients or members of the public, or with exposure to SARS-CoV-2, during their jobs.","https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Guidance-Documents/Personal-Protective-Equipment-for-SARS-CoV-2-Guidance-Document.pdf","Fuller, Thomas; Smith, Michele","Guideline/Assessment Tool","Link to Spanish version: https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Personal-Protective-Equipment-for-SARS-CoV-2-White-Paper_Spanish.pdf","false","24144"
"23993","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: Family Assistance Center (FAC) During the COVID-19 Pandemic","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-16T00:00:00.000","PDF","This three-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources in response to a request for response plans and planning documents for establishing a family assistance center (FAC) during the COVID-19 pandemic.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta-fac-during-covid-19-09-16-2020.pdf",,"Bibliography/Resource List",,"false","23993"
"23977","Medical Supply Chains and Policy Options: The Data Challenge","Congressional Research Service [Library of Congress]","2020-09-16T00:00:00.000","PDF","This three-page report details the data from an annual government survey of U.S. manufacturers, analyzed in conjunction with official U.S. trade statistics, that provides some insight into domestic medical supply production activities, including personal protective equipment and pharmaceuticals, and a rough estimate of the share that some imported medical products make up in total U.S. supply.","https://crsreports.congress.gov/product/pdf/IF/IF11648","Schwarzenberg, Andres; Sutter, Karen","Report",,"false","23977"
"23950","Evidence to Support Safe Return to Clinical Practice by Oral Health Professionals in Canada During the COVID-19 Pandemic","Government of Canada","2020-09-16T00:00:00.000","Text","This report is a comprehensive knowledge product concerning key issues that inform the provision of oral health care by relevant providers in Canada during the COVID-19 pandemic. It will be updated several times over the course of 2020-2021.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/health-professionals/evidence-safe-return-clinical-practice-oral-health.html",,"Report",,"false","23950"
"23948","Considerations for Infants and Toddlers During Disasters","Child Care Aware of America","2020-09-16T00:00:00.000","Video or Multimedia","This one-hour webinar features a discussion of the experiences of child care providers who have been impacted by emergencies, the ways Child Care Resource & Referral (CCR&R) agencies support their work, and the concrete steps agencies and child care providers can take to address the safety and wellbeing of infants and toddlers in emergencies.","https://info.childcareaware.org/ty-page-redirect-considerations-for-infants-and-toddlers-during-disasters","Coats, Julie Looper; Nett, Holly; Ritter, Jillian","Instructional/Training Material","Site requires free registration.","false","23948"
"23946","Avoiding Barriers to Access for a COVID-19 Vaccine","Johns Hopkins University, Bloomberg School of Public Health","2020-09-16T00:00:00.000","Video or Multimedia","In this one-hour, four-minute webinar, leaders and scientists in the international vaccine field discuss the barriers to vaccine access that must be overcome and avoided, and the role the international community will play in promoting equity in delivering a COVID-19 vaccine.","https://www.jhsph.edu/ivac/2020/08/26/webinar-avoiding-barriers-to-access-for-a-covid-19-vaccine/","Kim, Jerome; Bar-Zeev, Naor","Instructional/Training Material","Link to presentation slides: https://www.jhsph.edu/ivac/wp-content/uploads/2020/09/Presentation_Barriers-to-Vaccine-Access.pdf","false","23946"
"23786","Engaging Community Health Workers to Support Home-Based Care for People with COVID-19 in Low-Resource Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-16T00:00:00.000","Text","This web page provides suggestions for how Community Health Workers (CHWs) can support home-based care in low resource settings, including different actions CHWs can implement to support patients, their families, and their communities during COVID-19, and how to identify which people are eligible for home-based care.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/home-based-care.html",,"Guideline/Assessment Tool",,"false","23786"
"23785","Emergency Shelters in Disaster Response in Global, Low Resource Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-16T00:00:00.000","Text","This web page provides suggestions to assist disaster response shelter management and staff in taking appropriate actions for reducing the possibility of COVID-19 virus spread among shelter staff, volunteers, residents, and visitors before, during, or after a disaster.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/emergency-shelters-low-resource-global.html",,"Guideline/Assessment Tool",,"false","23785"
"23784","Frequently Asked Questions: Calculating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) RT-PCR Laboratory Test Percent Positivity","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-16T00:00:00.000","Text","This web page answers frequently asked questions about calculating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) RT-PCR laboratory test percent positivity, including how a high percent positivity can be reduced.","https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/calculating-percent-positivity-faq.html",,"Fact Sheet",,"false","23784"
"23783","Healthcare Workers: N95 and Other Respirators","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-16T00:00:00.000","Text","This web page describes N95 and other respirators, and how to learn strategies to optimize supplies of N95 respirators when supply is limited.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/n95-other-respirators.html",,"Guideline/Assessment Tool",,"false","23783"
"23771","Fact Sheet for Healthcare Providers: Visby Medical COVID-19","U.S. Food and Drug Administration","2020-09-16T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Visby Medical COVID-19. The Visby Medical COVID-19 is authorized for use with nasopharyngeal, nasal, or mid-turbinate swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/142226/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142227/downloadLink to Letter of Authorization: https://www.fda.gov/media/142225/downloadLink to Instructions for Use: https://www.fda.gov/media/142228/download","false","23771"
"23752","Review of Coronavirus Response Efforts","U.S. Senate, Committee on Appropriations","2020-09-16T00:00:00.000","Video or Multimedia","This three-hour, 12-minute Congressional hearing features witnesses who discuss the Department of Health and Human Services’ ongoing response to the COVID-19 pandemic, and address how each of their agencies and offices are harnessing innovation to prevent, diagnose, and treat the novel coronavirus SARs-CoV-2.","https://www.appropriations.senate.gov/hearings/review-of-coronavirus-response-efforts","Blunt, Roy; Redfield, Robert; Kadlec, Robert; Giroir, Brett","Hearing/Testimony",,"false","23752"
"23739","From the Factory to the Frontlines: The Operation Warp Speed Strategy for Distributing a COVID-19 Vaccine","U.S. Department of Health and Human Services","2020-09-16T00:00:00.000","PDF","This 11-page report to Congress details a strategy to achieve the principal purpose and objective of Operation Warp Speed (OWS): ensuring that every American who wants to receive a COVID-19 vaccine can receive one, by delivering safe and effective vaccine doses to the American people beginning January 2021.","https://www.hhs.gov/sites/default/files/strategy-for-distributing-covid-19-vaccine.pdf",,"Guideline/Assessment Tool","Link to COVID-19 Vaccine Distribution Process Infographic: https://media.defense.gov/2020/Sep/16/2002498504/-1/-1/1/OWS-VACCINE-DISTRIBUTION-GRAPHIC.pdf","false","23739"
"23738","COVID-19 Vaccination Program Interim Playbook for Jurisdiction Operations","Centers for Disease Control and Prevention","2020-09-16T00:00:00.000","PDF","This 57-page document serves as an interim playbook for state, territorial, and local public health programs and their partners on how to plan and operationalize a vaccination response to COVID-19 within their jurisdictions. The document’s sections cover specific areas of COVID-19 vaccination program planning and implementation, and provide key guidance documents and links to resources to assist those efforts.","https://www.cdc.gov/vaccines/imz-managers/downloads/COVID-19-Vaccination-Program-Interim_Playbook.pdf",,"Guideline/Assessment Tool",,"false","23738"
"22050","Ten Clinical Tips on COVID-19 for Healthcare Providers Involved in Patient Care","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-16T00:00:00.000","Text","This web page, updated on September 16, 2020, provides 10 clinical steps on COVID-19 for healthcare providers regarding Treatment and Prophylaxis, Symptoms and Diagnosis, Co-Infections, and Severe Illness.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-tips-for-healthcare-providers.html",,"Guideline/Assessment Tool",,"false","22050"
"21990","Homelessness and COVID-19 FAQs","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-16T00:00:00.000","Text","This web page, updated on September 16, 2020, provides answers to frequently asked questions about homeless and COVID-19, including about protection, shelters, and encampments.","https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/faqs.html",,"Fact Sheet","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/faqs.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/faqs.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/faqs.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/faqs.html","false","21990"
"17902","Continuity Resources and Technical Assistance: Federation Continuity Directives 1 and 2","Federal Emergency Management Agency [Department of Homeland Security]","2020-09-16T00:00:00.000","Text","This web page, updated in September 2020, provides information about FEMA’s National Continuity Programs, which provide outreach and technical assistance to whole community partners across the nation.","https://www.fema.gov/emergency-managers/national-preparedness/continuity",,"Guideline/Assessment Tool","Direct link to Federal Continuity Directive 1: https://www.fema.gov/media-library-data/1486472423990-f640b42b9073d78693795bb7da4a7af2/January2017FCD1.pdfDirect link to Federal Continuity Directive 2: https://www.fema.gov/media-library-data/1499702987348-c8eb5e5746bfc5a7a3cb954039df7fc2/FCD-2June132017.pdfDirect link to Continuity Risk Toolkit: https://www.fema.gov/media-library-data/1517503126676-1047d362dc8eb1bcaf92316879061b92/ContinuityRiskToolkit.pdf","false","17902"
"23854","Coronavirus Lessons Summary (2020)","Wildland Fire Lessons Learned Center","2020-09-15T00:00:00.000","PDF","This web page provides links to Coronavirus Rapid Lesson Sharing Reports, starting in June 2020.","https://www.wildfirelessons.net/orphans/viewincident?DocumentKey=1d838a70-f78c-4c47-a949-bde579427760",,"Report",,"false","23854"
"23850","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: Pediatric Infectious Disease Surge in Long-Term Care Facilities","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-15T00:00:00.000","PDF","This six-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides a list of resources in response to a request to conduct a literature search on pediatric surge of infectious disease at long-term care (LTC) facilities.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta---pediatric-infectious-disease-surge-in-ltc---9-15-2020.pdf",,"Bibliography/Resource List",,"false","23850"
"23812","COVID-19 in Pregnancy: Clinical, Research and Therapeutics Updates Virtual Workshop","National Institutes of Health","2020-09-15T00:00:00.000","Video or Multimedia","This five-hour, 47-minute workshop brings together experts in the field to discuss the progress and challenges in obstetric therapeutic research and patient care, share experiences in clinical management of pregnant women and newborns with COVID-19, and explore effective approaches to obstetric therapeutics during the COVID-19 pandemic.","http://www.cvent.com/events/covid-19-in-pregnancy-clinical-research-and-therapeutics-updates-virtual-workshop/event-summary-8c525a40fea1459e9b89f48e94b8ebb9.aspx",,"Instructional/Training Material","Link to recording: https://videocast.nih.gov/watch=38459","false","23812"
"23800","COVID-19 Testing Strategies and Objectives","European Union, European Centre for Disease Prevention and Control","2020-09-15T00:00:00.000","PDF","This 22-page document outlines strategies and objectives for sustainable SARS-CoV-2 testing of populations to achieve specific public health objectives in various epidemiological situations. General population-wide testing, as well as targeted testing of individuals, or specific populations related to particular settings, are presented on the basis of country experiences and information collected from scientific literature.","https://www.ecdc.europa.eu/en/publications-data/covid-19-testing-strategies-and-objectives",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/TestingStrategy_Objective-Sept-2020.pdfLink to related infographic:  https://www.ecdc.europa.eu/en/publications-data/infographic-objectives-covid-19-testing-strategies","false","23800"
"23761","SARS-CoV-2 Reference Panel Comparative Data","U.S. Food and Drug Administration","2020-09-15T00:00:00.000","Text","The FDA has published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The tables show the Limit of Detection (LoD) of more than 55 authorized molecular diagnostic COVID-19 tests against a standardized sample panel provided by the FDA. The FDA provided these standardized samples, known as a reference panel, to test developers who are required to assess their test’s performance against this panel (or other FDA-recommended reference materials) as a condition of their Emergency Use Authorization (EUA).","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/sars-cov-2-reference-panel-comparative-data",,"Guideline/Assessment Tool",,"false","23761"
"23744","Universal Screening for SARS‐CoV‐2 Infection: A Rapid Review","Cochrane Library","2020-09-15T00:00:00.000","PDF","This 75-page report details a rapid review to assess the effectiveness of universal screening for SARS‐CoV‐2 infection compared with no screening, and the accuracy of universal screening in people who have not presented to clinical care for symptoms of COVID‐19.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013718/full","Viswanathan, Meera; Kahwati, Leila; Jahn, Beate; Giger, Kayla; Dobrescu, Andreea","Report","Direct link to document: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013718/epdf/fullLink to abstract in Spanish: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013718/full/es#CD013718-abs-0003","false","23744"
"23741","Telehealth and Health Equity: Considerations for Addressing Health Disparities during the COVID-19 Pandemic","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-09-15T00:00:00.000","Video or Multimedia","In this one-hour, six-minute Clinician Outreach and Communication Activity (COCA) webinar, presenters discuss the intersection of telehealth and health equity and implications for health services during the COVID-19 pandemic. They identify long-standing systemic health and social inequities that contribute to COVID-19 health disparities, while highlighting opportunities and limitations of telehealth implementation as an actionable solution.","https://emergency.cdc.gov/coca/calls/2020/callinfo_091520.asp","Liburd, Leandris; McDow, Kendra; Alli, Kemi","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/2_COCA_Call-Slides_091520_Final.pdf","false","23741"
"23736","Indicators for Dynamic School Decision-Making","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-15T00:00:00.000","Text","This web page provides indicators to help schools make dynamic decisions about in-person learning as local conditions evolve throughout the COVID-19 pandemic. When coupled with local data about community spread, these indicators are an important tool to help local health officials, school administrators, and communities prepare, plan, and respond to COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/indicators.html",,"Guideline/Assessment Tool","Link to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/indicators.html","false","23736"
"23735","Estimating Under-Ascertainment of COVID-19 Mortality: An Analysis of Novel Data Sources to Provide Insight into COVID-19 Dynamics in Damascus, Syria","Imperial College London","2020-09-15T00:00:00.000","PDF","This 46-page report estimates the potential under-ascertainment of COVID-19 mortality in Damascus, Syria, where all-cause mortality data has been reported between July 25 and August 1, 2020. It fits a mathematical model of COVID-19 transmission to reported COVID-19 deaths in Damascus since the beginning of the pandemic and compares the model-predicted deaths to reported excess deaths.","https://www.imperial.ac.uk/mrc-global-infectious-disease-analysis/covid-19/report-31-syria/","Watson, Oliver; Alhaffar, Mervat; Mehchy, Zaki; Whittaker, Charles; Akil, Zack","Report","Direct link to document: https://www.imperial.ac.uk/media/imperial-college/medicine/mrc-gida/15-09-2020-COVID19-Report-31.pdf","false","23735"
"23277","Practice Reopening Guidance","American Academy of Family Physicians","2020-09-15T00:00:00.000","Text","This web page, updated on September 15, 2020, provides guidance for physicians who are considering re-opening their practices during the COVID-19 pandemic. It includes a Checklist to Support Reopening and Promote Safety.","https://www.aafp.org/family-physician/patient-care/current-hot-topics/recent-outbreaks/covid-19/covid-19-practice-management/practice-reopening-guidance.html",,"Guideline/Assessment Tool",,"false","23277"
"21892","Operational Considerations for Personal Protective Equipment in the Context of Global Supply Shortages for Coronavirus Disease 2019 (COVID-19) Pandemic: Non-US Healthcare Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-15T00:00:00.000","Text","This web page, updated on September 15, 2020, provides specific operational considerations that healthcare settings and healthcare authorities can review in the context of global supply shortages of personal protective equipment (PPE), to help with decision-making in order to provide needed surge capacity during the COVID-19 response.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/emergency-considerations-ppe.html",,"Guideline/Assessment Tool",,"false","21892"
"21731","Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19: Part 1","Infectious Diseases Society of America","2020-09-15T00:00:00.000","Text","This web page, updated on September 15, 2020, provides evidence-based rapid guidelines intended to support patients, clinicians, and other healthcare professionals in their decisions about treatment and management of patients with COVID-19. The guideline panel agreed on seven treatment recommendations, and provided narrative summaries of other treatments undergoing evaluations.","https://www.idsociety.org/practice-guideline/covid-19-guideline-treatment-and-management/","Bhimraj, Adarsh; Morgan, Rebecca; Shumaker, Amy Hirsch; Lavergne, Valery; Baden, Lindsey","Guideline/Assessment Tool","Link to Part 2: Infection Protection: https://www.idsociety.org/practice-guideline/covid-19-guideline-infection-prevention/Link to Part 3: Diagnostics: https://www.idsociety.org/practice-guideline/covid-19-guideline-diagnostics/Link to Part 4: Serology: https://www.idsociety.org/practice-guideline/covid-19-guideline-serology/","false","21731"
"21672","Management of Visitors to Healthcare Facilities in the Context of COVID-19: Non-US Healthcare Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-15T00:00:00.000","Text","This web page, updated on September 15, 2020, provides guidance to healthcare facilities on the management of visitors to reduce the risk of transmission of SARS-CoV-2, also known as COVID-19 virus, to visitors of patients with suspected or confirmed COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/hcf-visitors.html",,"Guideline/Assessment Tool",,"false","21672"
"23828","Loneliness Among Older Adults Before and During the COVID-19 Pandemic","University of Michigan","2020-09-14T00:00:00.000","Text","The University of Michigan National Poll on Healthy Aging (NPHA) asked a national sample of U.S. adults age 50–80 about lack of companionship and isolation (loneliness), social interactions, and health behaviors in June 2020. This was a follow-up to a similar NPHA survey conducted in October 2018 among a different national sample. The comparisons that follow show a substantial increase in loneliness among older adults from before the COVID-19 pandemic to the period March–June 2020.","https://www.healthyagingpoll.org/",,"Report",,"true","23828"
"23772","Fact Sheet for Healthcare Providers: MAGLUMI 2019-nCoV IgM/IgG","U.S. Food and Drug Administration","2020-09-14T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MAGLUMI 2019-nCoV IgM/IgG. The MAGLUMI 2019-nCoV IgM/IgG is authorized for the detection of antibodies to SARS-CoV-2 in human serum and serum in separating gel tubes (SST).","https://www.fda.gov/media/142231/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142232/downloadLink to Letter of Authorization: https://www.fda.gov/media/142230/downloadLink to Instructions for Use: https://www.fda.gov/media/142233/download","false","23772"
"23768","WHO SAGE (Strategic Advisory Group of Experts on Immunization) Values Framework for the Allocation and Prioritization of COVID-19 Vaccination","World Health Organization","2020-09-14T00:00:00.000","PDF","This 14-page Values Framework offers guidance globally on the allocation of COVID-19 vaccines between countries, and guidance nationally on the prioritization of groups for vaccination within countries while supply is limited. It has been endorsed by the Strategic Advisory Group of Experts on Immunization (SAGE).","https://apps.who.int/iris/bitstream/handle/10665/334299/WHO-2019-nCoV-SAGE_Framework-Allocation_and_prioritization-2020.1-eng.pdf?ua=1",,"Guideline/Assessment Tool",,"false","23768"
"23746","Fact Sheet for Healthcare Providers: cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System","U.S. Food and Drug Administration","2020-09-14T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the cobas SARS-CoV-2 & Influenza A/B Nucleic Acid Test for use on the cobas Liat System. Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by a healthcare provider. Symptoms of respiratory viral infection due to SARS-CoV-2 and influenza can be similar.","https://www.fda.gov/media/142191/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/142192/downloadLink to Letter of Authorization: https://www.fda.gov/media/142190/downloadLink to Instructions for Use: https://www.fda.gov/media/142193/download","false","23746"
"23728","World in Disorder: Global Preparedness Monitoring Board Annual Report 2020","World Health Organization","2020-09-14T00:00:00.000","PDF","This 52-page annual report provides a harsh assessment of the global COVID-19 response, warning that the world cannot afford to be unprepared again when the next pandemic hits. The Global Preparedness Monitoring Board calls for five urgent actions to be taken to bring order out of the catastrophe and chaos currently facing the world: responsible leadership; engaged citizenship; strong and agile systems for health security; sustained investment; and robust global governance of preparedness.","https://apps.who.int/gpmb/annual_report.html",,"Report","Direct link to document: https://apps.who.int/gpmb/assets/annual_report/GPMB_AR_2020_EN.pdfLink to executive summary in Arabic: https://apps.who.int/gpmb/assets/annual_report/GPMB_AWID_ES_2020_AR.pdfLink to executive summary in Chinese: https://apps.who.int/gpmb/assets/annual_report/GPMB_AWID_ES_2020_ZH.pdfLink to executive summary in French: https://apps.who.int/gpmb/assets/annual_report/GPMB_AWID_ES_2020_FR.pdfLink to executive summary in Russian: https://apps.who.int/gpmb/assets/annual_report/GPMB_AWID_ES_2020_RU.pdfLink to executive summary in Spanish: https://apps.who.int/gpmb/assets/annual_report/GPMB_AWID_ES_2020_ES.pdf","false","23728"
"23725","Topic Collection: Behavioral Health Compendium","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-14T00:00:00.000","Text","This interagency TRACIE (Technical Resources, Assistance Center, and Information Exchange) product, compiled by ASPR's Behavioral Health Team and the Division of Recovery, was designed to help regional emergency coordinators and federal and state planners support stakeholders in various areas of COVID-19 response and recovery. It features sections on steady state programs, grants, impacted HHS programs, online resources and training, waivers and flexibilities, and data sources, all of which include behavioral health components.","https://asprtracie.hhs.gov/technical-resources/146/behavioral-health-compendium/0",,"Bibliography/Resource List",,"false","23725"
"23721","Public Health Preparedness: Information on the Use of Medical Reserve Corps Volunteers during Emergencies","U.S. Government Accountability Office","2020-09-14T00:00:00.000","PDF","This 32-page report describes the number and type of Medical Reserve Corps volunteers; the types of public health emergencies volunteers have participated in; and how the Department of Health and Human Services (HHS) has assisted in developing volunteer capabilities.","https://www.gao.gov/products/GAO-20-630","Denigan-Macauley, Mary","Report","Direct link to document: https://www.gao.gov/assets/710/709350.pdf","false","23721"
"22223","Considerations for School-Related Public Health Measures in the Context of COVID-19","World Health Organization","2020-09-14T00:00:00.000","PDF","This 10-page document, updated on September 14, 2020, provides considerations for decision-makers and educators on how or when to reopen or close schools in the context of COVID-19. These decisions have important implications for children, parents or caregivers, teachers, and other staff, communities, and society at large.","https://www.who.int/publications/i/item/considerations-for-school-related-public-health-measures-in-the-context-of-covid-19",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1303058/retrieve","false","22223"
"23928","Guidance for Alternative Care Provision During COVID-19","Alliance for Child Protection in Humanitarian Action","2020-09-11T00:00:00.000","PDF","This 71-page document provides practical guidance to actors in humanitarian and development contexts on the adaptations and considerations needed to support children who are either currently in alternative care or are going into an alternative care placement during the COVID-19 pandemic.","https://www.alliancecpha.org/en/child-protection-online-library/guidance-alternative-care-provision-during-covid-19",,"Guideline/Assessment Tool","Direct link to document: https://www.alliancecpha.org/en/system/tdf/library/attachments/guidanceforalternativecarecovid19_0.pdf?file=1&type=node&id=40248","false","23928"
"23830","Collection: Chemical Hazards and Poisons Report","United Kingdom Department of Health","2020-09-11T00:00:00.000","Text","These documents provide chemical hazards and poisons information for health and emergency professionals involved in chemical incident response and preparedness, including first line responders such as fire and ambulance services.","https://www.gov.uk/government/collections/chemical-hazards-and-poisons-reports",,"Report",,"false","23830"
"23766","Health and Retirement Study","University of Michigan","2020-09-11T00:00:00.000","PDF","As a longitudinal study with rich measurement across a large number of social, health, and economic domains, the Health and Retirement Study (HRS) was designed to capture the impact of unexpected societal events, even without additional measurement specific to the event. To complement these longitudinal measures, HRS has developed several areas of content specifically in response to the coronavirus pandemic designed to dovetail with existing assessment. Information on lifestyle and psychosocial functioning is collected through a self-administered questionnaire (SAQ). Additional questions in the psychosocial SAQ were added to the 2020 wave of data collection. These questions obtain information on lifestyle, personal relationships, work, and feelings in response to the pandemic. These questions cover five subtopics: 1) pandemic-specific concerns related to health, finances, friends and family, and the future; 2) changes in social contact with family and friends, including social support given and received and changes in relationship quality; 3) impact on activities including pandemic-specific behaviors such as wearing a mask, washing hands, social distancing, and using hand sanitizer; 4) additional questions about work status that indicate if the respondent was an essential worker and whether or not they could work at home during the pandemic; and 5) emotional well-being, resilience, and coping during the pandemic.Population: Adults onlyLength: 77 questionsMode of Administration: Online (e.g., computer-assisted interview)Administered by: Professional InterviewerSelf AdministeredLanguage(s): EnglishHealth and Retirement Study: Core Interview COVID-19 Module: Full Survey https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module.pdfDirect Experience of COVID-19: General Symptoms; Diagnosis https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module_Experience.pdfHealth Care Access (general): Health Care https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module_Health_Care.pdfEconomic Impact Payments: Economic Insecurity https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module_Payments.pdfWork and Business: Employment; Economic Impact https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module_Employment.pdfLiving Arrangements: Housing Security; Home Life https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module_Living_Arrangements.pdfCaregiving: Community Assistance https://www.phenxtoolkit.org/toolkit_content/PDF/UMich_HRS_Module_Caregiving.pdf","https://hrs.isr.umich.edu/sites/default/files/meta/2020/core/qnaire/online/05hr20COVIDv2.pdf",,"Guideline/Assessment Tool","Free/Publicly AvailableWeb page for questionnaires: https://hrs.isr.umich.edu/data-products/covid-19 Web page for documentation, including a codebook: https://hrs.isr.umich.edu/documentationAvailable Formats: PDFContact Information: David WeirDirector of Health and Retirement Studydweir@umich.edu","true","23766"
"23754","Preprints and Peer Review in a Pandemic","Johns Hopkins University, Bloomberg School of Public Health","2020-09-11T00:00:00.000","Video or Multimedia","The COVID-19 pandemic has transformed the research publishing landscape as scientists investigate and try to understand the novel coronavirus SARS-CoV-2 and the complex disease it causes. This has led to unprecedented volume and speed in scientific publishing. This one-hour, 15-minute video presents speakers who discuss the risks and rewards of scientific publishing in this urgent and fast-paced environment.","https://www.jhsph.edu/events/2020/preprints-peer-review-in-a-pandemic/","Bauchner, Howard; Gurley, Emily; Krumholz, Harlan; Zimmer, Carl; Kirk, Gregory","Instructional/Training Material",,"false","23754"
"23749","From Grief to Endurance: Spiritual and Mental Health for the Long Haul","Wheaton College, Humanitarian Disaster Institute","2020-09-11T00:00:00.000","Video or Multimedia","This one-hour webinar presents a panel of experts who offer insight for addressing spiritual and mental health needs for the long haul during the COVID-19 pandemic, and understanding why it's important that we acknowledge our collective grief and look toward endurance.","https://vimeo.com/457940081","Aten, Jamie; Annan, Kent; Martin, Nicole; Louissaint, Nicolette; Monroe, Philip","Instructional/Training Material",,"false","23749"
"23712","Antigen-Detection in the Diagnosis of SARS-CoV-2 Infection Using Rapid Immunoassays","World Health Organization","2020-09-11T00:00:00.000","PDF","Acknowledging the inadequacy of current data on the performance and operational utility of tests using a lateral flow immunoassay (also called an RDT) that gives results in < 30 minutes, this nine-page document seeks to provide guidance to countries on considerations for integration into COVID-19 outbreak management programs.","https://www.who.int/publications/i/item/antigen-detection-in-the-diagnosis-of-sars-cov-2infection-using-rapid-immunoassays",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1302653/retrieve","false","23712"
"23711","Diagnostic Testing for SARS-CoV-2","World Health Organization","2020-09-11T00:00:00.000","PDF","This 20-page document provides interim guidance to laboratories and other stakeholders involved in diagnostics for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).  It covers the main considerations for specimen collection, nucleic acid amplification testing (NAAT), antigen (Ag), antibody (Ab) detection and quality assurance.","https://www.who.int/publications/i/item/diagnostic-testing-for-sars-cov-2",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1302661/retrieve","false","23711"
"23668","Personal Protective Equipment (PPE) Illustrated Guide for Community and Social Care Settings","United Kingdom Department of Health","2020-09-11T00:00:00.000","PDF","This eight-page guidance on personal protective equipment (PPE), updated on September 11, 2020, is for health and social care workers working in the community during this period of sustained transmission of COVID-19.","https://www.gov.uk/government/publications/personal-protective-equipment-ppe-illustrated-guide-for-community-and-social-care-settings",,"Guideline/Assessment Tool","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/925605/PHE_PPE_illustrated_guide_for_community_and_social_care_settings_OCT_2020.pdf","false","23668"
"23411","Guidance for Children and Families Involved with the Child Welfare System During the COVID-19 Pandemic","American Academy of Pediatrics","2020-09-11T00:00:00.000","Text","This web page, updated on September 11, 2020, provides guidance during the COVID-19 pandemic for pediatricians and others who care for children in the child welfare system that affirms that a stable home and caregiver are important to nurturing a child’s development and preventing trauma that can affect a child across the lifespan.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/guidance-for-children-and-families-involved-with-the-child-welfare-system-during-the-covid-19-pandemic/",,"Guideline/Assessment Tool",,"false","23411"
"22432","Coronavirus Disease (COVID-19) Training for Healthcare Professionals","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-11T00:00:00.000","Text","This web page, updated on September 11, 2020, provides links to COVID-19 training for healthcare professionals under these topics: Clinical Care and Infection Control, Personal Protective Equipment (PPE), Nonpharmaceutical Interventions (NPIs), Emergency Preparedness and Response, and COVID-19 Trainings on TRAIN.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/training.html",,"Instructional/Training Material",,"false","22432"
"22332","Additional COVID-19 Guidance for Caregivers of People Living with Dementia in Community Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-11T00:00:00.000","Text","Given the risks that older adults face from both COVID-19 and dementia, CDC is providing this additional guidance, updated on September 11, 2020, to caregivers of adults with Alzheimer’s disease and other types of dementia to reduce the spread of COVID-19 and to help them manage their patients’ physical and mental well-being, as well as their own well-being.","https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/caregivers-dementia.html",,"Guideline/Assessment Tool","Link to guidance in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/caregivers-dementia.htmlLink to guidance in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/caregivers-dementia.htmlLink to guidance in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/caregivers-dementia.htmlLink to guidance in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/caregivers-dementia.html","false","22332"
"22286","Safe Handling of Bodies of Deceased Persons with Suspected or Confirmed COVID-19","BC Centre for Disease Control [Government of British Columbia]","2020-09-11T00:00:00.000","Text","This provincial guidance, updated on September 11, 2020, will help to assist people who may handle the bodies of deceased persons during the COVID-19 pandemic. This guidance has been developed to ensure that the deceased are treated with sensitivity, dignity, and respect, and that people who come into contact with the deceased are protected from infection.","http://www.bccdc.ca/health-professionals/clinical-resources/covid-19-care/deceased-persons",,"Guideline/Assessment Tool",,"false","22286"
"21643","Implementing Safety Practices for Critical Infrastructure Workers Who May Have Had Exposure to a Person with Suspected or Confirmed COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-11T00:00:00.000","Text","To ensure continuity of operations of essential functions, this interim guidance, updated on September 11, 2020, advises that critical infrastructure workers may be permitted to continue work following potential exposure to COVID-19, provided they remain asymptomatic and additional precautions are implemented to protect them and the community.","https://www.cdc.gov/coronavirus/2019-ncov/community/critical-workers/implementing-safety-practices.html",,"Guideline/Assessment Tool","Link to guidance in a PDF file: https://www.cdc.gov/coronavirus/2019-ncov/downloads/critical-workers-implementing-safety-practices.pdfLink to guidance in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/critical-workers/implementing-safety-practices.htmlLink to guidance in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/critical-workers/implementing-safety-practices.html","false","21643"
"21514","Standard Operating Procedure (SOP) for Triage of Suspected COVID-19 Patients in non-US Healthcare Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-11T00:00:00.000","Text","This COVID-19 triage resource, updated on September 11, 2020, includes edits to clarify how healthcare workers can protect themselves during triage, and updates to the triage algorithm to allow for fever (>38°C) OR history of fever.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/non-us-settings/sop-triage-prevent-transmission.html",,"Guideline/Assessment Tool",,"false","21514"
"18857","Contingency Planning for Marine Pollution Preparedness and Response","United Kingdom Department for Environment, Food and Rural Affairs","2020-09-11T00:00:00.000","PDF","This 74-page document from the Maritime and Coastguard Agency, updated on September 11, 2020, provides guidelines for harbor authorities and oil handling facilities in relation to oil pollution. It provides guidance from the Nature Conservation Agencies, Environmental Regulator, and Fisheries Departments, and recommends a quantified and risk-based approach to contingency planning.","https://www.gov.uk/government/publications/contingency-planning-for-marine-pollution-preparedness-and-response-guidelines-for-ports",,"Guideline/Assessment Tool","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/916871/OPRC_GUIDELINES_DRAFT_SEP_2020_Changesaccepted.pdf","false","18857"
"24158","Mitigating the Impact of COVID-19 on Control of Vaccine-Preventable Diseases","World Health Organization, Regional Office for Europe","2020-09-10T00:00:00.000","PDF","The COVID-19 pandemic may cause disruptions in the provision of routine immunization services, but this risk can be reduced if national immunization programs take measures to minimize service interruptions, as well as plan for and implement catch-up vaccination. This 11-page document aims to support national decision-makers and  immunization programs ineffectively integrating the necessary response measures into existing programmatic areas.","https://apps.who.int/iris/handle/10665/334248",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334248/WHO-EURO-2020-1086-40832-55187-eng.pdf?sequence=1&isAllowed=y","false","24158"
"23949","Advancing the Science of Real-World Data to Address the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-09-10T00:00:00.000","Video or Multimedia","This one-hour presentation discusses the potential for diverse, real-world data sources such as electronic health records, insurance claims, patient registries, and lab results to further inform the science-based, all-of-America response to the COVID-19 public health emergency. These data can inform ongoing work to evaluate potential therapies, vaccines, or diagnostics for COVID-19.","https://www.fda.gov/science-research/fda-grand-rounds/advancing-science-real-world-data-address-covid-19-pandemic-09102020-09102020","Abernethy, Amy","Instructional/Training Material",,"false","23949"
"23914","COVID-19 Pandemic Impact on Patients, Families and Individuals in Recovery from Substance Use Disorders","Addiction Policy Forum","2020-09-10T00:00:00.000","PDF","This 22-page report sheds light on the experiences of patients and impacted individuals with a substance use disorder on the emotional and health consequences of COVID-19, overdose rates, and barriers in safely accessing care during the pandemic.","https://www.addictionpolicy.org/post/covid-19-pandemic-impact-on-patients-families-individuals-in-recovery-fromsubstance-use-disorder","Hulsey, Jessica; Mellis, Alexandra; Kelly, Braeden","Report","Direct link to document: https://54817af5-b764-42ff-a7e2-97d6e4449c1a.usrfiles.com/ugd/54817a_7ff82ba57ba14491b888d9d2e068782f.pdf","false","23914"
"23859","ADA (Americans with Disabilities Act) National Network Learning Session: Listos California Emergency Preparedness Campaign - An Innovative Community Based Approach to Disaster Preparedness","ADA [Americans with Disabilities Act] National Network","2020-09-10T00:00:00.000","Video or Multimedia","This one-hour, 18-minute webinar highlights the efforts of this ground-breaking $50 million approach to whole community preparedness. It discusses how with centering the community first, preparedness efforts are more accessible, relevant, and effective to target populations.","https://www.adapresentations.org/webinar.php?id=165","Baker, Karen; Knighten, Justin","Instructional/Training Material","Link to recording: https://us02web.zoom.us/rec/play/ixO0Bat1cvVFZKxDxI78W42EmjbR71yI_LGcH64C_VNKFeY2zsSJN8cDo2iQrCjRC8uBxsS0zaRR_mJ-.0sFTN6l6hFj5KDjO?continueMode=true&_x_zm_rtaid=bgb0uq4HTnKrWqCydw_8_Q.1601324691269.98b5a4dc573df9d81ea40e5a6c3b558d&_x_zm_rhtaid=406Link to presentation slides: https://www.adapresentations.org/doc/9_10_20/Listos%20California%20Emergency%20Preparedness%20Campaign.pdfLink to transcript: https://www.adapresentations.org/doc/9_10_20/Transcript%2009-10-20.pdf","false","23859"
"23834","Beyond the Case Count: The Wide-Ranging Disparities of COVID-19 in the United States","Commonwealth Fund","2020-09-10T00:00:00.000","Text","This report provides analysis of a survey that shows that Americans’ experience of economic hardship, their mental health concerns, and their opinion of government leaders during the COVID-19 pandemic varied by race, gender, and income.","https://www.commonwealthfund.org/publications/2020/sep/beyond-case-count-disparities-covid-19-united-states","Getachew, Yaphet; Zephyrin, Laurie; Abrams, Melinda; Shah, Arnav; Lewis, Corinne","Report",,"false","23834"
"23788","Guidance for Institutions of Higher Education with Students Participating in International Travel or Study Abroad Programs","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-10T00:00:00.000","Text","This guidance is for Institutes of Higher Education with international travel or study abroad programs, who should consider postponing or canceling these student international travel programs.","https://www.cdc.gov/coronavirus/2019-ncov/community/student-foreign-travel.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/student-foreign-travel.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/student-foreign-travel.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/student-foreign-travel.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/student-foreign-travel.html","false","23788"
"23769","Pandemic Forum: COVID-19’s Impact on Geopolitical Risk and Global Resiliency","Woodrow Wilson International Center for Scholars","2020-09-10T00:00:00.000","Video or Multimedia","This one-hour, 51-minute forum features healthcare professionals, former national security leaders, and risk management executives who discuss the wide reaching impacts of health and the COVID-19 pandemic on geopolitical risks and considerations for public and private resiliency.","https://www.wilsoncenter.org/event/pandemic-forum-covid-19s-impact-geopolitical-risk-and-global-resiliency","Weir, Tim; Johnson, Joyce; Wolff, Evan; Manyak, Michael; Chudnovskiy, Anatoliy","Instructional/Training Material",,"false","23769"
"23743","Opioid Addiction – Incarceration Pipeline: A National Health Crisis Compounded in Rural Areas","Montana State University","2020-09-10T00:00:00.000","Video or Multimedia","This 50-minute webinar highlights the connections between opioids and other types of substance misuse, incarceration, and chronic health conditions/early death of those who spend time in jail/prison. The discussion includes information about the linkages between adverse childhood experiences (ACEs), opioid misuse, chronic health conditions, health disparities, criminal activity, and imprisonment across the country.","https://www.youtube.com/watch?v=qT5pjuRAsNk&feature=youtu.be","Young, David","Instructional/Training Material","Link to presentation slides: https://www.canr.msu.edu/ncrcrd/uploads/files/NCRCRD%20Webinar%20PPT%20SEPT%2010%202020%20FINAL.pdf","false","23743"
"23742","Ebola Outbreaks in the Democratic Republic of Congo: Emergencies or Enduring Threat?","Congressional Research Service [Library of Congress]","2020-09-10T00:00:00.000","PDF","This 15-page report discusses how the prolonged battle to contain the Ebola outbreak in eastern Democratic Republic of the Congo (DRC), coupled with what appear to be more frequent outbreaks in the country, raises questions about the allocation of U.S. global health resources and bilateral aid for DRC.","https://crsreports.congress.gov/product/pdf/R/R45933","Salaam-Blyther, Tiaji ; Arieff, Alexis","Report",,"false","23742"
"23740","Coping with the Mental Health Effects of COVID-19","National Institutes of Health","2020-09-10T00:00:00.000","Video or Multimedia","The National Institutes of Health (NIH) is striving to combat the COVID-19 pandemic through a multifaceted approach that includes ensuring that the resources and support needed to manage stress and promote mental health are available. To support this effort, NIH presented this one-hour lecture on coping with the mental health effects of the COVID-19 pandemic.","https://videocast.nih.gov/watch=38425","Everly, George; Collins, Francis","Instructional/Training Material",,"false","23740"
"23694","Protect a Generation: The Impact of COVID-19 on Children's Lives","Save the Children International","2020-09-10T00:00:00.000","PDF","This 46-page report summarizes a survey taken among children and their caregivers during the outbreak of the COVID-19 pandemic, which found that 90 percent of the households that lost over half of their income due to the pandemic have struggled to access healthcare and medicine.","https://resourcecentre.savethechildren.net/library/protect-generation-impact-covid-19-childrens-lives","Edwards, Jess","Report","Direct link to document: https://resourcecentre.savethechildren.net/node/18218/pdf/vr59-01_protect_a_generation_report_en_0.pdfLink to document in Arabic: https://resourcecentre.savethechildren.net/node/18218/pdf/protect_a_generation_executivesummary_arabic.pdfLink to document in French: https://resourcecentre.savethechildren.net/node/18218/pdf/protect_a_generation_executivesummary_french.pdfLink to document in Spanish: https://resourcecentre.savethechildren.net/node/18218/pdf/protect_a_generation_executivesummary_sp.pdf","false","23694"
"23693","Hidden Impact of COVID-19 on Children: A Global Research Series","Save the Children International","2020-09-10T00:00:00.000","PDF","This global study, with several documents, reveals the hidden impacts of COVID-19 pandemic response measures that are impacting children’s health, nutrition, education, learning, protection, well-being, family finances, and poverty.Population:  Adults and teens (NOTE: it’s ages 11 and up, actually)Length:  approximately 100 questionsTime to Complete:  25 minutesMode of Administration: Online (e.g., computer-assisted interview)Administered by:  Parent/Teacher; Self AdministeredLanguage(s): English; Albanian; Amharic; Arabic; Bangla; Burmese; Dari; Filipino/Tagalog; French/ Hindi; Iindonesian; Korean; Khmer; Lao; Mongolian; Mindanao; Nepali; Pashto; Portuguese; Serbian; Sinhala; Spanish; Tamil; Thai; Urdu; Vietnamese","https://resourcecentre.savethechildren.net/library/hidden-impact-covid-19-children-global-research-series",,"Report","Free/Publicly Available Contact: Please contact the research team (attn: Melissa Burgess or Silvia Mila Arlini) at evidence.aro@savethechildren.org with any questions","true","23693"
"22274","COVID-19 Pandemic Planning Scenarios","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-10T00:00:00.000","Text","The Centers for Disease Control and Prevention and the Office of the Assistant Secretary for Preparedness and Response have developed these five COVID-19 Pandemic Planning Scenarios, updated on September 10, 2020, that are designed to help inform decisions by modelers and public health officials who utilize mathematical modeling. The planning scenarios are being used by mathematical modelers throughout the federal government.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/planning-scenarios.html",,"Guideline/Assessment Tool",,"false","22274"
"21942","FAQs: Management of Infants Born to Mothers with Suspected or Confirmed COVID-19","American Academy of Pediatrics","2020-09-10T00:00:00.000","PDF","These Frequently Asked Questions, updated on September 10, 2020, provide initial guidance for the management of infants born to mothers with confirmed and suspected COVID-19.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/faqs-management-of-infants-born-to-covid-19-mothers/",,"Guideline/Assessment Tool",,"false","21942"
"24110","Waves, Forest Fires, and Herd Immunity: The Language of a Pandemic","Harvard University, Harvard T.H. Chan School of Public Health","2020-09-09T00:00:00.000","Video or Multimedia","This 36-minute presentation discusses the COVID-19 pandemic, the regrets that have characterized the pandemic to date, and the language of the pandemic that has shaped public understanding and action.","https://www.youtube.com/watch?v=daz7VdKX36c&feature=youtu.be","Jones, David","Instructional/Training Material",,"false","24110"
"24024","Fair Allocation Mechanism for COVID-19 Vaccines Through the COVAX Facility","World Health Organization","2020-09-09T00:00:00.000","PDF","This 17-page document describes the WHO Secretariat’s proposal for the allocation of COVID-19 vaccines among countries (not within countries), specifically in the context of the COVID-19 Vaccines Global Access (COVAX) Facility access mechanism and developed in collaboration with the ACT-Accelerator vaccine partners.","https://www.who.int/publications/m/item/fair-allocation-mechanism-for-covid-19-vaccines-through-the-covax-facility",,"Guideline/Assessment Tool","Direct link to document: https://www.who.int/docs/default-source/coronaviruse/who-covid19-vaccine-allocation-final-working-version-9sept.pdf?sfvrsn=e1d0376_2&download=true","false","24024"
"23901","Eldercare in the Time of COVID-19","National Indian Health Board","2020-09-09T00:00:00.000","Video or Multimedia","This 53-minute webinar discusses topics that include caring for elders during the COVID-19 pandemic, preventing infection among this vulnerable population, tips for caregivers, and information about helping and protecting elders in the community.","https://www.youtube.com/watch?v=3BgpKGLepJw&feature=youtu.be",,"Instructional/Training Material",,"false","23901"
"23851","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: Injury Types Due to Explosions","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-09T00:00:00.000","PDF","This five-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources for a hospital that is working with its region’s healthcare coalition on a trauma mass casualty incident (MCI) virtual tabletop exercise (TTX), and would like to use the industry site explosion that occurred in Beirut, Lebanon, on August 4, 2020, as its TTX scenario. The requestor asked if ASPR TRACIE could help identify updated figures on the number of people injured and killed by the Beirut explosion, and the mechanism of injuries from the incident to help with victimology for the exercise’s scenario.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta---injury-types-from-explosions---09-09-2020.pdf",,"Bibliography/Resource List",,"false","23851"
"23717","Fact Sheet for Healthcare Providers: Wantai SARS-CoV-2 RT-PCR Kit","U.S. Food and Drug Administration","2020-09-09T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Wantai SARS-CoV-2 RT-PCR Kit. The Wantai SARS-CoV-2 RT-PCR Kit is authorized for use with oropharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141995/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141996/downloadLink to Letter of Authorization: https://www.fda.gov/media/141994/downloadLink to Instructions for Use: https://www.fda.gov/media/141997/download","false","23717"
"23716","Fact Sheet for Healthcare Providers: BioCheck SARS-CoV-2 IgG Antibody Test Kit","U.S. Food and Drug Administration","2020-09-09T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BioCheck SARS-CoV-2 IgG    Antibody Test Kit. The BioCheck SARS-CoV-2 IgG Antibody Test Kit is authorized for the qualitative detection of IgG antibodies to SARS-CoV-2 in human serum.","https://www.fda.gov/media/142004/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142005/downloadLink to Letter of Authorization: https://www.fda.gov/media/142003/downloadLink to Instructions for Use: https://www.fda.gov/media/142006/download","false","23716"
"23715","Fact Sheet for Healthcare Providers: BioCheck SARS-CoV-2 IgM Antibody Test Kit","U.S. Food and Drug Administration","2020-09-09T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BioCheck SARS-CoV-2 IgM Antibody Test Kit. The BioCheck SARS-CoV-2 IgM Antibody Test Kit is authorized for the qualitative detection of IgM antibodies to SARS-CoV-2 in human serum.","https://www.fda.gov/media/141999/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/142000/downloadLink to Letter of Authorization: https://www.fda.gov/media/141998/downloadLink to Instructions for Use: https://www.fda.gov/media/142002/download","false","23715"
"23708","CC (Clinical Center) Grand Rounds: Contemporary Clinical Medicine: Great Teachers: Treating the Other Epidemic: Anti-Opioid Vaccines","National Institutes of Health","2020-09-09T00:00:00.000","Video or Multimedia","This one-hour presentation discusses the impact of the COVID-19 pandemic on fentanyl overdoses and abuse in the U.S. opioid pandemic, the limitations for preventing fentanyl overdose for existing maintenance treatments, and lessons learned from 25 years of clinical trials of stimulant vaccine efficacy.","https://videocast.nih.gov/watch=38348","Kosten, Thomas","Instructional/Training Material",,"false","23708"
"23701","Vaccines: Saving Lives, Ensuring Confidence, and Protecting Public Health","U.S. Senate, Committee on Health, Education, Labor, and Pensions","2020-09-09T00:00:00.000","Video or Multimedia","The two government witnesses in this two-hour, 55-minute Congressional hearing discuss ongoing clinical trials of COVID-19 vaccine candidates, and some of the challenges the government faces in distributing a vaccine, which include misinformation about vaccines, and the current drop in general vaccination rates due to misinformation and distrust of government.","https://www.help.senate.gov/hearings/vaccines-saving-lives-ensuring-confidence-and-protecting-public-health","Collins, Francis; Adams, Jerome","Hearing/Testimony",,"false","23701"
"14567","Select Toxin Guidance: Regulatory Exemptions","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-09-09T00:00:00.000","Text","This guidance from the Division of Select Agents and Toxins, updated in September 2020, provides a list of product exemptions and investigational product exemption requirements for select toxins.","https://www.selectagents.gov/stg-exemptions.html",,"Guideline/Assessment Tool",,"false","14567"
"10134","Guidance for Select Agent Regulation Training Requirements: Training Program","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-09-09T00:00:00.000","Presentation Slides","This guidance from the Division of Select Agents and Toxins, updated in September 2020, provides guidance about the regulatory requirements for training that are found in Section 15 of the select agent regulations. Individuals that access select agents and toxins must know the requirements of their entity's safety, security, and incident response programs if their entity is to be compliant. The regulations define the training that must be provided, who must receive the training, and how often the training must be provided.","https://www.selectagents.gov/compliance/guidance/training/program.htm?CDC_AA_refVal=https%3A%2F%2Fwww.selectagents.gov%2Frtr-training-program.html",,"Guideline/Assessment Tool",,"false","10134"
"23719","Infectious Diseases Society of America Guidance on the Treatment of Antimicrobial Resistant Gram-Negative Infections","Infectious Diseases Society of America","2020-09-08T00:00:00.000","Text","The overarching goal of this guidance is to assist clinicians – including those with and without infectious diseases expertise – in selecting antibiotic therapy for infections caused by ESBL-E, CRE, and DTR-P. aeruginosa. The guidance is framed as answers to a series of clinical questions, each of which can stand on its own.","https://www.idsociety.org/practice-guideline/amr-guidance/","Tamma, Pranita; Ailken, Samuel; Bonomo, Robert; Mathers, Amy; Van Duin, David","Guideline/Assessment Tool",,"false","23719"
"23710","Promising Strategies for Encouraging the Adoption of COVID-19 Protective Behaviors","National Academies of Sciences, Engineering, and Medicine","2020-09-08T00:00:00.000","Video or Multimedia","This one-hour webinar discusses promising strategies from the behavioral and social sciences to make the adoption of protective behaviors against COVID-19 more likely. New guidance from the Societal Experts Action Network (SEAN) helps decision-makers understand strategies to increase adherence to protective behaviors to mitigate the spread of COVID-19.","https://www.nationalacademies.org/event/09-08-2020/promising-strategies-for-encouraging-the-adoption-of-covid-19-protective-behaviors","Brossard, Dominique; Wood, Wendy; Carlee, Ron; Graves, Robert","Instructional/Training Material",,"false","23710"
"23697","Fact Sheet for Healthcare Providers: Verily COVID-19 RT-PCR Test","U.S. Food and Drug Administration","2020-09-08T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Verily COVID-19 RT-PCR Test. The Verily COVID-19 RT-PCR Test is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141949/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141950/downloadLink to Letter of Authorization: https://www.fda.gov/media/141948/downloadLink to EUA Summary: https://www.fda.gov/media/141951/download","false","23697"
"23669","COVID-19: Mental Health and Wellbeing Surveillance Report","United Kingdom Department of Health","2020-09-08T00:00:00.000","Text","This report, available with links to individual chapters, is about population mental health and well-being in England during the COVID-19 pandemic. It includes up-to-date information to inform policy, planning, and commissioning in health and social care.","https://www.gov.uk/government/publications/covid-19-mental-health-and-wellbeing-surveillance-report",,"Report",,"false","23669"
"23671","Weight Management Services During COVID-19: Phase 1 Insights","United Kingdom Department of Health","2020-09-07T00:00:00.000","PDF","This 69-page document is a rapid review to gain an understanding of how the pandemic affected people in lockdown, changes to weight management delivery and commissioning, and how services need to adapt in response to the recovery strategy.","https://www.gov.uk/government/publications/weight-management-services-during-covid-19-phase-1-insights",,"Report","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/915274/WMS_Report.pdf","false","23671"
"23670","COVID-19: Long-Term Health Effects","United Kingdom Department of Health","2020-09-07T00:00:00.000","Text","This document provides information on the health problems reported in COVID-19 cases following acute disease, and guidance for healthcare professionals on how to advise recovering COVID-19 patients.","https://www.gov.uk/government/publications/covid-19-long-term-health-effects",,"Report","Direct link to report: https://www.gov.uk/government/publications/covid-19-long-term-health-effects/covid-19-long-term-health-effects","false","23670"
"23941","COVID-19: Guidance for Managing a Funeral During the Coronavirus Pandemic","United Kingdom Department of Health","2020-09-04T00:00:00.000","Text","This guidance provides advice to assist people who are involved in managing or organizing a funeral related to a death from any cause during the coronavirus (COVID-19) pandemic.","https://www.gov.uk/government/publications/covid-19-guidance-for-managing-a-funeral-during-the-coronavirus-pandemic",,"Guideline/Assessment Tool","Guidance is available in Arabic, Bengali, Simplified Chinese, Traditional Chinese, French, Gujarati, Polish, Portuguese, Punjabi, and Urdu.","false","23941"
"23698","Fact Sheet for Healthcare Providers: qSanger-COVID-19 Assay","U.S. Food and Drug Administration","2020-09-04T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the qSanger-COVID-19 Assay. The qSanger-COVID-19 Assay is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141933/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141934/downloadLink to Letter of Authorization: https://www.fda.gov/media/141932/downloadLink to Instructions for Use: https://www.fda.gov/media/141935/download","false","23698"
"23683","Mutual Recognition Agreements in the Regulation of Medicines","National Academies of Sciences, Engineering, and Medicine","2020-09-04T00:00:00.000","Video or Multimedia","This one-hour, 34-minute webinar focuses on the barriers to greater use of regulatory reliance during the COVID-19 pandemic by drawing upon messages from the recently released National Academies report on regulatory reliance.","https://www.nationalacademies.org/event/09-04-2020/mutual-recognition-agreements-in-the-regulation-of-medicines-regulatory-reliance-if-not-now-when-what-are-the-current-barriers","Wood, Alistair; Lumpkin, Murray; Rasi, Guido; Cooke, Emer; Bernat, Janis","Instructional/Training Material","Link to related report: Regulating Medicines in a Globalized World: The Need for Increased Reliance Among Regulators: https://www.nap.edu/catalog/25594/regulating-medicines-in-a-globalized-world-the-need-for-increased","false","23683"
"23447","Interim Guidance for Rapid Antigen Testing for SARS-CoV-2","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-04T00:00:00.000","Text","The purpose of this interim technical guidance, updated on September 4, 2020, is to support the most effective use of antigen tests for SARS-CoV-2 for different testing situations. It applies to all uses of antigen tests and is not specific to the application of antigen tests to any particular age group or setting. It is intended for clinicians who order antigen tests, receive antigen test results, and/or perform point-of-care testing, as well as for laboratory professionals who perform antigen testing in a laboratory setting or at the point of care and report those results.","https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antigen-tests-guidelines.html",,"Guideline/Assessment Tool",,"false","23447"
"21361","Infection Prevention and Control for the Safe Management of a Dead Body in the Context of COVID-19","World Health Organization","2020-09-04T00:00:00.000","PDF","This seven-page interim guidance, updated on September 4, 2020, is for all those, including managers of health care facilities and mortuaries, religious and public health authorities, and families, who tend to the bodies of persons who have died of suspected or confirmed COVID-19.","https://www.who.int/publications/i/item/infection-prevention-and-control-for-the-safe-management-of-a-dead-body-in-the-context-of-covid-19-interim-guidance",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1300088/retrieve","false","21361"
"23796","Contact Tracing and Case Investigation Training Modules","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-03T00:00:00.000","Video or Multimedia","The trainings listed on this web page are for public health professionals or the general public who are interested in becoming a contact tracer or case investigator, as well as for public health professionals who already serve in these roles and are seeking to improve their knowledge.","https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/general-training-modules.html",,"Instructional/Training Material",,"false","23796"
"23726","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: COVID-19 and Seasonal Flu Vaccination Planning Resources","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-03T00:00:00.000","PDF","This four-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) responds to a request for information and resources on how healthcare facilities are planning for seasonal influenza vaccination, including the possibility of also providing COVID-19 vaccination during flu season.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta--seasonal-influenza-planning---09-03-2020.pdf",,"Bibliography/Resource List",,"false","23726"
"23699","Guidance for Licensed Pharmacists and Pharmacy Interns Regarding COVID-19 Vaccines and Immunity under the PREP Act","Office of the Assistant Secretary for Health [U.S. Department of Health and Human Services]","2020-09-03T00:00:00.000","PDF","This three-page guidance authorizes state-licensed pharmacists to order and administer, and state-licensed or registered pharmacy interns acting under the supervision of the qualified pharmacist to administer, to persons ages three or older COVID-19 vaccinations that have been authorized or licensed by the Food and Drug Administration (FDA).","https://www.hhs.gov/sites/default/files/licensed-pharmacists-and-pharmacy-interns-regarding-covid-19-vaccines-immunity.pdf",,"Guideline/Assessment Tool",,"false","23699"
"23672","Calculating Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Laboratory Test Percent Positivity","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-03T00:00:00.000","Text","This web page about SARS-CoV-2 laboratory testing details Using Percent Positivity Calculation for Public Health Surveillance, Different Methods Used to Calculate Percent Positivity, CDC Methods for Calculating Percent Positivity, and Data resources where percent positivity for COVID-19 are currently reported.","https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/calculating-percent-positivity.html",,"Guideline/Assessment Tool",,"false","23672"
"23664","Principles for Managing SARS-CoV-2 Transmission Associated with Higher Education","United Kingdom Department of Health","2020-09-03T00:00:00.000","PDF","This 32-page paper is provided in the context of existing guidance and higher education sector plans, and aims to supplement these by summarizing the latest evidence relating to SARS-CoV-2 transmission associated with the resumption of higher education activities from Autumn 2020, particularly the return of undergraduate and postgraduate students.","https://www.gov.uk/government/publications/principles-for-managing-sars-cov-2-transmission-associated-with-higher-education-3-september-2020",,"Guideline/Assessment Tool","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/914978/S0728_Principles_for_Managing_SARS-CoV-2_Transmission_Associated_with_Higher_Education_.pdf","false","23664"
"23661","Medical Gloves for COVID-19","U.S. Food and Drug Administration","2020-09-03T00:00:00.000","Text","To help expand the availability of medical gloves, the FDA is providing regulatory flexibility, as described in the enforcement policy for gloves that is in effect during the COVID-19 public health emergency. The FDA is also providing regular updates about medical gloves, including the answers to frequently asked questions on this page.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/medical-gloves-covid-19",,"Guideline/Assessment Tool",,"false","23661"
"23655","Fact Sheet for Healthcare Providers: SGTi-flex COVID-19 IgG","U.S. Food and Drug Administration","2020-09-03T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SGTi-flex COVID-19 IgG. The SGTi-flex COVID-19 IgG is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum, venous whole blood (sodium heparin, lithium heparin, sodium citrate and tripotassium EDTA), andplasma (sodium heparin, lithium heparin, sodium citrate and tripotassium EDTA).","https://www.fda.gov/media/141889/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/141890/downloadLink to Letter of Authorization: https://www.fda.gov/media/141888/downloadLink to Instructions for Use: https://www.fda.gov/media/141891/download","false","23655"
"23654","Fact Sheet for Healthcare Providers: cobas SARS-CoV-2 & Influenza A/B","U.S. Food and Drug Administration","2020-09-03T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the cobas SARS-CoV-2 & Influenza A/B assay. Testing is to be conducted on specimens from individuals suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider.","https://www.fda.gov/media/141885/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141886/downloadLink to Letter of Authorization: https://www.fda.gov/media/141884/downloadLink to Instructions for Use: https://www.fda.gov/media/141887/download","false","23654"
"23640","Impact of the COVID-19 Pandemic on Noncommunicable Disease Resources and Services: Results of a Rapid Assessment","World Health Organization","2020-09-03T00:00:00.000","PDF","This 32-page report presents the results of a rapid assessment conducted by the Noncommunicable Disease Department in May 2020 detailing the initial impact of the COVID-19 pandemic on noncommunicable disease resources and services.","https://www.who.int/publications/i/item/ncds-covid-rapid-assessment",,"Report","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1299882/retrieve","false","23640"
"23720","Enforcement of Physical Health Protections for Front-line Workers","National Association of County and City Health Officials","2020-09-02T00:00:00.000","Video or Multimedia","This one-hour, 30-minute webinar explores how we ensure that all workers have access to the protective gear and procedures they need to remain safe and healthy during the COVID-19 pandemic, especially ones working in heavily impacted industries. Presenters discuss equitable enforcement of public health orders, workers’ rights, and employer responsibilities during this time.","https://naccho.zoom.us/rec/play/UB7k5BNL5-NLVkn-TXMtIN-psBTe9LZorRFVx29bsB-mq9SrIyGewrO6TGShHRn2UUCD94_vCNFWQCX1.GwHi1zY0OPE7NVYY?continueMode=true","Carlisle, L.D.; Hani, Krista; Jones, Melissa","Instructional/Training Material",,"false","23720"
"23675","Coronavirus (COVID-19): Admission and Care of People in Care Homes","United Kingdom Department of Health","2020-09-02T00:00:00.000","Text","This guidance for how to protect care home residents and staff during the coronavirus outbreak is for care homes, local health protection teams, local authorities, clinical commissioning groups (CCGs), and registered providers of accommodation for people who need personal or nursing care.","https://www.gov.uk/government/publications/coronavirus-covid-19-admission-and-care-of-people-in-care-homes",,"Guideline/Assessment Tool","Guidance is available on a web page and in a PDF file.","false","23675"
"23656","Fact Sheet for Healthcare Providers: Bio-Speedy Direct RT-qPCR SARS-CoV-2","U.S. Food and Drug Administration","2020-09-02T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Bio-Speedy Direct RT-qPCR SARS-CoV-2. The Bio-Speedy Direct RT-qPCR SARS-CoV-2 is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141822/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141825/downloadLink to Letter of Authorization: https://www.fda.gov/media/141824/downloadLink to Instructions for Use: https://www.fda.gov/media/141823/download","false","23656"
"23646","Interim SARS-CoV-2 Testing Guidelines for Patients in Outpatient Hemodialysis Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-02T00:00:00.000","Text","While this guidance focuses on testing patients undergoing hemodialysis at outpatient hemodialysis facilities, several of the recommendations – such as testing patients with signs or symptoms of COVID-19 and testing asymptomatic close contacts – should also be applied to end-stage renal disease patients undergoing home dialysis (i.e., home hemodialysis or peritoneal dialysis).","https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis/testing-patients.html",,"Guideline/Assessment Tool",,"false","23646"
"23635","Emergency Department Testing for COVID-19","National Emerging Special Pathogens Training and Education Center","2020-09-02T00:00:00.000","Text","COVID-19 testing strategies impact overall hospital operations, including the need for cohorting any amount of personal protective equipment used. Review the guidelines on this page to help balance the safety and efficacy of testing at your facility.","https://netec.org/2020/09/02/emergency-dept-testing-covid-19/",,"Guideline/Assessment Tool",,"false","23635"
"23607","Corticosteroids for COVID-19","World Health Organization","2020-09-02T00:00:00.000","PDF","Corticosteroids have received worldwide attention as a potentially effective treatment for COVID-19. This 25-page guideline reflects an innovation from the World Health Organization, driven by an urgent need for global collaboration to provide trustworthy and living COVID-19 guidance informing policy and practice worldwide during an outbreak of an emerging infectious disease, such as this pandemic.","https://www.who.int/publications/i/item/WHO-2019-nCoV-Corticosteroids-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1299344/retrieve","false","23607"
"23489","Recommendations for Investigational COVID-19 Convalescent Plasma","U.S. Food and Drug Administration","2020-09-02T00:00:00.000","Text","This guidance, updated on September 2, has been issued to provide recommendations to health care providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency.","https://www.fda.gov/vaccines-blood-biologics/investigational-new-drug-ind-or-device-exemption-ide-process-cber/recommendations-investigational-covid-19-convalescent-plasma",,"Guideline/Assessment Tool",,"false","23489"
"21653","Investigational COVID-19 Convalescent Plasma: Guidance for Industry","U.S. Food and Drug Administration","2020-09-02T00:00:00.000","PDF","This 17-page guidance, updated on September 2, 2020, provides recommendations to healthcare providers and investigators on the administration and study of investigational convalescent plasma collected from individuals who have recovered from COVID-19 (COVID-19 convalescent plasma) during the public health emergency. The guidance also provides recommendations to blood establishments on the collection of COVID-19 convalescent plasma.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/investigational-covid-19-convalescent-plasma",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/136798/downloadThis document supersedes the guidance of the same title issued in April 2020 and updated in May 2020.","false","21653"
"24184","Security Challenge: Mob Attacks","Insecurity Insight","2020-09-01T00:00:00.000","PDF","Health facilities may be easy targets that are difficult to protect even with security measures in place. This four-page document describes a few measures that can be considered to pre-empt and prepare for mob attacks. The recommendations were developed  in collaboration with Christian Blind Mission (CBM) with advisory provided by RiskVisibility. They have been funded by the H2H Fund, which is supported by UK aid from the UK government.","http://insecurityinsight.org/wp-content/uploads/2020/10/Security-Challenge-Mob-attacks-Recommendations-for-protection-of-medical-facilities-against-a-mob-attack-September-2020.pdf",,"Report",,"false","24184"
"24149","Knowledge, Attitudes and Practices (KAP) Assessment on COVID-19","International Federation of Red Cross and Red Crescent Societies","2020-09-01T00:00:00.000","PDF","To understand communities’ knowledge, attitudes, and practices (KAP), along with their information needs on COVID-19, this 48-page KAP assessment was conducted by the Turkish Red Crescent Society (TRCS), with support from IFRC, under the Community Based Migration Programme (CBMP). The findings are intended to inform understanding of community perceptions of, and knowledge about, COVID-19 and, in turn, shape risk communication, behavior change, and community engagement activities.","https://data2.unhcr.org/en/documents/details/82472",,"Report","Direct link to document: https://data2.unhcr.org/en/documents/download/82472","false","24149"
"24113","Influenza and Other Respiratory Viruses: Surveillance in the Americas 2019","World Health Organization, Pan American Health Organization","2020-09-01T00:00:00.000","PDF","This 136-page third edition of the landscape analysis of Influenza and Other Respiratory Viruses: Surveillance in the Americas provides regional and country-specific data of regional trends that include surveillance of severe acute respiratory infection (SARI), influenza-like illness (ILI), influenza vaccine, FluNet/FluID reporting, and participation in WHO’s External Quality Assessment Project (EQAP).","https://iris.paho.org/handle/10665.2/52741",,"Report","Direct link to document: https://iris.paho.org/bitstream/handle/10665.2/52741/9789275122792lowres_eng.pdf?sequence=1&isAllowed=y","false","24113"
"24112","Impact of Coronavirus on Households Across America","Robert Wood Johnson Foundation","2020-09-01T00:00:00.000","Text","This series of five polls conducted by NPR, the Harvard T.H. Chan School of Public Health, and the Robert Wood Johnson Foundation, finds that a substantial share of U.S. households have not been protected from serious impacts of the COVID-19 pandemic across many areas of residents' lives.","https://www.rwjf.org/en/library/research/2020/09/the-impact-of-coronavirus-on-households-across-america.html",,"Report",,"false","24112"
"24027","Washing/Drying of Biological Agent Contaminated Clothing","U.S. Environmental Protection Agency","2020-09-01T00:00:00.000","PDF","The overall purpose of this 91-page study was to assess the use of washers and dryers with a suitable decontamination solution as a potential self-help practice to reduce and/or inactivate biological spores from common clothing material. This approach may be used to lessen potential cross-contamination among emergency first responders, security personnel, or members of the public exposed to a wide area B. anthracis spore release.","https://cfpub.epa.gov/si/si_public_record_Report.cfm?dirEntryId=349831&Lab=CESER","Touati, Abderrahmane; Serre, Shannon","Report","Direct link to document: https://cfpub.epa.gov/si/si_public_file_download.cfm?p_download_id=541299&Lab=CESER","false","24027"
"23997","AMR (Antimicrobial Resistance) in the Light of COVID-19 Webinar Series","Antimicrobial Resistance Fighter Coalition","2020-09-01T00:00:00.000","Video or Multimedia","The Antimicrobial Resistance Fighter Coalition, in partnership with CIDRAP, the American Society for Microbiology, Wellcome, the Surveillance and Epidemiology of Drug-resistant Infections Consortium, and the Centers for Disease Control and Prevention, is hosting this webinar series about how the COVID-19 pandemic could reshape strategies for combating antimicrobial resistance around the world.","https://antimicrobialresistancefighters.org/webinars",,"Instructional/Training Material",,"false","23997"
"23996","COVID-19 and Achieving Health Equity","U.S. Senate, Committee on Health, Education, Labor, and Pensions","2020-09-01T00:00:00.000","PDF","This 46-page report examines the intersection of the COVID-19 pandemic, inequality in infection rates and health outcomes, and structural racism within the health care system. It describes the impact of COVID-19 on the health of communities of color and discusses a few of the factors that have contributed to inequality in health outcomes,  including  exploitation of communities of color, segregation, discrimination, and bias within the health care system, lack of access to high-quality care, and social  determinants of health.","https://www.help.senate.gov/imo/media/doc/Disparities%20Report%20Final.pdf",,"Report",,"false","23996"
"23990","COVID-19 Operationalization of the Global Response Strategy in the WHO European Region","World Health Organization, Regional Office for Europe","2020-09-01T00:00:00.000","PDF","This 35-page document outlines the WHO European Regional strategy to respond to COVID-19 and its consequences, based on WHO’s global strategy update for COVID-19, covering the period February-December 2020. The strategy is flexible and adaptable to national and subnational contexts, and guides countries in rapidly bringing COVID-19 cases under control, and in preparing for a phased transition from a widespread transmission to a steady state of low-level or no transmission.","https://www.euro.who.int/en/health-topics/health-emergencies/coronavirus-covid-19/publications-and-technical-guidance/2020/covid-19-operationalization-of-the-global-response-strategy-in-the-who-european-region-september-2020",,"Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334167/WHO-EURO-2020-1073-408190-55167-eng.pdfLink to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/335913/WHO-EURO-2020-1073-40819-55171-rus.pdf?sequence=1&isAllowed=y","false","23990"
"6925","Opportunities for U.S. Civilian and Military Collaboration in Health Surveillance and Emergency Preparedness","Johns Hopkins Center for Public Health Preparedness [Johns Hopkins University]","2009-06-17T00:00:00.000","Video or Multimedia","This conference features presentations from 11 speakers discussing civilian and military collaboration in emergency preparedness. Topics covered include an overview of the military surveillance systems, the role of the military in emergency response, an overview of civilian surveillance and response systems, military public health emergency management and support to civil authorities, and legal challenges. Several case studies are presented and discusses.","https://www.jhsph.edu/research/centers-and-institutes/johns-hopkins-center-for-public-health-preparedness/training/calendar/archives/Civilian%20and%20Military%20Collaboration","Barnett, Daniel J.; Otto, Jean; DeFraites, Robert","Conference/Meeting Material","Site requires free registration.","false","6925"
"3158","Guide to Public Health Measures to Reduce the Impact of Influenza Pandemics in Europe","European Union, European Centre for Disease Prevention and Control","2009-06-17T00:00:00.000","PDF","This 51-page document contains a selection of possible public measures to be taken during influenza pandemics, including personal protective measures, social distancing measures, antivirals, and vaccines.","https://www.ecdc.europa.eu/en/publications-data/guide-public-health-measures-reduce-impact-influenza-pandemics-europe-ecdc-menu",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0906_TER_Public_Health_Measures_for_Influenza_Pandemics.pdf","false","3158"
"3184","Model Memorandum of Understanding Between Hospitals during Declared Emergencies","National Center for the Study of Preparedness and Catastrophic Event Response [Johns Hopkins University]","2009-06-15T00:00:00.000","PDF","This is a memorandum of understanding  designed to assist with potential collaborative efforts among hospitals and potentially other healthcare facilities.","https://emergency.cdc.gov/planning/emac/pdf/pacer_model_mou.pdf",,"Legal Document",,"false","3184"
"23972","WHO Regional Office for Europe Recommendations on Influenza Vaccination for the 2020/2021 Season During the Ongoing  COVID-19 Pandemic","World Health Organization, Regional Office for Europe","2020-09-01T00:00:00.000","PDF","This seven-page document details how it will be critical in the upcoming influenza season to implement comprehensive measures that ensure best possible protection against influenza among risk groups that are also at high risk of severe COVID-19 disease, including hospitalization and death; decrease number of persons requiring medical care as a result of influenza infection to limit pressures on health services; and reduce the potential for SARS-CoV-2 exposure while seeking treatment for influenza or being admitted to hospital for influenza.","https://www.euro.who.int/en/health-topics/communicable-diseases/influenza/vaccination/who-regional-office-for-europe-recommendations-on-influenza-vaccination-for-the-20202021-season-during-the-ongoing-covid-19-pandemic-2020",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/335721/WHO-EURO-2020-1141-40887-55342-eng.pdf?sequence=1&isAllowed=yLink to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/335722/WHO-EURO-2020-1141-40887-55343-rus.pdf?sequence=1&isAllowed=y","false","23972"
"23964","Flatten Inaccessibility: Impact of COVID-19 on Blind or Visually Impaired Adults","American Foundation for the Blind","2020-09-01T00:00:00.000","PDF","This 94-page report provides information and results from a survey that investigated the experiences of participants who are blind or have low vision during the start of the COVID-19 pandemic to determine how they were affected in areas that include access to transportation, healthcare, access to food and supplies, employment, education, and voting.","https://static.afb.org/legacy/media/AFB_Flatten_Inaccessibility_Report_Accessible_FINAL.pdf","Rosenblum, L. Penny; Chanes-Mora, Paola; McBride, C. Rett; Flewellen, Joshua; Nagarajan, Niranjani","Report",,"false","23964"
"23945","2020 Public Health Law Virtual Summit: COVID-19 Response and Recovery","Network for Public Health Law","2020-09-01T00:00:00.000","Video or Multimedia","This two-day summit, held on September 16-17, 2020, featured experts who presented their key findings from the report on Assessing Legal Responses to COVID-19, and proposed paths forward to more effective and equitable response and recovery efforts. This web page provides links to recordings of all sessions.","https://events.networkforphl.org/2020-summit/schedule/","Silverman, Ross; Oliva, Jennifer; Wiley, Lindsay; Haddow, Kim; Burris, Scott","Conference/Meeting Material","Link to Disaster Lit record for Assessing Legal Responses to COVID-19: https://disasterinfo.nlm.nih.gov/search/id:23452.","false","23945"
"23942","Advancing CHW (Community Health Worker) Engagement in COVID-19 Response Strategies","National Association of Community Health Workers","2020-09-01T00:00:00.000","PDF","This 19-page document provides practical guidance to conceptualize and operationalize community health worker (CHW) and CHW Network engagement in COVID-19 response. A matrix of areas of engagement and a continuum of engagement (low/harmful to robust) are offered for local, state, and national actors to consider who want to amplify the roles and capacity of the CHW workforce. It was developed in partnership with the Community Based Workforce Alliance.","https://nachw.org/wp-content/uploads/2020/09/Advancing-CHW-Engagement-in-COVID-19-Response-Strategies.pdf",,"Guideline/Assessment Tool",,"false","23942"
"3086","2009 Influenza A(H1N1) Outbreak","Congressional Research Service [Library of Congress]","2009-06-15T00:00:00.000","PDF","This 36-page document discusses legal issues related to emergency measures, civil rights, liability, and employment issues surrounding the health threat of a pandemic, including  emergency measures which may help to contain or ameliorate an infectious disease outbreak.","https://www.hsdl.org/?view&did=35482","Jones, Nancy Lee; Swendiman, Kathleen","Guideline/Assessment Tool",,"false","3086"
"23940","Coronavirus Misinformation: Quantifying Sources and Themes in the COVID-19 ""Infodemic""","Cornell University","2020-09-01T00:00:00.000","PDF","This eight-page report summarizes a study that identifies the most prominent misinformation topics that appeared in traditional and online media in the early phase of the COVID-19 pandemic, from January 1 to May 26, 2020. The results come from a sample of 38 million articles published in English-language media around the world.","https://allianceforscience.cornell.edu/wp-content/uploads/2020/09/Evanega-et-al-Coronavirus-misinformationFINAL.pdf","Evanega, Sarah; Lynas, Mark; Adams, Jordan; Smolenyak, Karinne","Report",,"false","23940"
"23927","Engaging with Local Faith Actors and Communities: A Toolkit","ACT Alliance","2020-09-01T00:00:00.000","PDF","This 18-page toolkit aims to help answer the question of what staff in European Union Delegations or the ECHO field office can do to engage with religious leaders and faith communities when faced with a crisis with urgency of a pandemic such as COVID-19 or Ebola.","https://reliefweb.int/sites/reliefweb.int/files/resources/Toolkit-Engaging-with-religious-leaders-and-faith-communities.pdf",,"Guideline/Assessment Tool",,"false","23927"
"23925","Protecting Children: Coronavirus Considerations with Dr. Brent Kaziny","Institute for Childhood Preparedness","2020-09-01T00:00:00.000","Video or Multimedia","This course discusses how coronavirus impacts children, answers to frequently asked questions, health screenings, how the fall/winter flu season may impact coronavirus, and how we should handle children that present at health screenings with fever/signs of illness.","https://institute-for-childhood-preparedness.teachable.com/p/protecting-children-coronavirus-considerations-with-dr-brent-kaziny","Roszak, Andrew; Kaziny, Brent","Instructional/Training Material","Site requires free registration.","false","23925"
"23924","Protecting Children: Learning From Las Vegas Mass Shooting Survivor Lacey Newman","Institute for Childhood Preparedness","2020-09-01T00:00:00.000","Video or Multimedia","Participants in this course will learn to describe at least two steps they can take to be better prepared, identify at least two considerations when discussing these events to children, and describe two techniques to help stay calm during an emergency.","https://institute-for-childhood-preparedness.teachable.com/p/protecting-children-learning-from-las-vegas-mass-shooting-survivor-lacey-newman","Roszak, Andrew; Newman, Lacey","Instructional/Training Material","Site requires free registration.","false","23924"
"23922","CONVERGE Conducting Emotionally Challenging Research Training Module","Natural Hazards Center [University of Colorado at Boulder]","2020-09-01T00:00:00.000","Text","This four-lesson training module describes emotionally challenging research and highlights the ways that recognizing researchers’ emotions can lead to more ethical and methodologically sound research practices in the context of extreme events.","https://converge-training.colorado.edu/courses/conducting-emotionally-challenging-research-training-module/",,"Instructional/Training Material","Site requires free registration.","false","23922"
"23921","Health Worker Safety and Security in the Context of the COVID-19 Pandemic","Insecurity Insight","2020-09-01T00:00:00.000","PDF","This four-page brief provides an overview of the most recent conflict-violence trends and their impact on health care in 2020, including data compiled during the COVID-19 pandemic.","http://insecurityinsight.org/wp-content/uploads/2020/10/Update-Health-Worker-Safety-and-Security-in-the-Context-of-the-COVID-19-Pandemic-September-2020.pdf",,"Report",,"false","23921"
"23915","Hidden Consequences: How the COVID Pandemic is Impacting Children","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","PDF","This one-page document provides information and links to recordings for a TRACIE (Technical Resources, Assistance Center, and Information Exchange) webinar series focused on how the COVID-19 pandemic may affect children. Topics will include impacts on child health and wellness, child emotional and social effects, the impact of COVID-19 on children with special healthcare needs, and how secondary/other disasters may affect children during the pandemic.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-hidden-consequences-children-and-covid-19-webinar-series-summary.pdf",,"Instructional/Training Material",,"false","23915"
"23905","Long-Term Care Facilities in the Context of COVID-19","World Health Organization","2020-09-01T00:00:00.000","Video or Multimedia","This course consists of four modules that address infection prevention and control measures to support long-term care facilities in the context of COVID-19. Participants will learn to describe infection prevention and control principles and practices relevant to long-term care facilities for patient and staff safety during COVID-19, and apply the COVID-19 Long-Term Care Facility Checklist to their place of work.","https://openwho.org/courses/LTCF-COVID-19",,"Instructional/Training Material","Site requires free registration.","false","23905"
"23904","Ebola: Introduction","World Health Organization","2020-09-01T00:00:00.000","Video or Multimedia","This introductory session explains basic principles of Ebola disease and ways to protect yourself and others. By the end of this lecture, participants will be able to describe Ebola disease and how it is transmitted, recall basic measures to prevent Ebola disease, and list key public health concerns during an Ebola outbreak.","https://openwho.org/courses/ebola-introduction",,"Instructional/Training Material","Site requires free registration.Link to course in French: https://openwho.org/courses/introduction-a-ebolaLink to course in Lingala: https://openwho.org/courses/ebola-introduction-LNLink to course in Kiswahili: https://openwho.org/courses/ebola-introduction-SW","false","23904"
"23902","COVID-19: Community Insights from the Asia Pacific Region","International Federation of Red Cross and Red Crescent Societies","2020-09-01T00:00:00.000","PDF","This 16-page report summarizes the results of a survey initiated by the Asia Pacific Risk Communication and Community Engagement Working Group to find out what people know about the COVID-19 virus and how it spreads, in order to enable stronger community-based response. Reporting data was collected from May 29 to July 20, 2020, by the Red Cross and Red Crescent Movement, WHO, OCHA, UNICEF, and Kantar.","https://reliefweb.int/sites/reliefweb.int/files/resources/COVID-19_CommunityInsights_sept2020.pdf","Adsett, Eloise; Arriani, Aulia; Austin, Caroline; Bartholomew, Katie; Fluck, Viviane","Report",,"false","23902"
"23895","Health and Social Services in Puerto Rico Before and After Hurricane Maria","RAND Corporation","2020-09-01T00:00:00.000","PDF","In September 2017, Puerto Rico was struck by Hurricanes Irma and Maria. To establish an evidence-based foundation for the recovery plan, the Homeland Security Operational Analysis Center (HSOAC) was asked to conduct an assessment describing the damage from the hurricanes and remaining needs across Puerto Rico. This 215-page report focuses on the damage and needs assessment and related courses of action, which are a collection of activities, policies, and actions that support the human capital investments and that were developed for Puerto Rico’s health and social services sector by the Health and Social Services Sector team.","https://www.rand.org/pubs/research_reports/RR2603.html","Chandra, Anita; Marsh, Terry; Madrigano, Jaime; Simmons, Molly; Abir, Mahshid","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/research_reports/RR2600/RR2603/RAND_RR2603.pdfLink to research summary: https://www.rand.org/content/dam/rand/pubs/research_reports/RR2600/RR2603/RAND_RR2603.summary.pdf","false","23895"
"23894","Is the Rise in Illicit Opioids Affecting Labor Supply and Disability Claiming Rates?","RAND Corporation","2020-09-01T00:00:00.000","PDF","This 63-page paper examines how the recent transition of the opioid crisis from prescription opioids to more prevalent misuse of illicit opioids, such as heroin and fentanyl, altered labor supply behavior and disability insurance claiming rates. It exploits differential geographic exposure to the reformulation of OxyContin, the largest reduction in access to abusable prescription opioids to date, to study the effects of substitution to illicit markets.","https://www.rand.org/pubs/working_papers/WRA802-1.html","Park, Sujeong; Powell, David","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/working_papers/WRA800/WRA802-1/RAND_WRA802-1.pdf","false","23894"
"23892","CRED Crunch 60: Technological Disasters","Centre for Research on the Epidemiology of Disasters, a WHO Collaborating Centre","2020-09-01T00:00:00.000","PDF","This two-page report analyzes data about technological disasters from 1980 to 2019, including the types of disasters and geographical locations.","https://cred.be:443/downloadFile.php?file=sites/default/files/CC60.pdf","van Loenhout, Joris; Below, Regina; Horions, Matthias","Report",,"false","23892"
"23885","COVID-19: Considerations, Strategies, and Resources for Crisis Standards of Care in Post-Acute and Long-Term Care (PALTC) Facilities","U.S. Department of Health and Human Services","2020-09-01T00:00:00.000","PDF","This 36-page document from the COVID-19 Healthcare Resilience Working Group provides post-acute and long-term care facilities an overview of general considerations, potential strategies, and existing resources that they may use to inform changes to their operations and care processes during the COVID-19 pandemic. Sample tools and resources are provided for illustrative purposes only and should be modified to locally adopted protocols as appropriate.","https://files.asprtracie.hhs.gov/documents/covid-19-considerations-strategies-and-resources-for-crisis-standards-of-care-in-paltc-facilities.pdf",,"Guideline/Assessment Tool",,"false","23885"
"23871","COVID-19 and Violence Against Women and Children: A Second Research Round Up","Center for Global Development","2020-09-01T00:00:00.000","PDF","This 11-page report summarizes a study that reviewed 28 new reports about violence against women during the COVID-19 pandemic, and found increasing evidence that the COVID-19 pandemic and associated policy response measures increase violence against women and children across contexts.","https://www.cgdev.org/publication/covid-19-and-violence-against-women-and-children-second-research-round","Peterman, Amber; O'Donnell, Megan","Report","Direct link to document: https://www.cgdev.org/sites/default/files/covid-19-and-violence-against-women-and-children-second-research-round.pdf","false","23871"
"23853","COVID-19 FAQs: What Nurses Need to Know","American Nurses Association","2020-09-01T00:00:00.000","Text","This web page provides answers to some of the most common questions that the American Nurses Association has received about COVID-19, including clinical care, personal protective equipment (PPE), mental health, and licensure.","https://www.nursingworld.org/practice-policy/work-environment/health-safety/disaster-preparedness/coronavirus/faqs/",,"Fact Sheet",,"false","23853"
"23829","In Pursuit of Resilience: Assessing Threats and Trade-Offs for Risk-Informed Development in Myanmar and Niger","Overseas Development Institute","2020-09-01T00:00:00.000","PDF","This 61-page report builds on its predecessor – Risk-Informed Development: From Crisis to Resilience –  to inform the potential evolution of proposed or existing policies through case study applications of a risk-informed development (RID) approach. The approach was used for systematically assessing multiple, simultaneous threats and their interactions with policies, as well as potential trade-offs from policies, in two contexts: Myanmar and Niger.","https://www.odi.org/publications/17369-pursuit-resilience-assessing-threats-and-trade-offs-risk-informed-development-myanmar-and-niger","Mayhew, Leigh; Pichon, Florence; Opitz-Stapleton, Sarah; Nadin, Rebecca","Report","Direct link to document: https://www.odi.org/sites/odi.org.uk/files/resource-documents/202009_in_pursuit_of_resilience_rid_report.pdfLink to Disaster Lit record for Risk-Informed Development: From Crisis to Resilience: https://disasterinfo.nlm.nih.gov/search/id:19413","false","23829"
"23810","GLASS (Global Antimicrobial Resistance and Use Surveillance System) Guidance for National Reference Laboratories","World Health Organization","2020-09-01T00:00:00.000","PDF","Countries can use this 28-page technical guidance to establish or improve national reference laboratory capacity within the national antimicrobial resistance (AMR) surveillance system. Increased laboratory capacity in countries and rapid, accurate diagnostic testing will significantly strengthen global AMR surveillance and diagnostic stewardship.","https://apps.who.int/iris/handle/10665/334290",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334290/9789240010581-eng.pdf?sequence=1&isAllowed=y","false","23810"
"23809","Framework for Evaluating Approaches to Symptom Screening in the Workplace During the COVID-19 Pandemic","RAND Corporation","2020-09-01T00:00:00.000","PDF","The authors of this 20-page report assess five approaches to screening for symptoms of COVID-19 at the workplace: no screening, verbal screening, screening using a paper form or app, verbal screening plus a temperature check at the workplace, and screening using a paper form or app plus a temperature check at the workplace. They rate each approach on five criteria: likelihood of detecting infection, helping employees feel safer, safety of the screening interaction, feasibility, and privacy.","https://www.rand.org/pubs/perspectives/PEA653-1.html","Gidengil, Courtney; Fischer, Shira; Breton, Nicholas","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/perspectives/PEA600/PEA653-1/RAND_PEA653-1.pdf","false","23809"
"23805","COVID-19 Air Traffic Visualization: African Anchor States Face Higher Risk of Importing COVID-19 Cases","RAND Corporation","2020-09-01T00:00:00.000","Text","This report uses the COVID-19 Air Traffic Visualization (CAT-V) tool to quantify the potential vectors of COVID-19 transmission to countries in the U.S. Africa Command (AFRICOM) area of responsibility (AOR), which encompasses every country in Africa except Egypt.","https://www.rand.org/pubs/research_reports/RRA248-7.html","Hanson, Russell; Grissom, Adam; Mouton, Christopher; Godges, John","Report",,"false","23805"
"23804","COVID-19 Air Traffic Visualization: Worldwide Spread of COVID-19 Accelerated Starting on February 19, 2020","RAND Corporation","2020-09-01T00:00:00.000","Text","This report uses the COVID-19 Air Traffic Visualization (CAT-V) tool to estimate when COVID-19 transmission via commercial air travel began to rapidly accelerate throughout the world. It estimates the global spread of COVID-19 by international air passengers prior to the March 11, 2020, declaration by the World Health Organization (WHO) that the world was officially experiencing a pandemic.","https://www.rand.org/pubs/research_reports/RRA248-6.html","Mouton, Christopher; Grissom, Adam; Godges, John; Hanson, Russell","Report",,"false","23804"
"23802","COVID-19 Vaccinations: Liability and Compensation Considerations Critical for a Successful Campaign","RAND Corporation","2020-09-01T00:00:00.000","PDF","The authors of this 16-page report examine liability and compensation issues as they relate to the future distribution and administration of the COVID-19 vaccine. They provide a brief history of how the U.S. government has addressed liability and compensation concerns in previous public health threats — specifically by providing liability immunity to manufacturers and distributors of vaccines should lawsuits arise as the result of serious side effects, as well as by setting up compensation systems that provide some, but not all, benefits of traditional tort litigation.","https://www.rand.org/pubs/perspectives/PEA761-1.html","Pace, Nicholas; Dixon, Lloyd","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/perspectives/PEA700/PEA761-1/RAND_PEA761-1.pdf","false","23802"
"23798","Rapid Expert Consultation on Environmental Surveillance of SARS-CoV-2 in Wastewater","World Health Organization, Regional Office for Europe","2020-09-01T00:00:00.000","PDF","This 19-page report summarizes the findings of the rapid expert consultation on environmental surveillance of SARS-CoV-2 in wastewater that was organized by the WHO European Centre for Environment and Health on July 23, 2020, in a virtual format. It aimed to facilitate a rapid exchange of current knowledge, experience, and practices among countries that are in the forefront of research and environmental surveillance of SARS-CoV-2 in wastewater.","https://apps.who.int/iris/handle/10665/334305",,"Conference/Meeting Material","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334305/WHO-EURO-2020%20-1093-40839-55199-eng.pdf?sequence=3&isAllowed=y","false","23798"
"23795","COVID-19 Pandemic Response in the Eastern Mediterranean Region","World Health Organization, Regional Office for the Eastern Mediterranean","2020-09-01T00:00:00.000","PDF","This 68-page report summarizes a six-month review of the Incident Management Support Team (IMST) response to the COVID-19 pandemic in the Eastern Mediterranean Region. A theme running throughout is the IMST’s role in coordination of the COVID-19 response, particularly in bringing together regional partners and driving forward the operational response.","https://apps.who.int/iris/handle/10665/334319",,"Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334319/WHOEMHSEL002E-eng.pdf?sequence=1&isAllowed=y","false","23795"
"23781","Adapting Data Collection and Utilisation to a COVID-19 Reality","Overseas Development Institute","2020-09-01T00:00:00.000","PDF","This 11-page briefing note focuses on the remote collection and use of data for adaptive management during the COVID-19 pandemic, setting out key considerations to help practitioners think through a transition from more traditional monitoring, evaluation, and learning (MEL) to MEL for adaptive management (MEL4AM) that reflects the unique data collection challenges presented by COVID-19.","https://www.odi.org/publications/17352-adapting-data-collection-and-utilisation-covid-19-reality-monitoring-evaluation-and-learning","Ziegler, Jessica; Mason, Paige","Report","Direct link to document: https://www.odi.org/sites/odi.org.uk/files/resource-documents/odi-ml-mel4am-adaptingdatacollection-bn-sep20-final_3.pdf","false","23781"
"23776","Coronavirus Commission on Safety and Quality in Nursing Homes: Commission Final Report","Mitre","2020-09-01T00:00:00.000","PDF","This 186-page report summarizes an independent review and comprehensive assessment of the nursing home response to the COVID-19 pandemic in order to identify opportunities for improvement and inform immediate and future action. The Centers for Medicare & Medicaid Services (CMS) requested this commission of experts to solicit lessons learned from the early days of the pandemic and recommendations for future actions to improve infection prevention and control measures, safety procedures, and the quality of life of residents within nursing homes.","https://edit.cms.gov/files/document/covid-final-nh-commission-report.pdf",,"Report",,"false","23776"
"23775","Technical Note: Impact of COVID-19 on Child Poverty","United Nations Children's Fund","2020-09-01T00:00:00.000","PDF","Using data on access to education, healthcare, housing, nutrition, sanitation, and water from more than 70 countries, this three-page document finds that around 45 percent of children were severely deprived of at least one of these critical needs before the coronavirus pandemic even hit. The situation for children living in multidimensional poverty is likely to worsen unless national governments and the international community step up to soften the blow.","https://data.unicef.org/resources/impact-of-covid-19-on-multidimensional-child-poverty/",,"Report","Direct link to document: https://data.unicef.org/wp-content/uploads/2020/09/Technical-Note-Save-the-Children-UNICEF-COVID-and-impact-on-multidimensional-child-poverty.pdf","false","23775"
"23770","Respiratory Health Effects of Airborne Hazards Exposures in the Southwest Asia Theater of Military Operations","National Academies Press","2020-09-01T00:00:00.000","Text","This 254-page report reviews the scientific evidence regarding respiratory health outcomes in veterans of the Southwest Asia conflicts, and identifies research that could feasibly be conducted to address outstanding questions and generate answers, newly emerging technologies that could aid in these efforts, and organizations that the Veterans Administration might partner with to accomplish this work.","https://www.nap.edu/catalog/25837/respiratory-health-effects-of-airborne-hazards-exposures-in-the-southwest-asia-theater-of-military-operations",,"Report",,"false","23770"
"23760","How COVID-19 is Changing the World: A Statistical Perspective","United Nations Children's Fund","2020-09-01T00:00:00.000","PDF","The United Nations and all member organizations of the Committee for the Coordination of Statistical Activities (CCSA) collect and make available a wealth of information for assessing the multifaceted impacts of the COVID-19 pandemic. This 80-page report updates some of the global and regional trends presented in Volume I and offers a snapshot of how COVID-19 continues to affect the world today across multiple domains.","https://data.unicef.org/resources/how-covid-19-is-changing-the-world-a-statistical-perspective-volume-2/",,"Report","Direct link to document: file:///C:/Users/SINCLA~1/AppData/Local/Temp/COVID19-CCSA-report-final-English-Vol2_2020.pdf","false","23760"
"23755","Landscape of Emerging Infectious Disease R&D: Preventing the Next Pandemic","Policy Cures Research","2020-09-01T00:00:00.000","PDF","This 79-page report provides a comprehensive look at R&D to fight emerging infectious diseases (EIDs), covering global funding for WHO priority EIDs between 2014 and 2018. The funding data included in the report covers a range of pathogens with recognized pandemic potential, including coronaviruses, Ebola, Zika, and as-yet-unknown pathogens captured under the heading of Disease X.","https://s3-ap-southeast-2.amazonaws.com/policy-cures-website-assets/app/uploads/2020/09/16021708/EID20_Report_Web_1_FINAL.pdf","Chapman, Nick; Doubell, Anna; Tuttle, Andrew; Barnsley, Paul; Oversteegan, Lisette","Report","Link to Executive Summary: https://s3-ap-southeast-2.amazonaws.com/policy-cures-website-assets/app/uploads/2020/09/16021630/GFINDER_LEIDR_EXEC_SUMMARY.pdfLink to Explore data from the report: https://gfinderdata.policycuresresearch.org/","false","23755"
"23753","Expanding Our Vision for Mental Health: Listening to Young People and Learning from COVID-19","Wellcome Trust","2020-09-01T00:00:00.000","PDF","This seven-page document discusses how COVID-19 is an opportunity to learn about  mental health. It lays out a commitment by Wellcome, UNICEF, WHO, the World Economic  Forum, and the Office of the UN Secretary General to embark on a learning journey on how best to embed the following three principles across all our mental health work: Putting lived experience at the heart of policy and practice; positioning local innovation as a focus for learning and funding; and envisioning mental health as larger than healthcare.","https://wellcome.org/reports/mental-health-listening-young-people-and-learning-covid-19","Smith, Beck; Wolpert, Miranda","Report","Direct link to document: https://wellcome.org/sites/default/files/expanding-our-vision-for-mental-health-young-people-and-covid-19.pdf","false","23753"
"23748","COVID-19 Mental Health Handbook: Evidence-Informed Approaches to Mental Wellbeing During a Pandemic","Wheaton College, Humanitarian Disaster Institute","2020-09-01T00:00:00.000","PDF","This 195-page handbook covers a range of topics that live at the intersection of COVID-19 and mental health. This resource brings to attention the myriad mental health needs COVID-19 has brought to the surface while also suggesting ways to cope, move forward, and become more resilient.","https://www.spiritualfirstaidhub.com/covid19mentalhealthmanual",,"Report","Site requires free registration.","false","23748"
"23747","Maintaining Healthcare Safety During the COVID-19 Pandemic","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","Video or Multimedia","This one-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides links to a series of short presentations featuring healthcare professionals sharing their experiences as they work through the operational realities of maintaining and prioritizing healthcare safety during the COVID-19 pandemic.","https://files.asprtracie.hhs.gov/documents/maintaining-healthcare-safety-during-covid-19-speaker-series-.pdf",,"Instructional/Training Material",,"false","23747"
"23734","Resuming Normal Drug and Biologics Manufacturing Operations During the COVID-19 Public Health Emergency","U.S. Food and Drug Administration","2020-09-01T00:00:00.000","PDF","The FDA is issuing this 12-page guidance to help drug and biological product manufacturers during the COVID-19 public health emergency plan and prioritize current good manufacturing practice (CGMP) activities as they transition from operations impacted by the public health emergency to normal manufacturing operations.","https://www.fda.gov/media/142051/download",,"Guideline/Assessment Tool",,"false","23734"
"23733","Assessing COVID-19-Related Symptoms in Outpatient Adult and Adolescent Subjects in Clinical Trials of Drugs and Biological Products for COVID-19 Prevention or Treatment","U.S. Food and Drug Administration","2020-09-01T00:00:00.000","PDF","The FDA is issuing this 14-page guidance to provide sponsors and investigators with considerations for approaches on how common COVID-19-related symptoms can be measured and analyzed in clinical trials evaluating drugs or biological products for the prevention or treatment of COVID-19 in outpatient adult and adolescent subjects.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/assessing-covid-19-related-symptoms-outpatient-adult-and-adolescent-subjects-clinical-trials-drugs",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/142143/download","false","23733"
"23732","Moving Beyond the Numbers: What the COVID-19 Pandemic Means for the Safety of Women and Girls","United Nations Children's Fund","2020-09-01T00:00:00.000","PDF","This 10-page report illustrates some of the limitations of the statistics on gender-based violence that have been widely publicized in the context of the COVID-19 pandemic, provides additional contextual information to better understand the risks women and girls are facing, and outlines some priority recommendations to governments, policy makers, donors, and key humanitarian and development actors for addressing gender-based violence in the context of COVID-19.","https://www.corecommitments.unicef.org/covid19db/Moving-Beyond-the-Numbers-2.pdf",,"Report","Direct link to document: https://aa9276f9-f487-45a2-a3e7-8f4a61a0745d.usrfiles.com/ugd/aa9276_0b3161f4941049e4a740ef8586c96c15.pdf","false","23732"
"23731","SocialNet2019 Community Engagement Training: White Paper and SocialNet Experience","World Health Organization, Regional Office for Europe","2020-09-01T00:00:00.000","PDF","Over 50 participants from countries and territories in the WHO European Region participated in a training course on risk communication, community engagement, and social science. This 132-page training report consists of two main sections that both cover the core content, themes, and concepts of SocialNet – but considered through distinctive lenses.","https://www.euro.who.int/en/health-topics/health-emergencies/publications/2020/socialnet2019-community-engagement-training-white-paper-and-socialnet-experience-2020",,"Instructional/Training Material","Direct link to document: https://www.euro.who.int/__data/assets/pdf_file/0004/461794/SocialNet2019.pdf","false","23731"
"23729","World in Disorder: 2020 Background Papers","World Health Organization","2020-09-01T00:00:00.000","PDF","As part of the process for developing its annual report, the Global Preparedness Monitoring Board commissions review papers from world experts and leading institutions that explore the challenges of preparedness through various lenses. This web page provides links to the 2020 background papers.","https://apps.who.int/gpmb/thematic_report.html#2020",,"Report","Link to Governance Preparedness: Initial Lessons from COVID-19: https://apps.who.int/gpmb/assets/thematic_papers_2020/tp_2020_1.pdfLink to The Global Governance of Access to Countermeasures: https://apps.who.int/gpmb/assets/thematic_papers_2020/tp_2020_2.pdfLink to Building Trust Within and Across Communities for Health Emergency Preparedness: https://apps.who.int/gpmb/assets/thematic_papers_2020/tp_2020_3.pdfLink to Urbanization and Preparedness for Outbreaks with High-Impact Respiratory Pathogens: https://apps.who.int/gpmb/assets/thematic_papers_2020/tp_2020_4.pdfLink to The R&D Preparedness Ecosystem: Preparedness for Health Emergencies: https://apps.who.int/gpmb/assets/thematic_papers_2020/tp_2020_5.pdf","false","23729"
"23727","Region 1 Interagency Task Force for the Prevention of COVID-19 in the Long-Term Care Environment","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","PDF","This 20-page document, developed with the Federal Emergency Management Agency (FEMA), provides the conclusions and recommendations of the task force formed by FEMA and ASPR to contribute specifically to combating the spread of COVID-19 and mitigating its impacts on residents of long-term care facilities.","https://files.asprtracie.hhs.gov/documents/region-1-interagency-task-force-for-the-prevention-of-covid-19-in-the-long-term-care-environment.pdf",,"Report",,"false","23727"
"23724","Critical Care Load-Balancing Operational Template","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","PDF","This five-page template from the Healthcare Resilience Working Group provides a framework for indicators and triggers that may assist states that are implementing Medical Operations Coordination Cells (MOCCs). The goal of the MOCC toolkit is to assist regional, state, local, tribal, and territorial governments to ensure load-balancing across healthcare facilities and systems so that the highest possible level of care can be provided to each patient during the coronavirus disease 2019 (COVID-19) pandemic.","https://files.asprtracie.hhs.gov/documents/critical-care-load-balancing-operational-template.pdf",,"Guideline/Assessment Tool",,"false","23724"
"23723","Considerations for Assessing Regional Patient Load-Balancing Effects during COVID-19","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","PDF","This four-page document from the Healthcare Resilience Working Group promotes constructs such as the Medical Operations Coordination Cell (MOCC) during the COVID-19 pandemic to create a regional approach, including policies to support these load-balancing operations, particularly through hospital-to-hospital patient transfers.","https://files.asprtracie.hhs.gov/documents/considerations-for-assessing-regional-patient-load-balancing-effects-during-covid-9-1-2020.pdf",,"Guideline/Assessment Tool",,"false","23723"
"23714","WHO Guidance on Research Methods for Health and Disaster Risk Management","World Health Organization","2020-09-01T00:00:00.000","PDF","This guidance offers practical advice about how to plan, conduct, and report on a wide variety of quantitative and qualitative studies that can inform questions about policies and programs for health-related disasters and emergencies across different settings and level of resources. Case studies of direct relevance to Health Emergency and Disaster Risk Management provide real-life examples of research methods and how they have modified policies.","https://extranet.who.int/kobe_centre/en/project-details/GUIDANCE_ResearchMethods_HealthEDRM","Abrahams, Jonathan; Kayano, Ryoma; Clarke, Mike; Chan, Emily YY; Murray, Virginia","Guideline/Assessment Tool","Chapter sections are available in individual PDF files.","false","23714"
"23700","COVID-19 Supplement for Planning Considerations: Evacuation and Shelter-in-Place","Federal Emergency Management Agency [Department of Homeland Security]","2020-09-01T00:00:00.000","PDF","This 12-page document focuses on key considerations and principles associated with evacuation and shelter-in-place planning and execution, and identifies impacts that COVID-19 may have on planning and executing evacuation and shelter-in-place operations.","https://www.fema.gov/sites/default/files/2020-09/fema_covid-19_supplement-evacuation-shelter-in-place.pdf",,"Guideline/Assessment Tool",,"false","23700"
"23695","National Decision Point: Effective Testing and Screening for COVID-19","Rockefeller Foundation","2020-09-01T00:00:00.000","PDF","This 30-page report describes how to offer sufficient COVID-19 tests paired with sophisticated strategies for their effective use, in ways that can be tailored to local circumstances and risk tolerances. The goal is to give schools, businesses, and other critical institutions a pathway toward operating safely even for higher-risk populations and with continuing community spread.","https://www.rockefellerfoundation.org/report/a-national-decision-point-effective-testing-and-screening-for-covid-19/","Silcox, Christina; Anderson, David; Zavodszky, Anna; Borre, Ethan; Dentzer, Susan","Report","Direct link to document: https://www.rockefellerfoundation.org/wp-content/uploads/2020/09/A-National-Decision-Point-Effective-Testing-Screening-for-Covid-19-Full-Report.pdfLink to Executive Summary: https://www.rockefellerfoundation.org/wp-content/uploads/2020/09/A-National-Decision-Point-Effective-Testing-Screening-for-Covid-19-Executive-Summary.pdf","false","23695"
"23690","COVID-19 Considerations for Long-Term Care Facilities","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","PDF","This 16-page toolkit from TRACIE (Technical Resources, Assistance Center, and Information Exchange) is a compilation of considerations for long-term care facilities based on lessons learned during the early months of the COVID-19 pandemic, accompanied by resources to inform planning and response efforts.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-covid-19-long-term-care-considerations-toolkit-final.pdf",,"Guideline/Assessment Tool",,"false","23690"
"23688","Understanding and Responding to Global Health Security Risks from Microbial Threats in the Arctic","National Academies Press","2020-09-01T00:00:00.000","Text","This 84-page publication summarizes the presentation and discussion of a workshop held in November 2019 that examined case studies such as the specific case of Arctic region anthrax outbreaks, as a known, observed risk, as well as other types of human and animal microbial health risks that have been discovered in snow, ice, or permafrost environments, or that could conceivably exist.","https://www.nap.edu/catalog/25887/understanding-and-responding-to-global-health-security-risks-from-microbial-threats-in-the-arctic",,"Conference/Meeting Material",,"false","23688"
"23687","Framework for Assessing Mortality and Morbidity After Large-Scale Disasters","National Academies Press","2020-09-01T00:00:00.000","Text","This 208-page report reviews and describes the current state of the field of disaster-related mortality and significant morbidity assessment. It examines practices and methods for data collection, recording, sharing, and use across state, local, tribal, and territorial stakeholders; evaluates best practices; and identifies areas for future resource investment.","https://www.nap.edu/catalog/25863/a-framework-for-assessing-mortality-and-morbidity-after-large-scale-disasters",,"Report",,"false","23687"
"23686","Understanding Compliance with OSHA’s Respiratory Protection Standard During the Coronavirus Disease 2019 (COVID-19) Pandemic","Occupational Safety and Health Administration [U.S. Department of Labor]","2020-09-01T00:00:00.000","PDF","The coronavirus disease 2019 (COVID-19) pandemic has had an unprecedented impact on the availability of respirators and fit-testing supplies. This two-page document is intended to help employers understand and comply with OSHA’s temporary enforcement guidance for the Respiratory Protection standard.","https://www.osha.gov/sites/default/files/respiratory-protection-covid19-compliance.pdf",,"Guideline/Assessment Tool",,"false","23686"
"23682","ASHP Principles for COVID-19 Vaccine Distribution, Allocation, and Mass Immunization","American Society of Health-Systems Pharmacists","2020-09-01T00:00:00.000","PDF","This four-page document offers 10 principles for COVID-19 vaccine development, distribution, allocation, mass vaccination, monitoring, and surveillance.","https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-Principles-for-COVID-19-Vaccine",,"Guideline/Assessment Tool",,"false","23682"
"23681","Caring for Children and Youth With Special Health Care Needs During the COVID-19 Pandemic","American Academy of Pediatrics","2020-09-01T00:00:00.000","Text","This web page discusses the overall approach to minimizing the risk of infection while meeting the ongoing needs of children and youth with special health care needs during the COVID-19 pandemic.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/caring-for-children-and-youth-with-special-health-care-needs-during-the-covid-19-pandemic/",,"Guideline/Assessment Tool",,"false","23681"
"23678","Contagion Externality of a Superspreading Event: The Sturgis Motorcycle Rally and COVID-19","IZA Institute of Labor Economics","2020-09-01T00:00:00.000","PDF","Between August 7 and 16, 2020, nearly 500,000 motorcycle enthusiasts converged on Sturgis, South Dakota, for its annual motorcycle rally. Large crowds, coupled with minimal mask-wearing and social distancing by attendees, raised concerns that this event could serve as a COVID-19 “super-spreader.”  This 63-page study is the first to explore the impact of this event on social distancing and the spread of  COVID-19.","http://ftp.iza.org/dp13670.pdf","Dave, Dhaval; Friedson, Andrew; McNichols, Drew; Sabia, Joseph","Report",,"false","23678"
"23666","COVID-19 Information Metrics for Response Leadership's Decision Making: Guidance in Non-U.S. Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-09-01T00:00:00.000","Text","This web page aims to provide critical COVID-19 information metrics by technical area that response leaders in non-U.S. settings can request to aid in informing COVID-19 response decisions. It includes a set of core metrics within 10 technical areas for response leaders to help monitor response progress and guide decision making.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/leadership-emergency-response.html",,"Guideline/Assessment Tool",,"false","23666"
"23658","Fact Sheet for Healthcare Providers: MobileDetect Bio BCC19 Test Kit","U.S. Food and Drug Administration","2020-09-01T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the MobileDetect Bio BCC19 Test Kit. The MobileDetect Bio BCC19 Test Kit is authorized for use with certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141789/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141790/downloadLink to Letter of Authorization: https://www.fda.gov/media/141788/downloadLink to Instructions for Use: https://www.fda.gov/media/141791/download","false","23658"
"23657","Fact Sheet for Healthcare Providers: Kaira 2019-nCoV Detection Kit","U.S. Food and Drug Administration","2020-09-01T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Kaira 2019-nCoV Detection Kit. The Kaira 2019-nCoV Detection Kit is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141793/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141794/downloadLink to Letter of Authorization: https://www.fda.gov/media/141792/downloadLink to Instructions for Use: https://www.fda.gov/media/141795/download","false","23657"
"23647","Conversations on COVID-19: Impacts on Communities of Color","National Academies of Sciences, Engineering, and Medicine","2020-09-01T00:00:00.000","Video or Multimedia","This web page provides videos of conversations with experts on a variety of topics related to minority health and COVID-19, as well as information and resources from the National Academies on topics related to health equity.","https://www.nationalacademies.org/resource/conversations-on-covid-19-impacts-on-communities-of-color",,"Instructional/Training Material",,"false","23647"
"23643","Aid and Health Worker Safety and Security in the Context of the COVID-19 Pandemic","Insecurity Insight","2020-09-01T00:00:00.000","PDF","This six-page document provides an overview of developments that have affected the safety and security of aid and health workers in the first half of 2020 and in the context of the COVID-19 pandemic.","http://insecurityinsight.org/wp-content/uploads/2020/09/Aid-and-health-worker-safety-and-security-in-the-context-of-the-COVID-19-pandemic.pdf",,"Report",,"false","23643"
"23638","Occupational Health and Safety for Health Workers in the Context of COVID-19","World Health Organization","2020-09-01T00:00:00.000","Video or Multimedia","Participants in this course will learn to describe the most common occupational risks to health and safety to which health workers are exposed while responding to the COVID-19 pandemic; describe the rights of health workers to decent working conditions; describe how to apply measures for protecting their health and safety and actively propose improvements; and access and use supportive services for protection of health and safety of health workers.","https://openwho.org/courses/COVID-19-occupational-health-and-safety",,"Instructional/Training Material","Site requires free registration.","false","23638"
"23636","Federal Medical Stations: Training from the Strategic National Stockpile for the COVID-19 Response","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-09-01T00:00:00.000","Video or Multimedia","This web page provides a list of videos from the Strategic National Stockpile that are designed to assist in the assembly and/or operation of key components and equipment in the Federal Medical Station deployment cache.","https://www.phe.gov/emergency/events/COVID19/SNS/Pages/sns-trng-videos.aspx",,"Instructional/Training Material",,"false","23636"
"23629","What to Do if a Student Becomes Sick at School or Reports a New COVID-19 Diagnosis Flowchart","Centers for Disease Control and Prevention","2020-09-01T00:00:00.000","PDF","This one-page flowchart details what to do if a student becomes sick at school, reports a new COVID-19 diagnosis, or tests positive or negative.","https://www.cdc.gov/coronavirus/2019-ncov/images/community/schools-childcare/student-becomes-sick-diagnosis-flowchart.jpg",,"Guideline/Assessment Tool","Link to web page with more information: https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/student-becomes-sick-diagnosis-flowchart.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/student-becomes-sick-diagnosis-flowchart.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/student-becomes-sick-diagnosis-flowchart.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/student-becomes-sick-diagnosis-flowchart.html","false","23629"
"23628","Overlooked and Undercounted: The Growing Impact of COVID-19 on Assisted Living Facilities","Henry J. Kaiser Family Foundation","2020-09-01T00:00:00.000","Text","This analysis examines the impact of COVID-19 on assisted living facilities, as well as changes over time, using state-level data on COVID-19 cases and deaths reported in early June 2020, and again in early August.","https://www.kff.org/coronavirus-covid-19/issue-brief/overlooked-and-undercounted-the-growing-impact-of-covid-19-on-assisted-living-facilities/","True, Sarah; Ochieng, Nancy; Cubanski, Juliette; Chidambaram, Priya; Neuman, Tricia","Report",,"false","23628"
"23072","Multisystem Inflammatory Syndrome in Children (MIS-C) Interim Guidance","American Academy of Pediatrics","2020-09-01T00:00:00.000","Text","This web page, updated on September 1, 2020, provides answers to questions, and guidance for clinicians about multisystem inflammatory syndrome in children (MIS-C), including when to perform testing for MIS-C and what sort of testing to start with in the outpatient or emergency room setting.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/multisystem-inflammatory-syndrome-in-children-mis-c-interim-guidance/",,"Guideline/Assessment Tool",,"false","23072"
"3156","Surveillance and Studies in a Pandemic in Europe","European Union, European Centre for Disease Prevention and Control","2009-06-12T00:00:00.000","PDF","This 19-page report is a summary of Surveillance and Studies in a Pandemic in Europe, including early detection, investigation, early assessment, monitoring, and investigation of the effectiveness of countermeasures.","https://www.ecdc.europa.eu/en/publications-data/surveillance-and-studies-pandemic-europe?ID=169&List=4f55ad51-4aed-4d32-b960-af70113dbb90",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0906_TER_Surveillance_and_Studies_in_a_Pandemic_in_Europe.pdf","false","3156"
"19993","Internal Displacement 2020: Mid-Year Update","Internal Displacement Monitoring Centre","2020-09-01T00:00:00.000","PDF","This 60-page report reveals the most significant new internal displacements associated with conflict, violence, and disasters around the world between January and June 2020. It serves as an important temperature gauge of global displacement halfway through the year, looking ahead to the trends and patterns expected in the months to come.","https://www.internal-displacement.org/mid-year-figures",,"Report","Direct link to document: https://www.internal-displacement.org/sites/default/files/publications/documents/2020%20Mid-year%20update.pdfLink to chapter on Impacts of Covid-19 on iDPs: https://www.internal-displacement.org/sites/default/files/publications/documents/2020%20Mid-year%20update.pdf#page=41 Link to Mid-Year Figures, January to June 2019: https://www.internal-displacement.org/sites/default/files/inline-files/2019-mid-year-figures_for%20website%20upload.pdf","false","19993"
"13848","UK (United Kingdom) Recovery Handbook for Chemical Incidents","United Kingdom Department of Health","2020-09-01T00:00:00.000","PDF","This 600-page book, updated on September 1, 2020, was designed to help manage the recovery phase of a chemical incident where contamination has affected food production systems, inhabited areas, and water environments.","https://www.gov.uk/government/publications/uk-recovery-handbook-for-chemical-incidents-and-associated-publications",,"Book/Book Chapter","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/912808/UKRHCI_2019_Update_v1.1__2_.pdfLink to Disaster Lit record for Chemical Recovery Guidance and Tools: User Guide: https://disasterinfo.nlm.nih.gov/search/id:17955Link to Disaster Lit record for Chemical Recovery Record Form: https://disasterinfo.nlm.nih.gov/search/id:15073Link to Disaster Lit record for Chemical Recovery Navigation Tool: https://disasterinfo.nlm.nih.gov/search/id:9656","false","13848"
"7506","Curriculum Recommendations for Disaster Health Professionals","National Center for Disaster Medicine and Public Health [Uniformed Services University of the Health Sciences]","2020-09-01T00:00:00.000","PDF","This 48-page document, updated in September 2020, was created with the intent to provide a framework upon which to build disaster behavioral health curricula, and compile and give access to up-to-date, credible resources to support such curricula. It is intended for use by those developing and delivering disaster behavioral health training, as well as community leaders, policymakers, and others seeking to better understand the behavioral health impacts of disasters on individuals and communities.  It includes a table for COVID-19 Special Section: Behavioral Health Resources.","https://www.usuhs.edu/sites/default/files/media/ncdmph/pdf/ncdmph_csts_revised.pdf","Flynn, Brian; Vance, Mary; Morganstein, Joshua","Guideline/Assessment Tool",,"false","7506"
"24049","Response to the Ebola Virus Disease in the Eastern of the Democratic Republic of Congo","Enhancing Learning and Research for Humanitarian Assistance","2020-08-31T00:00:00.000","PDF","This 27-page report summarizes a study called “Humanizing the design of the Ebola response in DRC: Anthropological research on humane designs of Ebola treatment and care to build trust for better health,” which examined how humane designs of treatment and care at Ebola Treatment Centers (ETCs) influence the formation of trust into the response to the Ebola virus disease epidemic in Democratic Republic of Congo.","https://www.elrha.org/researchdatabase/ebola-drc-pole-institute-martin-luther-university/","Morisho, Nene; Park, Sung-Joon; Kalubi, Josepha; Lubula, Mumbere","Report","Direct link to document: https://www.elrha.org/wp-content/uploads/2020/09/2020-Elhra-Report_ENGL.pdfLink to report in French: https://www.elrha.org/wp-content/uploads/2020/09/2020-rapport-ELHRA.pdf","false","24049"
"23624","Fact Sheet for Healthcare Providers: TBG SARS-CoV-2 IgG/IgM Rapid Test Kit","U.S. Food and Drug Administration","2020-08-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the TBG SARS-CoV-2 IgG/IgM Rapid Test Kit. The TBG SARS-CoV-2 IgG/IgM Rapid Test Kit is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (Acid Citrate Dextrose -ACD).","https://www.fda.gov/media/141771/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/141772/downloadLink to Letter of Authorization: https://www.fda.gov/media/141770/downloadLink to Instructions for Use: https://www.fda.gov/media/141773/download","false","23624"
"23623","Fact Sheet for Healthcare Providers: COVID-19 ELISA pan-Ig Antibody Test","U.S. Food and Drug Administration","2020-08-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COVID-19 ELISA pan-Ig Antibody Test. The COVID-19 ELISA pan-Ig Antibody Test is authorized for the detection of antibodies to SARS-CoV-2 in human serum.","https://www.fda.gov/media/141775/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/141776/downloadLink to Letter of Authorization: https://www.fda.gov/media/141774/downloadLink to EUA Summary: https://www.fda.gov/media/141777/download","false","23623"
"23622","Fact Sheet for Healthcare Providers: T2SARS-CoV-2 Panel","U.S. Food and Drug Administration","2020-08-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the T2SARS-CoV-2 Panel. The T2SARS-CoV-2 Panel is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141753/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141754/downloadLink to Letter of Authorization: https://www.fda.gov/media/141752/downloadLink to Instructions for Use: https://www.fda.gov/media/141755/download","false","23622"
"23621","Fact Sheet for Healthcare Providers: MiraDx SARS-CoV-2 RT-PCR Assay","U.S. Food and Drug Administration","2020-08-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the MiraDx SARS-CoV-2 RT-PCR assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141757/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141758/downloadLink to Letter of Authorization: https://www.fda.gov/media/141756/downloadLink to EUA Summary: https://www.fda.gov/media/141760/download","false","23621"
"23620","Fact Sheet for Healthcare Providers: SARS-CoV-2 DETECTR Reagent Kit","U.S. Food and Drug Administration","2020-08-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 DETECTR Reagent Kit. The SARS-CoV-2 DETECTR Reagent Kit is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141763/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141764/downloadLink to Letter of Authorization: https://www.fda.gov/media/141762/downloadLink to Instructions for Use: https://www.fda.gov/media/141765/download","false","23620"
"23619","Fact Sheet for Healthcare Providers: BayCare SARS-CoV-2 RT PCR Assay","U.S. Food and Drug Administration","2020-08-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BayCare SARS-CoV-2 RT PCR Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The BayCare SARS-CoV-2 RT PCR Assay is authorized for use on nasopharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141767/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141768/downloadLink to Letter of Authorization: https://www.fda.gov/media/141766/downloadLink to EUA Summary: https://www.fda.gov/media/141769/download","false","23619"
"23593","COVID-19: Brief Update on Initial Federal Response to the Pandemic","U.S. Government Accountability Office","2020-08-31T00:00:00.000","PDF","This 44-page report examines federal spending on the COVID-19 response; indicators for monitoring public health and the economy; and the status of matters for congressional consideration and recommendations from GAO’s June 2020 report.","https://www.gao.gov/products/GAO-20-708","Clowers, A. Nicole","Report","Direct link to document: https://www.gao.gov/assets/710/709033.pdf","false","23593"
"24143","Reducing the Risk  of COVID-19 Using  Engineering Controls","American Industrial Hygiene Association","2020-08-28T00:00:00.000","PDF","This seven-page document provides details about the recommendations of the American Industrial Hygiene Association (AIHA) and its volunteer committees of industrial hygienists for the use of engineering controls in all indoor workplaces, even those outside of the health care industry, to reduce the spread of COVID-19.","https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Guidance-Documents/Reducing-the-Risk-of-COVID-19-using-Engineering-Controls-Guidance-Document.pdf",,"Guideline/Assessment Tool",,"false","24143"
"24013","FAQ: Should Antibiotic Therapy be Continued in Patients Diagnosed with COVID-19?","Duke University","2020-08-28T00:00:00.000","PDF","This three-page fact sheet provides information about the ability to streamline and de-escalate empiric antibiotic therapy and why it remains a challenge for antimicrobial stewardship programs. This challenge is further complicated by the ongoing pandemic and increased concern for COVID-19 infection, especially in light of reported mortality rates associated with severe disease presentation.","https://dason.medicine.duke.edu/sites/dason.medicine.duke.edu/files/antibiotic_use_in_covid-19_faq_updated_8-28-2020.pdf",,"Fact Sheet",,"false","24013"
"23713","Public Health Assessment Training","Agency for Toxic Substances and Disease Registry","2020-08-28T00:00:00.000","Video or Multimedia","This training provides the basics to conduct a public health assessment, consisting of six modules based on a realistic environmental health case study, problem-solving exercises, and comprehensive resources and references to conduct public health assessments. Modules 7 and 8 are under construction.","https://www.atsdr.cdc.gov/training/pha-training-section1.html",,"Instructional/Training Material","Site requires free registration.","false","23713"
"23691","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: Home Infusion Pharmacy Resources","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-28T00:00:00.000","PDF","This three-page document from TRACIE responds to a request for Emergency Operations Plans (EOPs) for home infusion pharmacies, and provides related resources.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta---home-infusion-pharmacy-resources---8-28-2020.pdf",,"Bibliography/Resource List",,"false","23691"
"23604","Fact Sheet for Healthcare Providers: PCL SARS-CoV-2 Real-Time RT-PCR Assay","U.S. Food and Drug Administration","2020-08-28T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the PCL SARS-CoV-2 Real-Time RT-PCR Assay that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141663/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141664/downloadLink to Letter of Authorization: https://www.fda.gov/media/141662/downloadLink to EUA Authorization: https://www.fda.gov/media/141665/download","false","23604"
"23603","Fact Sheet for Healthcare Providers: DxTerity SARS-CoV-2 RT-PCR CE Test","U.S. Food and Drug Administration","2020-08-28T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the DxTerity SARS-CoV-2 RT-PCR CE Test. The DxTerity SARS-CoV-2 RT-PCR CE Test is authorized for use with saliva specimens collected from individuals consistent with the Emergency Use Authorization (EUA).","https://www.fda.gov/media/141667/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141668/downloadLink to Letter of Authorization: https://www.fda.gov/media/141666/downloadLink to Instructions for Use (Home Collect): https://www.fda.gov/media/141670/downloadLink to EUA Summary: https://www.fda.gov/media/141669/download","false","23603"
"23602","Opioid Overdose","World Health Organization","2020-08-28T00:00:00.000","Text","This fact sheet provides information about opioid overdose, including risk factors for opioid overdose, emergency responses to opioid overdose, and prevention of opioid overdose.","https://www.who.int/news-room/fact-sheets/detail/opioid-overdose",,"Fact Sheet",,"false","23602"
"23616","Rights in a Pandemic: Lockdowns, Rights and Lessons from HIV in the Early Response to COVID-19","UNAIDS","2020-08-27T00:00:00.000","PDF","This 76-page report outlines 10 immediate areas for action for governments toward building effective, rights-based COVID-19 responses. These include taking proactive measures to ensure that people, particularly people in vulnerable groups, can access HIV treatment and prevention services; designating and supporting essential workers, including community-led organizations; and implementing measures to prevent and address gender-based violence.","https://www.unaids.org/en/resources/documents/2020/rights-in-a-pandemic",,"Report","Direct link to document: https://www.unaids.org/sites/default/files/media_asset/rights-in-a-pandemic_en.pdf","false","23616"
"23614","Health Conditions and an Older Population Increase COVID-19 Risks in Rural America","University of New Hampshire","2020-08-27T00:00:00.000","PDF","This eight-page brief discusses the likely influence that the age structure and the incidence of pre-existing health conditions have on the risks of those exposed to COVID-19 in rural and urban counties in the United States.","https://scholars.unh.edu/carsey/414/","Johnson, Kenneth","Report","Direct link to document: https://scholars.unh.edu/cgi/viewcontent.cgi?article=1415&context=carsey","false","23614"
"23613","Airborne Transmission of SARS-CoV-2: A Virtual Workshop","National Academies of Sciences, Engineering, and Medicine","2020-08-27T00:00:00.000","Video or Multimedia","This Environmental Health Matters Initiative (EHMI) workshop, held on August 26-27, 2020, delves into the rapidly evolving science on the spread of the SAR-CoV-2 virus, as part of a larger body of COVID-19 related work at the National Academies. It features experts in aerosol science, virology, infectious disease, and epidemiology. This page provides videos and materials from the workshop.","https://www.nationalacademies.org/event/08-26-2020/airborne-transmission-of-sars-cov-2-a-virtual-workshop",,"Instructional/Training Material",,"false","23613"
"23606","Promoting Mask-Wearing During the COVID-19 Pandemic: A Policymaker's Guide","Resolve to Save Lives","2020-08-27T00:00:00.000","PDF","This 18-page document draws on scientific evidence from the COVID-19 pandemic and from prior public health research on behavior change, with the purpose of empowering governments to measure face mask use in their jurisdictions and promote widespread adoption of masks in the general population. Annexes to the report, infographics, and press releases are included in the related playbook.","https://preventepidemics.org/wp-content/uploads/2020/08/Promoting-Mask-Wearing-During-COVID-19.pdf",,"Guideline/Assessment Tool","Link to Mask Guidance Playbook: https://preventepidemics.org/covid19/resources/mask-playbook/","false","23606"
"23587","Pulse Survey on Continuity of Essential Health Services During the COVID-19 Pandemic","World Health Organization","2020-08-27T00:00:00.000","PDF","The Pulse survey on continuity of essential health services during the COVID-19 pandemic aimed to gain initial insight from country key informants into the impact of the COVID-19 pandemic on essential health services across the life course. The survey results in this 29-page interim report can improve understanding of the extent of disruptions across all services, the reasons for disruptions, and the mitigation strategies countries are using to maintain service delivery.","https://www.who.int/publications/i/item/WHO-2019-nCoV-EHS_continuity-survey-2020.1",,"Report","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1297631/retrieve","false","23587"
"14574","Responsible Official Resource Manual","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-08-27T00:00:00.000","Text","This guidance from the Division of Select Agents and Toxins, updated on August 27, 2020, is for the responsible official (RO) for select agents, the individual designated by the registered entity with the authority and responsibility to act on behalf of the entity to ensure compliance with Section 9 of the select agent regulations. It describes the ore responsibilities of and criteria to be the RO.","https://www.selectagents.gov/compliance/guidance/ro/responsibilities.htm?CDC_AA_refVal=https%3A%2F%2Fwww.selectagents.gov%2Frorm-responsibilities.html",,"Guideline/Assessment Tool",,"false","14574"
"24163","Guidance on the Necessary Use of Telehealth During the COVID-19 Pandemic","American Academy of Pediatrics","2020-08-26T00:00:00.000","Text","This web page provides guidance on the use of telehealth to provide health care for children and adolescents during the COVID-19 pandemic. Use of telehealth should be based on the medical condition; preferences of the patients, families, and provider; and resources available.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/guidance-on-the-necessary-use-of-telehealth-during-the-covid-19-pandemic/",,"Guideline/Assessment Tool",,"false","24163"
"24117","Health Care and Health Care Financing for COVID-19 in Correctional Facilities","National Academies of Sciences, Engineering, and Medicine","2020-08-26T00:00:00.000","Video or Multimedia","This one-hour, 31-minute webinar discusses sick call and long-term care for COVID-19 patients in correctional facilities, protection of medically vulnerable people in correctional facilities, and opportunities for expansion of Medicaid coverage for correctional populations.","https://www.nationalacademies.org/event/08-26-2020/health-care-and-health-care-financing-for-covid-19-in-correctional-facilities","Clarke, Jennifer; Wachino, Vikki; Williams, Brie","Instructional/Training Material",,"false","24117"
"23648","Caring for Children With Acute Illness in the Ambulatory Care Setting During the Public Health Emergency","American Academy of Pediatrics","2020-08-26T00:00:00.000","Text","This interim guidance helps pediatricians through the unprecedented challenges of caring for acutely ill children during the coronavirus disease 2019 (COVID-19) pandemic. The value of pediatric expertise within the medical home for all children, especially vulnerable children with special health care needs, should be emphasized.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/caring-for-children-with-acute-illness-in-the-ambulatory-care-setting-during-the-public-health-emergency/",,"Guideline/Assessment Tool",,"false","23648"
"23573","Rapid, Point‐of‐Care Antigen and Molecular‐Based Tests for Diagnosis of SARS‐CoV‐2 Infection","Cochrane Library","2020-08-26T00:00:00.000","Text","This report assesses the diagnostic accuracy of point‐of‐care antigen and molecular‐based tests to determine if a person presenting in the community or in primary or secondary care has current SARS‐CoV‐2 infection.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013705/full","Dinnes, Jacqueline; Deeks, Jonathan; Adriano, Ada; Berhane, Sarah; Davenport, Clare","Report","Link to report in French: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013705/full/fr#CD013705-abs-0003","false","23573"
"23564","Fact Sheet for Healthcare Providers: BinaxNOW™ COVID-19 Ag Card","U.S. Food and Drug Administration","2020-08-26T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BinaxNOW™ COVID-19 Ag Card. The BinaxNOW™ COVID-19 Ag Card is authorized for use using nasal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first seven days of the onset of symptoms.","https://www.fda.gov/media/141568/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141569/downloadLink to Letter of Authorization: https://www.fda.gov/media/141567/downloadLink to Instructions for Use: https://www.fda.gov/media/141570/download","false","23564"
"23474","U.S. Blood Supply and the COVID-19 Response: In Brief","Congressional Research Service [Library of Congress]","2020-08-26T00:00:00.000","PDF","This 19-page report, updated on August 26, 2020, provides a brief background of the regulatory framework for the U.S. blood supply, explains the federal response to the current crisis, and discusses potential treatment of COVID-19 using blood-derived products.","https://crsreports.congress.gov/product/pdf/R/R46375","Sussman, Jared; Dabrowska, Agata","Report",,"false","23474"
"8463","Emergency Preparedness Tips for Those with Functional Needs","Illinois Emergency Management Agency","2009-06-11T00:00:00.000","PDF","This 26-page document is a tool for caregivers and healthcare providers to help assist those with functional needs prepare for an emergency or disaster situation. Included are tips regarding what items to have on hand such as extra batteries for devices and medications, as well as guidelines for making an emergency plan. A template for an emergency health information card is provided at the end of the document.","https://www2.illinois.gov/ready/sitecollectiondocuments/preparednesstips_functionalneeds.pdf",,"Guideline/Assessment Tool",,"false","8463"
"23135","Coronavirus Disease (COVID-19): Preparing K-12 School Administrators for a Safe Return to School in Fall 2020","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-26T00:00:00.000","Text","This guidance, updated on August 26, 2020, is intended to aid school administrators as they consider how to protect the health, safety, and well-being of students, teachers, other school staff, their families, and communities, and prepare for educating students this fall, with key COVID-19 considerations listed.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/prepare-safe-return.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/prepare-safe-return.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/prepare-safe-return.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/prepare-safe-return.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/prepare-safe-return.html","false","23135"
"21113","FAQs on Diagnostic Testing for SARS-CoV-2","U.S. Food and Drug Administration","2020-08-26T00:00:00.000","Text","This web page, updated regularly, provides answers to frequently asked questions relating to the development and performance of tests for SARS-CoV-2.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/faqs-testing-sars-cov-2",,"Fact Sheet",,"false","21113"
"23843","Adolescent Mental Health During COVID-19","Association of State and Territorial Health Officials","2020-08-25T00:00:00.000","Video or Multimedia","This one-hour webinar discusses the challenges that COVID-19 has created for youth mental health, shares lessons learned from a program that supports youth released from a detention center, and shares strategies that state health officials can implement to support and advocate for youth and adolescents with mental health needs both during and beyond the pandemic.","https://www.astho.org/generickey/GenericKeyDetails.aspx?contentid=22844&folderid=5162&catid=7254","Howdershelt, Marissa; Hsi, Andrew; Kimball, Angela","Instructional/Training Material",,"false","23843"
"23567","Fact Sheet for Healthcare Providers: Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM AntibodyTest","U.S. Food and Drug Administration","2020-08-25T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test. The Tell Me Fast Novel Coronavirus (COVID-19) IgG/IgM Antibody Test is authorized for the detection of antibodies to SARS-CoV-2 in human serum, plasma (Lithium-Heparin, Sodium-Citrate and Acid Citrate Dextrose (ACD)) and venous whole blood (Lithium-Heparin, Sodium-Citrate and Dipotassium EDTA).","https://www.fda.gov/media/141548/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/141549/downloadLink to Letter of Authorization: https://www.fda.gov/media/141547/downloadLink to Instructions for Use: https://www.fda.gov/media/141550/download","false","23567"
"23566","Fact Sheet for Healthcare Providers: Advanta Dx SARS-CoV-2 RT-PCR Assay","U.S. Food and Drug Administration","2020-08-25T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Advanta Dx SARS-CoV-2 RT-PCR Assay. The Advanta Dx SARS-CoV-2 RT-PCR Assay is authorized for use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141539/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141540/downloadLink to Letter of Authorization: https://www.fda.gov/media/141538/downloadLink to Instructions for Use: https://www.fda.gov/media/141541/download","false","23566"
"23565","Fact Sheet for Healthcare Providers: QDx Pathology Services – QDx SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-08-25T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the QDx SARS CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The QDx SARS CoV-2 Assay is authorized for use on nasal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141543/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141544/downloadLink to Letter of Authorization: https://www.fda.gov/media/141542/downloadLink to EUA Summary: https://www.fda.gov/media/141545/downloadLink to Instructions for Use - Home Collect: https://www.fda.gov/media/141546/download","false","23565"
"3490","Novel H1N1 Flu (Swine Flu) Public Service Announcements (PSAs)","Centers for Disease Control and Prevention","2009-06-10T00:00:00.000","Text","This Web page contains PSAs about preventing the spread of H1N1 influenza in script, MP3, and some as podcasts.","https://www.cdc.gov/h1n1flu/psa/",,"Instructional/Training Material",,"false","3490"
"23543","COVID-19 Essential Supplies Forecasting Tool","World Health Organization","2020-08-25T00:00:00.000","PDF","This 13-page document provides technical details and methodological explanations on the structure of the COVID-19 Essential Supplies Forecasting Tool (ESFT). It is intended  to provide information that will allow users to a) trace and understand the calculations, assumptions, and limitations of ESFT; and b) modify these assumptions for different contexts or use cases.","https://apps.who.int/iris/handle/10665/333983",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333983/WHO-2019-nCoV-Tools-Essential_forecasting-Overview-2020.1-eng.pdf?sequence=1&isAllowed=yLink to resource in French: https://apps.who.int/iris/handle/10665/336007Link to resource in Spanish: https://apps.who.int/iris/handle/10665/335942Link to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/333983/WHO-2019-nCoV-Tools-Essential_forecasting-Overview-2020.1-rus.pdf?sequence=5&isAllowed=y","false","23543"
"23527","Promoting Public Health Measures in Response to COVID-19 on Cargo Ships and Fishing Vessels","World Health Organization","2020-08-25T00:00:00.000","PDF","This 10-page document provides guidance for shipowners, seafarers, unions and associations, and competent authorities for health and transport on protecting seafarers working on cargo ships and fishing vessels from transmission of SARS-CoV-2 (the virus that causes COVID-19) and management of COVID-19.","https://www.who.int/publications/i/item/WHO-2019-nCoV-Non-passenger_ships-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1297150/retrieve","false","23527"
"22880","Information for Healthcare Professionals about Coronavirus (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-25T00:00:00.000","Text","This web page, updated on August 25, 2020, provides information, tools, and guidance about COVID-19 for healthcare professionals, including about Care for Patients, Protect Patients and Workers, and Facility Guidance. The page has been updated to organize content for simplified navigation and includes a search function to allow users to more easily find information and resources.","https://www.cdc.gov/coronavirus/2019-nCoV/hcp/index.html",,"Guideline/Assessment Tool",,"false","22880"
"22169","Responding to the Needs of Youth Involved With the Justice System During the COVID-19 Pandemic","American Academy of Pediatrics","2020-08-25T00:00:00.000","Text","The COVID-19 pandemic presents unique challenges to the health and well-being of youth involved with the justice system. This web page, updated on August 25, 2020, provides recommendations for juvenile justice agencies.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/responding-to-the-needs-of-youth-involved-with-the-justice-system--during-the-covid-19-pandemic/",,"Guideline/Assessment Tool",,"false","22169"
"22095","COVID-19 Management in Hotels and Other Entities of the Accommodation Sector","World Health Organization","2020-08-25T00:00:00.000","PDF","This eight-page document, updated on August 25, 2020, is designed to cover hotels and other accommodation facilities of all sizes, including campsites, operating in the time of the current COVID-19 pandemic.","https://www.who.int/publications/i/item/operational-considerations-for-covid-19-management-in-the-accommodation-sector-interim-guidance",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1297222/retrieveLink to Q&A: Staying at hotels and accommodation establishments and COVID-19: https://www.who.int/news-room/q-a-detail/q-a-staying-at-hotels-and-accommodation-establishments-and-covid-19Link to Q&A: Working in hotels and COVID-19: https://www.who.int/news-room/q-a-detail/q-a-working-in-hotels-and-covid-19Link to Guidance from April 30, 2020: Operational considerations for COVID-19 management in the accommodation sector: https://apps.who.int/iris/bitstream/handle/10665/331937/WHO-2019-nCoV-Hotels-2020.2-eng.pdf","false","22095"
"24136","State and Territory Policy Strategies Supporting Maternal and Child Health During COVID-19","National Governors Association","2020-08-24T00:00:00.000","Text","In June and July of 2020, the National Governors Association Center for Best Practices (NGA Center) surveyed executive branch officials regarding state policies to safeguard against COVID-19 for pregnant women, postpartum women, and infants. This web page provides the results of the survey.","https://www.nga.org/memos/policy-strategies-maternal-child-health-covid19/",,"Report","Link to results in a PDF file: https://www.nga.org/wp-content/uploads/2020/08/Maternal_Child_Health_COVID-19.pdf","false","24136"
"23881","Nursing Home Strategies for COVID-19 Only Isolation of COVID-19 Residents","Centers for Medicare & Medicaid Services","2020-08-24T00:00:00.000","PDF","This five-page document highlights specific actions that certain states have already taken to better support the nursing facilities’ ability to safely care for all residents, including COVID-19-positive residents, during this public health emergency, and how enhanced nursing facility payment supported those efforts.","https://www.medicaid.gov/federal-policy-guidance/downloads/cib082420.pdf",,"Guideline/Assessment Tool",,"false","23881"
"23659","Pooled Sample Testing and Screening Testing for COVID-19","U.S. Food and Drug Administration","2020-08-24T00:00:00.000","Text","This web page provides an overview of available resources related to SARS-CoV-2 screening testing and testing using pooled samples.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/pooled-sample-testing-and-screening-testing-covid-19",,"Guideline/Assessment Tool",,"false","23659"
"23637","SNS (Strategic National Stockpile)-Held Ventilator Resources","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-24T00:00:00.000","Text","This web page provides training on the use of ventilator models held in the Strategic National Stockpile.","https://www.phe.gov/emergency/events/COVID19/SNS/ventilators/Pages/training.aspx",,"Instructional/Training Material","Link to Ventilator Training Alliance App: https://vta.allego.com/home.do Link to SNS-held Ventilator Maintenance: https://www.phe.gov/emergency/events/COVID19/SNS/ventilators/Pages/default.aspx","false","23637"
"23585","CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel","Centers for Disease Control and Prevention","2020-08-24T00:00:00.000","PDF","The lots of N1, N2, and RP primers and probes on this one-page document have passed functional testing at CDC and may be used with the CDC 2019-nCoV Real-Time RT-PCR Diagnostic Panel Instructions for Use under CDC’s Emergency Use Authorization (EUA).","https://www.cdc.gov/coronavirus/2019-ncov/downloads/List-of-Acceptable-Commercial-Primers-Probes.pdf",,"Guideline/Assessment Tool",,"false","23585"
"23551","Compounding Activities: COVID-19","U.S. Food and Drug Administration","2020-08-24T00:00:00.000","Text","This web page provides guidance to states and compounders on issues associated with compounding drugs during the COVID-19 pandemic. The guidance aims to protect patients from unsafe, ineffective and poor-quality compounded drugs, while preserving access for patients.","https://www.fda.gov/drugs/coronavirus-covid-19-drugs/compounding-activities-covid-19",,"Guideline/Assessment Tool",,"false","23551"
"23548","Coronavirus Disease (COVID-19): Nursing Homes and Long-Term Care Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-24T00:00:00.000","Text","This web page provides COVID-19 guidance for nursing homes and long-term care facilities, with topics covering Infection Control Guidance, SARS-CoV-2 Testing Guidance, Infection Control Assessment Tool, Training Resources, and Videos for Training Front Line Long-Term Care Staff.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-home-long-term-care.html",,"Guideline/Assessment Tool",,"false","23548"
"23538","COVID-19 Partner Update Call: Health and Safety at the Polling Place","Centers for Disease Control and Prevention","2020-08-24T00:00:00.000","Video or Multimedia","Speakers in this 48-minute presentation share updates on the CDC’s COVID-19 response, including the latest scientific information and what everyone should know about protecting themselves and others; and review the CDC’s updated considerations for election polling locations and voters.","https://www.youtube.com/watch?v=c3a_paGrZNs&feature=youtu.be","McDonald, Clifford; Kirby, Amy; Hall, Diane","Instructional/Training Material",,"false","23538"
"23537","Providing Care and Treatment for People Living with HIV in Low-Resource Non-US Settings During COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-24T00:00:00.000","Text","This web page offers operational considerations and guidance for maintaining essential HIV services in low-resource settings in the context of COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/maintaining-essential-HIV-services.html",,"Guideline/Assessment Tool",,"false","23537"
"23519","Communicable Disease Threats to Public Health in the European Union","European Union, European Centre for Disease Prevention and Control","2020-08-24T00:00:00.000","PDF","This 13-page report covers the events and threats detected by the ECDC epidemic intelligence (EI) team in 2019 and the actions taken in relation to these findings. In 2019, 306 new events were monitored and discussed at the daily round table meeting.","https://www.ecdc.europa.eu/en/publications-data/communicable-disease-threats-public-health-european-union-2019",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2019_threats.docx.pdf","false","23519"
"23161","HIPAA and COVID-19","U.S. Department of Health and Human Services","2020-08-24T00:00:00.000","Text","The HHS Office for Civil Rights (OCR) has provided these Bulletins, Notifications of Enforcement Discretion, Guidance, and Resources that help explain how patient health information may be used and disclosed in response to the COVID-19 nationwide public health emergency, including under the Health Insurance Portability and Accountability Act (HIPAA). This page was updated on August 24, 2020.","https://www.hhs.gov/hipaa/for-professionals/special-topics/hipaa-covid19/index.html",,"Guideline/Assessment Tool",,"false","23161"
"21116","Interim Additional Guidance for Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed COVID-19 in Outpatient Hemodialysis Facilities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-24T00:00:00.000","Text","This information, updated on August 24, 2020, is provided to clarify COVID-19 infection prevention and control (IPC) recommendations that are specific to outpatient hemodialysis facilities. This information complements, but does not replace, the general IPC recommendations for COVID-19. As part of routine infection control, outpatient dialysis facilities should have established policies and practices to reduce the spread of contagious respiratory pathogens, which are listed on this page.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis.html",,"Guideline/Assessment Tool","Link to Coronavirus Disease 2019 (COVID-19) Outpatient Dialysis Facility Preparedness Assessment Tool: https://www.cdc.gov/coronavirus/2019-ncov/downloads/COVID-19-outpatient-dialysis.pdf Link to Frontline Staff Toolkit: Tips for Outpatient Hemodialysis Facilities During COVID-19: https://www.cdc.gov/coronavirus/2019-ncov/hcp/dialysis.html#anchor_1588604087","false","21116"
"16419","Disaster Behavioral Health","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-24T00:00:00.000","Text","This resource collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange), updated on August 24, 2020, can help stakeholders incorporate disaster behavioral health (DBH) into all phases of emergency management to ensure resident and responder preparedness; an effective, compassionate response effort; and a more resilient community moving forward. Resource categories are Topic Collections; Other ASPR TRACIE-Developed DBH Resources; ASPR At-Risk Individuals, Behavioral Health, and Community Resilience Resources; and Other Federal Resources.","https://asprtracie.hhs.gov/dbh-resources",,"Bibliography/Resource List",,"false","16419"
"24135","Prevention of Targeted Violence and Terrorism Against Public Health Personnel and Assets","National Governors Association","2020-08-23T00:00:00.000","Text","This memorandum provides guidance in topics that cover Actions for Governors to Protect Public Health Personnel and Assets; Overview of Key Strategies for Preventing Targeted Violence; Coordinate Protection Activities to Address Immediate Threats; and Buy Down Long-term Risk by Mitigating Motivations to Violence and Strengthening the Social Fabric.","https://www.nga.org/memos/prevention-targeted-violence-against-public-health-personnel/",,"Guideline/Assessment Tool","Link to memorandum in a PDF file: https://www.nga.org/wp-content/uploads/2020/08/NGA-Memo-on-TVTP-for-PH-Assets.pdf","false","24135"
"23692","Elastomeric Half-Mask Respirators and Powered Air-Purifying Respirators in Healthcare and Emergency Medical Service Settings","Federal Emergency Management Agency [Department of Homeland Security]","2020-08-23T00:00:00.000","PDF","This eight-page fact sheet provides useful information for healthcare and emergency medical service organizations regarding re-usable, National Institute for Occupational Safety and Health (NIOSH)- approved elastomeric half-mask respirators (EHMRs) and powered air-purifying respirators (PAPRs) to expand options to meet respiratory protection demand.","https://files.asprtracie.hhs.gov/documents/elastomeric-half-mask-respirators-and-powered-air-purifying-respirators-in-healthcare-and-ems-settings-fact-sheet.pdf",,"Fact Sheet",,"false","23692"
"23515","Fact Sheet for Healthcare Providers: Emergency Use Authorization (EUA) of COVID-19 Convalescent Plasma for Treatment of COVID-19 in Hospitalized Patients","U.S. Food and Drug Administration","2020-08-23T00:00:00.000","PDF","This five-page fact sheet provides information for healthcare providers about the Emergency Use Authorization (EUA) to permit the emergency use of the unapproved product COVID-19 convalescent plasma to treat hospitalized  patients with  COVID-19.","https://www.fda.gov/media/141478/download",,"Guideline/Assessment Tool","Link to Providers Fact Sheet in Chinese: https://www.fda.gov/media/141983/downloadLink to Providers Fact Sheet in Korean: https://www.fda.gov/media/141981/downloadLink to Providers Fact Sheet in Spanish: https://www.fda.gov/media/141978/downloadLink to Providers Fact Sheet in Tagalog: https://www.fda.gov/media/141979/downloadLink to Providers Fact Sheet in Vietnamese: https://www.fda.gov/media/141982/downloadLink to Fact Sheet for Patients and Parents/Caregivers: https://www.fda.gov/media/141479/downloadLink to Patients Fact Sheet in Chinese: https://www.fda.gov/media/141983/downloadLink to Patients Fact Sheet in Korean: https://www.fda.gov/media/141987/downloadLink to Patients Fact Sheet in Spanish: https://www.fda.gov/media/141984/downloadLink to Patients Fact Sheet in Tagalog: https://www.fda.gov/media/141985/downloadLink to Patients Fact Sheet in Vietnamese: https://www.fda.gov/media/141986/downloadLink to Letter of Authorization: https://www.fda.gov/media/141477/downloadLink to Decision Memorandum: https://www.fda.gov/media/141480/downloadLink to EUA Request: https://www.fda.gov/media/141481/download","false","23515"
"23777","COVID-19 Guidance for Shared or Congregate Housing","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-22T00:00:00.000","Text","This web page provides guidance that was created to help owners, administrators, or operators of shared (also called “congregate”) housing facilities – working together with residents, staff, and public health officials – prevent the spread of COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/community/shared-congregate-house/guidance-shared-congregate-housing.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/shared-congregate-house/guidance-shared-congregate-housing.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/shared-congregate-house/guidance-shared-congregate-housing.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/shared-congregate-house/guidance-shared-congregate-housing.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/shared-congregate-house/guidance-shared-congregate-housing.html","false","23777"
"24186","Effective and Safe  Practices, Guidance for  Custodians, Cleaning, and Maintenance Staff","American Industrial Hygiene Association","2020-08-21T00:00:00.000","PDF","This 14-page document provides cleaning and disinfection guidance for custodians, cleaning, and maintenance staff to reduce transmission of COVID-19 within workplaces.","https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Guidance-Documents/Effective-and-Safe-Practices-Guidance-for-Custodians-Cleaning-and-Maintenance-Staff-Guidance-Document.pdf",,"Guideline/Assessment Tool","Link to document in Spanish: https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Effective-and-Safe-Practices-Guidance-for-Custodians-Cleaning-and-Maintenance-Staff-Guidance-Document_Spanish.pdf","false","24186"
"23663","Future of Emergency Medicine – The Pandemic Factor","American College of Emergency Physicians","2020-08-21T00:00:00.000","Video or Multimedia","This summit, held in July 2020, brought together leaders across the College to discuss the future of emergency medicine and pandemics in four main areas: people (workforce), patients, practice, and payment.","https://www.acep.org/corona/COVID-19-alert/covid-19-articles/the-future-of-emergency-medicine--the-pandemic-factor/",,"Conference/Meeting Material",,"false","23663"
"23617","Environmental Health: Air Pollution, COVID-19 and Health Disparities","National Institute for Health Care Management Foundation","2020-08-21T00:00:00.000","Video or Multimedia","This one-hour, five-minute webinar explores how the environmental justice movement can address air pollution, health disparities, and COVID-19, and offers solutions to improve health outcomes. Speakers discuss what contributes to air pollution, how environmental injustice has been highlighted during COVID-19, and how neighborhoods experiencing environmental injustice face poorer air quality and extreme heat while also bearing the brunt of this pandemic.","https://www.nihcm.org/categories/environmental-health-air-pollution-covid-19-health-disparities","Lee, Charles; Hoffman, Jeremy; Stewart, Valerie; Williams, Josie","Instructional/Training Material",,"false","23617"
"23546","Exploration of COVID-19 Health-Care Worker Cases: Implications for Action","World Health Organization, Regional Office for the Western Pacific","2020-08-21T00:00:00.000","PDF","This four-page guidance describes a system to detect healthcare worker COVID-19 cases, investigate avenues of infections, and guide appropriate responses at the facility and public health levels based on the investigation findings. It is intended for national and sub-national public health authorities and healthcare facility managers.","https://apps.who.int/iris/handle/10665/333945",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333945/WPR-DSE-2020-027-eng.pdf?sequence=1&isAllowed=y","false","23546"
"23532","CDC COVID-19 Response Health Equity Strategy: Accelerating Progress Towards Reducing COVID-19 Disparities and Achieving Health Equity","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-21T00:00:00.000","Text","This web page details the CDC’s COVID-19 Response Health Equity Strategy, which broadly seeks to improve the health outcomes of populations disproportionately affected by the COVID-19 pandemic. The population health impact of COVID-19 has exposed long-standing inequities that have systematically undermined the physical, social, economic, and emotional health of racial and ethnic minority populations and other population groups that are bearing a disproportionate burden of COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/cdc-strategy.html",,"Web Page","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/health-equity/cdc-strategy.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/health-equity/cdc-strategy.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/health-equity/cdc-strategy.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/health-equity/cdc-strategy.html","false","23532"
"23530","Fact Sheet for Healthcare Providers: Guardant-19 Test","U.S. Food and Drug Administration","2020-08-21T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Guardant-19 test that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141485/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141486/downloadLink to Letter of Authorization: https://www.fda.gov/media/141484/downloadLink to EUA Summary: https://www.fda.gov/media/141487/download","false","23530"
"23529","Fact Sheet for Healthcare Providers: DxTerity SARS-CoV-2 RT-PCR Test","U.S. Food and Drug Administration","2020-08-21T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the DxTerity SARS-CoV-2 RT-PCR Test. he DxTerity SARS-CoV-2 RT-PCR Test is authorized for use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141489/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141490/downloadLink to Letter of Authorization: https://www.fda.gov/media/141488/downloadLink to EUA Summary: https://www.fda.gov/media/141491/download","false","23529"
"23528","Fact Sheet for Healthcare Providers: Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-08-21T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Texas Department of State Health Services (DSHS) SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141494/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141495/downloadLink to Letter of Authorization: https://www.fda.gov/media/141493/downloadLink to EUA Summary: https://www.fda.gov/media/141496/download","false","23528"
"23522","Protective Barrier Enclosures Without Negative Pressure Used During the COVID-19 Pandemic May Increase Risk to Patients and Health Care Providers","U.S. Food and Drug Administration","2020-08-21T00:00:00.000","Text","This letter alerts health care providers (HCP) and health care facilities that the use of passive protective barrier enclosures (those without negative pressure) when treating patients who are known or suspected to have coronavirus disease 2019 (COVID-19) may pose an increased health risk to patients and HCPs, and provides recommendations.","https://www.fda.gov/medical-devices/letters-health-care-providers/protective-barrier-enclosures-without-negative-pressure-used-during-covid-19-pandemic-may-increase",,"Guideline/Assessment Tool",,"false","23522"
"23511","Advice on the Use of Masks for Children in the Community in the Context of COVID-19","World Health Organization","2020-08-21T00:00:00.000","PDF","This nine-page document, co-published with UNICEF, provides guidance to decision-makers, the public, and child health professionals to inform policy on the use of masks for children in the context of the COVID-19 pandemic. It does not address the use of masks for adults working with children or parents/guardians or the use of masks for children in healthcare settings.","https://www.who.int/publications/i/item/WHO-2019-nCoV-IPC_Masks-Children-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1296520/retrieve","false","23511"
"24116","Preventing the Spread of COVID-19 in Correctional Facilities","National Academies of Sciences, Engineering, and Medicine","2020-08-20T00:00:00.000","Video or Multimedia","Jails and prisons are epicenters of the COVID-19 pandemic in the United States. This one-hour, 33-minute webinar discusses preventing new cases, testing, and contract tracing in correctional facilities; vaccine distribution; and best practices for decarceration.","https://www.nationalacademies.org/event/08-20-2020/preventing-the-spread-of-covid-19-in-correctional-facilities","Chambers-Smith, Annette; Kariko, Sara; Puglisi, Lisa; Venters, Homer; Western, Bruce","Instructional/Training Material",,"false","24116"
"23938","Strengthening Nursing Home Policy for the Post-Pandemic World: How Can We Improve Residents’ Health Outcomes and Experiences?","Commonwealth Fund","2020-08-20T00:00:00.000","Text","This report assesses how nursing home policies might be strengthened to improve health outcomes and experiences for residents, and improve the work environment for staff post-COVID-19 pandemic. It provides a number of possible nursing home reform options to better protect nursing home residents and the individuals who care for them.","https://www.commonwealthfund.org/publications/issue-briefs/2020/aug/strengthening-nursing-home-policy-postpandemic-world","Grabowski, David","Report","Link to report in a PDF file: https://www.commonwealthfund.org/sites/default/files/2020-08/Grabowski_strengthening_nursing_home_policy_postpandemic_ib.pdf","false","23938"
"23600","Dilemma Facing America’s Schools During COVID-19","American Academy of Arts & Sciences","2020-08-20T00:00:00.000","Video or Multimedia","Speakers in this one-hour webinar discuss the daunting choices facing school leaders this fall as they navigate the conflict between community health and the learning needs of students during the COVID-19 pandemic.","https://www.amacad.org/events/dilemma-facing-americas-schools-during-covid-19","Beutner, Austin; Bleich, Sara; Oxtoby, David","Instructional/Training Material",,"false","23600"
"23556","Considerations for School Nurses in Return to School: Dental Screening","National Association of School Nurses","2020-08-20T00:00:00.000","PDF","This four-page document provides a summary of currently available resources about dental screening that school nurses can consult as they formulate independent nursing judgment for their practice or when participating in policy discussions in their districts.","https://higherlogicdownload.s3.amazonaws.com/NASN/3870c72d-fff9-4ed7-833f-215de278d256/UploadedImages/PDFs/Dental_Screening_Considerations_for_School_Nurses_in_Return_to_School.pdf",,"Guideline/Assessment Tool",,"false","23556"
"23550","Nursing’s Role in Health Equity, Public Health Emergencies, and COVID-19","National Academy of Medicine","2020-08-20T00:00:00.000","Video or Multimedia","This one-hour, 30-minute webinar features speakers from the study on the Future of Nursing 2020-2030 who share updates on the study’s status and sought public input on nurses’ roles in responding to COVID-19. A panel of experts also discusses how nursing can advance health equity, the role of nurses in public health emergencies, and nurses’ experiences on the frontlines of COVID-19.","https://nam.edu/event/32356/","Dzau, Victor; Hassmiller, Susan; Cooper, Lisa; Qureshi, Kristine; Baez, Frank","Instructional/Training Material",,"false","23550"
"23507","2020-2021 Influenza Vaccination Recommendations and Clinical Guidance during the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-20T00:00:00.000","Video or Multimedia","Presenters in this one-hour Clinician Outreach and Communication Activity (COCA) call discuss updates to the Advisory Committee on Immunization Practices (ACIP) recommendations for the 2020-2021 influenza vaccination season. Topics include the Standards for Adult Immunization Practice, flu vaccination planning, general vaccination guidance during the COVID-19 pandemic, and guidance for large vaccination clinics held in satellite, temporary, or off-site locations.","https://emergency.cdc.gov/coca/calls/2020/callinfo_082020.asp","Grohskopf, Lisa ; Jalaoui, Tara; Fiebelkorn, Amy","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/COCA_Call_Slides_08_20_20_final.pdf","false","23507"
"23505","Fact Sheet for Healthcare Personnel: Nova2200 for Decontaminating Compatible N95 Respirators","U.S. Food and Drug Administration","2020-08-20T00:00:00.000","PDF","This three-page fact sheet informs healthcare personnel of the significant known and potential risks and benefits of the emergency use of decontaminated, compatible N95 respirators. These compatible N95 respirators have been decontaminated with the Nova2200 using the NovaClean decontamination process.","https://www.fda.gov/media/141383/download",,"Guideline/Assessment Tool","Link to Instructions for Healthcare Facilities: https://www.fda.gov/media/141384/downloadLink to Instructions for Healthcare Personnel: https://www.fda.gov/media/141385/downloadLink to Letter of Authorization: https://www.fda.gov/media/141382/downloadLink to Instructions for Decontamination Personnel: https://www.fda.gov/media/141386/download","false","23505"
"23920","Coronavirus Disease (COVID-19): Clinical Mitigation (Non-US Settings)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-19T00:00:00.000","Text","This web page provides resources about clinical mitigation, which encompasses strategies to ensure adequate provision of care for mildly to moderately ill COVID-19 patients, and delivery of other non-COVID-19 essential health services during the COVID-19 outbreak.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/non-us-clinical-mitigation.html",,"Web Page",,"false","23920"
"23751","Federal/Provincial/Territorial Public Health Response Plan for Ongoing Management of COVID-19","Public Health Agency of Canada","2020-08-19T00:00:00.000","Text","The purpose of this plan is to provide federal, provincial, and territorial public health officials; Indigenous partners; health system partners; and other stakeholders with a common forward planning approach for ongoing management of COVID-19 in Canada. It promotes a long-term approach that covers immediate planning imperatives for the fall/winter 2020 period and thereafter until population herd immunity in one form or another is sufficient to bring the pandemic activity in Canada to an end.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/federal-provincial-territorial-public-health-response-plan-ongoing-management-covid-19.html",,"Guideline/Assessment Tool","Link to plan in a PDF file: https://www.canada.ca/content/dam/phac-aspc/documents/services/diseases/2019-novel-coronavirus-infection/federal-provincial-territorial-public-health-response-plan-ongoing-management-covid-19/fpt-response-plan-english.pdf","false","23751"
"23702","E4GDH (Evidence for Global and Disaster Health) and HBS (Health and Biosciences Libraries) Webinar: Librarians Supporting Humanitarian Information Efforts","International Federation of Library Associations and Institutions","2020-08-19T00:00:00.000","Video or Multimedia","This 64-minute webinar highlights two outlets in which librarians are key players in humanitarian information efforts: OpenStreetMap mapping to create a free editable map of the world, and the Evidence Aid COVID-19 Evidence Collection, which contains summaries of high-quality systematic reviews related to the impact of COVID-19.","https://www.ifla.org/publications/node/93252","McGowan, Bethany; Wood, Jo","Instructional/Training Material",,"false","23702"
"23677","Advances in Science and Technology in the Life Sciences","United Nations","2020-08-19T00:00:00.000","PDF","This 36-page report summarizes several trends facilitating advances across the life sciences: immunology, neuroscience, human genetics and reproductive science, agriculture, and infectious disease. Though research and development in these fields is by and large conducted for peaceful purposes in order to benefit society, the same outputs can pose serious ethical, safety, and security concerns if they are misused.","https://www.unidir.org/publication/advances-science-and-technology-life-sciences","Warmbrod, Kelsey; Revill, James; Connell, Nancy","Report","Direct link to document: https://www.unidir.org/sites/default/files/2020-08/Advances%20in%20Science%20and%20Technology%20in%20the%20Life%20Sciences%20-%20Final.pdf","false","23677"
"23667","Protecting Building Engineering and Maintenance Staff from COVID-19","National Academies of Sciences, Engineering, and Medicine","2020-08-19T00:00:00.000","Video or Multimedia","This one-hour, three-minute webinar discusses protecting building engineering and maintenance staff from COVID-19. While many people are working remotely, the staff who keep facilities functioning must generally be on-site to do their jobs - telework is not an option.","https://vimeo.com/451985300","Boles, Corey; Krause, David","Instructional/Training Material",,"false","23667"
"23572","Well-Being of Underserved Populations during COVID-19 Crisis","National Center for Disaster Medicine and Public Health [Uniformed Services University of the Health Sciences]","2020-08-19T00:00:00.000","Video or Multimedia","This one-hour webinar explores the physical and mental well-being of vulnerable populations during the COVID-19 crisis. Trusted experts in public health, behavioral health, social work, and indigenous science address many of the conditions and situations underserved populations have encountered during COVID-19.","https://www.youtube.com/watch?v=ECYZ6pBWPhI&feature=youtu.be","Quintanilla, Norma; Wolfe, Elizabeth; Flores, Noemi; Blanchard, Paulette; Patterson, Jacqueline","Instructional/Training Material",,"false","23572"
"23571","CDC Webinar – Strengthening Vaccine Confidence in Pediatric and Family Practice Offices During the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-19T00:00:00.000","Video or Multimedia","Participants in this one-hour webinar will learn to describe trends in vaccine hesitancy among American parents; describe the Centers for Disease Control and Prevention (CDC)’s Vaccinate with Confidence framework; identify strategies for reducing vaccine hesitancy and addressing vaccine myths; describe CDC guidance for immunization during the COVID-19 pandemic, including strategies for ensuring safe well-visits; and locate CDC communication resources for providers and parents.","https://register.gotowebinar.com/register/1944534001330205707","Schillie, Sarah; MacNeil, Jessica","Instructional/Training Material","Site requires free registration.","false","23571"
"23547","Considerations for Quarantine of Contacts of COVID-19 Cases","World Health Organization","2020-08-19T00:00:00.000","PDF","This six-page document is an update of COVID-19 interim guidance published on March 19, 2020. It provides updated guidance for the implementation of quarantine, as well as additional guidance on ventilation and on the care of children in quarantine.","https://apps.who.int/iris/handle/10665/333901",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333901/WHO-2019-nCoV-IHR_Quarantine-2020.3-eng.pdf?sequence=1&isAllowed=yLink to document in Arabic: https://apps.who.int/iris/bitstream/handle/10665/333901/WHO-2019-nCoV-IHR_Quarantine-2020.3-ara.pdf?sequence=5&isAllowed=yLink to document in Russian: https://apps.who.int/iris/bitstream/handle/10665/333901/WHO-2019-nCoV-IHR_Quarantine-2020.3-rus.pdf?sequence=10&isAllowed=y","false","23547"
"23523","Employee Health and Food Safety Checklist for Human and Animal Food Operations During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-19T00:00:00.000","PDF","The Food and Drug Administration (FDA) and the Occupational Safety and Health Administration (OSHA) are providing this 16-page checklist for FDA-regulated human and animal food operations to use when assessing operations during the COVID-19 pandemic, especially when re-starting operations after a shutdown or when reassessing operations because of changes due to the COVID-19 public health emergency.","https://www.fda.gov/food/food-safety-during-emergencies/employee-health-and-food-safety-checklist-human-and-animal-food-operations-during-covid-19-pandemic",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/141141/download","false","23523"
"23506","Rescission of Guidances and Other Informal Issuances Concerning Premarket Review of Laboratory Developed Tests","U.S. Department of Health and Human Services","2020-08-19T00:00:00.000","Text","The Department of Health and Human Services has determined that the Food and Drug Administration will not require premarket review of laboratory developed tests absent notice-and-comment rulemaking, as opposed to through guidance documents, compliance manuals, website statements, or other informal issuances.","https://www.hhs.gov/coronavirus/testing/recission-guidances-informal-issuances-premarket-review-lab-tests/index.html",,"Guideline/Assessment Tool",,"false","23506"
"23488","Operational Considerations for Community Isolation Centers for COVID-19 in Low-Resource Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-19T00:00:00.000","Text","This web page provides operational considerations for CDC Country Offices, Ministries of Health, and partners about establishing and operating community isolation centers (CICs) for people with suspected or confirmed COVID-19 who are remaining in the CIC voluntarily, and ensuring that people in CICs are safe and have access to adequate healthcare, food, water, sanitation, and hygiene products and services.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/operational-considerations-isolation-centers.html",,"Guideline/Assessment Tool",,"false","23488"
"5562","IS-806","Federal Emergency Management Agency [Department of Homeland Security]","2009-06-06T00:00:00.000","Video or Multimedia","This 30 minute course provides an overview of one of the 15 Emergency Support Functions (ESFs).  This course introduces ESF #6 - Mass Care, Emergency Assistance, Housing, and Human Services. At the end of this course, users will be able to: describe the overall purpose and scope of ESF #6; identify the types of supplemental assistance ESF #6 provides to individuals and state, tribal, and local governments; identify typical activities accomplished by ESF #6 resources and teams; and describe the types of partnerships formed between ESF #6 and other response agencies and organizations.","https://training.fema.gov/is/courseoverview.aspx?code=is-806",,"Instructional/Training Material",,"false","5562"
"23483","Interim Framework for COVID-19 Vaccine Allocation and Distribution in the United States","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-08-19T00:00:00.000","PDF","This 46-page document provides an ethical framework to guide discussion and inform decisions about COVID-19 vaccine allocation. It compares the implications of the framework to the prior Centers for Disease Control and Prevention guidance for prioritization of pandemic influenza vaccine allocation, and suggests candidate groups who should be given serious consideration for inclusion in the top allocation tier when vaccine availability is limited and in a second tier (those also prioritized before the general public) if/when more vaccine supply becomes available.","https://www.centerforhealthsecurity.org/our-work/publications/interim-framework-for-covid-19-vaccine-allocation-and-distribution-in-the-us","Toner, Eric; Barnill, Anne; Krubiner, Carleigh; Bernstein, Justin; Privor-Dunn, Lois","Report","Direct link to document: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200819-vaccine-allocation.pdfLink to Q&A with author: https://www.jhsph.edu/covid-19/articles/interim-framework-for-covid-19-vaccine-allocation-in-the-united-states.html","false","23483"
"23464","Population-Wide Testing of SARS-CoV-2: Country Experiences and Potential Approaches in the EU/EEA and the United Kingdom","European Union, European Centre for Disease Prevention and Control","2020-08-19T00:00:00.000","PDF","This 12-page document summarizes country experiences and perspectives relating to the objective and application of different population-wide SARS-CoV-2 testing approaches and discusses the options in the context of the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK).","https://www.ecdc.europa.eu/en/publications-data/population-wide-testing-sars-cov-2-country-experiences-and-potential-approaches",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-population-wide-testing-country-experiences.pdf","false","23464"
"22837","COVID-19 Planning Considerations: Guidance for School Re-Entry","American Academy of Pediatrics","2020-08-19T00:00:00.000","Text","The purpose of this guidance, updated on August 16, 2020, is to support education, public health, local leadership, and pediatricians collaborating with schools in creating policies for school re-entry during the COVID-19 pandemic that foster the overall health of children, adolescents, staff, and communities, and are based on available evidence.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/clinical-guidance/covid-19-planning-considerations-return-to-in-person-education-in-schools/",,"Guideline/Assessment Tool",,"false","22837"
"22296","Coronavirus Disease (COVID-19): Using Personal Protective Equipment (PPE)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-19T00:00:00.000","Video or Multimedia","This web page, updated on August 19, 2020, details who needs to use personal protective equipment (PPE), and how to put it on and take it off. The updated guidance adds a statement about the importance of the selected respirator and eye protection not interfering with the correct fit or function of the other, and removes a second hand hygiene step from step 6 in How to Put On (Don) PPE Gear.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/using-ppe.html",,"Guideline/Assessment Tool","Scroll down for infographics and video.","false","22296"
"21001","Considerations for Quarantine of Individuals in the Context of Containment for Coronavirus Disease (COVID-19)","World Health Organization","2020-08-19T00:00:00.000","PDF","The purpose of this six-page document, updated on August 19, 2020, is to offer guidance to Member States on quarantine measures for individuals in the context of COVID-19. It provides updated guidance for the implementation of quarantine, as well as additional guidance on ventilation and on the care of children in quarantine.","https://www.who.int/publications/i/item/considerations-for-quarantine-of-individuals-in-the-context-of-containment-for-coronavirus-disease-(covid-19)",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1296389/retrieveLink to document in Arabic: https://apps.who.int/iris/bitstream/handle/10665/331299/WHO-2019-nCov-IHR_Quarantine-2020.1-ara.pdfLink to document in Chinese: https://apps.who.int/iris/bitstream/handle/10665/331299/WHO-2019-nCov-IHR_Quarantine-2020.1-chi.pdfLink to document in French: https://apps.who.int/iris/bitstream/handle/10665/331364/WHO-2019-nCov-IHR_Quarantine-2020.1-fre.pdf","false","21001"
"23574","Digital Contact Tracing Technologies in Epidemics: A Rapid Review","Cochrane Library","2020-08-18T00:00:00.000","Text","This report assesses the benefits, harms, and acceptability of personal digital contact tracing solutions for identifying contacts of an identified positive case of an infectious disease. Digital technology could be implemented to augment and accelerate manual contact tracing.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013699/full","Anglemyer, Andrew; Moore, Theresa; Parker, Lisa; Chambers, Timothy; Grady, Alice","Report","Link to report in Arabic: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013699/full/fa#CD013699-abs-0004Link to report in French: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013699/full/fr#CD013699-abs-0006Link to report in Spanish: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013699/full/es#CD013699-abs-0009","false","23574"
"23501","Fact Sheet for Healthcare Providers: LumiraDx SARS-CoV-2 Antigen (Ag) Test","U.S. Food and Drug Administration","2020-08-18T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the LumiraDx SARS-CoV-2 Antigen (Ag) Test. The LumiraDx SARS-CoV-2 Ag Test is authorized for use using nasal swab specimens collected from individuals who are suspected of COVID-19 by their healthcare provider within the first 12 days of the onset of symptoms.","https://www.fda.gov/media/141302/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141303/downloadLink to Letter of Authorization: https://www.fda.gov/media/141301/downloadLink to Instructions for Use: https://www.fda.gov/media/141304/download","false","23501"
"23485","2020 Survey of America's Physicians: COVID-19 Impact Edition","Physicians Foundation","2020-08-18T00:00:00.000","PDF","Part One of The Physicians Foundation’s Survey of America’s Physicians: COVID-19 Impact Edition focuses on how the coronavirus has affected physicians’ practices and their patients. Among the findings in this 20-page report is that nearly 50 percent of physicians believe the coronavirus pandemic will not be under control until sometime after June 1, 2021.","https://physiciansfoundation.org/research-insights/2020physiciansurvey/",,"Report","Direct link to document: http://physiciansfoundation.org/wp-content/uploads/2020/08/20-1278-Merritt-Hawkins-2020-Physicians-Foundation-Survey.6.pdf","false","23485"
"23482","Considerations for Selecting Respirators for Your Health Care Facility","U.S. Food and Drug Administration","2020-08-18T00:00:00.000","PDF","This flowchart and the information on this web page illustrate which Emergency Use Authorization (EUA) applies to specific respirator types, and provide links to information on performance factors for each type to consider when selecting respirators for use in health care facilities in the United States.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/considerations-selecting-respirators-your-health-care-facility",,"Guideline/Assessment Tool","Direct link to flowchart: https://www.fda.gov/media/141263/download","false","23482"
"23481","Manufacturing and Distributing Respirators for Health Care Use in the United States Under an Existing Emergency Use Authorization (EUA) During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-18T00:00:00.000","PDF","This flowchart provides information on manufacturing and distributing respirators for health care use in the United States under an existing emergency use authorization (EUA) during the COVID-19 public health emergency. It also provides links to detailed information provided by the FDA, the Centers for Disease Control and Prevention (CDC), and the National Institute for Occupational Safety and Health (NIOSH).","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/manufacturing-and-distributing-respirators-health-care-use-united-states-under-existing-emergency",,"Guideline/Assessment Tool","Direct link to flowchart: https://www.fda.gov/media/141261/download","false","23481"
"23457","Monitoring and Evaluation Action Guide: Wearing Masks as a COVID-19 Community Mitigation Strategy","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-18T00:00:00.000","Text","This action guide is developed to help evaluators, program implementers, and policymakers monitor and evaluate wearing masks as a COVID-19 community mitigation strategy. It is not meant for healthcare settings. The guide provides practical considerations and examples of evaluation questions, indicators, and data sources.","https://www.cdc.gov/coronavirus/2019-ncov/php/mask-evaluation.html",,"Guideline/Assessment Tool",,"false","23457"
"21377","Master Question List for COVID-19 (Caused by SARS-CoV-2)","U.S. Department of Homeland Security","2020-08-18T00:00:00.000","PDF","This Master Question List (MQL), updated on August 18, 2020, is intended to quickly present the current state of available information to government decision-makers in the operational response to COVID-19, and allow structured and scientifically guided discussions across the federal government without burdening them with the need to review scientific reports, and to prevent duplication of efforts by highlighting and coordinating research.  This document is a “living document” that will be updated as needed when new information becomes available.","https://www.dhs.gov/publication/st-master-question-list-covid-19",,"Fact Sheet",,"false","21377"
"24036","COVID-19 and People with Disabilities in Canada","Government of Canada","2020-08-17T00:00:00.000","Text","This web page discusses some of the factors that may make a person with a disability more at risk of acquiring COVID-19 or progressing to more severe COVID-19 infection, other than age and underlying chronic condition, and how to protect people with disabilities from COVID-19.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/people-with-disabilities.html",,"Web Page",,"false","24036"
"23539","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: CMS Emerging Infectious Disease Terminology Requirements in Hazard Vulnerability Assessments","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-17T00:00:00.000","PDF","This three-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides resources in response to a requestor who asked if their healthcare facility needed to change their current terminology from “pandemic/ epidemic” to “emerging infectious diseases” (EID) in their Hazard Vulnerability Assessment (HVA) per the Centers for Medicare & Medicaid Services (CMS) Emergency Preparedness (EP) Rule.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta---cms---eid-terminology-in-hva.pdf",,"Bibliography/Resource List",,"false","23539"
"23518","Key Components for Continued COVID-19 Management for Dialysis Facilities","Centers for Medicare & Medicaid Services","2020-08-17T00:00:00.000","PDF","To assist in preventing the transmission of COVID-19 within the dialysis population, CMS is reinforcing this 11-page infection control guidance based upon the current Centers for Disease Control and Prevention (CDC) recommendations for dialysis facilities, which include screening for COVID-19, patient placement, personal protective equipment, isolation, cleaning, and disinfection.","https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/key-components-continued-covid-19-management-dialysis-facilities",,"Guideline/Assessment Tool","Direct link to document: https://www.cms.gov/files/document/qso-20-36-esrd.pdfLink to Checklist for Dialysis Facilities in COVID-19 Hotspots: https://www.cms.gov/files/document/checklist-dialysis-facilities-covid-19-hotspots.pdf","false","23518"
"23517","Enforcement Cases Held during the Prioritization Period and Revised Survey Prioritization","Centers for Medicare & Medicaid Services","2020-08-17T00:00:00.000","PDF","This nine-page document describes how the Centers for Medicare & Medicaid Services is revising guidance on the expansion of survey activities to authorize on site revisits and other survey types, and to State Survey Agencies (SAs) on resolving enforcement cases.","https://www.cms.gov/medicareprovider-enrollment-and-certificationsurveycertificationgeninfopolicy-and-memos-states-and/enforcement-cases-held-during-prioritization-period-and-revised-survey-prioritization",,"Guideline/Assessment Tool","Direct link to document: https://www.cms.gov/files/document/qso-20-35-all.pdf","false","23517"
"23504","Fact Sheet for Healthcare Providers: Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit","U.S. Food and Drug Administration","2020-08-17T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit. The Diazyme DZ-Lite SARS-CoV-2 IgM CLIA Kit is authorized for the detection of antibodies to SARS-CoV-2 in human serum or plasma (potassium EDTA, disodium EDTA and lithium heparin).","https://www.fda.gov/media/141253/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/141254/downloadLink to Letter of Authorization: https://www.fda.gov/media/141252/downloadLink to Instructions for Use: https://www.fda.gov/media/141255/download","false","23504"
"23503","Fact Sheet for Healthcare Providers: BioCheck SARS-CoV-2 IgG and IgM Combo Test","U.S. Food and Drug Administration","2020-08-17T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the BioCheck SARS-CoV-2 IgG and IgM Combo Test. The BioCheck SARS-CoV-2 IgG and IgM Combo Test is authorized for the qualitative detection and differentiation of IgG and IgM antibodies to SARS-CoV-2 in human serum.","https://www.fda.gov/media/141248/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/141249/downloadLink to Letter of Authorization: https://www.fda.gov/media/141247/downloadLink to Instructions for Use: https://www.fda.gov/media/141251/download","false","23503"
"23502","Fact Sheet for Healthcare Providers: COVID-19 Nucleic Acid RT-PCR Test Kit","U.S. Food and Drug Administration","2020-08-17T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the COVID-19 Nucleic Acid RT-PCR Test Kit. The COVID-19 Nucleic Acid RT-PCR Test Kit is authorized for use with upper respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141244/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141245/downloadLink to Letter of Authorization: https://www.fda.gov/media/141243/downloadLink to Instructions for Use: https://www.fda.gov/media/141246/download","false","23502"
"23498","Racial Disparities in COVID-19","Henry J. Kaiser Family Foundation","2020-08-17T00:00:00.000","Text","This brief summarizes key findings from data and analyses examining COVID-19-related cases, deaths, hospitalizations, and testing by race and ethnicity as of early August 2020 to provide increased insight into racial disparities.","https://www.kff.org/racial-equity-and-health-policy/issue-brief/racial-disparities-covid-19-key-findings-available-data-analysis/","Artiga, Samantha; Corallo, Bradley; Pham, Olivia","Report",,"false","23498"
"23460","Operational Considerations for Maintaining Essential Services and Providing Prevention, Care, and Treatment for Tuberculosis (TB) in Low-Resource non-US Settings During the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-17T00:00:00.000","Text","This web page summarizes operational considerations to assist tuberculosis (TB) programs, health service managers, and healthcare personnel in maintaining continuity of essential TB services in low-resource, non-U.S. settings during the COVID-19 pandemic.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/TB-non-us-settings.html",,"Guideline/Assessment Tool",,"false","23460"
"23458","National Wastewater Surveillance System (NWSS)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-17T00:00:00.000","Text","The Centers for Disease Control and Prevention (CDC) and the U.S. Department of Health and Human Services (HHS), in collaboration with agencies throughout the federal government, are initiating the National Wastewater Surveillance System (NWSS) in response to the COVID-19 pandemic. The data generated by NWSS will help public health officials to better understand the extent of COVID-19 infections in communities.","https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/wastewater-surveillance.html",,"Guideline/Assessment Tool",,"false","23458"
"22247","EUA (Emergency Use Authorization) Authorized Serology Test Performance","U.S. Food and Drug Administration","2020-08-17T00:00:00.000","Text","This web page, updated on August 17, 2020, summarizes the expected performance of the COVID-19/SARS-CoV-2 serology tests the Food and Drug Administration (FDA) has authorized based on the information FDA reviewed when deciding whether or not to grant these tests an Emergency Use Authorization. It also provides a calculator that will allow users to see the estimated performance of a single test or two independent tests based on their performance characteristics and the estimated prevalence of SARS-CoV-2 antibodies in the target population.","https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/eua-authorized-serology-test-performance",,"Web Page","Link to calculator: https://www.fda.gov/media/137612/download","false","22247"
"21592","Clinical Management of Patients with Moderate to Severe COVID-19: Second Interim Guidance","Government of Canada","2020-08-17T00:00:00.000","Text","This guidance, updated on August 17, 2020, provides clinicians with interim advice on timely, effective, and safe supportive management of adult and pediatric patients with suspected or confirmed COVID-19. It is not meant to replace clinical judgment or specialist consultation, but rather to strengthen the clinical management of these patients. Best practices for triage and optimized supportive care are included.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/clinical-management-covid-19.html",,"Guideline/Assessment Tool","Link to guidance in French: https://www.canada.ca/fr/sante-publique/services/maladies/2019-nouveau-coronavirus/professionnels-sante/prise-charge-clinique-covid19.html","false","21592"
"23434","Fact Sheet for Healthcare Providers: SalivaDirect","U.S. Food and Drug Administration","2020-08-15T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SalivaDirect assay. The SalivaDirect assay is authorized for use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141193/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141195/downloadLink to Letter of Authorization: https://www.fda.gov/media/141194/downloadLink to EUA Summary: https://www.fda.gov/media/141192/download","false","23434"
"22893","Guidance for General Laboratory Safety Practices During the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-15T00:00:00.000","Text","This guidance, updated on August 15, 2020, is to address the general workflow safety concerns of laboratory personnel during the COVID-19 pandemic, including guidance on social distancing, face coverings, and personal hygiene and disinfection. All laboratories should perform site- and activity-specific risk assessments to determine the most appropriate safety measures to implement for particular circumstances.","https://www.cdc.gov/coronavirus/2019-ncov/lab/lab-safety-practices.html",,"Guideline/Assessment Tool",,"false","22893"
"23874","COVID-19 Toolkit: Information for Long-Term Care Facilities","Minnesota Department of Health","2020-08-14T00:00:00.000","PDF","This 51-page toolkit was created for long-term care facilities to implement measures to prevent and control disease spread in a facility, and to collect data that will help to track respiratory illness and COVID-19 in residents and staff.","https://www.health.state.mn.us/diseases/coronavirus/hcp/ltctoolkit.pdf",,"Guideline/Assessment Tool",,"false","23874"
"23569","Physician Liability for COVID-19 Testing","Network for Public Health Law","2020-08-14T00:00:00.000","Text","This web page provides a response to a public health physician's request seeking clarification of their duties in light of Michigan Governor Whitmer’s Emergency Declaration (Executive Order 2020-104) to increase COVID-19 testing, and if testing for COVID-19 establishes a physician-patient duty to patients for whom a physician orders or conducts a test.","https://www.networkforphl.org/resources/physician-liability-for-covid-19-testing/","Jacobson, Peter","Guideline/Assessment Tool",,"false","23569"
"23568","Issuing a COVID-19 Press Release That Identifies a Specific Location","Network for Public Health Law","2020-08-14T00:00:00.000","Text","This web page provides a response to a county health department's request seeking guidance on whether the department can issue a press release indicating that individuals who attended a party on a specific date at a specific address may have been exposed to COVID-19. There are no legal barriers to issuing the proposed press release. Instead, this is a policy question within the health department’s discretion.","https://www.networkforphl.org/resources/issuing-a-covid-19-press-release-that-identifies-a-specific-location/","Jacobson, Peter","Guideline/Assessment Tool",,"false","23568"
"23560","Study of the COVID-19 Outbreak and Response in Connecticut Long-Term Care Facilities","Mathematica","2020-08-14T00:00:00.000","PDF","This 93-page report describes the impact of COVID-19 in Connecticut as a whole and in long-term care facilities compared with other states in the region and the country. It presents a preliminary assessment and interim recommendations for short-term changes Connecticut and industry can take to mitigate a potential second wave of COVID-19.","https://www.mathematica.org/our-publications-and-findings/publications/a-study-of-the-covid-19-outbreak-and-response-in-connecticut-long-term-care-facilities","Rowan, Patricia; Lester, Rebecca; Levere, Michael; Libersky, Jenna; Lipson, Debra","Report",,"false","23560"
"23499","Community Health Centers and Medication-Assisted Treatment for Opioid Use Disorder","Henry J. Kaiser Family Foundation","2020-08-14T00:00:00.000","Text","This issue brief presents findings from a 2019 survey of community health centers on activities related to the prevention and treatment of opioid use disorder, with a focus on medication-assisted treatment (MAT), to assess services and capacity prior to the recent surge in need.","https://www.kff.org/uninsured/issue-brief/community-health-centers-and-medication-assisted-treatment-for-opioid-use-disorder/","Corallo, Bradley; Tolbert, Jennifer; Sharac, Jessica; Markus, Anne; Rosenbaum, Sara","Report",,"false","23499"
"23446","Medical Device Shortages During the COVID-19 Public Health Emergency","U.S. Food and Drug Administration","2020-08-14T00:00:00.000","Text","This web page provides an up-to-date list of the devices the Food and Drug Administration (FDA) has determined to be in shortage during the COVID-19 pandemic. It also provides a list of medical devices for which the FDA has been notified that manufacturing has been permanently discontinued.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/medical-device-shortages-during-covid-19-public-health-emergency",,"Guideline/Assessment Tool",,"false","23446"
"23445","NETEC COVID-19 Webinar Series: Approach to Anticoagulation in COVID-19: Evidence and Practice Patterns","National Emerging Special Pathogens Training and Education Center","2020-08-14T00:00:00.000","Video or Multimedia","This 54-minute webinar articulates the pathophysiology of the hypercoagulable state seen in COVID-19 and discusses current evidence surrounding anticoagulation in COVID-19. Institutional practice patterns for anticoagulation are also discussed.","https://repository.netecweb.org/items/show/1269","Tennill, Trish; Gaddh, Manila; Pradhan, Deepak; Mukherjee, Vikram","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/1220661bf117f7c223ff49df98bbc921.pdf","false","23445"
"23397","Personal Protective Equipment EUAs","U.S. Food and Drug Administration","2020-08-14T00:00:00.000","Text","This web page provides information and documents about the Food and Drug Administration's issuing of Emergency Use Authorizations (EUAs) for certain personal protective equipment products, including face shields, other barriers, and respiratory protective devices such as respirators, during the COVID-19 pandemic.","https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/personal-protective-equipment-euas",,"Guideline/Assessment Tool",,"false","23397"
"20702","COVID-19 Emergency Legal Preparedness Primer","Network for Public Health Law","2020-08-14T00:00:00.000","PDF","This primer, updated on August 14, 2020, provides key information on the public health emergency response to the COVID-19.  It includes information about a COVID-19 Epi Snapshot; International legal response efforts; and U.S. legal preparedness/response (including emergency declarations).","https://www.networkforphl.org/resources/emergency-legal-preparedness-covid19/","Hodge, James G.","Report",,"false","20702"
"23510","ADA (Americans with Disabilities Act) National Network Learning Session: FEMA Perspective on Emergency Management, COVID-19 and People with Disabilities","ADA [Americans with Disabilities Act] National Network","2020-08-13T00:00:00.000","Video or Multimedia","This one-hour, 35-minute webinar provides an overview of the Federal Emergency Management Agency (FEMA)'s roles and responsibilities in the midst of COVID-19, how FEMA continued to serve people with disabilities during that response, and how it continued to plan and prepare for the 2020 natural disaster season in the midst of the pandemic.","https://www.adapresentations.org/webinar.php?id=164","Lewis, Charlotte; Crawford, Roxann; Adler, Candice; Ahern, Edward; Gottesman, Jessica","Instructional/Training Material","Link to presentation slides: https://www.adapresentations.org/doc/8_12_20/FEMA%20Perspective%20on%20Emergency%20Management,%20COVID-19%20and%20People%20with%20Disabilities.pdfLink to transcript: https://www.adapresentations.org/doc/8_12_20/Transcript%2008-13-20.pdf","false","23510"
"23422","COVID-19 Public Health and Economic Crises Leave Vulnerable Populations Exposed","Brookings Institution","2020-08-13T00:00:00.000","Text","This report uses a novel panel data set collected between March and July of 2020 to describe disparities in outcomes related to the COVID-19 pandemic across race/ethnicity and employment status. The evidence suggests a need for a more robust safety net, such as an expanded unemployment benefits program and more accessible public health insurance during the COVID-19 pandemic, as well as more deliberate targeting of federal support to Black and Hispanic households.","https://www.brookings.edu/blog/up-front/2020/08/13/the-covid-19-public-health-and-economic-crises-leave-vulnerable-populations-exposed/","Grooms, Jevay; Ortega, Alberto; Rubalcaba, Joaquin","Report",,"false","23422"
"23383","Fact Sheet for Healthcare Providers: Pro-AmpRT SARS-CoV-2 Test","U.S. Food and Drug Administration","2020-08-13T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Pro-AmpRT SARS-CoV-2 Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141147/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141148/downloadLink to Letter of Authorization: https://www.fda.gov/media/141146/downloadLink to EUA Summary: https://www.fda.gov/media/141149/download","false","23383"
"23382","Fact Sheet for Healthcare Providers: REGIOCIT","U.S. Food and Drug Administration","2020-08-13T00:00:00.000","PDF","This six-page fact sheet informs healthcare providers about REGIOCIT, which has been authorized for emergency use as a replacement solution in adult patients treated with Continuous Renal Replacement Therapy (CRRT), and for whom RCA is appropriate, during the COVID-19 pandemic.","https://www.fda.gov/media/141170/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients and Caregivers: https://www.fda.gov/media/141172/downloadLink to Letter of Authorization: https://www.fda.gov/media/141168/downloadLink to Package Insert: https://www.fda.gov/media/141186/download","false","23382"
"23379","Epidemiological Alert: COVID-19 During Pregnancy","World Health Organization, Pan American Health Organization","2020-08-13T00:00:00.000","PDF","This eight-page document details how the Pan American Health Organization/World Health Organization (PAHO/WHO) requests that Member States intensify efforts to ensure access to prenatal care services, as well as to implement preventive measures to reduce morbidity and mortality associated with COVID-19 across all levels of the health system, in order to maintain the commitment to reducing maternal and perinatal mortality and the progress achieved to date.","https://www.paho.org/en/documents/epidemiological-alert-covid-19-during-pregnancy-13-august-2020",,"Guideline/Assessment Tool","Direct link to document: https://www.paho.org/en/file/70317/download?token=G29wByLG","false","23379"
"23367","Progress on Drinking-Water, Sanitation and Hygiene in Schools","World Health Organization","2020-08-13T00:00:00.000","PDF","This 82-page report, co-published with UNICEF, details the latest data from the WHO/UNICEF Joint Monitoring Programme (JMP), which reveal that 43 percent of schools around the world lacked access to basic hand-washing with soap and water in 2019 – a key condition for schools to be able to operate safely in the midst of the COVID-19 pandemic.","https://www.who.int/publications/i/item/progress-on-drinking-water-sanitation-and-hygiene-in-schools",,"Report","Direct link to document: https://www.who.int/docs/default-source/wash-documents/progress-of-drinking-water-sanitation-and-hygiene-in-schools---special-focus-on-covid-19.pdf?sfvrsn=d5b40ebd_6&download=true","false","23367"
"23589","SARS-CoV-2 Infection and Transmission in Educational Settings","United Kingdom Department of Health","2020-08-12T00:00:00.000","PDF","Public Health England initiated enhanced national surveillance following the reopening of educational settings during the summer mini-term on June 1, 2020. COVID-19-related situations in educational settings across England were reviewed daily and followed up until July 31, 2020. SARS-CoV-2 infection and outbreak rates were calculated for staff and students attending early year settings, primary, and secondary schools during June 2020. This 28-page report summarizes those findings.","https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/911267/School_Outbreaks_Analysis.pdf","Ismail, Sharif; Saliba, Vanessa; Bernal, Jamie; Ramsey, Mary; Ladhani, Shamez","Report",,"false","23589"
"23491","Considerations for Systematic Screening PK-12: Universal Screening for Internalizing and Externalizing Behaviors in the COVID-19 Era","Mental Health Technology Transfer Center Network","2020-08-12T00:00:00.000","Video or Multimedia","This one-hour, 33-minute webinar for educational leaders offers considerations for conducting systematic screenings for internalizing and externalizing behaviors in the COVID-19 era.","https://mhttcnetwork.org/centers/northwest-mhttc/considerations-systematic-screening-pk-12-universal-screening-internalizing","Lane, Kathleen","Instructional/Training Material","Link to recording: https://www.youtube.com/watch?v=b-d5BNkrGRU&feature=youtu.beLink to presentation slides: https://mhttcnetwork.org/sites/default/files/2020-08/2020.8.12%20Screening_Lane%20MHTTC%20FINAL.pdf","false","23491"
"23490","Guidelines for Healthy In-Person Voting","Brennan Center for Justice","2020-08-12T00:00:00.000","PDF","The Brennan Center and the Infectious Diseases Society of America have issued these four-page joint guidelines to minimize the risk of transmitting COVID-19 at the polls this November.","https://www.brennancenter.org/our-work/research-reports/guidelines-healthy-person-voting",,"Guideline/Assessment Tool","Direct link to document: https://www.brennancenter.org/sites/default/files/2020-08/2020_08_Guide%20for%20Healthy%20In%20Person%20Voting_Finalv2.pdf","false","23490"
"23369","Epidemiological Alert: Complications and Sequelae of COVID-19","World Health Organization, Pan American Health Organization","2020-08-12T00:00:00.000","PDF","Through this 16-page alert, the Pan American Health Organization/World Health Organization (PAHO/WHO) urges Member States to keep health professionals informed as new information continues to become available in order to strengthen the timely detection and proper management of COVID-19 cases, complications, and sequelae.","https://www.paho.org/en/documents/epidemiological-alert-complications-and-sequelae-covid-19-12-august-2020",,"Report","Direct link to document: https://www.paho.org/en/file/70246/download?token=Y4NGNdQv","false","23369"
"23684","Collaborating to Learn from Hurricanes","Natural Hazards Center [University of Colorado at Boulder]","2020-08-11T00:00:00.000","Video or Multimedia","This 32-minute webinar features the leaders of the National Science Foundation-supported Nearshore Extreme Events Reconnaissance (NEER) Association, which organizes interdisciplinary teams and supports travel for rapid, pre-event site characterization and instrument deployments to collect perishable data needed to understand impacts of major storms on the nearshore system.","https://converge.colorado.edu/communications/webinar-series/collaborating-to-learn-from-hurricanes-the-nearshore-extreme-events-reconnaissance-association","Raubenheimer, Britt; Chen, Qin Ben; Elgar, Steve; Michael, Holly; Moore, Laura","Instructional/Training Material",,"false","23684"
"23540","Interim Guidance: SARS-CoV-2 (COVID-19) and Field Trauma Triage Principles","National Highway Traffic Safety Administration, Office of Emergency Medical Services","2020-08-11T00:00:00.000","PDF","This three-page document provides a brief overview of how the coronavirus disease 2019 (COVID-19) impacts trauma triage for first responders, including Emergency Medical Service (EMS), fire and rescue, and law enforcement.","https://www.ems.gov/pdf/Federal_Guidance_and_Resources/Patient_Care/Interim_Guidance_Field_Trauma_Triage_Principles.pdf",,"Guideline/Assessment Tool",,"false","23540"
"23466","COVID-19 and Child Welfare: A Series of Virtual Meetings","National Conference of State Legislatures","2020-08-11T00:00:00.000","Video or Multimedia","This web page provides information and links for a webinar series that highlights state and federal policy responses to COVID-19 in the child welfare system. Sessions feature state legislators and legislative staff, National Conference of State Legislatures staff, and other experts.","https://www.ncsl.org/research/human-services/covid-19-child-welfare-a-series-of-virtual-meetings637256622.aspx",,"Instructional/Training Material",,"false","23466"
"23423","Providing Medical Respite for People Experiencing Homelessness during COVID-19","Center for Health Care Strategies, Inc.","2020-08-11T00:00:00.000","Video or Multimedia","This one-hour, 31-minute webinar highlights the experiences and innovations of three medical respite centers in California and Washington State during COVID-19.  Presenters provide an overview of programs and share how their medical respite centers responded to COVID-19, including changes to structures, processes, and partners, as well as lessons for how to improve their services for people experiencing homelessness.","https://www.chcs.org/resource/providing-medical-respite-for-people-experiencing-homelessness-during-covid-19/","Moses, Kathy; Dobbins, Julia; Bhalla, Pooja; Jeevanjee, Sara; Enzian, Leslie","Instructional/Training Material",,"false","23423"
"23418","Scramble for Vaccines and the COVAX Facility","Center for Strategic and International Studies","2020-08-11T00:00:00.000","Video or Multimedia","This one-hour video features a discussion on the ACT Accelerator’s COVAX Facility. COVAX has emerged as a promising, nascent, international initiative to develop and equitably distribute COVID-19 vaccines to benefit all countries.","https://healthsecurity.csis.org/events/online-event-the-scramble-for-vaccines-and-the-covax-facility/","Gilbert, Nikolaj; Hoyt, Kendall; Lurie, Nicole; Morrison, J. Stephen; Hamburg, Margaret A.","Instructional/Training Material",,"false","23418"
"23396","Registration and Listing of Medical Devices during the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-11T00:00:00.000","Text","This web page provides information for medical device establishments, including owners and operators of places of business (also called facilities) that are involved in the production (e.g., manufacturing, assembling, or processing) and distribution of medical devices that are authorized by Emergency Use Authorizations (EUAs) or that are the subject of one of FDA’s COVID-19 guidance documents.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/registration-and-listing-medical-devices-during-covid-19-pandemic",,"Guideline/Assessment Tool",,"false","23396"
"23394","Importing Medical Devices During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-11T00:00:00.000","Text","This web page provides information on importing certain medical devices during the COVID-19 pandemic. It describes procedures for importing devices that have been issued Emergency Use Authorizations (EUAs) and for devices for which an enforcement discretion policy has been published in guidance.","https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/importing-medical-devices-during-covid-19-pandemic",,"Guideline/Assessment Tool",,"false","23394"
"23393","Fact Sheet for Healthcare Providers: Biomeme SARS-CoV-2 Real-Time RT-PCR Test","U.S. Food and Drug Administration","2020-08-11T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Biomeme SARS-CoV-2 Real-Time RT-PCR Test. The Biomeme SARS-CoV-2 Real-Time RT-PCR Test is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141050/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141051/downloadLink to Letter of Authorization: https://www.fda.gov/media/141049/downloadLink to Instructions for Use: https://www.fda.gov/media/141052/download","false","23393"
"23381","Fact Sheet for Healthcare Providers: LumiraDx SARS-CoV-2 RNA STAR","U.S. Food and Drug Administration","2020-08-11T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the LumiraDx SARS-CoV-2 RNA STAR. The LumiraDx SARS-CoV-2 RNA STAR test is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141055/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141056/downloadLink to Letter of Authorization: https://www.fda.gov/media/141054/downloadLink to Instructions for Use: https://www.fda.gov/media/141057/download","false","23381"
"23365","Joseph Leiter NLM/MLA Lectureship: Digital Epidemiology and the COVID-19 Pandemic","National Library of Medicine [National Institutes of Health]","2020-08-11T00:00:00.000","Video or Multimedia","The Joseph Leiter NLM/MLA Lectureship was established in 1983 to stimulate intellectual liaison between the Medical Library Association (MLA) and the National Library of Medicine (NLM). The presenter in this one-hour lecture speaks on translation impact on the surveillance, control, and prevention of disease; the development and application of data mining; and citizen science to public health in relation to his work with the COVID-19 pandemic.","https://videocast.nih.gov/watch=38269","Brownstein, John","Instructional/Training Material",,"false","23365"
"23360","COVID-19 Considerations for Labor and Delivery Patients","National Emerging Special Pathogens Training and Education Center","2020-08-11T00:00:00.000","Text","COVID-19-positive pregnant, birth, and labor and delivery patients should follow the specific, recommended infectious disease, screening/testing, and medical practice considerations on this web page.","https://netec.org/2020/08/11/covid-19-considerations-labor-delivery-patients/",,"Guideline/Assessment Tool","Link to related flyer: https://repository.netecweb.org/files/original/83496a89e330e33749d8cbaa7483e5ed.pdf","false","23360"
"23353","COVID-19 Clusters and Outbreaks in Occupational Settings in the EU/EEA and the UK","European Union, European Centre for Disease Prevention and Control","2020-08-11T00:00:00.000","PDF","The aim of this 17-page document is to describe COVID-19 clusters and outbreaks in the European Union/European Economic Area (EU/EEA) and the United Kingdom (UK) linked to occupational settings, including healthcare and non-healthcare settings, and to identify possible factors contributing to transmission in these settings.","https://www.ecdc.europa.eu/en/publications-data/covid-19-clusters-and-outbreaks-occupational-settings-eueea-and-uk",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-in-occupational-settings.pdf","false","23353"
"22484","Disparities in the Risk and Outcomes of COVID-19","United Kingdom Department of Health","2020-08-11T00:00:00.000","PDF","This 92-page document, updated on August 11, 2020, is a descriptive review of surveillance data on disparities in the risk and outcomes from COVID-19. The review looked at different factors, including age and sex, where people live, deprivation, ethnicity, people’s occupation, and care home residence.","https://www.gov.uk/government/publications/covid-19-review-of-disparities-in-risks-and-outcomes",,"Report","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/908434/Disparities_in_the_risk_and_outcomes_of_COVID_August_2020_update.pdfLink to data pack: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/889167/Disparities_risks_outcomes_of_COVID19_data_pack.ods","false","22484"
"23582","Coronavirus (COVID-19): Support for Well-being in the Healthcare Workforce","Cochrane Library","2020-08-10T00:00:00.000","Text","This report brings together Cochrane evidence on interventions that may help support the well-being of the healthcare workforce and reduce occupational stress during the COVID-19 pandemic.","https://www.cochranelibrary.com/collections/doi/SC000045/full",,"Report","Report is available in German, Farsi, French, Japanese, Malay, Portuguese, Russian, and Spanish.","false","23582"
"23440","Joint Statement: Roadmap for Maintaining Essential Surgery during COVID-19 Pandemic","American Hospital Association","2020-08-10T00:00:00.000","Text","The American Hospital Association, American College of Surgeons, American Society of Anesthesiologists, and Association of periOperative Registered Nurses, have released this updated joint statement that provides a list of principles and considerations to guide physicians, nurses, and hospitals and health systems during the COVID-19 pandemic as they provide essential care to their patients and communities, and seek to ensure ongoing preparation to meet patients’ needs for recommended essential procedures.","https://www.aha.org/2020-08-12-joint-statement-roadmap-maintaining-essential-surgery-during-covid-19-pandemic",,"Report",,"false","23440"
"23386","Fact Sheet for Healthcare Providers: Alpha Genomix TaqPath SARS-CoV-2 Combo Assay","U.S. Food and Drug Administration","2020-08-10T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Alpha Genomix TaqPath SARS-CoV-2 Combo Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141019/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141020/downloadLink to Letter of Authorization: https://www.fda.gov/media/141017/downloadLink to EUA Summary: https://www.fda.gov/media/141021/download","false","23386"
"23385","Fact Sheet for Healthcare Providers: Solaris Multiplex SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-08-10T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Solaris Multiplex SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/141014/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141015/downloadLink to Letter of Authorization: https://www.fda.gov/media/141013/downloadLink to EUA Summary: https://www.fda.gov/media/141016/download","false","23385"
"23384","Fact Sheet for Healthcare Providers: Emergency Use of the Prismaflex HF20 Set During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-10T00:00:00.000","PDF","This two-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Prismaflex HF20 Set to provide continuous renal replacement therapy (CRRT) to treat low weight (8-20 kg) and low blood volume patients who have acute renal failure, fluid overload, or both, and who cannot tolerate a larger extracorporeal circuit volume in an acute care environment during the COVID-19 pandemic.","https://www.fda.gov/media/141032/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/141033/downloadLink to Letter of Authorization: https://www.fda.gov/media/141031/downloadLink to Instructions for Use: https://www.fda.gov/media/141034/download, and https://www.fda.gov/media/141035/download","false","23384"
"23371","Critical Role of Health Care Professionals During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-10T00:00:00.000","Video or Multimedia","This 58-minute speech discusses COVID-19, the Food and Drug Administration’s role in responding to this public health emergency, and the continuing challenges the agency and the medical profession face as it continues to evolve.","https://www.fda.gov/news-events/speeches-fda-officials/critical-role-health-care-professionals-during-covid-19-pandemic-08102020","Hahn, Stephen","Instructional/Training Material",,"false","23371"
"23348","Coronavirus Disease 2019 (COVID-19) in the EU/EEA and the UK – Eleventh Update: Resurgence of Cases","European Union, European Centre for Disease Prevention and Control","2020-08-10T00:00:00.000","PDF","This 34-page update analyzes the risk of further escalation of COVID-19 in the countries that have reported a recent increase in COVID-19 cases, and the risk of further escalation of COVID-19 across all European Union/European Economic Area countries and the United Kingdom (UK).","https://www.ecdc.europa.eu/en/publications-data/rapid-risk-assessment-coronavirus-disease-2019-covid-19-eueea-and-uk-eleventh",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-rapid-risk-assessment-20200810.pdf","false","23348"
"23347","Objectives for COVID-19 Testing in School Settings","European Union, European Centre for Disease Prevention and Control","2020-08-10T00:00:00.000","PDF","The aim of this four-page document is to provide an overview of major aspects of COVID-19 testing, contact tracing, contact identification, and contact follow-up in school settings within the European Union/European Economic Area countries and the United Kingdom (UK).","https://www.ecdc.europa.eu/en/publications-data/objectives-covid-19-testing-school-settings",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/covid-19-objectives-school-testing.pdf","false","23347"
"23172","Criteria for Return to Work for Healthcare Personnel with SARS-CoV-2 Infection (Interim Guidance)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-10T00:00:00.000","Text","This guidance, updated on August 10, 2020, is for occupational health programs and public health officials making decisions about return to work for healthcare personnel (HCP) with confirmed SARS-CoV-2 infection, or who have suspected SARS-CoV-2 infection (e.g., developed symptoms of COVID-19) but were never tested for SARS-CoV-2. For HCP with severe to critical illness or who are severely immunocompromised, the recommended duration for work exclusion was changed to at least 10 days and up to 20 days after symptom onset.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/return-to-work.html",,"Guideline/Assessment Tool",,"false","23172"
"22345","Children and COVID-19: State-Level Data Report","American Academy of Pediatrics","2020-08-10T00:00:00.000","PDF","The American Academy of Pediatrics is collecting and sharing all publicly available data from states on child COVID-19 cases. This web page, updated on August 10, 2020, provides state-level data on confirmed COVID-19 cases for children; detail varies substantially by state and by week.","https://services.aap.org/en/pages/2019-novel-coronavirus-covid-19-infections/children-and-covid-19-state-level-data-report/",,"Report","This web page is frequently updated.","false","22345"
"20815","Discontinuation of Transmission-Based Precautions and Disposition of Patients with COVID-19 in Healthcare Settings (Interim Guidance)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-10T00:00:00.000","Text","This guidance, updated on August 10, 2020, is a reference to guide healthcare personnel regarding discontinuing transmission-based precautions and discharging hospitalized patients with COVID-19. It includes updated guidance for a test-based strategy.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-hospitalized-patients.html",,"Guideline/Assessment Tool",,"false","20815"
"23814","Contact Tracing: A Community Engagement Checklist for Health Departments","Centers for Disease Control and Prevention","2020-08-08T00:00:00.000","PDF","Health departments often collaborate with other organizations to improve the health and well-being of their community. This three-page document provides a list of tips for health departments when they are working with community organizations on contact tracing.","https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/open-america/Contact-Tracing-Community-Engagement-Checklist.pdf",,"Guideline/Assessment Tool",,"false","23814"
"23436","CDC/IDSA COVID-19 Clinician Call: Neurologic Manifestations in Patients with COVID-19","Infectious Diseases Society of America","2020-08-08T00:00:00.000","Video or Multimedia","This one-hour webinar features speakers who discuss neurologic manifestations in patients with COVID-19, what is known and not known about the neurology of COVID-19, and several case scenarios.","https://www.idsociety.org/Podcasts/clinician-calls/cdcidsa-covid-19-clinician-call-neurologic-manifestations-in-patients-with-covid-19/","Wollins, Dana; Russman, Andrew; Sejvar, James","Instructional/Training Material",,"false","23436"
"24171","Project Firstline Training Modules","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-07T00:00:00.000","Video or Multimedia","These training modules on infection control were designed with workers in healthcare facilities in mind, so regardless of workers' previous training or education, they will gain critical information from this training.","https://www.cdc.gov/infectioncontrol/projectfirstline/training/index.html",,"Instructional/Training Material",,"false","24171"
"23634","Law and Epidemic Emergency Preparedness (LEEP) Online Training","Centers for Disease Control and Prevention","2020-08-07T00:00:00.000","Video or Multimedia","This Law and Epidemic Emergency Preparedness (LEEP) training covers provisions and concepts applicable to epidemic response, including various challenges faced during the 2014 Ebola response, and applies them to future infectious disease emergency response planning. LEEP examines legal underpinnings of emergency preparedness and response systems, what actions are authorized, and how to minimize legal barriers to an effective large-scale communicable disease response.","https://www.cdc.gov/phlp/publications/topic/trainings/leep.html",,"Instructional/Training Material","Site requires free registration.Unit 3 of this training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092660.Unit 4 of this training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092873.Unit 5 of this training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092874.Unit 8 of this training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092877.","false","23634"
"23549","COVID-19 and Dentistry: Challenges and Opportunities for Providing Safe Care","Agency for Healthcare Research and Quality  [U.S. Department of Health and Human Services]","2020-08-07T00:00:00.000","Text","This web page provides information and guidance for planning for the resumption of routine dental care during the COVID-19 pandemic, and finding creative ways to care for dental patients who are reluctant to come to the dental office for the foreseeable future.","https://psnet.ahrq.gov/primer/covid-19-and-dentistry-challenges-and-opportunities-providing-safe-care",,"Guideline/Assessment Tool",,"false","23549"
"23433","Additional Expiration Date Extensions of Certain Lots of Doxycycline Hyclate 100 mg Capsules Held in Strategic Stockpiles","U.S. Food and Drug Administration","2020-08-07T00:00:00.000","PDF","This three-page memorandum was written in response to a stakeholder request to extend the manufacturer labeled expiration date of five (5) lots of doxycycline hyclate 100 mg capsules manufactured by West-Ward Pharmaceuticals (West-Ward) that have been stockpiled for anthrax preparedness under the manufacturer labeled storage conditions.","https://www.fda.gov/media/141039/download",,"Guideline/Assessment Tool","Link to Disaster Lit record for previous date extension: https://disasterinfo.nlm.nih.gov/search/id:14828","false","23433"
"23387","Fact Sheet for Healthcare Providers: GWU COVID-19 RT-PCR Test","U.S. Food and Drug Administration","2020-08-07T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the emergency use of a Molecular LDT COVID-19 Authorized Test called the GWU COVID-19 RT-PCR Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140978/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140979/downloadLink to Letter of Authorization: https://www.fda.gov/media/140977/downloadLink to EUA Summary: https://www.fda.gov/media/140980/download","false","23387"
"23343","NETEC COVID-19 Webinar Series: Supply Management and Inventory Control During COVID-19 – Part Two","National Emerging Special Pathogens Training and Education Center","2020-08-07T00:00:00.000","Video or Multimedia","In this 56-minute webinar, participants discuss the principles of the Hospital Incident Command System (HICS) and other innovative approaches to assist with making informed decisions related to COVID-19 preparedness, mitigation, and response. Participants will learn how to articulate creative ways to manage reusable and disposable supplies and how to approach the need for substitution during the pandemic crisis.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1243","Vanairsdale, Sharon; Love, Kari; Spencer, Brian","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/34243d3a9fe410401150468e61b55255.pdf","false","23343"
"23342","Global Surveillance of COVID-19: WHO Process for Reporting Aggregated Data","World Health Organization","2020-08-07T00:00:00.000","Text","This spreadsheet is for weekly reporting of new COVID-19 cases and aggregated data. It includes tabs for transmission classification per week at subnational level 1, and a data dictionary.","https://apps.who.int/iris/rest/bitstreams/1291160/retrieve",,"Guideline/Assessment Tool",,"false","23342"
"23341","Public Health Surveillance for COVID-19","World Health Organization","2020-08-07T00:00:00.000","PDF","This 10-page document summarizes current WHO guidance for public health surveillance of coronavirus disease 2019 (COVID-19) in humans caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","https://www.who.int/publications/i/item/who-2019-nCoV-surveillanceguidance-2020.7",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1291156/retrieve","false","23341"
"22048","COVID-19: HEALTH DEPARTMENTS COVID-19 Contact Tracing Training","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-07T00:00:00.000","Text","This web page, updated August 7, 2020, provides a sample training plan, including training topics that may be helpful for state and local public health jurisdictions to consider when designing their own training plan for COVID-19 contact tracers. Each heading represents the learning objective for that section. Suggested training modalities/formats are provided, as well as information about sample existing trainings and resources.","https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/index.html",,"Instructional/Training Material","Link to Special Considerations for Health Departments: https://www.cdc.gov/coronavirus/2019-ncov/php/contact-tracing/contact-tracing-plan/special-considerations.html","false","22048"
"21263","Policy for Temporary Compounding of Certain Alcohol-Based Hand Sanitizer Product During the Public Health Emergency","U.S. Food and Drug Administration","2020-08-07T00:00:00.000","PDF","This 19-page guidance, updated on August 7, 2020, communicates the FDA's policy for the temporary compounding of certain alcohol-based hand sanitizer products by pharmacists in state-licensed pharmacies or federal facilities and registered outsourcing facilities (referred to collectively in this guidance as compounders) for the duration of the COVID-19 public health emergency.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/policy-temporary-compounding-certain-alcohol-based-hand-sanitizer-products-during-public-health",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/136118/download","false","21263"
"14351","Topic Collection","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-07T00:00:00.000","Text","This Topic Collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange, updated on August 7, 2020, provides resources about utility failures, and include lessons learned from recent disasters, case studies, and toolkits designed to help healthcare planners prepare to respond to, continue functioning during, and recover from post-disaster utility failures. Resources are in categories that include Education and Training, Guidance, Lessons Learned, and Plans, Tools, and Templates.","https://asprtracie.hhs.gov/technical-resources/35/utility-failures/0",,"Bibliography/Resource List","Link to resource from February 2017 in a PDF file: https://files.asprtracie.hhs.gov/documents/utility-failure.pdf","false","14351"
"11713","Topic Collection","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-07T00:00:00.000","Text","This Topic Collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange), updated on August 7, 2020, highlights key health and medical preparedness resources for natural disasters. The resources highlight lessons learned from recent events, communication tools and information, and checklists, plans, tools, and templates that can be modified to suit specific threats and needs. Articles in this Topic Collection address specific natural disasters and hazards and elements of their planning.","https://asprtracie.hhs.gov/technical-resources/36/Natural-Disasters/0",,"Bibliography/Resource List",,"false","11713"
"11675","Topic Collection","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-07T00:00:00.000","Text","This Topic Collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange), updated on August 7, 2020, highlights key health and medical preparedness resources for Healthcare Facility Evacuation and Sheltering. The resources include plans, guidelines, lessons learned from recent events, and promising practices that can help healthcare facility staff develop evacuation and sheltering plans, and facilitate their training and exercise development.","https://asprtracie.hhs.gov/technical-resources/57/Healthcare-Facility-Evacuation-Sheltering/57",,"Bibliography/Resource List","Link to PDF file of resources: https://files.asprtracie.hhs.gov/documents/healthcare-facility-evacuation-shelter.pdf","false","11675"
"23432","Respiratory Protection Resources in Long-Term Care","Centers for Disease Control and Prevention","2020-08-06T00:00:00.000","Video or Multimedia","This one-hour, 19-minute webinar presents information about respiratory protection resources in long-term care during the COVID-19 pandemic. Speakers define ""respirator,"" discuss the hierarchy of controls, and discuss hazard assessment criteria.","https://www.youtube.com/watch?v=NAnZNvGqa34&feature=youtu.be","Gackle, Tim; Rogers, Bonnie; Casey, Megan; de Perio, Marie","Instructional/Training Material",,"false","23432"
"23391","Fact Sheet for Healthcare Providers: VIDAS® SARS-COV-2 IgG","U.S. Food and Drug Administration","2020-08-06T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the VIDAS® SARS-COV-2 IgG. The VIDAS® SARS-COV-2 IgG is authorized for the detection of antibodies to SARS-CoV-2 in human serum or plasma (lithium heparin).","https://www.fda.gov/media/140935/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140936/downloadLink to Letter of Authorization: https://www.fda.gov/media/140934/downloadLink to Instructions for Use: https://www.fda.gov/media/140937/download","false","23391"
"23390","Fact Sheet for Healthcare Providers: VIDAS® SARS-COV-2 IgM","U.S. Food and Drug Administration","2020-08-06T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the VIDAS® SARS-COV-2 IgM.  The VIDAS® SARS-COV-2 IgM is authorized for the detection of antibodies to SARS-CoV-2 in human serum or plasma (lithium heparin).","https://www.fda.gov/media/140931/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140932/downloadLink to Letter of Authorization: https://www.fda.gov/media/140930/downloadLink to Instructions for Use: https://www.fda.gov/media/140933/download","false","23390"
"23388","Fact Sheet for Healthcare Providers: Helix COVID-19 NGS Test","U.S. Food and Drug Administration","2020-08-06T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Helix COVID-19 NGS Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140915/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140916/downloadLink to Letter of Authorization: https://www.fda.gov/media/140914/downloadLink to EUA  Summary: https://www.fda.gov/media/140917/download","false","23388"
"23362","Veterans Health Administration’s Role During the COVID-19 Response","Henry J. Kaiser Family Foundation","2020-08-06T00:00:00.000","Text","Within the context of the coronavirus pandemic, this brief examines the role of the Veterans Health Administration (VHA) during the COVID-19 public health emergencies and its capacity to support the broader community if called upon.","https://www.healthsystemtracker.org/brief/the-veteran-health-administrations-role-during-the-covid-19-response/","McDermott, Daniel; Hudman, Julie; Cox, Cynthia","Report",,"false","23362"
"23351","Could the President or Congress Enact a Nationwide Mask Mandate?","Congressional Research Service [Library of Congress]","2020-08-06T00:00:00.000","PDF","Several public officials have begun to call for a federal nationwide mask mandate to stem the tide of COVID-19 cases. This four-page document provides an overview of the relevant federal authority to issue such a mandate, as well as other legal considerations for Congress.","https://crsreports.congress.gov/product/pdf/LSB/LSB10530","Shen, Wen","Report",,"false","23351"
"23345","Frequently Asked Questions about Coronavirus (COVID-19) for Laboratories","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-06T00:00:00.000","Text","This web page provides answers to frequently asked questions about COVID-19 for laboratories, in these categories: Accessing Laboratory Testing, General Guidance and Regulatory Requirements, Test Developers, Serology, Specimen Handling, Specimen Packing and Shipping, Specimen Types, Anatomic Pathology, Ordering Supplies (For Public Health Laboratories), and Ordering Supplies (For Clinical Laboratories).","https://www.cdc.gov/coronavirus/2019-ncov/lab/faqs.html",,"Fact Sheet",,"false","23345"
"23338","COVID-19 in Children and the Role of School Settings in COVID-19 Transmission","European Union, European Centre for Disease Prevention and Control","2020-08-06T00:00:00.000","PDF","The aim of this 31-page document is to provide an overview of the epidemiology and disease characteristics of COVID-19 in children (0-18 years) in the European Union/European Economic Area countries and the United Kingdom (UK), and an assessment of the role of childcare (preschools; ages 0-<5 years) and educational (primary and secondary schools; ages 5-18 years) settings in COVID-19 transmission.","https://www.ecdc.europa.eu/en/publications-data/children-and-school-settings-covid-19-transmission",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-schools-transmission-August%202020.pdfLink to Related Infographic: COVID-19 in Children and the Role of Schools: https://www.ecdc.europa.eu/en/publications-data/infographic-covid-19-children-and-role-schools","false","23338"
"23331","Do Americans Face Greater Mental Health and Economic Consequences from COVID-19?","Commonwealth Fund","2020-08-06T00:00:00.000","Text","This report illustrates COVID-19’s effects on people’s mental health and economic security, and compares levels of public trust in national leaders in responding to the pandemic in the United States and other countries.","https://www.commonwealthfund.org/publications/issue-briefs/2020/aug/americans-mental-health-and-economic-consequences-COVID19","Williams II, Reginald; Shah, Arnav; Tikkanen, Roosa; Schneider, Eric; Doty, Michelle","Report",,"false","23331"
"23326","Challenges to Safely Reopening K-12 Schools","U.S. House of Representatives, Committee on Oversight and Reform","2020-08-06T00:00:00.000","Video or Multimedia","This two-hour, eight-minute hearing of the House Select Subcommittee on the Coronavirus Crisis features education and public health professionals who examine the challenges to safely reopening K-12 schools during the coronavirus pandemic, and the steps the federal government can take to help schools safely reopen in person and stay open.","https://coronavirus.house.gov/subcommittee-activity/hearings/remote-hearing-challenges-safely-reopening-k-12-schools","Clyburn, James; Duncan, Arne; Rivers, Caitlin; Skillings, Angela","Hearing/Testimony",,"false","23326"
"23325","COVAX Facility: Global Procurement for COVID-19 Vaccines","World Health Organization","2020-08-06T00:00:00.000","PDF","This six-page document provides information about the COVID-19 Vaccines Global Access (COVAX) Facility, where countries have the opportunity to benefit from a portfolio of vaccine candidates so that their populations can have early access to effective vaccines.","https://www.who.int/docs/default-source/act/covax-facility-background.pdf?sfvrsn=810d3c22_2&download=true",,"Report","Link to COVAX, the Act-Accelerator Vaccines Pillar: Insuring Accelerated Vaccine Development and Manufacture: https://www.who.int/docs/default-source/act/covax-pillar-background.pdf?sfvrsn=b6d9a2a8_2&download=true","false","23325"
"21437","Assessment of Evidence for COVID-19-Related Treatments","American Society of Health-Systems Pharmacists","2020-08-06T00:00:00.000","PDF","The information in this 102-page evidence table, updated on August 6, 2020, is emerging and rapidly evolving because of ongoing research and is subject to the professional judgment and interpretation of the practitioner due to the uniqueness of each medical facility’s approach to the care of patients with COVID-19 and the needs of individual patients. This evidence table is provided to help practitioners better understand current approaches related to treatment and care.","https://www.ashp.org/-/media/assets/pharmacy-practice/resource-centers/Coronavirus/docs/ASHP-COVID-19-Evidence-Table.ashx",,"Guideline/Assessment Tool",,"false","21437"
"24088","Contact Tracing in the Context of COVID-19 Response","European Union, European Centre for Disease Prevention and Control","2020-08-05T00:00:00.000","Video or Multimedia","Participants in this course will learn to explain to decision makers the importance of contact tracing as public health measure in the context of COVID-19; adapt to the local context the processes of contact tracing for COVID-19; and identify ways to scale up contact tracing and reflect on how to adapt them to the local context.","https://eva.ecdc.europa.eu/enrol/index.php?id=351",,"Instructional/Training Material","Site requires free registration.This training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092903.","false","24088"
"23495","Emergency Use of Authorized Disposable, Single-Use Surgical Masks During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-08-05T00:00:00.000","PDF","This two-page fact sheet informs healthcare personnel of the significant known and potential risks and benefits of the emergency use of authorized disposable, single-use surgical masks during the COVID-19 pandemic. It is specific to surgical masks that were authorized by the Food and Drug Administration (FDA) under an emergency use authorization (EUA).","https://www.fda.gov/media/140895/download",,"Guideline/Assessment Tool","Link to Appendix A Authorized Surgical Masks: https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-use-authorizations-medical-devices/personal-protective-equipment-euas#appendixasurgicalmasks","false","23495"
"23484","Legislative and Regulatory Steps for a National COVID-19 Testing Strategy","Duke University","2020-08-05T00:00:00.000","PDF","This 13-page report outlines legislative actions and federal appropriation targets that Duke-Margolis and its collaborating experts believe are needed to get a robust, diversified COVID-19 testing strategy in place for the nation by fall 2020.","https://healthpolicy.duke.edu/publications/legislative-and-regulatory-steps-national-covid-19-testing-strategy","McClellan, Mark; Rivers, Caitlin; Silcox, Christina","Report","Direct link to document: https://healthpolicy.duke.edu/sites/default/files/2020-08/COVID%20testing%20legislative%20recs%208-6%20correction_WITH%20COVER%20V2%208-6-2020.pdf","false","23484"
"23414","Guidance for Influenza Vaccine Delivery in the Presence of COVID-19","Government of Canada","2020-08-05T00:00:00.000","Text","This web page provides guidance for the delivery of seasonal influenza vaccine in fall 2020, when ongoing COVID-19 activity may continue to stress public health capacity and affect clinic operations and attendance.","https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/guidance-influenza-vaccine-delivery-covid-19.html",,"Guideline/Assessment Tool",,"false","23414"
"23392","Fact Sheet for Healthcare Providers: WANTAI SARS-CoV-2 Ab ELISA","U.S. Food and Drug Administration","2020-08-05T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the WANTAI SARS-CoV-2 Ab ELISA. The WANTAI SARS-CoV-2 Ab ELISA is authorized for the detection of total antibodies to SARS-CoV-2 inhuman serum and Acid Citrate Dextrose (ACD) plasma.","https://www.fda.gov/media/140927/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140928/downloadLink to Letter of Authorization: https://www.fda.gov/media/140926/downloadLink to Instructions for Use: https://www.fda.gov/media/140929/download","false","23392"
"23389","Fact Sheet for Healthcare Providers: ViroKey™ SARS-CoV-2 RT-PCR Test","U.S. Food and Drug Administration","2020-08-05T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ViroKey™ SARS-CoV-2 RT-PCR Test. The ViroKey™ SARS-CoV-2 RT-PCR Test is authorized for use with certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140920/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140921/downloadLink to Letter of Authorization: https://www.fda.gov/media/140919/downloadLink to Instructions for Use: https://www.fda.gov/media/140922/download","false","23389"
"23363","Ethical Issues in the Age of COVID-19: Part 1 of 2","Alabama Department of Public Health","2020-08-05T00:00:00.000","Video or Multimedia","This one-hour, 31-minute workshop looks at unique ethical challenges that have arisen in the age of COVID-19. Ethical issues include maintaining privacy, challenges in providing telehealth services, and working remotely; the need to use caution with digital communication is also explored.","https://www.alabamapublichealth.gov/alphtn/ondemand/2020/08-05.html","Sacco, James","Instructional/Training Material","Link to presentation slides: https://www.alabamapublichealth.gov/alphtn/assets/08052020handouts.pdf","false","23363"
"23335","NETEC COVID-19 Webinar Series: Supply Management and Inventory Control During COVID-19 – Part One","National Emerging Special Pathogens Training and Education Center","2020-08-05T00:00:00.000","Video or Multimedia","In this 55-minute webinar, participants will foster effective team strategies to assist in problem-solving to collectively control inventory and supply chain needs during the coronavirus pandemic; integrate approaches for optimizing personal protective equipment supply when caring for patients with COVID-19, including CAPRs/ PAPRs, masks, face shields, and other essential supplies; and discuss options for product substitution while maintaining a safe clinical environment as derived from case-based scenarios.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1242","Vanairsdale, Sharon; White, Bethany; Arguinchona, Christa; Maharaj, John; Tennill, Trish","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/68201dc38aa9c032a12151769cdebbff.pdf","false","23335"
"23453","Physician Guide to Keeping Your Practice Open During COVID-19","American Medical Association","2020-08-04T00:00:00.000","PDF","This six-page checklist was developed for physicians to ensure that their medical practice is ready for reopening and is well-situated to remain open going forward during the COVID-19 pandemic.","https://www.ama-assn.org/system/files/2020-08/physican-guide-keep-practices-open-covid-19.pdf",,"Guideline/Assessment Tool",,"false","23453"
"23357","Implementing Filtering Facepiece Respirator (FFR) Reuse, Including Reuse after Decontamination, When There Are Known Shortages of N95 Respirators","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-04T00:00:00.000","Text","N95 filtering facepiece respirators (FFRs) are meant to be disposed of after each use. The Centers for Disease Control and Prevention developed these contingency and crisis strategies to help healthcare facilities conserve their supplies in the face of shortages.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/decontamination-reuse-respirators.html",,"Guideline/Assessment Tool",,"false","23357"
"23301","Information for Health Care Facilities and Providers on “In-Use Time:” COVID-19","U.S. Food and Drug Administration","2020-08-04T00:00:00.000","Text","During the COVID-19 pandemic, health care facilities and providers have reported that care of ventilated patients can be complicated by the need to discard containers of medications before they are fully administered because of the in-use time specified on the FDA-approved label. This web page provides information to minimize the likelihood of physicochemical degradation or microbial proliferation during use in situations where a provider is considering use beyond the labeled in-use time for the products listed on this page.","https://www.fda.gov/drugs/coronavirus-covid-19-drugs/information-health-care-facilities-and-providers-use-time-covid-19",,"Guideline/Assessment Tool",,"false","23301"
"23286","COVID-19 and Telehealth Implementation: Stories from the Field","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-08-04T00:00:00.000","Video or Multimedia","In this one-hour, 30-minute Clinician Outreach and Communication Activity (COCA) call, presenters discuss telehealth benefits and challenges during and after the COVID-19 pandemic. Presenters share their experiences implementing telehealth across diverse healthcare settings and address considerations for its future use.","https://emergency.cdc.gov/coca/calls/2020/callinfo_080420.asp","Tindall, Erica; Prescott, Rasheda; Alli, Kemi; Wallace, Febe","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/Slides_08_04_2020_v2.pdf","false","23286"
"23271","Estimating Mortality from COVID-19","World Health Organization","2020-08-04T00:00:00.000","PDF","Differences in mortality between groups of people and countries are important proxy indicators of relative risk of death that guide policy decisions regarding scarce medical resource allocation during the ongoing COVID-19 pandemic. This four-page document is intended to help countries estimate case fatality ratio (CFR), and, if possible, infection fatality ratio (IFR), as appropriately and accurately as possible, while accounting for possible biases in their estimation.","https://www.who.int/publications/i/item/WHO-2019-nCoV-Sci-Brief-Mortality-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1289937/retrieve","false","23271"
"21398","Dental Settings: Interim Infection Prevention and Control Guidance for Dental Settings During the COVID-19 Response","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-04T00:00:00.000","Text","This web page, updated on August 4, 2020, includes additional guidance on physical distancing and how to respond to SARS-CoV-2 exposures among dental healthcare personnel and others. It includes recommendations for routine care, and recommendations for patients with suspected or confirmed COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/dental-settings.html",,"Guideline/Assessment Tool",,"false","21398"
"20828","Clinical Questions about COVID-19: Questions and Answers","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-04T00:00:00.000","Text","This web page, updated on August 4, 2020, provides answers to clinical questions about COVID-19, in these categories: COVID-19 Risk; Infection Control; Transmission; Testing, Diagnosis, and Notification; Testing in Nursing Homes; Treatment and Management; Patients with Persistent or Recurrent Positive Tests; Obstetrical Care;  Drugs and Investigational Therapies; Patients with Asthma; Patients with Liver Disease; Patients with Hypertension; and Waste Management.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/faq.html",,"Fact Sheet",,"false","20828"
"20725","Coronavirus Disease 2019 (COVID-19) Frequently Asked Questions and Answers","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-04T00:00:00.000","Text","This web page, updated on August 4, 2020,  provides answers to frequently asked questions about Coronavirus Disease 2019 Basics; How COVID-19 Spreads; How to Protect Yourself; COVID-19 and Children; School Dismissals and Children; Preparing Your Home and Family for COVID-19; In Case of an Outbreak in Your Community; Symptoms and Testing; Higher Risk; Healthcare Professionals and Health Departments; COVID-19 and Funerals; What CDC is Doing; and COVID-19 and Animals.","https://www.cdc.gov/coronavirus/2019-ncov/faq.html",,"Fact Sheet",,"false","20725"
"23361","Preparing for the COVID-19 Vaccine and Considerations for Mass Distribution","National Governors Association","2020-08-03T00:00:00.000","PDF","This nine-page memorandum provides COVID-19 information about Actions for Governors Preparing for Mass Distribution of a Vaccine; Overview of Planning Considerations for Mass Distribution; Distribution: From Industry to States; Distribution: From States to the Public; Prioritization of Critical Populations; Previous Planning Efforts and Lessons Learned;       Addressing Vaccine Hesitancy and Misinformation; and Legal Considerations.","https://www.nga.org/memos/covid-19-vaccine-considerations-mass-distribution/",,"Guideline/Assessment Tool","Direct link to document: https://www.nga.org/wp-content/uploads/2020/08/NGA-Memorandum-on-COVID-19-Vaccine-and-Mass-Distribution-Considerations.pdf","false","23361"
"23350","Considerations for the Provision of Essential Oral Health Services in the Context of COVID-19","World Health Organization","2020-08-03T00:00:00.000","PDF","The purpose of this five-page document is to address specific needs and considerations for essential oral health services in the context of COVID-19 in accordance with WHO operational guidance on maintaining essential health services.","https://www.who.int/publications/i/item/who-2019-nCoV-oral-health-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1289841/retrieve","false","23350"
"23349","Environmental Health Assessment Form for Disaster Shelters During COVID-19","Centers for Disease Control and Prevention","2020-08-03T00:00:00.000","PDF","The CDC’s Interim Guidance for General Population Shelters During COVID-19 provides guidelines with in-depth steps on how to prevent transmission of COVID-19 in general population shelters. The CDC recommends reviewing those guidelines in addition to using this four-page assessment form.","https://emergency.cdc.gov/shelterassessment/pdf/Shelter_Assessment_COVID_508.pdf",,"Guideline/Assessment Tool",,"false","23349"
"23307","Fact Sheet for Healthcare Providers: Emergency Use of Impella Left Ventricular Support Systems During the COVID-19 Outbreak","U.S. Food and Drug Administration","2020-08-03T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Impella Left Ventricular (LV) Support Systems. The Impella LV Support Systems are authorized for emergency use by healthcare providers (HCP) in the hospital setting for providing temporary LV unloading and support to treat critical care patients with confirmed COVID-19 infection who are undergoing extracorporeal membrane oxygenation (ECMO) treatment and who develop pulmonary edema while on veno-arterial (V-A) ECMO support or late cardiac decompensation from myocarditis while on veno-venous (V-V) ECMO support.","https://www.fda.gov/media/140763/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140764/downloadLink to Letter of Authorization: https://www.fda.gov/media/140762/downloadLink to three sets of Instructions for Use: https://www.fda.gov/media/140765/download; https://www.fda.gov/media/140766/download; https://www.fda.gov/media/140767/download","false","23307"
"23306","Fact Sheet for Healthcare Providers: Poplar SARS-CoV-2 TMA Pooling Assay","U.S. Food and Drug Administration","2020-08-03T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Poplar SARS-CoV-2 TMA Pooling assay. The Poplar SARS-CoV-2 TMA Pooling assay is authorized for use with certain respiratory specimens collected from individuals who are suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140790/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140791/downloadLink to Letter of Authorization: https://www.fda.gov/media/140789/downloadLink to EUA Summary: https://www.fda.gov/media/140792/download","false","23306"
"23305","Fact Sheet for Healthcare Providers: Cleveland Clinic SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-08-03T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Cleveland Clinic SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140786/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140787/downloadLink to Letter of Authorization: https://www.fda.gov/media/140785/downloadLink to EUA Summary: https://www.fda.gov/media/140788/download","false","23305"
"23304","Fact Sheet for Healthcare Providers: Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay","U.S. Food and Drug Administration","2020-08-03T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Ethos Laboratories SARS-CoV-2 MALDI-TOF Assay is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140778/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140779/downloadLink to Letter of Authorization: https://www.fda.gov/media/140777/downloadLink to EUA Summary: https://www.fda.gov/media/140780/downloadLink to Instructions for Use: https://www.fda.gov/media/140781/download","false","23304"
"23303","Fact Sheet for Healthcare Providers: Wren Laboratories COVID-19 PCR Test","U.S. Food and Drug Administration","2020-08-03T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Wren Laboratories COVID-19 PCR Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140774/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140775/downloadLink to Letter of Authorization: https://www.fda.gov/media/140773/downloadLink to EUA Summary: https://www.fda.gov/media/140776/download","false","23303"
"23289","Key Questions About Nursing Home Regulation and Oversight in the Wake of COVID-19","Henry J. Kaiser Family Foundation","2020-08-03T00:00:00.000","Text","This brief answers key questions about nursing home oversight and explains how federal policy has changed in light of COVID-19. While the pandemic has led to new federal guidance, funding, and reporting requirements, state survey agencies and nursing homes each may face issues related to funding, capacity, and data as the pandemic continues.","https://www.kff.org/coronavirus-covid-19/issue-brief/key-questions-about-nursing-home-regulation-and-oversight-in-the-wake-of-covid-19/","Musumeci, MaryBeth; Chidambaram, Priya","Report",,"false","23289"
"23280","Contact Tracing for COVID-19: Domestic Policy Issues","Congressional Research Service [Library of Congress]","2020-08-03T00:00:00.000","PDF","As the COVID-19 pandemic progresses, Congress may consider whether and how to guide U.S. contact tracing efforts. This three-page document discusses COVID-19-specific aspects of contact tracing, and issues for Congress to consider.","https://crsreports.congress.gov/product/pdf/IF/IF11609","Sekar, Kavya; Harris, Laurie","Report",,"false","23280"
"23279","Recommendations for Disaster Sheltering of Household Pets, Service Animals, and Support Animals during the COVID-19 Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-03T00:00:00.000","Text","The information on this web page is provided to assist emergency planners who may need to consider local conditions, statutory authorities, resources, agreements, and other critical factors to form the final plan for disaster sheltering of household pets, service animals, and support animals during the COVID-19 pandemic.","https://www.cdc.gov/coronavirus/2019-ncov/php/mass-animal-care.html",,"Guideline/Assessment Tool",,"false","23279"
"23264","COVID-19: An ACP Physician's Guide and Resources","American College of Physicians","2020-08-03T00:00:00.000","Text","This guide and its collected national resources support physicians as they respond to the COVID-19 pandemic. They include guidance about coronaviruses in general, and COVID-19 specifically.","https://assets.acponline.org/coronavirus/scormcontent/#/",,"Guideline/Assessment Tool",,"false","23264"
"23249","WHO COVID-19 Preparedness and Response Progress Report: 1 February to 30 June 2020","World Health Organization","2020-08-03T00:00:00.000","PDF","This 26-page report highlights the main points of progress that were made up to June 30, 2020, under the three objectives outlined in the COVID-19 Strategic Response and Preparedness Plan: scaling up international coordination and support; scaling up country preparedness and response by pillar; and accelerating research and innovation. The report also discusses some of the key challenges faced so far, and provides an update on the resource requirements for the next phase of WHO’s response as part of an unprecedented whole-of-UN approach to the pandemic.","https://www.who.int/publications/m/item/who-covid-19-preparedness-and-response-progress-report---1-february-to-30-june-2020",,"Report","Direct link to document: https://www.who.int/docs/default-source/coronaviruse/srp-covid-19-6month.pdf?sfvrsn=a7ac05b1_2&download=true","false","23249"
"3186","Preliminary Report on Case-based Analysis of Influenza A(H1N1) in EU (European Union) and EEA/EFTA (European Economic Area/European Free Trade Association) Countries","European Union, European Centre for Disease Prevention and Control","2009-06-06T00:00:00.000","PDF","This eight-page report contains statistics, graphs, and charts concerning cases of influenza A(H1N1) in EU and EEA/EFTA countries provided by the national contact points for surveillance and the Early Warning and Response System.","https://www.ecdc.europa.eu/en/publications-data/preliminary-report-case-based-analysis-influenza-ah1n1-eu-and-eeaefta-countries",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/media/en/publications/Publications/0906_SUR_Preliminary_report_on_case_based_analysis_of_influenza_AH1N1_in_EU_and_EEA_EFTA_countries.pdf","false","3186"
"21523","Screening Clients for COVID-19 at Homeless Shelters or Encampments","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-03T00:00:00.000","Text","This web page, updated on August 3, 2020, provides a simple screening tool that can be used to identify people with symptoms that indicate they might have a respiratory infection. Although not every person who has respiratory infection symptoms will have coronavirus disease 2019 (COVID-19), using this tool during community spread of COVID-19 may help separate those who are more likely to have COVID-19 from the general population at entry to a homeless shelter or other homeless service program.","https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/screening-clients-respiratory-infection-symptoms.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/screening-clients-respiratory-infection-symptoms.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/screening-clients-respiratory-infection-symptoms.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/screening-clients-respiratory-infection-symptoms.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/screening-clients-respiratory-infection-symptoms.html","false","21523"
"24185","Considerations on the Safe Use of UVC Radiation for Surface and Air Disinfection","American Industrial Hygiene Association","2020-08-01T00:00:00.000","PDF","This one-page fact sheet describes the safe use of UVC radiation for surface and air disinfection, and how studies have indicated that UV radiation also has the capability of killing SARS-CoV-2.","https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Public-Resources/UVC-RadiationInfographic_V6.pdf",,"Fact Sheet","Link to document in Spanish: https://aiha-assets.sfo2.digitaloceanspaces.com/AIHA/resources/Public-Resources/UVC-RadiationInfographic_Spanish.pdf","false","24185"
"24126","Preparation of Viral Transport Medium Standard Operating Procedure","Centers for Disease Control and Prevention","2020-08-01T00:00:00.000","PDF","Virus sample on a nasal swab might spoil if it is not kept in a special liquid that keeps it fresh and viable during transport on its way from the nose to a COVID-19 testing lab. The liquid is called viral transport medium (VTM), and in the pandemic, supplies of VTM have run low. These eight-page instructions for professionals to make VTM themselves, and many labs and hospitals have used the document to increase their supplies.","https://www.cdc.gov/coronavirus/2019-ncov/downloads/Viral-Transport-Medium.pdf",,"Guideline/Assessment Tool",,"false","24126"
"23821","COVID-19 Community Response: Emerging Themes Across Sentinel Communities","Robert Wood Johnson Foundation","2020-08-01T00:00:00.000","Text","The Sentinel Communities project described on this web page follows the experiences of nine diverse communities to understand how they are responding to and recovering from the COVID-19 crisis.","https://www.rwjf.org/en/library/interactives/covid-19-community-response--emerging-themes-across-sentinel-communities.html",,"Report",,"false","23821"
"23820","First Aid for Severe Trauma: Empowering High Schoolers to Respond to Traumatic Injuries","National Center for Disaster Medicine and Public Health [Uniformed Services University of the Health Sciences]","2020-08-01T00:00:00.000","Video or Multimedia","In partnership with the American Red Cross, the National Center for Disaster Medicine and Public Health is creating a curriculum geared toward high school students focusing on applying pressure to stop bleeding, communication in emergencies, situational awareness, and body positioning. This 31-minute video discusses the program.","https://www.youtube.com/watch?v=Z0UPDxfUsf8&feature=youtu.be","Levy, Matt; Gausche-Hill, Marianne; Neal, Matthew","Instructional/Training Material",,"false","23820"
"23815","Training, Evaluation, and Monitoring Guidance for Health Departments","Centers for Disease Control and Prevention","2020-08-01T00:00:00.000","PDF","Case investigation, a core activity in COVID-19 control, is crucial to an effective COVID-19 public health control program. As a management tool for quality assurance for case investigation, this 24-page document will help supervisors and training leads to effectively develop and assess Case Investigators’ interviewing skills.","https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/open-america/Training-Evaluation-and-Monitoring-Guidance-for-Health-Departments.pdf",,"Guideline/Assessment Tool",,"false","23815"
"23794","Monitoring and Evaluation Framework for the COVID-19 Response in the WHO African Region","World Health Organization, Regional Office for Africa","2020-08-01T00:00:00.000","PDF","This 27-page monitoring and evaluation framework targets ministries of health, WHO country offices, and the Regional Office, and aims to assess national, country, and regional response performance and progress, measured against country national plans, response efforts, and the broader WHO COVID-19 Strategic Preparedness and Response Plan.","https://apps.who.int/iris/handle/10665/334344",,"Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/334344/9789290234432-eng.pdf?sequence=1&isAllowed=yLink to resource in French: https://apps.who.int/iris/handle/10665/334343","false","23794"
"23722","Rapid Stocktake of Lessons Learnt and Good Practice in the Management of Local COVID-19 Outbreaks","United Kingdom Department of Health","2020-08-01T00:00:00.000","PDF","This 27-page report sets out learning and best practice drawn from Dame Mary Ney’s rapid stocktake of lessons learned from the Leicester City/Leicestershire experience of responding to a local surge in COVID-19 cases. The Leicester City/Leicestershire Intervention was the first of its type and commenced when some of the architecture for managing such an event was underdeveloped and had never been exercised.","https://www.gov.uk/government/publications/local-covid-19-outbreaks-lessons-learnt-and-good-practice","Ney, Mary","Report","Direct link to document: https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/924639/Local_COVID-19_outbreaks_lessons_learnt_and_good_practice.pdf","false","23722"
"23703","Tackling COVID-19 Pandemic through Integrating Digital Technology and Public Health","Rockefeller Foundation","2020-08-01T00:00:00.000","PDF","Through a combination of desktop research and key informant interviews used in this study, this 142-page report documents and analyses the impact and implications of the actions of the Chinese government and digital technology solutions during the COVID-19 pandemic. It offers an in-depth understanding of the actions and strategies implemented by the government, the roles digital technology played, the technologies used, and the impact made across six outbreak response categories.","https://www.rockefellerfoundation.org/report/tackling-covid-19-pandemic-through-integrating-digital-technology-and-public-health/",,"Report","Direct link to document: https://www.rockefellerfoundation.org/wp-content/uploads/2020/09/v7_RF-Final-Report_AHI_2020903_reduced.pdf","false","23703"
"23679","Remote Work and the Heterogeneous Impact of COVID-19 on Employment and Health","IZA Institute of Labor Economics","2020-08-01T00:00:00.000","PDF","This 35-page paper examines the impact of the COVID-19 pandemic on employment and respiratory health for remote workers (i.e., those who can work from home) and non-remote workers in the United States.","https://covid-19.iza.org/publications/dp13620/","Angelucci, Manuela; Angrisani, Marco; Bennett, Daniel; Kapteyn, Arie; Schaner, Simone","Report","Direct link to document: http://ftp.iza.org/dp13620.pdf","false","23679"
"23644","Methodology: COVID-19 Pandemic: Attacks on Health Care in 2020","Insecurity Insight","2020-08-01T00:00:00.000","PDF","This six-page document provides the definitions for the data used in the report on COVID-19 pandemic: Attacks on health care in 2020, and information on the methodology used  to  generate  the data.","http://insecurityinsight.org/wp-content/uploads/2020/08/Methodology-COVID-19-pandemic-Attacks-on-health-care-in-2020.pdf",,"Guideline/Assessment Tool",,"false","23644"
"23626","Childhood Traumatic Grief: Youth Information Sheet","National Child Traumatic Stress Network","2020-08-01T00:00:00.000","PDF","This two-page fact sheet offers information for youth to help them understand the differences between grief and traumatic grief, the signs and symptoms of traumatic grief in children and youth, and what to do to feel better.","https://www.nctsn.org/resources/childhood-traumatic-grief-youth-information-sheet",,"Fact Sheet","Direct link to document: https://www.nctsn.org/sites/default/files/resources/fact-sheet/childhood_traumatic_grief_youth_information_sheet.pdf","false","23626"
"23625","Childhood Traumatic Separation: Youth Information Sheet","National Child Traumatic Stress Network","2020-08-01T00:00:00.000","PDF","This two-page fact sheet provides information for youth about separation distress, when separation can be traumatic for children and youth, traumatic reactions to separation, and what to do to feel better.","https://www.nctsn.org/resources/childhood-traumatic-separation-youth-information-sheet",,"Fact Sheet","Direct link to document: https://www.nctsn.org/sites/default/files/resources/fact-sheet/childhood_traumatic_separation_youth_information_sheet.pdf","false","23625"
"23618","Supporting a Nation in Crisis: Solutions for Local Leaders to Improve Mental Health and Well-Being During and Post-COVID-19","Well Being Trust","2020-08-01T00:00:00.000","PDF","This 34-page action guide, published with the de Beaumont Foundation, is intended for local policymakers and civic institutions (e.g., universities, hospitals, and other organizations that play a vital role in their local communities and economies; chambers of commerce; philanthropies; and multi-sector collaboratives). It provides recommendations that can be implemented to address mental health in both the immediate response and recovery phases of the COVID-19 pandemic.","https://www.debeaumont.org/wp-content/uploads/2020/08/mental-health-action-guide.pdf","Bork, Rachel; Gendelman, Moriah","Report","Link to one-page summary: https://www.debeaumont.org/wp-content/uploads/2020/08/One-Pager.pdf","false","23618"
"23612","COVID-19: Ambulatory PPE","National Emerging Special Pathogens Training and Education Center","2020-08-01T00:00:00.000","Text","This web page provides links to documents and guidance about ambulatory personal protective equipment (PPE) for COVID-19.","https://repository.netecweb.org/exhibits/show/ppe-cons/ambulatory",,"Guideline/Assessment Tool",,"false","23612"
"23605","Fighting Compassion Fatigue During Public Health Epidemics","Association of State and Territorial Health Officials","2020-08-01T00:00:00.000","PDF","Compassion and empathy have been relentlessly challenged by multiple epidemics in the United States. This two-page brief examines the opioid overdose epidemic as a case study in compassion fatigue during public health epidemics.","https://www.astho.org/ASTHOBriefs/Fighting-Compassion-Fatigue-During-Public-Health-Epidemics/",,"Fact Sheet",,"false","23605"
"23594","Exploring the Impact of COVID-19 on Social Services for Vulnerable Populations in Los Angeles","RAND Corporation","2020-08-01T00:00:00.000","PDF","The authors of this 30-page report conducted semi-structured interviews with representatives from social services organizations in Los Angeles County to assess how these service providers are responding to COVID-19. The interviews also uncovered lessons learned and innovative strategies for dealing with the pandemic that could be more broadly disseminated. The authors recount these interviews and lessons learned, and provide recommendations for social services organizations.","https://www.rand.org/pubs/research_reports/RRA431-1.html","Holliday, Stephanie; Hunter, Sarah; Dopp, Alex; Chamberlin, Margaret; Iguchi, Martin","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/research_reports/RRA400/RRA431-1/RAND_RRA431-1.pdf","false","23594"
"23590","America at a Glance: Social Isolation and Loneliness During the First Wave of COVID-19","University of Montana","2020-08-01T00:00:00.000","PDF","To learn more about how COVID-19 and related responses (i.e., stay-at-home orders) may contribute to feelings of social isolation and loneliness among people with disabilities, this study, summarized in this eight-page document, compared data from two cross-sectional samples collected before and after the first wave of “stay-at-home” orders. Post-COVID rural and urban samples reported significantly more interactions with family and close friends.","https://scholarworks.umt.edu/ruralinst_health_wellness/50/","Ipsen, Catherine; Myers, Andrew; Smith, Lauren","Report","Direct link to document: https://scholarworks.umt.edu/cgi/viewcontent.cgi?article=1050&context=ruralinst_health_wellness","false","23590"
"23588","COVID-19 Testing Database","B.Next","2020-08-01T00:00:00.000","Text","This database is a tool for those who need to quickly obtain information about COVID-19 test kits and services for use in the United States. The database includes molecular tests that have received Emergency Use Authorization (EUA) from the Food and Drug Administration (FDA), whether they are kits that can be purchased by lab managers, or tests performed as a service by laboratories, whether sourced from manufacturers, or developed for their own use (so called “laboratory-developed tests”, or LDTs).","https://covidtestdb.com/",,"Database/Dataset","Link to background information: https://www.bnext.org/article/b-next-covid-19-test-database/","false","23588"
"23586","LabTrainingVR: Biosafety Cabinet Edition","Centers for Disease Control and Prevention","2020-08-01T00:00:00.000","Video or Multimedia","This course enables learners to apply knowledge and practice setting up a biosafety cabinet (also known as a biological safety cabinet, or BSC) in a virtual laboratory. Participants can step into a virtual laboratory and learn how to work safely in the first Centers for Disease Control and Prevention (CDC) virtual reality (VR) laboratory training course.","https://www.cdc.gov/labtraining/training-courses/vr/labtrainingVR_BSC.html",,"Instructional/Training Material","Site requires free registration.This training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/cdctrain/course/1091139/.","false","23586"
"23584","COVID-19","University of California, Davis","2020-08-01T00:00:00.000","PDF","This is a mixed-method, interviewer-administered tool to (1) identify barriers that WIC (Special Supplemental Nutrition Program for Women, Infants, and Children) participants in California are experiencing in using WIC food benefits (e.g., access to WIC-eligible foods); and (2) identify additional short-term unmet basic needs (e.g., food and housing insecurity, as well as access to unemployment benefits, healthcare, childcare, and social support while required to remain at home) of low-income families during the COVID-19 pandemic.Questions Adapted From: U.S. Household Food Security Survey Module, USDA ERS: Q43COVID-19 Community Outcomes (COCO) Needs Assessment, Stanford University: Q1, Q4The Epidemic Pandemic Impacts Inventory (EPII): Q10aPatient Health Questionnaire-2 (PHQ-2): Q48Population: Adults OnlyLength: 55 questionsTime to Complete: 30-35 minutesMode of Administration: TelephoneAdministered by: Professional InterviewerLanguage(s): English; SpanishCOVID-19 Documenting Challenges Faced by California Families with Children 0-5 Years Old on WIC: Full Questionnaire https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC.pdfCOVID Impacts: Diagnosis; Overall Impact https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Impacts.pdfWIC participation and enrollment: Federal Assistance https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Participation.pdfWIC services: Sources of information about COVID-19  https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Services.pdfShopping for WIC foods: Food Security https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Foods.pdfGeneral food shopping: Food Security; Dietary Intake https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_General_Food.pdfImmigration status: Personal Demographics https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Immigration.pdfMental health: General Mental Health https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Mental_Health.pdf COVID-19 Documenting Challenges Faced by California Families with Children 0-5 Years Old on WIC (Spanish): Full Questionniare https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Spanish.pdfCOVID Impacts (Spanish): Diagnosis; Overall Impact https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Impacts_Spanish.pdfWIC participation and enrollment (Spanish): Federal Assistance https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Participation_Spanish.pdfWIC services (Spanish): Sources of information about COVID-19 https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Services_Spanish.pdfShopping for WIC foods (Spanish): Food Security https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Foods_Spanish.pdfGeneral food shopping (Spanish): Food Security; Dietary Intake https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_General_Food_Spanish.pdfImmigration status (Spanish): Personal Demographics https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Immigration_Spanish.pdfMental health (Spanish): General Mental Health https://www.phenxtoolkit.org/toolkit_content/PDF/UCANR_WIC_Mental_Health_Spanish.pdf","https://www.nlm.nih.gov/dr2/WIC_COVID_Interview_guide_ENGLISH.pdf",,"Guideline/Assessment Tool","Free/Publicly AvailableLink to Spanish survey: https://www.nlm.nih.gov/dr2/WIC_COVID_Interview_Guide_SPANISH.pdfCitation(s):Ritchie, LD & Whaley, SE (2020). COVID-19: Documenting Challenges Faced by California Families with Children 0-5 Years Old on WIC.Available Formats: PDFContact Information: Lorrene Ritchie, PhD, RDDirector and Cooperative Extension Specialist, Nutrition Policy InstituteUniversity of California Division of Agriculture and Natural ResourcesEmail: lritchie@ucanr.edu","true","23584"
"23562","Views from the Big Cities: Webinar Series","Big Cities Health Coalition","2020-08-01T00:00:00.000","Video or Multimedia","This web page provides links to a series of webinars that share wisdom, experience, and lessons learned related to COVID-19 from communities that experienced the earliest and greatest impact of the pandemic.","https://www.bigcitieshealth.org/pandemic-response-webinars",,"Instructional/Training Material",,"false","23562"
"23561","Leadership Check-Up Series: Developing Your Resiliency as a Public Health Professional","Association of State and Territorial Health Officials","2020-08-01T00:00:00.000","Video or Multimedia","As the nation continues to struggle with COVID-19, public health professionals working on the front lines leading activities may be feeling angry, confused, stressed, and dismayed. Join national behavioral health and resilience experts for these 60-minute sessions of conversation, reflection, and nourishment to help professionals continue the vital work of responding to COVID-19 while better supporting their families, friends, co-workers, and communities.","https://www.astho.org/Events/Leadership-Check-Up-Series/",,"Instructional/Training Material","Link to recordings: https://www.youtube.com/playlist?list=PL-GVXxC1njCD1tXpDB1KNdKjeXU3v0Sne","false","23561"
"23558","School Attendance, Asthma and COVID-19: Considerations for School Nurses","National Association of School Nurses","2020-08-01T00:00:00.000","PDF","The purpose of this two-page document is to summarize current overall recommendations during the COVID-19 pandemic for students with asthma, which may be modified in the future as more is learned about COVID-19.","https://www.aaaai.org/Aaaai/media/MediaLibrary/PDF%20Documents/Libraries/SchoolAsthmaCovid_Final.pdf",,"Guideline/Assessment Tool",,"false","23558"
"23544","Long-Stay Mental Health Care Institutions and the COVID-19 Crisis","World Health Organization, Regional Office for Europe","2020-08-01T00:00:00.000","PDF","This 20-page report presents the results of a survey conducted by the Mental Health Programme, WHO Regional Office for Europe, with 169 long-stay institutions in the WHO European Region to assess the impact of the COVID-19 pandemic on services, staff, service users, and residents with psychosocial and intellectual disabilities.","https://www.euro.who.int/en/health-topics/noncommunicable-diseases/mental-health/publications/2020/long-stay-mental-health-care-institutions-and-the-covid-19-crisis-identifying-and-addressing-the-challenges-for-better-response-and-preparedness-2020",,"Report","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333964/WHO-EURO-2020-40745-54930-eng.pdf","false","23544"
"23542","Encouraging Participation and Cooperation in Contact Tracing: Lessons from Survey Research","National Academies Press","2020-08-01T00:00:00.000","Text","This 11-page report is intended to help decision-makers in local public health departments and local governments increase participation and cooperation in contact tracing related to COVID-19. It focuses on contact tracing methods that involve phone, text, or email interviews with people who have tested positive and with others they may have exposed to the virus.","https://www.nap.edu/catalog/25916/encouraging-participation-and-cooperation-in-contact-tracing-lessons-from-survey","Groves, Robert; Bassett, Mary; Hout, Michael","Report",,"false","23542"
"23541","Exchange Newsletter: Volume 1, Issue 11: Special Edition: COVID-19 Healthcare Lessons Learned","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-01T00:00:00.000","PDF","This 12-page issue of The Exchange from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides articles that highlight lessons learned (from the responder, practitioner, and planner perspectives) specific to COVID-19 patient surge; patient, caregiver, and provider behavioral health; operational considerations; and telehealth.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-the-exchange-issue11-final-508.pdf",,"Report",,"false","23541"
"23535","Coronavirus Victimization Distress Scale (CVDS)","Fordham University","2020-08-01T00:00:00.000","PDF","The Coronavirus Victimization Distress Scale (CVDS) is a brief self-report questionnaire developed by Fordham University's Center for Ethics Education and Applied Developmental Psychology Program as part of the Pathways to Health Study. The CVDS assesses bully and cyberbully victimization distress results from being viewed as having coronavirus. Questions include distress about being verbally and physically bullied, treated rudely or unfairly, verbally taunted in public, and cyberbullied because of coronavirus.Population: Adults and TeensEthnic/Religious GroupsSexual or Gender MinoritiesLength: 5 itemsTime to Complete: Less than 5 minutesMode of Administration: Online (e.g., computer-assisted interview)Administered by: Self AdministeredLanguage(s): English","https://www.fordham.edu/download/downloads/id/14918/coronavirus_covid-19_victimization_distress_scale_cvds.pdf",,"Guideline/Assessment Tool","Free/Publicly AvailableAvailable Formats: PDFContact Information:Celia B. Fisher, Ph.D.Center for Ethics EducationFordham UniversityEmail: Fisher@fordham.eduAdministrator: Lori MeroneEmail: lmerone@fordham.edu","true","23535"
"23534","Aid Worker Security Report 2020","Humanitarian Outcomes","2020-08-01T00:00:00.000","PDF","This 22-page annual Aid Worker Security Report focuses on humanitarians working in the health sector. It examines the data from 2019 on attacks against health workers, and discusses how the humanitarian sector is dealing with the new risks and disruptions caused by major epidemics occurring in contexts of broader complex emergency.","https://www.humanitarianoutcomes.org/AWSR2020","Stoddard, Abby; Harvey, Paul; Czwarno, Monica; Breckenridge, Meriah-Jo","Report","Direct link to document: https://www.humanitarianoutcomes.org/sites/default/files/publications/awsr2020_0.pdfLink to Figures at a Glance 2020: https://www.humanitarianoutcomes.org/publications/AWSDfigures2020","false","23534"
"23533","PPE CASE - Filtration Efficiency Performance of Non-NIOSH-Approved International Respiratory Protective Devices","National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention]","2020-08-01T00:00:00.000","PDF","This eight-page report summarizes the filtration performance results from the assessments that took place as a result of the initial Emergency Use Authorization (EUA) issued by the Food and Drug Administration (FDA), and discusses important considerations when purchasing non-NIOSH approved international respiratory devices temporarily authorized for occupational use in the United States.","https://www.cdc.gov/niosh/npptl/ppecase/PPE-CASE-P2020-0112.html","Andrews, A.; Powers, J.; Cichowicz, J.; Coffey, C.; Friese, M.L.","Report","Direct link to document: https://www.cdc.gov/niosh/npptl/ppecase/pdfs/PPE-CASE-P2020-0112-508.pdf","false","23533"
"23524","Returnee Migrants-Focused Rapid Assessment on Impacts of COVID-19 and Preparedness and Response Plans of Local Governments, Nepal","International Organization for Migration","2020-08-01T00:00:00.000","PDF","This 75-page rapid assessment on COVID-19 in Nepal was conducted through phone interviews and covered 730 municipalities of all 77 districts. The census survey was carried out with the objective of obtaining baseline information on returnee migrants, along with the challenges they could face in the public health and socio-economic spheres following the pandemic.","https://nepal.iom.int/sites/default/files/publication/FINAL_REPORT_IOM.pdf",,"Report",,"false","23524"
"23521","Manufacturing,  Supply Chain, and Drug and Biological Product Inspections During COVID-19 Public Health Emergency Questions and Answers","U.S. Food and Drug Administration","2020-08-01T00:00:00.000","PDF","This 12-page guidance provides answers to frequently asked questions about regulatory and policy issues related to inspections, pending drug applications, and changes in manufacturing facilities for approved pharmaceutical products during the COVID-19 epidemic.","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/manufacturing-supply-chain-and-drug-and-biological-product-inspections-during-covid-19-public-health",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/141312/download","false","23521"
"23509","Foundational Training for COVID-19 Responders","Public Health Foundation","2020-08-01T00:00:00.000","Video or Multimedia","This training plan provides foundational COVID-19 information for individuals assisting in the COVID-19 response. The plan includes required, recommended, and supplemental training. After completing this training, responders will be better prepared to receive specialized training required by the jurisdictions for the role they are serving (e.g., contact tracers, case investigators, epidemiologists, data analysts).","https://www.train.org/main/training_plan/4530",,"Instructional/Training Material","Site requires free registration.","false","23509"
"23500","Trauma-Informed, Recovery-Oriented System of Care Toolkit","Indiana Family and Social Services Administration","2020-08-01T00:00:00.000","PDF","This 151-page toolkit provides information, resources, and tools to guide implementation of Trauma-Informed, Recovery-Oriented Systems of Care (TI-ROSC) to best serve individuals with opioid use disorder (OUD) and other substance use disorders.","https://www.in.gov/fssa/dmha/files/TI-ROSC_Toolkit_Final_4.20_compressed.pdf",,"Guideline/Assessment Tool",,"false","23500"
"23497","COVID-19 Severity Classification Tool","American College of Emergency Physicians","2020-08-01T00:00:00.000","Text","ACEP and EvidenceCare created this seven-step triage process for emergency physicians to better classify COVID-19 patients and inform next steps. It classifies patients on a range from mild/low risk to critical, based on seven categories of measurement: assessing vital signs, a qCSI calculator, symptoms and risk factors, discharge home criteria, diagnostic testing and suggested labs, imaging and lab results, and the disposition.","https://covid19.evidence.care/dashboard/covid/pathway/198712647/-2018406099",,"Guideline/Assessment Tool","Link to summary document: https://www.acep.org/globalassets/sites/acep/media/covid-19-main/acep_evidencecare_covid19severitytool.pdf","false","23497"
"23493","COVID-19 Real-Time Learning Resource Center","Infectious Diseases Society of America","2020-08-01T00:00:00.000","Video or Multimedia","This curated COVID-19 resource center is updated daily to reflect rapidly emerging literature and multimedia resources. It provides must-have information to clinicians and decision-makers, including COVID-19 clinician calls in the Latest Media section.","https://www.idsociety.org/covid-19-real-time-learning-network/",,"Bibliography/Resource List",,"false","23493"
"23479","Heat and Health Tracker","Centers for Disease Control and Prevention","2020-08-01T00:00:00.000","Text","This tracker map provides local heat and health information so communities can better prepare for and respond to extreme heat events. The search function allows users to explore how extreme heat affects a specific county, populations that are at risk, and resources for response.","https://ephtracking.cdc.gov/Applications/heatTracker/",,"Guideline/Assessment Tool",,"false","23479"
"23478","Basic Microbiology","World Health Organization","2020-08-01T00:00:00.000","Video or Multimedia","In this course, participants will learn about how disease-causing microbes, called pathogens, are classified, identified and transmitted. Participants will be introduced to basic microbiological principles, fundamental laboratory diagnostics, and mechanisms by which microbes transmit and cause diseases.","https://openwho.org/courses/IPC-MICRO-EN",,"Instructional/Training Material","Site requires free registration.","false","23478"
"23461","National Crisis Support Hotlines and Directories: For Healthcare Workers Experiencing COVID-19-Related Stress and Burnout","U.S. Department of Health and Human Services","2020-08-01T00:00:00.000","PDF","This one-page document lists hotlines and directories to support healthcare workers experiencing COVID-19-related stress and burnout.","https://files.asprtracie.hhs.gov/documents/national-crisis-support-hotlines-and-directories-for-healthcare-workers-experiencing-covid-19-related-stress-and-burnout.pdf",,"Bibliography/Resource List",,"false","23461"
"23459","Topic Collection: COVID-19 Health Equity","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-08-01T00:00:00.000","Text","This collection from TRACIE (Technical Resources, Assistance Center, and Information Exchange) provides a set of resources on the topic of Health Equity and Health Disparities associated with the COVID-19 emergency. The collection includes but is not limited to a wide spectrum of topics ranging from cultural competency in the wake of a global pandemic and general guidance to mitigate racial and ethnic inequities in our healthcare system.","https://asprtracie.hhs.gov/technical-resources/145/covid-19-health-equity/99",,"Bibliography/Resource List",,"false","23459"
"23452","Assessing Legal Responses to COVID-19","American Public Health Association","2020-08-01T00:00:00.000","PDF","This 261-page collection of 36 expert assessments shows that the COVID-19 failure is, in important ways, also a legal failure. It offers more than 100 specific legal recommendations for the president and Congress, governors and state legislatures, and mayors and city councilors across the country. Sponsored by the de Beaumont Foundation and the American Public Health Association, the report was produced by Public Health Law Watch in cooperation with the Center for Public Health Law Research at Temple University Beasley School of Law, the Center for Health Policy and Law at Northeastern University, Wayne State University Law School, the Hall Center for Law and Health, the Network for Public Health Law, and ChangeLab Solutions.","https://static1.squarespace.com/static/5956e16e6b8f5b8c45f1c216/t/5f36c0702e9042616f13505c/1597423914220/COVID19PolicyPlaybook_Aug2020.pdf","Burris, Scott; de Gaia, Sarah; Levin, Donna; Parmet, Wendy; Terry, Nicholas","Report","Link to Summary of findings and recommendations for action: https://static1.squarespace.com/static/5956e16e6b8f5b8c45f1c216/t/5f33fcd1b1efb82ac2a50331/1597242577976/COVID19PolicyPlaybook_Aug2020-Summary.pdf","false","23452"
"23439","UCSF Collaborative to Advise on Re-opening Education Safely (CARES) Webinar Series","University of California, San Francisco","2020-08-01T00:00:00.000","Video or Multimedia","This web page provides information and links for a series of webinar conversations hosted by UCSF Benioff Children's Hospitals on the re-opening of schools during the COVID-19 pandemic.","https://coronavirus.ucsf.edu/cares",,"Instructional/Training Material",,"false","23439"
"23438","EMS COVID Resource Reporting Tool","National Highway Traffic Safety Administration, Office of Emergency Medical Services","2020-08-01T00:00:00.000","Text","This tool has been created to document, in one place, EMS agency personal protective equipment (PPE) needs and personnel shortages related to the COVID-19 crisis. Data collected will be used to communicate needs and critical information from the local agency to state and federal partners.","https://nemsis.org/ems-covid-resource-reporting-tool/",,"Guideline/Assessment Tool",,"false","23438"
"23428","2019 National Profile of Local Health Departments","National Association of County and City Health Officials","2020-08-01T00:00:00.000","PDF","This 147-page study summarizes the collection of data about local health department infrastructure and practice at the national level. It discusses how crises like the COVID-19 pandemic emphasize the need for timely information and data to support public health practice, especially at the local level, and how the pandemic has impacted local health departments.","https://www.naccho.org/uploads/downloadable-resources/Programs/Public-Health-Infrastructure/NACCHO_2019_Profile_final.pdf",,"Report",,"false","23428"
"23427","Framework for Equitable Allocation of Vaccine for the Novel Coronavirus","National Academies of Sciences, Engineering, and Medicine","2020-08-01T00:00:00.000","Text","This web page provides information and webinars from an ad hoc committee of the National Academies of Sciences, Engineering, and Medicine and the National Academy of Medicine, which will develop an overarching framework for vaccine allocation to assist policymakers in the domestic and global health communities in planning for equitable allocation of vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","https://www.nationalacademies.org/our-work/a-framework-for-equitable-allocation-of-vaccine-for-the-novel-coronavirus",,"Web Page","Link to Disaster Lit record for Framework for Equitable Allocation of COVID-19 Vaccine document: https://disasterinfo.nlm.nih.gov/search/id:24190","false","23427"
"23426","COVID-19 Rapid Needs Assessments","HelpAge International","2020-08-01T00:00:00.000","Text","This web page provides country COVID-19 Rapid Needs Assessments that contain key findings, observations, and a detailed analysis of the many challenges older people face as a result of COVID-19.","https://www.helpage.org/what-we-do/coronavirus-covid19/covid19-rapid-needs-assessment-rnas/",,"Report",,"false","23426"
"23421","Psychosocial Support for Older People in the Context of COVID-19","HelpAge International","2020-08-01T00:00:00.000","PDF","This 15-page document discusses how providing psychosocial support during the different phases of the COVID-19 crisis can help people cope better, including older people, their caregivers, and their families.","https://www.helpage.org/download/5efdb79f261e5/",,"Report",,"false","23421"
"23407","Harvard Dataverse: COVID-19 Research and Evaluations","Harvard University","2020-08-01T00:00:00.000","Text","This is a free data repository open to all researchers from any discipline, both inside and outside of the Harvard community, where they can share, archive, cite, access, and explore research data. Partnering with national health ministries and other government agencies in sub-Saharan Africa, South Asia, and Latin America, Population Council global and in-country scientists are conducting COVID-19 public health and social science research to produce relevant and timely evidence to support policymakers in controlling the spread of coronavirus, evaluating the effectiveness of prevention and mitigation measures, and assessing longer-term health, social, and economic effects of the pandemic.","https://dataverse.harvard.edu/dataverse/Covid19researchandevaluation",,"Database/Dataset",,"false","23407"
"23403","Guidelines for Tsunami Warning Services, Evacuation, and Sheltering during COVID-19","United Nations Educational, Scientific and Cultural Organization","2020-08-01T00:00:00.000","PDF","This four-page document is aimed at national authorities responsible for the organization of tsunami warning and emergency response. It clarifies the status of the regional tsunami services for the Indian Ocean and suggests best practices for national and local actions during the COVID-19 pandemic.","http://www.ioc-tsunami.org/components/com_oe/oe.php?task=download&id=45326&version=1.0&lang=1&format=1",,"Guideline/Assessment Tool",,"false","23403"
"23380","PPE (Personal Protective Equipment) (COVID-19) Use and Conservation","National Emerging Special Pathogens Training and Education Center","2020-08-01T00:00:00.000","Text","The resources on this web page reflect the current supply shortage in which masks, goggles, and face shields may be conserved during the COVID-19 pandemic. Flyers, PAPR and CAPR flyers, guides, videos, and checklists are provided, with additional materials to be added in the future.","https://repository.netecweb.org/exhibits/show/ppe-cons/ppe-cons",,"Guideline/Assessment Tool",,"false","23380"
"23373","Vaccine Access and Hesitancy: Part One of a Workshop Series","National Academies Press","2020-08-01T00:00:00.000","Text","This five-page publication summarizes the presentations and discussions from a workshop, the first in a series on the topic of vaccine access and vaccine hesitancy, held via Zoom on May 28, 2020. The remaining meetings are scheduled for August 17–20, 2020. The coronavirus pandemic made clear that people want scientific information, but many distrust it at the same time, making questions of vaccine hesitancy even more prominent.","https://www.nap.edu/catalog/25895/vaccine-access-and-hesitancy-part-one-of-a-workshop-series",,"Conference/Meeting Material",,"false","23373"
"23372","Mass Attacks in Public Spaces – 2019","U.S. Department of Homeland Security","2020-08-01T00:00:00.000","PDF","This 36-page report examines 34 targeted attacks that occurred in public or semi-public spaces (e.g., schools, places of business, houses of worship, open spaces) from January through December 2019. It is the agency’s third in a series of annual reports that have examined mass attacks in the United States, during which three or more individuals were harmed.","https://www.secretservice.gov/data/protection/ntac/MAPS2019.pdf","Alathari, Lina; Drysdale, Diana; Blair, Ashley; Carlock, Arna; Cotkin, Aaron","Report",,"false","23372"
"23370","Exploring the Frontiers of Innovation to Tackle Microbial Threats","National Academies Press","2020-08-01T00:00:00.000","Text","This 158-page publication summarizes the presentations and discussions from a workshop held on December 4-5, 2019, that examined major advances in scientific, technological, and social innovations against microbial threats. Such innovations include diagnostics, vaccines (both development and production), and antimicrobials, as well as non-pharmaceutical interventions and changes in surveillance.","https://www.nap.edu/catalog/25746/exploring-the-frontiers-of-innovation-to-tackle-microbial-threats-proceedings",,"Conference/Meeting Material","This text is also available from the National Library of Medicine Bookshelf at https://www.ncbi.nlm.nih.gov/books/NBK560433/.","false","23370"
"23366","NIEHS Worker Training Program COVID-19 Webinars and Presentations","National Institute of Environmental Health Sciences [National Institutes of Health]","2020-08-01T00:00:00.000","Video or Multimedia","In response to COVID-19, the National Institute of Environmental Health Sciences (NIEHS) Worker Training Program (WTP) has been conducting these webinars and presentations on technical topics related to COVID-19, with a focus on protecting workers who may be at risk of exposure to COVID-19.","https://tools.niehs.nih.gov/wetp/index.cfm?id=2592",,"Instructional/Training Material","Link to related flyer: https://tools.niehs.nih.gov/wetp/public/hasl_get_blob.cfm?ID=12185","false","23366"
"23364","Contact Tracing Resources for COVID-19 Response","National Association of County and City Health Officials","2020-08-01T00:00:00.000","Text","This web page highlights the most useful resources from governmental public health, academia, think tanks, and nonprofits to support local health departments in designing, establishing, scaling up, and strengthening COVID-19 contact tracing programs.","https://www.naccho.org/programs/our-covid-19-response/contact-tracing-resources-for-covid19-response",,"Web Page",,"false","23364"
"23346","Frequently Asked Questions: COVID-19 Testing at Skilled Nursing Facilities/ Nursing Homes","Centers for Medicare & Medicaid Services","2020-08-01T00:00:00.000","PDF","This eight-page document provides answers to 27 frequently asked questions about COVID-19 testing at skilled nursing facilities and nursing homes.","https://www.cms.gov/files/document/covid-faqs-snf-testing.pdf",,"Fact Sheet",,"false","23346"
"23334","COVID-19 Event Risk Assessment Planning Tool","Georgia Institute of Technology","2020-08-01T00:00:00.000","Text","This web page provides interactive context in a map to assess the risk that one or more individuals infected with COVID-19 are present in an event of various sizes. The model is simple and provides some context for the rationale to halt large gatherings in early-mid March and newly relevant context for considering when and how to re-open.","https://covid19risk.biosci.gatech.edu/","Chande, A.T.; Gussler, W.; Harris, M.; Lee, S.; Rishishwar, L.","Guideline/Assessment Tool",,"false","23334"
"3146","Anthrax Vaccine","Military Vaccine Agency","2009-06-06T00:00:00.000","Video or Multimedia","This is a presentation on the Anthrax Vaccine Immunization Program that contains information on current policy, the threat, the disease and the vaccine, dosage schedule and route of administration, exemptions, adverse reactions, storage and handling of the vaccine, and documentation. This briefing can be viewed as a guest or for credit by health care providers.","http://www.vaccines.mil/AdobeConnect/MultimediaDetails.aspx?SCO-ID=785476&GroupID=70163",,"Conference/Meeting Material","This link is no longer available. 10/12/2016.","false","3146"
"23328","2020 Emergency Response Guidebook","U.S. Department of Transportation, Pipeline and Hazardous Materials Safety Administration","2020-08-01T00:00:00.000","PDF","This 396-page guidebook provides first responders with a go-to manual to help deal with hazmat transportation accidents during the critical first 30 minutes. It provides a flow chart for how to use the guidebook in an incident, and detailed chapters to help quickly identify emergency response procedures.","https://www.phmsa.dot.gov/hazmat/erg/emergency-response-guidebook-erg",,"Guideline/Assessment Tool","Direct link to document: https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/2020-08/ERG2020-WEB.pdfLink to mobile apps: https://www.phmsa.dot.gov/hazmat/erg/erg2020-mobileappLink to document in French: https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/2020-07/GMU2020-WEB.pdfLink to document in Spanish: https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/2020-07/GRE2020-WEB.pdfLink to data files in English, French, and Spanish: https://www.phmsa.dot.gov/hazmat/erg/erg-data-filesLink to tutorial video: https://www.youtube.com/watch?v=WCpr4XmhrssLink to 2020 Windows software: https://www.phmsa.dot.gov/hazmat/erg/erg2020-windows-softwareLink to Changes from 2016 Guide: https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/docs/Summary_changes_ERG2016.pdf","false","23328"
"23298","Natural Disasters 2019","Centre for Research on the Epidemiology of Disasters, a WHO Collaborating Centre","2020-08-01T00:00:00.000","PDF","This eight-page report provides information about the 396 natural disasters that occurred in 2019 and were recorded in the Emergency Events Database (EM-DAT), with 11,755 deaths, 95 million people affected, and $103 billion in economic losses across the world.","https://cred.be:443/downloadFile.php?file=sites/default/files/adsr_2019.pdf","Below, Regina; Wathelet, Valentin; Froment, Remi","Report",,"false","23298"
"23287","Rural Healthcare Surge Readiness","Health Resources and Services Administration","2020-08-01T00:00:00.000","Text","The Federal Healthcare Resilience Working Group has developed this web portal, a collection of essential rural healthcare resources, tools, and trainings that healthcare workers and organizations – including EMS and 9-1-1, inpatient and hospital care, ambulatory care, and long-term care – can utilize to prepare for and respond to COVID-19. This one-stop shop for rural healthcare lets users quickly find the information they need to prepare for or respond to surge events, navigate financial challenges related to the pandemic, and enhance their capacity and capability to provide lifesaving care to Americans who live in rural areas across the country.","https://www.ruralhealthinfo.org/healthcare-surge-readiness",,"Website",,"false","23287"
"23265","Statement on the Fourth Meeting of the International Health Regulations (2005) Emergency Committee Regarding the Outbreak of Coronavirus Disease (COVID-19)","World Health Organization","2020-08-01T00:00:00.000","Text","This report summarizes the fourth meeting of the Emergency Committee convened by the WHO Director-General under the International Health Regulations (IHR) (2005) regarding the coronavirus disease (COVID-19), which took place on July 31, 2020. Recommendations for state parties include sharing best practices, including from intra-action reviews, with WHO; and applying lessons learned from countries that are successfully re-opening their societies (including businesses, schools, and other services) and mitigating resurgence of COVID-19.","https://www.who.int/news/item/01-08-2020-statement-on-the-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)",,"Conference/Meeting Material","Link to statement in Arabic: https://www.who.int/ar/news/item/11-12-1441-statement-on-the-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)Link to statement in Chinese: https://www.who.int/zh/news/item/01-08-2020-statement-on-the-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)Link to statement in French: https://www.who.int/fr/news/item/01-08-2020-statement-on-the-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)Link to statement in Russian: https://www.who.int/ru/news/item/01-08-2020-statement-on-the-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)Link to statement in Spanish: https://www.who.int/es/news/item/01-08-2020-statement-on-the-fourth-meeting-of-the-international-health-regulations-(2005)-emergency-committee-regarding-the-outbreak-of-coronavirus-disease-(covid-19)","false","23265"
"23141","Interim Guidance for Use of Pooling Procedures in SARS-CoV-2 Diagnostic, Screening, and Surveillance Testing","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-01T00:00:00.000","Text","This web page, updated on August 1, 2020, provides guidance on Definitions of Diagnostic, Screening, and Surveillance Testing for SARS-CoV-2;  Diagnostic or Screening Testing Using a Pooling Strategy; Surveillance Testing Using a Pooling Strategy; and Summary Tables.","https://www.cdc.gov/coronavirus/2019-ncov/lab/pooling-procedures.html",,"Guideline/Assessment Tool",,"false","23141"
"22627","Guidance on HIPAA and Contacting Former COVID-19 Patients about Blood and Plasma Donation","U.S. Department of Health and Human Services","2020-08-01T00:00:00.000","PDF","This two-page document, updated in August 2020, details how a covered health care provider may use protected health information to identify patients who have recovered from COVID-19 to provide them with information about how they can donate their blood and plasma containing antibodies to the virus that causes COVID-19, to help treat other patients with COVID-19.","https://www.hhs.gov/sites/default/files/guidance-on-hipaa-and-contacting-former-covid-19-patients-about-plasma-donation.pdf",,"Guideline/Assessment Tool",,"false","22627"
"22330","Interim Guidelines for COVID-19 Antibody Testing","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-01T00:00:00.000","Text","This web page, updated on August 1, 2020, provides guidelines for COVID-19 antibody testing, under these topics: Background, Development of Antibodies and Immunity, Current Status of Antibody Testing in the United States, Types of Antibody Testing, Optimizing Testing Outcomes, Limitations, and Recommendations for Use.","https://www.cdc.gov/coronavirus/2019-ncov/lab/resources/antibody-tests-guidelines.html",,"Guideline/Assessment Tool",,"false","22330"
"21517","Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products","U.S. Food and Drug Administration","2020-08-01T00:00:00.000","PDF","This 21-page revised guidance document, updated in August 2020, provides blood establishments that collect blood or blood components, including Source Plasma, with the Food and Drug Administration’s revised donor deferral recommendations for individuals with increased risk for transmitting human immunodeficiency virus (HIV) infection. There is a significant shortage in the supply of blood in the United States, which early implementation of the recommendations in this guidance may help to address (even though the recommendations in this guidance are broadly applicable beyond the COVID-19 public health emergency).","https://www.fda.gov/regulatory-information/search-fda-guidance-documents/revised-recommendations-reducing-risk-human-immunodeficiency-virus-transmission-blood-and-blood",,"Guideline/Assessment Tool","Direct link to document: https://www.fda.gov/media/92490/download","false","21517"
"21304","Interim Guidance on Unsheltered Homelessness and Coronavirus Disease 2019 (COVID-19) for Homeless Service Providers and Local Officials","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-08-01T00:00:00.000","Text","This guidance, updated on August 1, 2020, is intended to provide key actions that local and state health departments, homelessness service systems, housing authorities, emergency planners, healthcare facilities, and homeless outreach services can take to protect people experiencing homelessness from the spread of COVID-19 (coronavirus).","https://www.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/unsheltered-homelessness.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/unsheltered-homelessness.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/unsheltered-homelessness.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/unsheltered-homelessness.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/homeless-shelters/unsheltered-homelessness.html","false","21304"
"24130","Strategies for COVID-19 Response for Populations Receiving Long-Term Care","National Governors Association","2020-07-31T00:00:00.000","PDF","This 12-page document provides key considerations for governors and state leaders as they develop strategies during the COVID-19 pandemic to protect the health and well-being of individuals receiving long-term care. It includes a high-level review of considerations for governors; a detailed briefing of considerations and related state examples; and an appendix with quick links to additional resources, including relevant federal guidance.","https://www.nga.org/memos/strategies-covid-19-response-long-term-care/",,"Guideline/Assessment Tool","Direct link to document: https://www.nga.org/wp-content/uploads/2020/06/Strategies-for-COVID-19-Response-for-Populations-Receiving-Long-Term-Care.pdf","false","24130"
"23314","REaL Data Collection, Stratification and Utilization in Response to COVID-19","American Hospital Association","2020-07-31T00:00:00.000","Video or Multimedia","Speakers in this 50-minute webinar share strategies on leveraging race, ethnicity and language (REaL) data collection, stratification, and utilization during the COVID-19 pandemic.","https://www.youtube.com/watch?v=LQ7zBw4jnFQ&feature=youtu.be","Mieres, Jennifer; Wright, Michael","Instructional/Training Material",,"false","23314"
"23269","Letter of Authorization: UCSD RC SARS-CoV-2 Assay; University of California San Diego Health","U.S. Food and Drug Administration","2020-07-31T00:00:00.000","PDF","This eight-page letter details the Emergency Use Authorization (EUA) for the UCSD RC SARS-CoV-2 Assay for qualitative detection of nucleic acid from SARS-CoV-2 in clinician-instructed self-collected nasal swab specimens (collected on site), and clinician-collected upper respiratory specimens (nasopharyngeal, mid-turbinate, anterior nares or oropharyngeal swab specimens) collected from individuals suspected of COVID-19 by their healthcare provider. This test is also for the qualitative detection of nucleic acid from the SARS-CoV-2 in pooled samples.","https://www.fda.gov/media/140714/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140715/downloadLink to EUA Summary: https://www.fda.gov/media/140712/download","false","23269"
"23268","Fact Sheet for Healthcare Providers: SARS-CoV-2 Test Kit (Real-time PCR)","U.S. Food and Drug Administration","2020-07-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the SARS-CoV-2 Test Kit (Real-time PCR). The SARS-CoV-2 Test Kit (Real-time PCR) is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140716/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140719/downloadLink to Letter of Authorization: https://www.fda.gov/media/140718/downloadLink to Instructions for Use: https://www.fda.gov/media/140717/download","false","23268"
"23267","Fact Sheet for Healthcare Providers: ADVIA Centaur® SARS-CoV-2 IgG (COV2G)","U.S. Food and Drug Administration","2020-07-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the ADVIA Centaur® SARS-CoV-2 IgG (COV2G) assay. The ADVIA Centaur® SARS-CoV-2 IgG (COV2G) assay is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (potassium EDTA and lithium heparin).","https://www.fda.gov/media/140702/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140705/downloadLink to Letter of Authorization: https://www.fda.gov/media/140703/downloadLink to Instructions for Use: https://www.fda.gov/media/140704/download","false","23267"
"23266","Fact Sheet for Healthcare Providers: Atellica® IM SARS-CoV-2 IgG (COV2G)","U.S. Food and Drug Administration","2020-07-31T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Atellica® IM SARS-CoV-2 IgG (COV2G) assay. The Atellica® IM SARS-CoV-2 IgG (COV2G) assay is authorized for the detection of antibodies to SARS-CoV-2 in human serum and plasma (potassium EDTA and lithium heparin).","https://www.fda.gov/media/140698/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140701/downloadLink to Letter of Authorization: https://www.fda.gov/media/140700/downloadLink to Instructions for Use: https://www.fda.gov/media/140699/download","false","23266"
"23257","Coronavirus Disease (COVID-19) Toolkit for People Experiencing Homelessness","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-31T00:00:00.000","Text","This web page provides COVID-19 guidance and tools to help homeless service providers make decisions and protect and communicate with staff and with people who are experiencing homelessness.","https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/people-experiencing-homelessness.html",,"Guideline/Assessment Tool",,"false","23257"
"23239","Urgent Need for a National Plan to Contain the Coronavirus","U.S. House of Representatives, Committee on Oversight and Reform","2020-07-31T00:00:00.000","Video or Multimedia","This three-hour, 30-minute Congressional hearing of the House Select Subcommittee on the Coronavirus Crisis examines the urgent need for a national comprehensive plan to address the coronavirus pandemic with three key officials leading the response. The hearing discusses how to identify and correct past failures, and what steps need to be taken from now on.","https://coronavirus.house.gov/subcommittee-activity/hearings/hybrid-hearing-urgent-need-national-plan-contain-coronavirus","Clyburn, James; Fauci, Anthony S.; Redfield, Robert; Giroir, Brett","Hearing/Testimony",,"false","23239"
"23229","Draft Landscape of COVID-19 Candidate Vaccines","World Health Organization","2020-07-31T00:00:00.000","PDF","This nine-page document provides details about 26 COVID-19 candidate vaccines in clinical evaluation. Inclusion of any particular product or entity in any of these landscape documents does not constitute, and shall not be deemed or construed as, any approval or endorsement by WHO of such product or entity (or any of its businesses or activities).","https://www.who.int/publications/m/item/draft-landscape-of-covid-19-candidate-vaccines",,"Report","Direct link to document: https://www.who.int/docs/default-source/coronaviruse/novel-coronavirus-landscape-covid-19cc0e97e4ea1b4458a05bbd6f5ac6d3fe.pdf?sfvrsn=5c754439_3&download=true","false","23229"
"22984","COVID-19 One-Stop Shop Toolkits","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-31T00:00:00.000","Text","This web page, updated on July 31, 2020, provides COVID-19 videos, social media, PSAs, print resources, checklists, FAQs, and web resources, with tabs for communicating with 18 different audiences.","https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/index.html",,"Guideline/Assessment Tool",,"false","22984"
"22714","Coronavirus (COVID-19): Personal Protective Equipment (PPE) Hub","United Kingdom Department of Health","2020-07-31T00:00:00.000","Text","This guidance, updated on July 31, 2020, contains information on personal protective equipment (PPE), and infection prevention and control (IPC).","https://www.gov.uk/government/collections/coronavirus-covid-19-personal-protective-equipment-ppe",,"Guideline/Assessment Tool",,"false","22714"
"24083","COVID-19 Contact Tracing","South University","2020-07-30T00:00:00.000","Video or Multimedia","This course consists of six learning modules that cover an overview of COVID-19, the role of public health in pandemics, how ethics and effective communication play a part in contact tracing, and steps to investigate cases and trace contacts. Each module concludes with a brief knowledge check, and the course concludes with a culminating assessment.","https://southucc.brightspace.com/course/2/covid-19-contact-tracing-course",,"Instructional/Training Material","Site requires free registration.This training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092698.","false","24083"
"23526","Considerations for School Nurses When Providing Virtual Care","National Association of School Nurses","2020-07-30T00:00:00.000","PDF","This four-page document describes tools and resources for school nurses to consider when delivering direct care to students via live audio-visual technology. Direct care is defined as a service provided by a licensed school nurse, such as attending to identified health needs, providing treatments and medications, as well as care provided under the supervision of a school nurse.","https://higherlogicdownload.s3.amazonaws.com/NASN/3870c72d-fff9-4ed7-833f-215de278d256/UploadedImages/PDFs/2020_05_13_Considerations_for_School_Nurses_When_Providing_Virtual_Care.pdf",,"Guideline/Assessment Tool",,"false","23526"
"23525","Return to School Post COVID-19 Closure Considerations for Students with Disabilities and Special Healthcare Needs","National Association of School Nurses","2020-07-30T00:00:00.000","PDF","The purpose of this eight-page document is to guide school nurses when planning for return to school for students with disabilities and special healthcare needs (D/SHN) as defined by Section 504 or Individual Education Program (IEP) teams.","https://higherlogicdownload.s3.amazonaws.com/NASN/3870c72d-fff9-4ed7-833f-215de278d256/UploadedImages/PDFs/2020_07_23_Considerations_for_Post_COVID_Return_to_School_for_Students_with_Disabilities_and_Special_Healthcare_Needs.pdf",,"Guideline/Assessment Tool",,"false","23525"
"23494","UK Biobank COVID-19 Antibody Study: Round 1 Results","United Kingdom Department of Health","2020-07-30T00:00:00.000","Text","This web page reports on an antibody study, undertaken by UK Biobank, to help understand the extent of previous infection with SARS-CoV-2 in different populations across the UK and whether they persist over time.","https://www.gov.uk/government/publications/uk-biobank-covid-19-seroprevalence-study-round-1-results/uk-biobank-covid-19-seroprevalence-study-round-1-results",,"Report",,"false","23494"
"23420","Ending the Triple Pandemic: Advancing Racial Equity by Promoting Health, Economic Opportunity and Criminal Justice Reform","Dialogue4Health","2020-07-30T00:00:00.000","Video or Multimedia","This one-hour, 27-minute Congressional briefing features presenters from Trust for America’s Health, American Public Health Association, NAACP, the National Black Nurses Association, the National Collaborative for Health Equity, and the National Medical Association, who discuss the disproportionate health and economic impacts of the COVID-19 pandemic on the Black community and other communities of color, and how structural racism drives systemic inequities in health, the economy, and criminal justice.","http://www.dialogue4health.org/web-forums/detail/ending-the-triple-pandemic-advancing-racial-equity","Kelly, Robin; Jones, Camara; Johnson, Derrick; Logan, Trevon","Instructional/Training Material",,"false","23420"
"23270","Fact Sheet for Healthcare Providers: CRL Rapid Response; Clinical Reference Laboratory, Inc.","U.S. Food and Drug Administration","2020-07-30T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the CRL Rapid Response test, which includes the DNA Genotek OMNIgene ORAL OM-505 collection device, that has been authorized for emergency use with saliva specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140662/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140665/downloadLink to Letter of Authorization: https://www.fda.gov/media/140664/downloadLink to EUA Summary: https://www.fda.gov/media/140661/downloadLink to Instructions for Use (Home Collect): https://www.fda.gov/media/140663/download","false","23270"
"23248","Critical Care Workforce and COVID-19: A State-by-State Analysis","Henry J. Kaiser Family Foundation","2020-07-30T00:00:00.000","Text","There is concern that the availability of medical personnel capable of providing intensive care could be a limiting factor in the care of COVID-19 patients. This Data Note reports baseline estimates of the number of active critical care physicians and nurses in each state relative to state population.","https://www.kff.org/coronavirus-covid-19/issue-brief/the-critical-care-workforce-and-covid-19-a-state-by-state-analysis/","Lopez, Eric","Report",,"false","23248"
"23236","Health and the Economy: A Convergence Needed to Address COVID-19 and Retake the Path of Sustainable Development in Latin America and the Caribbean","World Health Organization, Pan American Health Organization","2020-07-30T00:00:00.000","PDF","This 24-page joint report by the Economic Commission for Latin America and the Caribbean (ECLAC) and the Pan American Health Organization (PAHO) is issued at a time when several Latin American countries have become the epicenter of the coronavirus disease (COVID-19) pandemic. The main conclusion of this report is that if the pandemic transmission curve is not brought under control, the countries’ economies will be unable to recover.","https://iris.paho.org/handle/10665.2/52535",,"Report","Direct link to document: https://iris.paho.org/bitstream/handle/10665.2/52535/PAHOHSSCOVID-19200027_eng.pdf?sequence=5&isAllowed=yLink to resource in Spanish: https://iris.paho.org/handle/10665.2/52536","false","23236"
"23228","Public Health Considerations While Resuming International Travel","World Health Organization","2020-07-30T00:00:00.000","Text","The objective of this guidance is to provide governments, health authorities of WHO Member States, and relevant stakeholders with elements to consider in adjusting international travel measures to the changing epidemiological situation of the COVID-19 pandemic, national public health and health service capacity available in countries, and evolving understanding of the virus.","https://www.who.int/news-room/articles-detail/public-health-considerations-while-resuming-international-travel",,"Guideline/Assessment Tool",,"false","23228"
"23217","COVID-19: Data Quality and Considerations for Modeling and Analysis","U.S. Government Accountability Office","2020-07-30T00:00:00.000","PDF","This 49-page technology assessment examines collection methods and limitations of COVID-19 surveillance data reported by the Centers for Disease Control and Prevention (CDC); approaches for analyzing COVID-19 data; and uses and limitations of forecast modeling for understanding COVID-19.","https://www.gao.gov/products/GAO-20-635SP","Persons, Timothy; Moessbauer, SaraAnn; Denigan-Macauley, Mary","Report","Direct link to document: https://www.gao.gov/assets/710/708527.pdf","false","23217"
"21880","Coronavirus Disease 2019 (COVID-19) Treatment Guidelines","National Institutes of Health","2020-07-30T00:00:00.000","Text","A panel of U.S. physicians, statisticians, and other experts has developed these treatment guidelines for coronavirus disease 2019 (COVID-19), updated on July 30, 2020. The 205-page guidelines consider two broad categories of therapies currently in use by healthcare providers for COVID-19: antivirals, which may target the coronavirus directly, and host modifiers and immune-based therapies, which may influence the immune response to the virus or target the virus. The guidelines provide background information about each agent—such as clinical data about its use, ongoing clinical trials, and known interactions with other drugs—that forms the basis for the recommendation.","https://www.covid19treatmentguidelines.nih.gov/",,"Guideline/Assessment Tool","Direct link to document: https://files.covid19treatmentguidelines.nih.gov/guidelines/covid19treatmentguidelines.pdf","false","21880"
"23947","Responding to the Impact of COVID-19 on Refugees","Johns Hopkins University, Bloomberg School of Public Health","2020-07-29T00:00:00.000","Video or Multimedia","In this one-hour webinar, disease modeling and humanitarian health experts at Johns Hopkins University discuss what impact COVID-19 will have in terms of infections and outcomes in refugee camps, and the response needed to protect children with routine immunizations and a potential COVID-19 vaccine.","https://www.jhsph.edu/ivac/2020/07/15/webinar-responding-to-the-impact-of-covid-19-on-refugees/","Truelove, Shaun; Spiegel, Paul","Instructional/Training Material","Link to presentation slides: https://www.jhsph.edu/ivac/wp-content/uploads/2020/07/Slides_Responding-to-the-Impact-of-COVID-19-on-Refugees.pdf","false","23947"
"23431","Guidance on Federal Health Privacy Laws for Behavioral Health Practitioners and Peer Support Specialists for Virtual Service Delivery during COVID-19","Mountain Plains Addiction Technology Transfer Center Network","2020-07-29T00:00:00.000","Video or Multimedia","This one-hour, 14-minute webinar features speakers who provide information regarding the COVID-19 pandemic and HIPAA, 42 CFR Part 2, and the CARES Act as it relates to virtual services. Participants will be introduced to the tip sheets and technical assistance services provided by the  Center of Excellence for Protected Health Information.","https://attcnetwork.org/centers/mountain-plains-attc/product/guidance-federal-health-privacy-laws-behavioral-health","Khaikin, Christine; Waterman, Caroline; Seitz, Jacqueline; Graziano, Michael","Instructional/Training Material",,"false","23431"
"23417","What Do We Know About Children and Coronavirus Transmission?","Henry J. Kaiser Family Foundation","2020-07-29T00:00:00.000","Text","This review of the latest available data indicates that, while children who are infected with COVID-19 are more likely to be asymptomatic and less likely to experience severe disease (though a small subset become quite sick), they are capable of transmitting to both children and adults.","https://www.kff.org/coronavirus-covid-19/issue-brief/what-do-we-know-about-children-and-coronavirus-transmission/","Michaud, Josh; Kates, Jennifer","Report",,"false","23417"
"23327","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: COVID-19 and Skilled Nursing Facility Lessons Learned","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-07-29T00:00:00.000","PDF","This two-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange) responds to a request for resources that highlight lessons learned from skilled nursing facilities (SNFs) during the COVID-19 pandemic.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta---covid-19-skilled-nursing-facility-lessons-learned---7-29-2020.pdf",,"Bibliography/Resource List",,"false","23327"
"23293","Experiences of Community Health Centers in Expanding Telemedicine","RAND Corporation","2020-07-29T00:00:00.000","PDF","Safety-net medical providers can substantially increase their telemedicine services with modest investments in new staff and technology, a move that can help them expand patients' access to specialized medical care, according to this 60-page study. The findings in the report are relevant to health centers that are trying to rapidly expand telemedicine in response to the COVID-19 pandemic.","https://www.rand.org/pubs/research_reports/RRA100-1.html","Uscher-Pines, Lori ; Sousa, Jessica; Palimaru, Alina; Zocchi, Mark; Kapinos, Kandice","Report","Direct link to document: https://www.rand.org/content/dam/rand/pubs/research_reports/RRA100/RRA100-1/RAND_RRA100-1.pdf","false","23293"
"23235","Q&A: Ventilation and Air Conditioning in Public Spaces and Buildings and COVID-19","World Health Organization","2020-07-29T00:00:00.000","Text","This web page provides answers to questions about ventilation in the context of COVID-19, including what steps can be undertaken to improve the ventilation in indoor public spaces and buildings.","https://www.who.int/emergencies/diseases/novel-coronavirus-2019/question-and-answers-hub/q-a-detail/q-a-ventilation-and-air-conditioning-in-public-spaces-and-buildings-and-covid-19",,"Fact Sheet",,"false","23235"
"23230","Survey Tool and Guidance: Rapid, Simple, Flexible Behavioural Insights on COVID-19","World Health Organization, Regional Office for Europe","2020-07-29T00:00:00.000","PDF","This 42-page document provides guidance to Member States in the WHO European Region that wish to conduct behavioral insights studies related to COVID-19. This tool is evidence-informed; can be regularly applied; is flexible to adjust to the changing situation; and follows high ethical standards.","https://apps.who.int/iris/handle/10665/333549",,"Guideline/Assessment Tool","Free/Publicly AvailableContact information: Katrine Habersaat (habersaatk@who.int) or Martha Scherzer (scherzerm@who.int)Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333549/WHO-EURO-2020-696-40431-54222-eng.pdf?sequence=1&isAllowed=yLink to resource in Russian: https://apps.who.int/iris/handle/10665/333550","false","23230"
"23226","COVID-19 Response: Promising Practices in Health Equity (II)","Centers for Disease Control and Prevention","2020-07-29T00:00:00.000","Video or Multimedia","In this one-hour webinar, presenters from local jurisdictions and national organizations discuss actions taken to mitigate the disproportionate impact on racial and ethnic minorities during the COVID-19 pandemic. They discuss strategies to reduce COVID-19 health inequities for racial and ethnic minorities at the local, state, and national level.","https://www.youtube.com/watch?v=e2XXXyb7C28&feature=youtu.be","Maybank, Aletha; Saunders, David; Bloyd, James","Instructional/Training Material","Link to Disaster Lit record for Part I: https://disasterinfo.nlm.nih.gov/search/id:23225","false","23226"
"23224","NETEC COVID-19 Webinar Series: Infection Control Precautions in Dentistry During the COVID-19 Pandemic","National Emerging Special Pathogens Training and Education Center","2020-07-29T00:00:00.000","Video or Multimedia","This 58-minute webinar discusses infection control precautions in dentistry during the COVID-19 pandemic. Objectives include defining standard and transmission-based precautions, applying the proper sequence for donning and doffing personal protective equipment (PPE), and describing the characteristics of surgical masks, filtering facepiece respirators, and face shields.","https://repository.netecweb.org/items/show/1234","Grindle, Amanda; Cuny, Eve; Morgan, Jill","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/4880856dddff504317e0db9f6d5fdc88.pdf","false","23224"
"23219","Resetting Our Response: Changes Needed in the U.S. Approach to COVID-19","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-07-29T00:00:00.000","PDF","This 15-page report describes 10 concrete policy actions at the federal, state, and local levels that are needed to get control of the COVID-19 pandemic in the United States. Recommendations identify “quarterbacks,” or responsible designees, to lead each policy action.","https://www.centerforhealthsecurity.org/our-work/publications/resetting-our-response-changes-needed-in-the-us-approach-to-covid-19","Rivers, Caitlin; Martin, Elena; Watson, Crystal; Schoch-Spana, Monica; Cicero, Anita","Report","Direct link to document: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200729-resetting-our-response.pdf","false","23219"
"23216","UVGI Decontamination Cycle for N95 Respirators","National Emerging Special Pathogens Training and Education Center","2020-07-29T00:00:00.000","Text","In the ongoing COVID-19 pandemic, healthcare has experienced significant shortages of personal protective equipment (PPE), including N95 respirators. In an effort to extend the use and reduce risks with reuse of untreated respirators, NETEC has developed this four-step decontamination procedure with the use of Ultraviolet Germicidal Irradiation (UVGI).","https://netec.org/2020/07/29/uvgi-decontamination-cycle-n95-respirators/",,"Guideline/Assessment Tool",,"false","23216"
"23208","Water, Sanitation, Hygiene, and Waste Management for SARS-CoV-2, the Virus that Causes COVID-19","World Health Organization","2020-07-29T00:00:00.000","PDF","This 11-page interim guidance supplements COVID-19 infection prevention and control (IPC) documents by summarizing WHO guidance on water, sanitation, hygiene (WASH), and waste management relevant to viruses, including coronaviruses. This document is an update to the interim guidance document entitled Water, Sanitation, Hygiene, and Waste Management for the COVID-19 Virus, published on April 23, 2020.","https://www.who.int/publications/i/item/water-sanitation-hygiene-and-waste-management-for-the-covid-19-virus-interim-guidance",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1292822/retrieveLink to Disaster Lit record for Water, Sanitation, Hygiene, and Waste Management for the COVID-19 Virus: https://disasterinfo.nlm.nih.gov/search/id:21955","false","23208"
"23206","Public Health Preparedness: HHS Has Taken Some Steps to Implement New Authority to Speed Medical Countermeasure Innovation","U.S. Government Accountability Office","2020-07-29T00:00:00.000","PDF","The COVID-19 pandemic and other infectious disease outbreaks have raised concern about the nation's ability to prevent, respond to, or mitigate potential public health emergencies. Congress allowed the Department of Health and Human Services (HHS) to partner with a private, nonprofit entity to work on this problem. This 11-page report describes the status of the Biomedical Advanced Research and Development Authority (BARDA)'s implementation of the innovation partner authority.","https://www.gao.gov/products/GAO-20-601R","Denigan-Macauley, Mary","Report","Direct link to document: https://www.gao.gov/assets/710/708466.pdf","false","23206"
"23205","COVID-19 Contracting: Observations on Federal Contracting in Response to the Pandemic","U.S. Government Accountability Office","2020-07-29T00:00:00.000","PDF","This 46-page report describes, among other objectives, key characteristics of federal contracting obligations awarded in response to the COVID-19 pandemic. Federal agencies awarded $17.8 billion in contracts as of mid-June 2020 for critical goods and services supporting responses to the COVID-19 pandemic. Contracts often play a key role in federal emergency response.","https://www.gao.gov/products/GAO-20-632","Mak, Marie","Report","Direct link to document: https://www.gao.gov/assets/710/708455.pdf","false","23205"
"21573","Preparedness Tools for Healthcare Professionals and Facilities Responding to Coronavirus (COVID-19)","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-29T00:00:00.000","Text","This web page, updated on July 29, 2020, provides resources for hospitals and healthcare professionals preparing for patients with suspected or confirmed COVID-19 in these topics: Healthcare Provider Checklist; Steps Healthcare Facilities Can Take; Healthcare Facility Guidance; Framework for Non-COVID-19 Care; COVID-19 Surge Tool; Hospital Preparedness Tool; Get Your Clinic Ready; Mitigating Staff Shortages; and Print Resources.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/preparedness-checklists.html",,"Guideline/Assessment Tool",,"false","21573"
"23705","Rapid Onboarding for Redeployed Clinicians: What Matters to Them?","Ariadne Labs","2020-07-28T00:00:00.000","Text","The COVID-19 pandemic has led to redeployment of thousands of U.S. clinicians to treat patients using new or updated skills and practicing in unfamiliar locations of the hospital. This research brief provides three key recommendations for onboarding for redeployment under conditions of limited time and resources.","https://covid19.ariadnelabs.org/rapid-onboarding-for-redeployed-clinicians-what-matters-to-them-a-research-brief-for-system-leaders/","Haas, Susan; Smith, Rachel","Report",,"false","23705"
"23674","COVID-19: Paediatric Surveillance","United Kingdom Department of Health","2020-07-28T00:00:00.000","Text","This web page provides information about how Public Health England, along with National Health Service partners and academic collaborators, has implemented a number of ongoing surveillance programs to monitor the course, progression, and outcomes of COVID-19 in children.","https://www.gov.uk/guidance/covid-19-paediatric-surveillance",,"Guideline/Assessment Tool",,"false","23674"
"23358","eCR Now: COVID-19 Electronic Case Reporting: Health Departments","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-28T00:00:00.000","Text","This web page provides information for Public Health Agencies and Healthcare Providers about COVID-19 Electronic Case Reporting (eCR), the automated generation and transmission of case reports from the electronic health record (EHR) to public health agencies for review and action.","https://www.cdc.gov/coronavirus/2019-ncov/php/electronic-case-reporting.html",,"Web Page",,"false","23358"
"23296","Population in Peril","Harvard University","2020-07-28T00:00:00.000","PDF","This 16-page report explores the relationship between insufficient housing, basic sanitation and healthcare, and the high prevalence of violence and disease among asylum seekers and migrants on the northern Mexico Border. It demonstrates how harsh U.S policies that force thousands of asylum seekers and migrants to wait indefinitely on the border, and an inadequate response to meet their basic needs by the Government of Mexico, created the crisis and are fueling it.","https://globalhealth.harvard.edu/wp-content/uploads/2020/07/A_Population_in_Peril.pdf","Diamond, Megan; Testa, Luke; Novak, Carissa; Kempton-Amaral, Kathryn; Olayo-Mendez, Alejandro","Report",,"false","23296"
"23292","Evidence Used to Update the List of Underlying Medical Conditions that Increase a Person’s Risk of Severe Illness from COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-28T00:00:00.000","Text","Updates to this list of underlying medical conditions that put individuals at increased risk for severe illness from COVID-19 were based on published reports, articles in press, unreviewed pre-prints, and internal data available between December 1, 2019 and July 10, 2020.","https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/evidence-table.html","false","23292"
"23237","NIHB Webinar: Strengthening Tribal COVID-19 Laboratory Testing Capacity","National Indian Health Board","2020-07-28T00:00:00.000","Video or Multimedia","This one-hour, 32-minute webinar provides an overview on using the Public Health Accreditation Board (PHAB) Standards and Measures as a framework for strengthening Tribal Public Health Agencies' ability to work with laboratories on COVID-19 testing. Panelists from Pascua Yaqui Health Services, Osage Nation Health Services, and Tribal Diagnostics, an Oklahoma-based, Native-owned laboratory, discuss how they used the PHAB framework, and other performance improvement tools in their own COVID-19 responses.","https://vimeo.com/442712158","Stone, David; Clark, Jaime; Sawney, Laura; Krause, Apryl; Littlepage, Cory","Instructional/Training Material",,"false","23237"
"3141","How to communicate response strategies to influenza A(H1N1)","European Union, European Centre for Disease Prevention and Control","2009-06-06T00:00:00.000","PDF","This document discusses influenza H1N1 background, evidence, experience and practical considerations in making policy decisions on containment and mitigation.","http://ecdc.europa.eu/en/healthtopics/Documents/0906_Influenza_AH1N1_How_to_Communicate_Response_Strategies_Mitigation_Versus_Delaying.pdf",,"Guideline/Assessment Tool","This link is no longer available. 2/22/2018.","false","3141"
"23215","Multisectoral Checklist for School Reopening and School Based Nutrition in the Context of COVID-19","World Food Programme","2020-07-28T00:00:00.000","PDF","This 12-page document, co-published with UNICEF, provides a non-exhaustive list of recommended multi-sectoral actions for government, UNICEF, World Food Programme, and other partners to consider as part of their short and longer-term planning for and implementation of school reopening. Part one of this checklist is focused on key nutrition actions, with part two focusing on child protection, WASH, education, and health actions.","https://www.wfp.org/publications/joint-wfp-and-unicef-multisectoral-checklist-school-reopening-and-school-based",,"Guideline/Assessment Tool","Direct link to document: https://docs.wfp.org/api/documents/WFP-0000118125/download/?_ga=2.66997998.1728482108.1596130625-1605233867.1596130625","false","23215"
"23204","Rapid Expert Consultation on Staffing Considerations for Crisis Standards of Care for the COVID-19 Pandemic (July 28, 2020)","National Academies Press","2020-07-28T00:00:00.000","Text","This 16-page rapid expert consultation builds on prior National Academies reports on the Crisis Standards of Care (CSC) and the rapid expert consultation on March 28, 2020, and focuses on staffing needs for the care of COVID-19 patients, including adjusting staff responsibilities, providing “hazard pay” to staff, ensuring adequate time off, offering child care and other benefits, and leveraging health care coalitions to ensure appropriate transfer of patients between hospitals.","https://www.nap.edu/catalog/25890/rapid-expert-consultation-on-staffing-considerations-for-crisis-standards-of-care-for-the-covid-19-pandemic-july-28-2020","Hanfling, Dan; Hick, John L.","Report","Link to Disaster Lit record for  Rapid Expert Consultation on Crisis Standards of Care for the COVID-19 Pandemic (March 28, 2020): https://disasterinfo.nlm.nih.gov/search/id:21465","false","23204"
"23198","Medicare Beneficiary Use of Telehealth Visits: Early Data From the Start of the COVID-19 Pandemic","U.S. Department of Health and Human Services","2020-07-28T00:00:00.000","PDF","This 24-page issue brief from the Assistant Secretary for Planning and Evaluation examines changes in Medicare fee-for-service primary care visits and use of telehealth at the start of the COVID-19 public health emergency (PHE). It seeks to address the issue of how and whether the Medicare telehealth flexibilities introduced to address the COVID-19 pandemic may have helped maintain access to primary health care during the PHE.","https://aspe.hhs.gov/pdf-report/medicare-beneficiary-use-telehealth",,"Report","Direct link to document: https://aspe.hhs.gov/system/files/pdf/263866/HP_IssueBrief_MedicareTelehealth_final7.29.20.pdf","false","23198"
"23195","Use of Telemedicine in Alternate Care Sites","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-07-28T00:00:00.000","Video or Multimedia","Speakers on this webinar from TRACIE (Technical Resources, Assistance Center, and Information Exchange) discussed operations, management, and lessons learned of using telemedicine in alternate care sites, which can serve various patient types (e.g., COVID-19 or non-COVID-19) and purposes (e.g., non-acute, hybrid, or acute care).","https://files.asprtracie.hhs.gov/documents/telemedicine-in-alternate-care-sites-webinar-ppt-final.pdf","Treber, Meghan; Jolly, Til; Biddinger, Paul; Connelly, Mary; Sommer, Darren","Instructional/Training Material","Site requires free registration.Link to recording: https://register.gotowebinar.com/recording/3569767218279856910Link to webinar Q&A: https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta-telemedicine-in-alternate-care-sites-qa---final.pdfThis training can be found in the Public Health Foundation TRAIN Learning Network at: https://www.train.org/main/course/1092677.","false","23195"
"23194","Coronavirus Disease 2019 (COVID-19) and Diabetes: The Importance of Prevention, Management, and Support","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-07-28T00:00:00.000","Video or Multimedia","During this one-hour Clinician Outreach and Communication Activity (COCA) Call, presenters focus on current information about the impact and increased risk for COVID-19 complications in people with diabetes; the importance of diabetes prevention, management, and support; and the many resources and programs available to help patients continue to manage their diabetes and prevent type 2 diabetes during the pandemic.","https://emergency.cdc.gov/coca/calls/2020/callinfo_072820.asp","Philip, Celeste; Albright, Ann; Saydah, Sharon","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/COCA-Call-Slides_07-28-20.pdf","false","23194"
"23193","Science and Tech Spotlight: Contact Tracing Apps","U.S. Government Accountability Office","2020-07-28T00:00:00.000","PDF","This two-page document explains how contact tracing can help reduce transmission rates for infectious diseases like COVID-19 by identifying and notifying people who may have been exposed. Contact tracing apps, notably those using proximity tracing, could expedite such efforts. However, there are challenges, including accuracy, adoption rates, and privacy concerns about these apps.","https://www.gao.gov/products/GAO-20-666SP",,"Report","Direct link to document: https://www.gao.gov/assets/710/708405.pdf","false","23193"
"23627","School-Based Health Care in the Era of COVID-19","Johns Hopkins University","2020-07-27T00:00:00.000","Video or Multimedia","Speakers in this one-hour webinar discuss what school-based health care provides, issues for school-based health care and COVID-19, and the role of school health during COVID-19 closing and re-entry.","https://www.youtube.com/watch?v=cra0f22aZ1k&feature=youtu.be","Johnson, Sara; Connor, Katherine; Dooley, Danielle; Lever, Nancy","Instructional/Training Material",,"false","23627"
"5281","Communication Considerations for Vulnerable Populations","Florida Department of Health","2009-06-05T00:00:00.000","PDF","This document is a resource guide for public health and medical professionals who seek to provide vulnerable populations with critical information before, during and after a disaster or incident. It provides information on how to shape messages, identify preferred modes of delivery and choose mediums for each audience.","http://www.floridahealth.gov/programs-and-services/emergency-preparedness-and-response/healthcare-system-preparedness/vulnerable-populations/_documents/comms-resource-guide.pdf",,"Guideline/Assessment Tool","This link is no longer available. 4/12/2018.","false","5281"
"23259","COVID-19: EU Guidance for Cruise Ship Operations","European Union, European Centre for Disease Prevention and Control","2020-07-27T00:00:00.000","PDF","The objective of this 36-page guidance is to facilitate the re-start of operations of cruise ships in the European Union (EU), by recommending minimum measures expected to be implemented by all those concerned, while maintaining general safety and security standards. This COVID-19 guidance is meant for EU/EEA (European Economic Area) flagged ships engaged in international voyages and for ships calling at an EU/EEA port irrespective of flag.","https://www.ecdc.europa.eu/en/publications-data/COVID-19-cruise-ship-guidance",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/COVID-19-cruise-guidance-27-07-2020.pdfLink to related infographic: COVID-19 and Cruise Ship Operations: https://www.ecdc.europa.eu/en/publications-data/infographic-covid-19-and-cruise-ship-operations","false","23259"
"23231","Considerations for Implementing Mass Treatment, Active Case-Finding and Population-Based Surveys for Neglected Tropical Diseases in the Context of the COVID-19 Pandemic","World Health Organization","2020-07-27T00:00:00.000","PDF","This eight-page document outlines a decision-making framework for implementation of mass treatment interventions, active case-finding campaigns, and population-based surveys for neglected tropical diseases (NTDs) in the context of the COVID-19 pandemic. It formulates considerations aimed at providing guidance to relevant health authorities, NTD program managers, and their supporting partners.","https://apps.who.int/iris/handle/10665/333499",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333499/WHO-2019-nCoV-neglected_tropical_diseases-2020.1-eng.pdf?sequence=1&isAllowed=y","false","23231"
"23221","COVID-19 Experiences and Challenges in Fragile Contexts: Building Resilience to Future Shocks","United Nations Office for Disaster Risk Reduction","2020-07-27T00:00:00.000","Video or Multimedia","This one-hour, 49-minute webinar provides a platform to share information on COVID-19 preparedness, response, and recovery efforts, with a focus on lessons learned, good practices, challenges, and experiences in fragile contexts. Experiences of countries from different contexts are highlighted, and attention is given to lessons learned from previous crises such as the Ebola outbreak, among others.","https://www.undrr.org/event/covid-19-experiences-and-challenges-fragile-contexts-building-resilience-future-shocks","Abbashar, Amjad; Mizutori, Mami; Jackson, Ronald; Peters, Katie; Williams, Henry","Instructional/Training Material","Link to recording: https://www.youtube.com/watch?v=0TGmqXayQDs&list=PLBDwPnveHho9iFI5fyO2vYYPChiIAJ-X4","false","23221"
"23199","Operational Considerations for Maintaining Essential Services for and Providing Maternal, Newborn, and Child Healthcare in Low-Resource Countries","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-27T00:00:00.000","Text","While current data suggest that pregnant women, newborns, and children are not at highest risk for COVID-19 deaths, disruption of routine essential services poses a threat to their survival and health. This web page provides guidance for essential maternal, newborn, and child health (MNCH) services to provide during COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/pregnant.html",,"Guideline/Assessment Tool",,"false","23199"
"23190","Fact Sheet for Healthcare Providers: Lilly SARS-CoV-2 Assay","U.S. Food and Drug Administration","2020-07-27T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Lilly SARS-CoV-2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140541/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140542/downloadLink to Letter of Authorization: https://www.fda.gov/media/140540/downloadLink to EUA Summary: https://www.fda.gov/media/140543/download","false","23190"
"23189","Fact Sheet for Healthcare Providers: SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic Assay","U.S. Food and Drug Administration","2020-07-27T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the SNL-NM 2019 nCoV Real-Time RT-PCR Diagnostic assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140545/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140546/downloadLink to Letter of Authorization: https://www.fda.gov/media/140544/downloadLink to EUA Summary: https://www.fda.gov/media/140547/download","false","23189"
"23177","Considerations for Implementing Mass Treatment, Active Case-Finding and Population-Based Surveys for Neglected Tropical Diseases in the Context of the COVID-19 Pandemic","World Health Organization","2020-07-27T00:00:00.000","PDF","This eight-page document provides a decision-making framework for implementation of mass treatment interventions, active case-finding campaigns, and population-based surveys for neglected tropical diseases in the context of the COVID-19 pandemic. A two-step approach is proposed: a risk-benefit assessment, to decide if the planned activity should proceed; and an examination of a list of precautionary measures that should be applied with the aim of decreasing the risk of transmission of COVID-19 associated with the activity, and strengthening the capacity of the health system to manage any residual risk.","https://www.who.int/publications/i/item/WHO-2019-nCoV-neglected-tropical-diseases-2020-1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1289077/retrieve","false","23177"
"21924","COVID-19 Fact Sheets and Guidance","Federal Emergency Management Agency [Department of Homeland Security]","2020-07-27T00:00:00.000","Text","This web page, updated on July 27, 2020, provides COVID-19 fact sheets and guidance documents from the Federal Emergency Management Agency (FEMA). It is continually updated.","https://www.fema.gov/disasters/coronavirus/fact-sheets",,"Web Page","Some fact sheets and guidance documents are in Spanish and Haitian Creole.","false","21924"
"23181","Interim Operational Considerations for Implementing the Shielding Approach to Prevent COVID-19 Infections in Humanitarian Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-26T00:00:00.000","Text","This web page presents considerations from the perspective of the Centers for Disease Control and Prevention (CDC) for implementing the shielding approach in humanitarian settings as outlined in COVID-19 guidance documents focused on camps, displaced populations, and low-resource settings. It highlights potential implementation challenges of the shielding approach from CDC’s perspective.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/shielding-approach-humanitarian.html",,"Guideline/Assessment Tool",,"false","23181"
"23210","Coronavirus Disease (COVID-19) Operational Considerations for Schools","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-25T00:00:00.000","Text","This guidance is intended for use by any person, institution, or organization preparing for or responding to community transmission of COVID-19, and for those assisting these entities (e.g., national and local governments, CDC country offices, and others); it contains special considerations for mitigating the risks of resumption and sustained operation of schools in low-resource, international settings.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/schools.html",,"Guideline/Assessment Tool",,"false","23210"
"23178","Safe Eid al Adha Practices in the Context of COVID-19: Interim Guidance","World Health Organization","2020-07-25T00:00:00.000","PDF","Eid al Adha is a festival during which Muslim families and friends unite to pray together and give alms, especially in the form of sacrificed animal meat. In light of the COVID-19 pandemic, this four-page document highlights public health advice for social gatherings and religious practices that can be applied across different national contexts.","https://www.who.int/publications/i/item/safe-eid-al-adha-practices-in-the-context-of-covid-19-interim-guidance",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1288874/retrieve","false","23178"
"24037","Guidance for Post-Secondary Institutions During the COVID-19 Pandemic","Government of Canada","2020-07-24T00:00:00.000","Text","This web page provides guidance for post-secondary institutions, administrators, and local public health authorities (PHAs) in jurisdictions where these institutions exist in the context of the COVID-19 pandemic. These settings include public and private colleges, universities, and vocational/technical schools.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/covid-19-guidance-post-secondary-institutions-during-pandemic.html",,"Guideline/Assessment Tool",,"false","24037"
"23531","Coronavirus Disease 2019 (COVID-19): Health Equity Considerations and Racial and Ethnic Minority Groups","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-24T00:00:00.000","Text","This web page discusses how long-standing systemic health and social inequities have put many people from racial and ethnic minority groups at increased risk of getting sick and dying from COVID-19. Topics include factors that contribute to increased risk, what we can do, and data on COVID-19 and race and ethnicity.","https://www.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.html",,"Web Page","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/health-equity/race-ethnicity.html","false","23531"
"23278","NETEC COVID-19 Webinar Series: Surgical Cases and Considerations for COVID-19 Patients: Part Two","National Emerging Special Pathogens Training and Education Center","2020-07-24T00:00:00.000","Video or Multimedia","This 49-minute webinar describes strategies used for testing COVID-19 patients requiring surgical procedures, and reviews the approach at the University of Nebraska Medical Center and Emory University on virus transmission and personal protective equipment use for infection control. It also defines the setup and pre-briefing process for surgeries during COVID-19, and reviews physical infrastructure setup in alignment with engineering controls in an intraoperative, and post-anesthesia care unit setting.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1215","Cieslak, Ted; Schulte, Thomas; Sullivan, James; Collins, Jeremy; Klopman, Matthew","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/7e37460b6be226430ddf1de8c245610b.pdfLink to Disaster Lit record for webinar Part One: https://disasterinfo.nlm.nih.gov/search/id:23078","false","23278"
"23258","Government-University Dialogue on COVID-19 Surveillance and Testing: Opportunities, Challenges, and Capacity","National Institutes of Health","2020-07-24T00:00:00.000","Video or Multimedia","This one-hour, 31-minute panel discussion of federal health and university representatives focuses on COVID-19 diagnostics and universities, how diagnostic testing can be speeded up, and what speakers can learn from each other.","https://videocast.nih.gov/watch=38226","Collins, Francis; Giroir, Brett; Verma, Seema; Byington, Carrie; Feser, Edward","Instructional/Training Material",,"false","23258"
"23192","Fact Sheet for Healthcare Providers: Michigan State University System for Decontaminating Compatible N95 Respirators","U.S. Food and Drug Administration","2020-07-24T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of decontaminated, compatible N95 respirators. These compatible N95 respirators have been decontaminated using the Michigan State University Animal Care Program’s (MSU) System for Decontamination and Reuse of Compatible N95 Respirators with Vaporized Hydrogen Peroxide.","https://www.fda.gov/media/140468/download",,"Guideline/Assessment Tool","Link to Letter of Authorization: https://www.fda.gov/media/140472/downloadLink to Instructions for Michigan State University Staff: https://www.fda.gov/media/140471/downloadLink to Instructions for Healthcare Facilities and Operator Teams: https://www.fda.gov/media/140469/downloadLink to Instructions for Healthcare Personnel: https://www.fda.gov/media/140470/download","false","23192"
"23191","Fact Sheet for Healthcare Providers: Emergency Use of the Airway Dome","U.S. Food and Drug Administration","2020-07-24T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Airway Dome. This device is    authorized for use by healthcare providers (HCP) as an extra layer of barrier protection in addition to personal protective equipment (PPE) to prevent HCP exposure to pathogenic biological airborne particulates by providing isolation of hospitalized patients with suspected or confirmed diagnosis of COVID-19, at the time of definitive airway management, or when performing airway-related medical procedures, or during certain transport of such patients during the COVID-19 pandemic.","https://www.fda.gov/media/140452/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140456/downloadLink to Letter of Authorization: https://www.fda.gov/media/140455/downloadLink to Instructions for Healthcare Facilities: https://www.fda.gov/media/140453/downloadLink to Instructions for Healthcare Providers: https://www.fda.gov/media/140454/download","false","23191"
"23183","What Public Health Inspectors Need to Know about COVID-19","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-24T00:00:00.000","Text","This web page provides information about COVID-19 for public health inspectors, including how to protect themselves, and how to work with employers on protection.","https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employees.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employees.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employees.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employees.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employees.html","false","23183"
"23164","Fact Sheet for Healthcare Providers: Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing)","U.S. Food and Drug Administration","2020-07-24T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing). The Novel Coronavirus (SARS-CoV-2) Fast Nucleic Acid Detection Kit (PCR-Fluorescence Probing) is authorized for use with oropharyngeal swab specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140424/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140427/downloadLink to Letter of Authorization: https://www.fda.gov/media/140426/downloadLink to Instructions for Use: https://www.fda.gov/media/140425/download","false","23164"
"23146","Preventing and Managing COVID-19 Across Long-Term Care Services","World Health Organization","2020-07-24T00:00:00.000","PDF","This 54-page policy brief provides 11 policy objectives and key action points to prevent and manage COVID-19 across long-term care. It builds on currently available evidence on the measures taken to prevent, prepare for, and respond to the COVID‑19 pandemic across long-term care services, including care providers.","https://www.who.int/publications/i/item/WHO-2019-nCoV-Policy_Brief-Long-term_Care-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://www.who.int/docs/default-source/coronaviruse/who-2019-ncov-policy-brief-long-term-care-2020-1-eng.pdf?sfvrsn=c6763d51_1&download=trueLink to Web Annex: https://www.who.int/publications/i/item/WHO-2019-nCoV-Policy_Brief-Long-term_Care-web-annex-2020.1","false","23146"
"23138","Coronavirus Disease (COVID-19) FAQs for School Administrators on Reopening Schools","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-24T00:00:00.000","Text","This web page for school administrators provides answers to frequently asked questions about reopening schools, and planning and responding to COVID-19.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/reopening-schools-faqs.html",,"Fact Sheet","Link to page in Chinese; https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/reopening-schools-faqs.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/reopening-schools-faqs.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/reopening-schools-faqs.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/reopening-schools-faqs.html","false","23138"
"21202","Fact Sheet for Healthcare Providers: LabCorp’s COVID-19 RT-PCR Test","U.S. Food and Drug Administration","2020-07-24T00:00:00.000","PDF","This three-page fact sheet, updated on July 24, 2020, informs healthcare providers of the significant known and potential risks and benefits of the emergency use of LabCorp’s COVID-19 RT-PCR test. The Food and Drug Administration reissued the LabCorp COVID-19 RT-PCR Test emergency use authorization (EUA) to include two new indications for use: testing for people who do not have COVID-19 symptoms or who have no reason to suspect COVID-19 infection, and to allow pooled sample testing.","https://www.fda.gov/media/136149/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/136150/downloadLink to Letter of Authorization: https://www.fda.gov/media/136148/downloadLink to EUA Summary: https://www.fda.gov/media/136151/download","false","21202"
"23580","Interventions Commonly Available During Pandemics for Heavy Menstrual Bleeding: An Overview of Cochrane Reviews","Cochrane Library","2020-07-23T00:00:00.000","Text","This report summarizes the evidence from Cochrane Reviews evaluating interventions for heavy menstrual bleeding that are commonly available during pandemics. Within the context of heavy menstrual bleeding, pandemics impact women's assessment and treatment by healthcare providers.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013651.pub2/full","Rodriguez, Magdalena; Lethaby, Anne; Farquar, Cindy; Duffy, James","Report","Link to report in Arabic: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013651.pub2/full/fa#CD013651-abs-0003Link to report in French: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013651.pub2/full/fr#CD013651-abs-0005Link to report in Spanish: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013651.pub2/full/es#CD013651-abs-0007","false","23580"
"23514","COVID-19 Surge Planning: Considerations for the Home-based Care Population","University of North Carolina at Chapel Hill","2020-07-23T00:00:00.000","PDF","This four-page document provides guidelines and resources to prepare organizations for an increase in patient volume in the wake of the COVID-19 pandemic. Surge planning for COVID-19 patients requires administrators to evaluate capacity and capability in space, skills, and supplies, and then develop and apply structures to move current capacity to maximum capability.","https://public.3.basecamp.com/p/zgHYZWS8fN4uc4csx7BVbHNu/upload/download/07.23%20COVID-19%20Preparedness%20Checklist_Home-Based%20Care.pdf?disposition=attachment",,"Guideline/Assessment Tool",,"false","23514"
"23408","COVID-19 Confirmed Cases by Occupation and Industry","Washington State Department of Health","2020-07-23T00:00:00.000","PDF","This eight-page report was a collaboration between Department of Health and Labor and Industries, Safety and Health Assessment and Research for Prevention Program, and contains data on occupation and industry among lab-confirmed cases of COVID-19 among Washington residents reported through June 16, 2020.","https://www.doh.wa.gov/Portals/1/Documents/1600/coronavirus/OccupationIndustryReport.pdf",,"Report",,"false","23408"
"23337","Underfunded and Unprepared: Examining How to Overcome Obstacles to Safely Reopen Public Schools","U.S. House of Representatives, Committee on Education and Labor","2020-07-23T00:00:00.000","Video or Multimedia","This three-hour, seven-minute Congressional hearing features witnesses who discuss what Congress must do to help America’s students get back to school during the COVID-19 pandemic.","https://edlabor.house.gov/hearings/underfunded-and-unprepared-examining-how-to-overcome-obstacles-to-safely-reopen-public-schools-","Sablan, Gregorio; Hinojosa, Michael; Boggs, Leslie; Schwinn, Leslie; O'Leary, Sean","Hearing/Testimony",,"false","23337"
"23182","COVID-19 Employer Information for Public Health Inspectors","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-23T00:00:00.000","Text","This web page provides information for public health inspectors, including how public health inspectors and their workforce might come into contact withe the COVID-19 virus, and how they can protect their staff and others, and slow the spread of the virus.","https://www.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employers.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employers.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employers.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employers.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/organizations/ph-inspectors-employers.html","false","23182"
"23170","Guidance for Planning Vaccination Clinics Held at Satellite, Temporary, or Off-Site Locations","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-23T00:00:00.000","Text","The purpose of this guidance is to assist with jurisdictional planning and implementation of satellite, temporary, or off-site vaccination clinics by public and private vaccination organizations. It also provides information on additional considerations that are required during the COVID-19 pandemic, including physical distancing, personal protective equipment (PPE), and enhanced sanitation efforts.","https://www.cdc.gov/vaccines/hcp/admin/mass-clinic-activities/index.html",,"Guideline/Assessment Tool",,"false","23170"
"23165","Fact Sheet for Healthcare Providers: Helix COVID-19 Test","U.S. Food and Drug Administration","2020-07-23T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Helix COVID-19 Test that has been issued an Emergency Use Authorization (EUA) by FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140421/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140423/downloadLink to Letter of Authorization: https://www.fda.gov/media/140422/downloadLink to EUA Summary: https://www.fda.gov/media/140420/download","false","23165"
"23143","COVID-19 Research Synergies Meetings","Global Research Collaboration for Infectious Disease Preparedness","2020-07-23T00:00:00.000","Video or Multimedia","The COVID-19 Research Synergies Meetings took place on July 16-23, 2020, to bring together key stakeholders in the research response to combat COVID-19, and provide a platform to promote and establish collaboration and synergies between researchers funded by GloPID-R members. This web page provides the agenda, programs, and recordings of the four meetings.","https://www.glopid-r.org/covid-19-research-synergies-meetings/",,"Conference/Meeting Material",,"false","23143"
"3147","Updated Interim Recommendations-HIV-Infected Adults and Adolescents","Centers for Disease Control and Prevention","2009-06-05T00:00:00.000","Text","This Web page contains guidance for clinicians concerning HIV infected individuals and the H1N1 virus, including clinical presentation, treatment, and chemoprophylaxis. The English language content on this page is being archived for historic and reference purposes only.","https://www.cdc.gov/h1n1flu/guidance_HIV.htm",,"Guideline/Assessment Tool",,"false","3147"
"23142","COVID-19 Inter-Agency Guidance for the Management of the Dead in Humanitarian Settings","United Nations Office for the Coordination of Humanitarian Affairs, Inter-Agency Standing Committee","2020-07-23T00:00:00.000","PDF","This 11-page inter-agency guidance was jointly drafted by the International Committee of the Red Cross, International Federation of Red Cross and Red Crescent Societies, and World Health Organization colleagues (in addition to consultation with the Centers for Disease Control and Prevention, and Pan American Health Organization), and is targeted toward humanitarian settings. It aims to complement other guidance on the management of the dead with a stronger focus on the practical realities faced when dealing with the dead in humanitarian settings.","https://interagencystandingcommittee.org/other/covid-19-inter-agency-guidance-management-dead-humanitarian-settings","Baller, April; Connix, Rudi; Eamer, Gwendolen; Toledo, Joao; Finegan, Oran","Guideline/Assessment Tool","Direct link to document: https://interagencystandingcommittee.org/system/files/2020-07/Interagency%20COVID-19%20Guidance%20for%20the%20Management%20of%20the%20Dead%20in%20Humanitarian%20Settings%20%28July%202020%29.pdf","false","23142"
"23136","Guidance for K-12 School Administrators on the Use of Cloth Face Coverings in Schools","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-23T00:00:00.000","Text","The CDC suggests that all school reopening plans address adherence to behaviors that prevent the spread of COVID-19. When used consistently and correctly, cloth face coverings are important to help slow the spread of COVID-19. This web page provides general considerations for face coverings in schools.","https://www.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/cloth-face-cover.html",,"Guideline/Assessment Tool","Link to page in Chinese: https://chinese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/cloth-face-cover.htmlLink to page in Korean: https://korean.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/cloth-face-cover.htmlLink to page in Spanish: https://espanol.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/cloth-face-cover.htmlLink to page in Vietnamese: https://vietnamese.cdc.gov/coronavirus/2019-ncov/community/schools-childcare/cloth-face-cover.html","false","23136"
"23125","Guidance for Conducting a Country COVID-19 Intra-Action Review (IAR)","World Health Organization","2020-07-23T00:00:00.000","PDF","This 16-page document was developed to guide countries to conduct periodic review(s) of their national and subnational COVID-19 response, so countries do not miss critical opportunities for learning and improvement to better respond to the COVID-19 outbreak in their countries, especially as the possibility of a protracted pandemic becomes increasingly probable.","https://www.who.int/publications/i/item/WHO-2019-nCoV-Country_IAR-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1288630/retrieveThis page provides links to these tools:Country COVID-19 intra-action review (IAR) Concept Note TemplateCountry COVID-19 intra-action review: Facilitator’s manualCountry COVID-19 intra-action review (IAR): Generic agenda template Country COVID-19 intra-action review (IAR): Generic presentationCountry COVID-19 intra-action review (IAR): Trigger question databaseCountry COVID-19 intra-action review (IAR): Note taking templateCountry COVID-19 intra-action review (IAR): Final report templateCountry COVID-19 intra-action review (IAR): Participant feedback formCountry COVID-19 intra-action review (IAR): Participant feedback summaryCountry COVID-19 intra-action review (IAR): Success story template","false","23125"
"23119","COVID-19 Webinar and Partner Calls Videos","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-23T00:00:00.000","Video or Multimedia","This web page provides COVID-19 webinar and partner calls videos from the Centers for Disease Control and Prevention. They can be filtered by audience, including first responders, healthcare facilities, healthcare professionals, and public health professionals.","https://www.cdc.gov/coronavirus/2019-ncov/communication/videos-webinars-calls.html?Sort=Date%3A%3Adesc",,"Instructional/Training Material",,"false","23119"
"23297","NACo Town Hall: County Public Health Departments on the Front Lines","National Association of Counties","2020-07-22T00:00:00.000","Video or Multimedia","This one-hour webinar features a discussion on the role of local public health in combating the COVID-19 pandemic and other public health emergencies. It provides an inside look at how county public health departments are addressing the current crisis, an overview of contact tracing tools for interested public health officials, and an update on federal legislative efforts to aid local public health departments in tracing and tracking the pandemic.","https://www.naco.org/events/naco-town-hall-county-public-health-departments-front-lines","Moehrle, Carol; Bryant, Blaire; Huston, Amanda","Instructional/Training Material","Site requires free registration.","false","23297"
"23282","Protection of Children During COVID-19 Webinars","Alliance for Child Protection in Humanitarian Action","2020-07-22T00:00:00.000","Video or Multimedia","This web page provides links to a webinar series about protection of children during the COVID-19 pandemic. Some webinars are available in Arabic, French, Portuguese, and Spanish.","https://www.alliancecpha.org/en/webinar-recordings-covid-19-and-child-protection",,"Instructional/Training Material","Recordings can also be found at https://www.youtube.com/playlist?list=PLTqpcYbBSkF_qHlkT7PoKcDvHtyGVHKan","false","23282"
"23184","CDC COVID-19 Response Health Equity Strategy: Accelerating Progress Towards Reducing COVID-19 Disparities and Achieving Health Equity","Centers for Disease Control and Prevention","2020-07-22T00:00:00.000","PDF","This five-page document details the Centers for Disease Control and Prevention's strategy to reduce the disproportionate burden of COVID-19 among populations at increased risk for infection, severe illness, and death; broadly address health disparities and inequities related to COVID-19 with a holistic, all-of-response approach; and develop a strategic plan to help us realize these goals.","https://www.cdc.gov/coronavirus/2019-ncov/downloads/community/CDC-Strategy.pdf",,"Fact Sheet",,"false","23184"
"23150","COVID-19 Law Lab","United Nations Development Programme","2020-07-22T00:00:00.000","Text","This database gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the COVID-19 pandemic. The goal is to ensure that laws protect the health and well-being of individuals and communities, and that they adhere to international human rights standards. It is a joint project of United Nations Development Programme (UNDP), World Health Organization (WHO), Joint United Nations Programme on HIV/AIDS (UNAIDS) and O’Neill Institute for National and Global Health Law at Georgetown University.","https://covidlawlab.org/",,"Database/Dataset",,"false","23150"
"23144","Supporting Children and Adolescents During COVID-19","Centers for Disease Control and Prevention","2020-07-22T00:00:00.000","Video or Multimedia","The National Child Traumatic Stress Network (NCTSN) joined the CDC Emergency Partners Information Connection (EPIC) Team to present this 56-minute webinar featuring Dr. Melissa Brymer, Director of the Terrorism and Disaster Program UCLA/Duke University National Center for Child Traumatic Stress, who discussed possible ways to support young people during COVID-19. She also described NCTSN’s available resources and outlined how to have conversations with children and adolescents about what is happening.","https://emergency.cdc.gov/epic/learn/2020/webinar_20200722.asp","Brymer, Melissa","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/epic/pdf/2020_07_22_Supporting-Children-and-Adolescents-During-COVID-19_clean_final_508.pdfLink to transcript: https://emergency.cdc.gov/epic/pdf/07222020-transcript.txt","false","23144"
"23121","NETEC COVID-19 Webinar Series: Identifying Hazards and Mitigating Risks for Long Term Care Facilities","National Emerging Special Pathogens Training and Education Center","2020-07-22T00:00:00.000","Video or Multimedia","In this 54-minute webinar, participants discuss different policies and processes taken at long-term care facilities caring for COVID-19-positive residents based on case-based experiences, describe mitigation strategies involved to promptly identify and isolate residents with possible COVID-19 utilizing appropriate infection prevention practices, and describe the role of local and state public health in the identification, prevention, and control of COVID-19 in long-term facilities.","https://repository.netecweb.org/items/show/1207","Schwedhelm, Shelly; Boulter, Kate; Tennill, Trish; Morgan, Jill","Instructional/Training Material","Link to Part One: Tackling the COVID-19 Storm through the lens of Long-Term Care Facilities: https://www.youtube.com/watch?v=G62D2h9vW-w&feature=youtu.beLink to Presentation slides: https://repository.netecweb.org/files/original/d38ed6f3e55aadb604be0796d3e6a28e.pdf Link to Part Two: Identifying Hazards and Mitigating Risks for Long Term Care Facilities: https://www.youtube.com/watch?v=1HBVVeVOAuk&feature=youtu.be","false","23121"
"23116","Examining the National Response to the Worsening Coronavirus Pandemic: Part II","U.S. House of Representatives, Committee on Homeland Security","2020-07-22T00:00:00.000","Video or Multimedia","The main witness at this three-hour, seven-minute Congressional hearing is the director of the Federal Emergency Management Agency (FEMA), who responds to members’  questions about the COVID-19 pandemic, where we currently stand, and how the response to this public health emergency can be improved.","https://homeland.house.gov/examining-the-national-response-to-the-worsening-coronavirus-pandemic-part-ii","Thompson, Bennie; Gaynor, Peter","Hearing/Testimony","Link to Disaster Lit record for Examining the National Response to the Worsening Coronavirus Pandemic: Part I: https://disasterinfo.nlm.nih.gov/search/id:22949.","false","23116"
"22953","eCR Now: COVID-19 Electronic Case Reporting for Healthcare Providers","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-22T00:00:00.000","Text","Electronic Case Reporting (eCR) is the automated generation and transmission of case reports from the electronic health record (EHR) to public health agencies for review and action. eCR makes disease reporting from healthcare to public health faster and easier. It moves data securely and seamlessly—from the EHR at the point of care, to data systems at state, territorial, and local agencies. This data sharing provides a real-time picture of COVID-19 to support outbreak management. This page was update on July 22, 2020.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/electronic-case-reporting.html",,"Guideline/Assessment Tool",,"false","22953"
"23930","Uses of Telehealth during COVID-19 in Low Resource Non-U.S. Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-21T00:00:00.000","Text","This web page describes types of telehealth and their potential uses during the COVID-19 pandemic.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/telehealth-covid19-nonUS.html",,"Web Page","Link to fact sheet on What is Telemedicine in a non-US Setting: https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/telemedicine.html","false","23930"
"23207","COVID-19 Essential Information for States and Counties to Publicly Report","Resolve to Save Lives","2020-07-21T00:00:00.000","PDF","This two-page list of information captures essential data required for an effective COVID-19 response. Information should be stratified by key demographic variables weekly, including race, sex, ethnicity, age and, where appropriate and available, zip code (all but indicators 5, 7, and 15 are available from some areas stratified in this way). Case and death data (indicators 1, 2, 9, and 13) should be stratified by whether they occurred in recognized outbreaks (e.g., in nursing homes or correctional facilities) or in the community.","https://preventepidemics.org/wp-content/uploads/2020/07/Essential-information-for-states-and-counties-to-publicly-report.pdf",,"Guideline/Assessment Tool",,"false","23207"
"23171","Coronavirus Disease (COVID-19) Toolkit for Tribal Communities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-21T00:00:00.000","Text","This toolkit provides COVID-19 guidance and tools to help tribal organizations make decisions, communicate with their members, and protect their families and communities. It includes posters, fact sheets, videos, and social media messages.","https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/tribal-communities.html",,"Guideline/Assessment Tool",,"false","23171"
"23166","Fact Sheet for Healthcare Providers: QuantiVirus™ SARS-CoV-2 Multiplex Test Kit","U.S. Food and Drug Administration","2020-07-21T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the QuantiVirus™ SARS-CoV-2 Multiplex Test Kit. The QuantiVirus™ SARS-CoV-2 Multiplex Test Kit is authorized for use with upper respiratory specimens and sputum collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140353/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140356/downloadLink to Letter of Authorization: https://www.fda.gov/media/140355/downloadLink to Instructions for Use: https://www.fda.gov/media/140354/download","false","23166"
"23147","Coronavirus Disease (COVID-19) Toolkit for Retirement Communities","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-21T00:00:00.000","Text","This web page provides COVID-19 guidance and tools to help retirement communities make decisions, protect their residents and staff, and communicate with their communities. It includes social media messages, fact sheets, posters, and videos.","https://www.cdc.gov/coronavirus/2019-ncov/communication/toolkits/retirement-communities.html",,"Guideline/Assessment Tool",,"false","23147"
"23115","Rising Cases in Long-term Care Facilities Are Cause for Concern","Henry J. Kaiser Family Foundation","2020-07-21T00:00:00.000","Text","This report discusses recent trends in COVID-19 cases among residents and staff in long-term care facilities and how these relate to surges in “hotspot” states. Long-term care cases in hotspot states with wider community transmission have risen at four times the rate as long-term care cases in non-hotspot states.","https://www.kff.org/coronavirus-covid-19/issue-brief/rising-cases-in-long-term-care-facilities-are-cause-for-concern/","Chidambaram, Priya","Report",,"false","23115"
"23112","Tracking COVID-19 in the United States: From Information Catastrophe to Empowered Communities","Resolve to Save Lives","2020-07-21T00:00:00.000","PDF","It is crucial that state, county, and city health departments publicly report essential data on COVID-19 using consistent indicators that can be compared both across regions and over time. To better understand the publicly available data that currently exists, this 21-page report reviewed the state-level data dashboard for all 50 U.S. states, and the District of Columbia.","https://preventepidemics.org/covid19/resources/indicators/",,"Report","Direct link to document: https://preventepidemics.org/wp-content/uploads/2020/07/Tracking-COVID-19-in-the-United-States-Report.pdf","false","23112"
"23111","COVID Complexities: Converging Threats, Fractured Resources","Bipartisan Commission on Biodefense","2020-07-21T00:00:00.000","Video or Multimedia","This three-hour, 56-minute virtual meeting was held to help us better understand the potential for COVID-19’s reemergence, the country’s efforts to track the spread of the disease, and national readiness to address future biological threats. Speakers discuss the potential for compoundment of the biological threat, disease-tracking needs, hospital preparedness, and emergency management challenges.","https://biodefensecommission.org/events/covid-complexities-converging-threats-fractured-resources/","Crow, Jason; Moskowitz, Jared; Madrigal, Alexis; Mitchell, David","Conference/Meeting Material",,"false","23111"
"23110","Pathway to a Vaccine: Efforts to Develop a Safe, Effective and Accessible COVID-19 Vaccine","U.S. House of Representatives, Committee on Energy and Commerce","2020-07-21T00:00:00.000","Video or Multimedia","This three-hour, four-minute Congressional hearing examines the current state of research, development, and manufacturing of potential vaccines for COVID-19. Witnesses are representatives of five of the multiple companies that are currently developing COVID-19 vaccines for use in the United States.","https://energycommerce.house.gov/committee-activity/hearings/hearing-on-pathway-to-a-vaccine-efforts-to-develop-a-safe-effective-and","Pallone, Jr., Frank; DeGette, Diana; Pangolos, Mene; Douoguih, Macaya; Gerberding, Julie L.","Hearing/Testimony",,"false","23110"
"23092","COVID-19 Rail Protocol: Recommendations for Safe Resumption of Railway Services in Europe","European Union, European Centre for Disease Prevention and Control","2020-07-21T00:00:00.000","PDF","The European Union’s Agency for Railways (ERA), the European Commission, and the European Centre for Disease Prevention and Control (ECDC) have developed this 19-page COVID-19 railway protocol, outlining the operational guidelines for the resumption of railway operations in Europe. This protocol reflects the current status of knowledge about the COVID-19 disease and its pandemic effect.","https://www.ecdc.europa.eu/en/publications-data/covid-19-rail-protocol",,"Guideline/Assessment Tool","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/Covid-19-Rail-Protocol_v1.4.pdfLink to related infographic: https://www.ecdc.europa.eu/en/publications-data/infographic-covid-19-and-railway-services","false","23092"
"23557","Interim Guidance: Role of the School Nurse in Return to School Planning","National Association of School Nurses","2020-07-20T00:00:00.000","PDF","This eight-page document provides a summary of currently available resources about returning to school that school nurses can consult as they formulate independent nursing judgment for their practice or when participating in policy discussions in their districts.","https://higherlogicdownload.s3.amazonaws.com/NASN/3870c72d-fff9-4ed7-833f-215de278d256/UploadedImages/PDFs/COVID-19_Interim_Guidance_Role_of_the_School_Nurse_in_Return_to_School_Planning.pdf",,"Guideline/Assessment Tool",,"false","23557"
"23117","Civil Rights Protections Prohibiting Race, Color and National Origin Discrimination During COVID‐19","U.S. Department of Health and Human Services","2020-07-20T00:00:00.000","PDF","This eight-page bulletin focuses on recipients’ compliance with the prohibitions against race, color, and national origin discrimination contained in Title VI of the Civil Rights Act of 1964 (Title VI), with regard to federal financial assistance to state and local agencies, hospitals, and other healthcare providers on the frontlines of the COVID‐19 response.","https://www.hhs.gov/sites/default/files/title-vi-bulletin.pdf",,"Guideline/Assessment Tool",,"false","23117"
"23098","Epidemiology and Inequalities in Brazil: The EpiCOVID19 Study","World Health Organization, Pan American Health Organization","2020-07-20T00:00:00.000","Video or Multimedia","This one-hour, 20-minute seminar presents the results of the EpiCOVID19 Study: From Oiapoque to Pelotas, the first and, to date, the only large-scale epidemiological study on the prevalence, epidemiology, and social inequalities associated with SARS-CoV-2 infection in three survey rounds in each of Brazil's 133 most representative cities.","https://www.youtube.com/watch?v=ABcMMf4jG2E",,"Instructional/Training Material",,"false","23098"
"16466","NIMS (National Incident Management System) Components - Guidance and Tools","Federal Emergency Management Agency [Department of Homeland Security]","2020-07-20T00:00:00.000","Text","This web page, updated in July 2020, provides National Incident Management System Resource Management Supplemental Guidance and Tools, which are part of an effort to lead a whole community effort to strengthen the Resource Management component of the National Incident Management System (NIMS). Tool topics are National Qualification System; Resource Typing; Inventorying; Mutual Aid; Incident Command System; and Emergency Operations Centers.","https://www.fema.gov/emergency-managers/nims/components",,"Guideline/Assessment Tool",,"false","16466"
"23102","Path to Zero and Schools: Achieving Pandemic Resilient Teaching and Learning Spaces","Harvard University, Harvard T.H. Chan School of Public Health","2020-07-19T00:00:00.000","PDF","This four-page document explains how risk incidence levels, the creative adaptation of infection control guidelines for healthy buildings, and national investment in pandemic resilient schools can optimize operations, keep people safe, and restore our schools as trusted sites of learning in a densely populated world in which novel coronavirus and influenza epidemics are becoming increasingly frequent. It is co-published with the Harvard Global Health Institute, and Edmond J. Safra Center for Ethics.","https://globalepidemics.org/wp-content/uploads/2020/07/pandemic_resilient_schools_briefing_7.19.20.pdf",,"Report",,"false","23102"
"3170","Role of the Department of Defense During a Flu Pandemic","Congressional Research Service [Library of Congress]","2009-06-04T00:00:00.000","PDF","This 18-page document discusses role of the Department of Defense (DOD) in supporting the domestic and international response effort to the flu pandemic, which is assisting in disease surveillance, assisting partner nations, protecting, and treating U.S. forces and dependents, and providing support to civil authorities in the United States.","https://www.hsdl.org/?view&did=17892","Kapp, Lawrence; Jansen, Don J.","Guideline/Assessment Tool",,"false","3170"
"3149","Anticipated Cost for Novel H1N1 Vaccine Administration","Association of State and Territorial Health Officials","2009-06-02T00:00:00.000","PDF","This is a fact sheet about the estimated cost of H1N1 vaccine per dose and other facts about vaccine cost.","http://www.astho.org/pubs/VaccineCostEstimate6-03-09Draft_2_.pdf?PHPSESSID=706bccc4b0666e9b1afa037535a6c633",,"Fact Sheet","This link is no longer available. 1/30/13.","false","3149"
"21260","Fact Sheet for Healthcare Providers: Quest SARS-CoV-2 rRT-PCR; Quest Diagnostics","U.S. Food and Drug Administration","2020-07-18T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers  of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics SARS-CoV-2 RNA, Qualitative Real-Time RT-PCR (Quest SARS-CoV-2 rRT-PCR) test, which received an Emergency Use Authorization from the Food and Drug Administration on March 17, 2020. The Quest SARS-CoV-2 rRT-PCR test is authorized for use on respiratory specimens from individuals suspected of COVID-19 (coronavirus) by their healthcare provider. The U.S. Food and Drug Administration reissued an emergency use authorization (EUA) on July 18, 2020, to Quest Diagnostics to authorize its Quest SARS-CoV-2 rRT-PCR test for use with pooled samples containing up to four individual swab specimens collected under observation.","https://www.fda.gov/media/136229/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/136230/downloadLink to Letter of Authorization: https://www.fda.gov/media/136228/downloadLink to Instructions for Use: https://www.fda.gov/media/136231/download","false","21260"
"23317","Interim Guidance: Care of Residents in Long Term Care Homes During the COVID-19 Pandemic","Government of Canada","2020-07-17T00:00:00.000","Text","This web page provides care guidance specific to the COVID-19 pandemic in Canadian homes/facilities where older adults require continuous supervised care, including professional health services, personal care, and other services such as meals, laundry, and housekeeping.","https://www.canada.ca/en/public-health/services/diseases/2019-novel-coronavirus-infection/guidance-documents/residents-long-term-care-homes-covid-19.html",,"Guideline/Assessment Tool",,"false","23317"
"23262","COVID-19 Recovery CISA (Cybersecurity and Infrastructure Security Agency) Tabletop Exercise Package (CTEP)","U.S. Department of Homeland Security","2020-07-17T00:00:00.000","Video or Multimedia","This exercise package was developed to assist private sector stakeholders and critical infrastructure owners and operators in assessing short-term, intermediate, and long-term recovery and business continuity plans related to the COVID-19 pandemic. It provides organizations the opportunity to discuss how ongoing recovery efforts would be impacted by concurrent response operations to a potential “second wave” of global pandemic infections.","https://www.cisa.gov/covid-19-recovery-ctep",,"Instructional/Training Material",,"false","23262"
"23252","COVID-19 Resources for Health Care Facilities","American Society for Health Care Engineering","2020-07-17T00:00:00.000","Text","This resource page was created to assist health care facilities professionals in their efforts to reduce the spread of COVID-19. The resources cover critical operations such as air quality, safety and security, emergency preparedness, and infection prevention.","https://www.ashe.org/COVID19resources",,"Bibliography/Resource List",,"false","23252"
"23145","Fact Sheet for Healthcare Providers: Megna Health, Inc. - Rapid COVID-19 IgM/IgG Combo Test Kit","U.S. Food and Drug Administration","2020-07-17T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Rapid COVID-19 IgM/IgG Combo Test Kit. The Rapid COVID-19 IgM/IgG Combo Test Kit is authorized for detection of IgG and IGM antibodies to SARS-CoV-2 in serum and acid citrate dextrose (ACD) plasma specimens.","https://www.fda.gov/media/140295/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140296/downloadLink to Letter of Authorization: https://www.fda.gov/media/140294/downloadLink to Instructions for Use: https://www.fda.gov/media/140297/download","false","23145"
"23088","Fact Sheet for Healthcare Providers: OraRisk COVID-19 RT-PCR Test","U.S. Food and Drug Administration","2020-07-17T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the OraRisk COVID-19 RT-PCR test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140291/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140292/downloadLink to Letter of Authorization: https://www.fda.gov/media/140290/downloadLink to EUA Summary: https://www.fda.gov/media/140293/download","false","23088"
"23078","NETEC COVID-19 Webinar Series: Surgical Cases and Considerations for COVID-19 Patients: Part Two","National Emerging Special Pathogens Training and Education Center","2020-07-17T00:00:00.000","Video or Multimedia","This 53-minute webinar describes strategies used for testing COVID-19 patients requiring surgical procedures, and reviews the approach at the University of Nebraska Medical Center and Emory University on virus transmission and personal protective equipment (PPE) use for infection control. It also defines the setup and pre-briefing process for surgeries during COVID-19, and reviews physical infrastructure setup in alignment with engineering controls in an intraoperative, and post-anesthesia care unit setting.","https://repository.netecweb.org/exhibits/show/ppe-cons/item/1208","Cieslak, Ted; Sullivan, James; Schulte, Thomas; Klopman, Matthew; Collins, Jeremy","Instructional/Training Material","Link to presentation slides: https://repository.netecweb.org/files/original/8a2eac3d4827b9461b7532ccb068d444.pdfLink to Disaster Lit record for webinar Part Two: https://disasterinfo.nlm.nih.gov/search/id:23278","false","23078"
"23070","Practical Actions in Cities to Strengthen Preparedness for the COVID-19 Pandemic and Beyond","World Health Organization","2020-07-17T00:00:00.000","PDF","This 28-page document accompanies the interim guidance on “Strengthening Preparedness for COVID-19 in Cities and Urban Settings.” It provides local authorities, leaders, and policy-makers in cities with a checklist tool to ensure that key areas have been covered. An Excel version that local authorities may wish to adapt to meet their needs is also available.","https://www.who.int/publications/i/item/WHO-2019-nCoV-ActionsforPreparedness-Checklist-2020.1",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1287712/retrieveLink to Excel checklist tool: https://apps.who.int/iris/bitstream/handle/10665/333296/WHO-2019-nCoV-ActionsforPreparedness-Tool-2020.1-eng.xlsxLink to Disaster Lit record for Strengthening Preparedness for COVID-19 in Cities and Urban Settings: https://disasterinfo.nlm.nih.gov/search/id:21984","false","23070"
"22371","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: COVID-19 Clinical Experiences from the Field","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-07-17T00:00:00.000","PDF","This 16-page document from TRACIE (Technical Resources, Assistance Center, and Information Exchange), updated on July 17, 2020, responds to a request for information on clinical presentation, disease progression, and related information from clinicians in the field treating COVID-19 patients.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-covid-19-clinical-experience-from-the-field-final.pdf",,"Bibliography/Resource List",,"false","22371"
"21185","Coronavirus Disease 2019 (COVID-19) Information for Pediatric Healthcare Providers","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-17T00:00:00.000","Text","This web page, updated on July 17, 2020, provides information about COVID-19 (coronavirus) for pediatric healthcare providers, and includes current information and guidance related to multisystem inflammatory syndrome in children (MIS-C).","https://www.cdc.gov/coronavirus/2019-ncov/hcp/pediatric-hcp.html",,"Guideline/Assessment Tool",,"false","21185"
"21096","Discontinuation of Isolation for Persons with COVID-19 Not in Healthcare Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-17T00:00:00.000","Text","This guidance, updated on July 17, 2020, is for healthcare providers and public health officials managing persons with coronavirus disease 2019 (COVID-19) under isolation who are not in healthcare settings. This includes, but is not limited to, at home, in a hotel or dormitory room, or in a group isolation facility.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/disposition-in-home-patients.html",,"Guideline/Assessment Tool",,"false","21096"
"24141","SARS CoV 2 in Indoor Air: Principles and Scenarios","U.S. Environmental Protection Agency","2020-07-16T00:00:00.000","Video or Multimedia","This one-hour, 28-minute webinar features a presentation of fundamental principles related to the generation and fate of SARS-CoV-2 in aerosols, with several practical scenarios, including cars, elevators, bathrooms, and classrooms.","https://www.youtube.com/watch?v=fSQ0ah_OArU&feature=youtu.be","Marr, Linsey; Corsi, Richard","Instructional/Training Material",,"false","24141"
"23745","COVID-19 Survey for Workers","University of California, Davis","2020-07-16T00:00:00.000","PDF","The purpose of this COVID-19 survey is to facilitate a rapid research response to the COVID-19 pandemic that will describe the affected population of frontline workers, their vulnerabilities, and their most urgent needs; and identify critical unmet needs and compare across geographic areas, types of facilities, job types, and sociodemographic characteristics.Population: Adult WorkersLength: 80 questionsTime to Complete: 15-20 minutesMode of Administration: Online (e.g., computer-assisted interview)Pen and PaperTelephoneAdministered by: Self AdministeredLanguage(s): English, SpanishSurvey for Workers: Full Questionnaire https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers.pdfCovid-19 Infection: General Symptoms; Diagnosis https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Infection.pdfThe Workplace: Employment; Personal Protective Equipment; Health Care https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Workplace.pdfDemographics: Personal Demographics; Chronic Health Conditions https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Demographics.pdfChanges to your life since COVID-19: Overall Impact https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Life_Changes.pdfFinancial situation: Economic Insecurity https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Financial.pdfLiving situation: Personal Demographics; Home Life https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Living_Situation.pdfKnowledge about COVID-19 protection measures: Attitudes; Knowledge https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Knowledge.pdfPregnancy: Current Pregnancy; Past Pregnancy https://www.phenxtoolkit.org/toolkit_content/PDF/UCD_Workers_Pregnancy.pdf","https://www.nlm.nih.gov/dr2/UCD_COVID-19_Survey_for_Workers.pdf",,"Guideline/Assessment Tool","Free/Publicly AvailablePublic survey available: https://redcap.ucdmc.ucdavis.edu/redcap/surveys/index.php?s=AXALYRE8RFAvailable Formats: PDFContact Information: University of California, DavisNatalie Nardone, nlnardone@ucdavis.edu","true","23745"
"23159","NYC Mass Fatality Management Guidance","Greater New York Hospital Association","2020-07-16T00:00:00.000","Text","This web page provides guidance and resources collected by the New York City Office of Chief Medical Examiner (OCME) and New York City Emergency Management to assist hospitals with mass fatality management during the COVID-19 pandemic.","https://www.gnyha.org/tool/nyc-mass-fatality-management-guidance/",,"Guideline/Assessment Tool","This link is no longer available. 8/25/2020.","false","23159"
"23084","Summary Strategies to Optimize the Supply of PPE During Shortages","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-16T00:00:00.000","Text","This quick reference table summarizes the Centers for Disease Control and Prevention (CDC)’s strategies to optimize personal protective equipment (PPE) supplies in healthcare settings, including during the COVID-19 pandemic, and provides links to CDC’s full guidance documents on optimizing supplies. These strategies offer a continuum of options using the framework of surge capacity when PPE supplies are stressed, running low, or absent.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/strategies-optimize-ppe-shortages.html",,"Guideline/Assessment Tool",,"false","23084"
"23080","Fact Sheet for Healthcare Providers: xMAP® SARS-CoV-2 Multi-Antigen IgG Assay; Luminex Corporation","U.S. Food and Drug Administration","2020-07-16T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the xMAP® SARS-CoV-2 Multi-Antigen IgG Assay. The xMAP® SARS-CoV-2 Multi-Antigen IgG Assay is authorized for the detection of IgG antibodies to SARS-CoV-2 in human serum and plasma (dipotassium EDTA).","https://www.fda.gov/media/140255/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140258/downloadLink to Letter of Authorization: https://www.fda.gov/media/140257/downloadLink to Instructions for Use: https://www.fda.gov/media/140256/download","false","23080"
"23079","Fact Sheet for Healthcare Providers: Boston Heart COVID-19 RT-PCR Test","U.S. Food and Drug Administration","2020-07-16T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the Boston Heart COVID-19 RT-PCR Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140260/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140262/downloadLink to Letter of Authorization: https://www.fda.gov/media/140261/downloadLink to EUA Summary: https://www.fda.gov/media/140259/download","false","23079"
"23074","Issue Guide: COVID-19 Case Investigation and Contract Tracing","Association of State and Territorial Health Officials","2020-07-16T00:00:00.000","PDF","This 25-page document is a guide to support state health officials, public health experts, and policy leaders in understanding the evolving role and functions of digital technologies in COVID-19 contact tracing and case investigation, including mobile phone-based exposure notification apps.","https://www.astho.org/ASTHOReports/COVID-19-Case-Investigation-and-Contact-Tracing-Considerations-for-Using-Digital-Technologies/07-16-20/",,"Guideline/Assessment Tool",,"false","23074"
"23069","Clinical Management of Multisystem Inflammatory Syndrome in Children (MIS-C) Associated with Coronavirus Disease 2019 (COVID-19)","Centers for Disease Control and Prevention, Center for Preparedness and Response","2020-07-16T00:00:00.000","Video or Multimedia","During this one-hour, 10-minute Clinician Outreach and Communication Activity (COCA) Call, clinicians can learn about clinical management of multisystem inflammatory syndrome in children (MIS-C) associated with coronavirus disease 2019 (COVID-19). Clinicians share their experiences treating patients with MIS-C, present treatment details from published literature on patients with MIS-C, and provide an overview of the treatment guidelines published by the American College of Rheumatology.","https://emergency.cdc.gov/coca/calls/2020/callinfo_071620.asp","Belay, Ermias; Cheung, Eva; Oster, Matthew; Tremoulet, Adrianna","Instructional/Training Material","Link to presentation slides: https://emergency.cdc.gov/coca/ppt/2020/Slides_07_16_20.pdf","false","23069"
"21586","Strategies to Mitigate Healthcare Personnel Staffing Shortages","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-16T00:00:00.000","Text","This guidance, updated on July 17, 2020, is provided to assist healthcare facilities in mitigating healthcare personnel staffing shortages that might occur because of COVID-19, and details contingency capacity strategies to mitigate staffing shortages.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/mitigating-staff-shortages.html",,"Guideline/Assessment Tool",,"false","21586"
"21226","Optimizing Personal Protective Equipment (PPE) Supplies","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-16T00:00:00.000","Text","This web page, updated on July 16, 2020, provides strategies for optimizing PPE supplies, with information on General Optimization Strategies, N95 and Other Respirators, Facemasks, Eye Protection, Gowns, and Gloves.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/index.html",,"Guideline/Assessment Tool","For direct access to individual pages:  Strategies for Optimizing the Supply of Eye Protection: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/eye-protection.html Strategies for Optimizing the Supply of Isolation Gowns: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/isolation-gowns.htmlStrategies for Optimizing the Supply of Facemasks: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/face-masks.html Strategies for Optimizing the Supply of N95 Respirators: https://www.cdc.gov/coronavirus/2019-ncov/hcp/respirators-strategy/index.htmlChecklist for Healthcare Facilities: Strategies for Optimizing the Supply of N95 Respirators during the COVID-19 Response: https://www.cdc.gov/coronavirus/2019-ncov/hcp/checklist-n95-strategy.htmlStrategies to Allocate Ventilators from Stockpiles to Facilities: https://www.cdc.gov/coronavirus/2019-ncov/hcp/ppe-strategy/ventilators.html","false","21226"
"23929","Coronavirus Disease (COVID-19): Maintaining Essential Services for Malaria in Low-Resource Countries","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-15T00:00:00.000","Text","This web page provides key considerations for continuing essential malaria prevention and control activities safely and effectively during the COVID-19 pandemic; these should supplement country Ministry of Health guidance.","https://www.cdc.gov/coronavirus/2019-ncov/global-covid-19/maintain-essential-services-malaria.html",,"Guideline/Assessment Tool",,"false","23929"
"23415","Research Priorities for COVID-19 Vaccines to Support Public Health Decisions","Government of Canada","2020-07-15T00:00:00.000","Text","This web page provides recommendations that were developed to inform clinical trials of candidate COVID-19 vaccines to protect against infection, serious illness, and deaths caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).","https://www.canada.ca/en/public-health/services/immunization/national-advisory-committee-on-immunization-naci/research-priorities-covid-19-vaccines.html",,"Guideline/Assessment Tool",,"false","23415"
"23083","Fact Sheet for Healthcare Providers: Quest Diagnostics PF SARS-CoV-2 Assay; Quest Diagnostics","U.S. Food and Drug Administration","2020-07-15T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics PF SARS-CoV-2 Assay. The Quest Diagnostics PF SARS-CoV-2 Assay is authorized for use with nasal swab specimens self-collected using a home collection kit under telemedicine supervision by individuals suspected of COVID-19 when home collection is determined to be appropriate by a healthcare provider.","https://www.fda.gov/media/140227/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140228/downloadLink to Letter of Authorization: https://www.fda.gov/media/140226/downloadLink to EUA Summary: https://www.fda.gov/media/140229/downloadLink to Instructions for Use (Home Collect): https://www.fda.gov/media/140230/download","false","23083"
"23082","Fact Sheet for Healthcare Providers: Quest Diagnostics RC SARS-CoV-2 Assay; Quest Diagnostics","U.S. Food and Drug Administration","2020-07-15T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics RC SARS-CoV-2 Assay. The Quest Diagnostics RC SARS-CoV-2 Assay is authorized for use with nasal swab specimens self-collected using a home-collection kit under telemedicine supervision for use by individuals suspected of COVID-19 when home collection is determined to be appropriate by a healthcare provider.","https://www.fda.gov/media/140232/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140233/downloadLink to Letter of Authorization: https://www.fda.gov/media/140231/downloadLink to EUA Summary: https://www.fda.gov/media/140234/downloadLink to Instructions for Use (Home Collect): https://www.fda.gov/media/140235/download","false","23082"
"23081","Fact Sheet for Healthcare Providers: Quest Diagnostics HA SARS-CoV-2 Assay; Quest Diagnostics","U.S. Food and Drug Administration","2020-07-15T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Quest Diagnostics HA SARS-CoV-2 Assay. The Quest Diagnostics HA SARS-CoV-2 Assay is authorized for use with nasal swab specimens self-collected using a home collection kit under telemedicine supervision for use by individuals suspected of COVID-19 when home collection is determined to be appropriate by a healthcare provider.","https://www.fda.gov/media/140237/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140238/downloadLink to Letter of Authorization: https://www.fda.gov/media/140236/downloadLink to EUA Summary: https://www.fda.gov/media/140239/downloadLink to Instructions for Use (Home Collect): https://www.fda.gov/media/140240/download","false","23081"
"23068","COVID-19 Research Priorities Identified by the Global Research Community: Survey and Workshops","UK Collaborative on Development Research","2020-07-15T00:00:00.000","PDF","This 71-page report aims to identify the current global COVID-19 research priorities for this and future pandemics of COVID-19 or new pathogens, and calls for the use of research evidence on the optimal implementation of public health interventions for COVID-19 in varied global settings.","https://reliefweb.int/report/world/global-research-community-asks-right-research-right-places-covid-19",,"Report","Direct link to document: https://reliefweb.int/sites/reliefweb.int/files/resources/COVID-19_Research_Priorities_REPORT_15-7-2020_Final_Version.pdf","false","23068"
"23065","NIH COVID-19 Lecture: Nucleic Acid Delivery Systems for RNA Therapy and Gene Editing","National Institutes of Health","2020-07-15T00:00:00.000","Video or Multimedia","The speaker in this one-hour lecture describes his work on the combinatorial development of nanoparticulate, intracellular delivery systems for RNA therapy and gene editing. Libraries of degradable polymers and lipid-like materials have been synthesized, formulated, and screened for their ability to deliver macromolecular payloads inside of cells. These nanoformulations facilitate in vivo delivery, enabling gene suppression with small-interfering RNA, gene expression with messenger RNA, or permanent genetic editing using the CRISPR/Cas9 system. This is part of the NIH COVID-19 Scientific Interest Group Lecture Series.","https://videocast.nih.gov/watch=37814","Anderson, Dan","Instructional/Training Material",,"false","23065"
"23040","Guidance for Health Care Worker (HCW) Surveys in Humanitarian Contexts in LMICs (Low- and Middle-Income Countries)","United Nations Children's Fund","2020-07-15T00:00:00.000","PDF","This eight-page document has been developed for response actors working in humanitarian contexts who seek rapid approaches to gathering evidence about the experience of healthcare workers, and the communities of which they are a part. Understanding healthcare worker experience is critical to inform and guide humanitarian programming and effective strategies to promote infection prevention and control, and identify psychosocial support needs. Links to surveys, including about COVID-19, are on page 8.","https://reliefweb.int/report/world/guidance-health-care-worker-hcw-surveys-humanitarian-contexts-lmics",,"Study Design/Protocol","Direct link to document: https://reliefweb.int/sites/reliefweb.int/files/resources/2020-07%20Social%20Sciences%20Research%20Guidance%20HCW%20surveys%20in%20humanitarian%20contexts-%20final%20draft.pdf","true","23040"
"18572","Method Validation Guide for Qualifying Methods Used by Radiological Laboratories Participating in Incident Response Activities","U.S. Environmental Protection Agency, Office of Air and Radiation","2009-06-01T00:00:00.000","PDF","This 71-page document describes project method validation guidance that a radioanalytical laboratory should comply with in order to validate methods used to process samples submitted during a radiological or nuclear incident, such as that caused by a terrorist attack. This guidance will help fulfill EPA's responsibilities, which include response and recovery actions to detect and identify radioactive substances, and to coordinate federal radiological monitoring and assessment activities.","https://www.epa.gov/sites/production/files/2015-05/documents/method_validation_final_with_web_cover_6-24-09.pdf","Griggs, John","Guideline/Assessment Tool",,"false","18572"
"22228","National COVID-19 Testing & Tracing Action Plan","Rockefeller Foundation","2020-07-15T00:00:00.000","PDF","This report, National COVID-19 Testing Action Plan: Pragmatic Steps to Reopen Our Workplaces and Our Communities, was updated on July 15, 2020. The 51 page updated report lays out the precise steps necessary to enact robust testing, tracing, and coordination to more safely reopen our economy – starting with a dramatic expansion of testing from one million tests per week to initially three million per week and then 30 million per week, backed by an Emergency Network for COVID-19 Testing to coordinate and underwrite the testing market, a public-private testing technology accelerator, and a national initiative to rapidly expand and optimize the use of U.S., university, and local lab capacity.","https://www.rockefellerfoundation.org/national-covid-19-testing-and-tracing-action-plan/?doing_wp_cron=1595001935.4668600559234619140625",,"Guideline/Assessment Tool","This page includes a link to download the full report, an Executive Summary, and a Social Media Toolkit.","false","22228"
"20813","Interim Recommendations for Emergency Medical Services (EMS) Systems and 911 Public Safety Answering Points/Emergency Communication Centers (PSAP/ECCs) in the United States During the Coronavirus Disease (COVID-19) Pandemic","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-15T00:00:00.000","Text","This web page, updated on July 15, 2020, applies to all medical first responders, including fire services, emergency medical services, and emergency management officials, who anticipate close contact with persons with suspected or confirmed Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in the course of their work. Sections cover recommended infection prevention and control (IPC) practices for routine healthcare delivery during the COVID-19 pandemic, and recommended IPC practices when caring for a patient with suspected or confirmed SARS-CoV-2 infection.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/guidance-for-ems.html",,"Guideline/Assessment Tool",,"false","20813"
"20659","Interim Infection Prevention and Control Recommendations for Patients with Suspected or Confirmed Coronavirus Disease 2019 (COVID-19) in Healthcare Settings","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-15T00:00:00.000","Text","This guidance, updated on July 15, 2020, is based on the currently limited information available about the coronavirus disease 2019 (COVID-19) and the current situation in the United States, which includes reports of cases of community transmission, infections identified in healthcare personnel (HCP), and shortages of facemasks, N95 filtering facepiece respirators (FFRs) (commonly known as N95 respirators), and gowns.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/infection-control-recommendations.html",,"Guideline/Assessment Tool",,"false","20659"
"23662","Fostering Mutuality: How One Library Prepared for the Opioid Crisis","Network of the National Library of Medicine Greater Midwest Region","2020-07-14T00:00:00.000","Video or Multimedia","The speakers in this one-hour webinar discuss how the Kalamazoo Public Library took very proactive steps to educate staff on opioid use, stock anti-overdose at public desks, partner with social service agencies, and advocate for changes in the state laws.","https://nnlm.gov/class/fostering-mutuality-how-one-library-prepared-opioid-crisis/25423","King, Kevin; Newman, Bobbi","Instructional/Training Material","Link to recording: https://www.youtube.com/watch?v=e1SmluBzkSA&list=PLUlRqrjIldD7eDlywRR-Bqj8QJGQmBGPZ&index=2&t=0s","false","23662"
"23470","Emergency Authorities Under the National Emergencies Act, Stafford Act, and Public Health Service Act","Congressional Research Service [Library of Congress]","2020-07-14T00:00:00.000","PDF","This 42-page report summarizes emergency authorities under the National Emergencies Act, Stafford Act, and Section 312 of the Public Health Service Act, including the methodology and limitations of each.","https://crsreports.congress.gov/product/pdf/R/R46379","Elsea, Jennifer; Sykes, Jay; Lampe, Joanna; Lewis, Kevin; Askins, Bryan","Report",,"false","23470"
"23131","ASPR TRACIE (Assistant Secretary for Preparedness and Response/Technical Resources, Assistance Center, and Information Exchange) Technical Assistance Request: Handling and Viewing the Remains of a Deceased COVID-19 Patient","Office of the Assistant Secretary for Preparedness and Response [U.S. Department of Health and Human Services]","2020-07-14T00:00:00.000","PDF","This three-page document, updated on July 14, 2020, provides resources in response to a request for precautions or guidance related to handling and viewing the remains of a deceased COVID-19 patient, as well as planning resources for mass fatality management.","https://files.asprtracie.hhs.gov/documents/aspr-tracie-ta-infectious-diseases-fatality-management-resources-3-18-2020.pdf",,"Bibliography/Resource List",,"false","23131"
"23126","COVID 19: FEMA’s Role in the Response and Related Challenges","U.S. Government Accountability Office","2020-07-14T00:00:00.000","PDF","This 20-page Congressional testimony addresses the Federal Emergency Management Agency (FEMA)’s role in managing the COVID-19 pandemic, including efforts to acquire and distribute critical medical supplies. It discusses GAO’s recent report on the COVID-19 pandemic response and past work on other disasters, which identified potential challenges FEMA faces in responding to the pandemic and any future nationally significant biological incidents.","https://www.gao.gov/products/GAO-20-685T","Currie, Christopher","Hearing/Testimony","Direct link to document: https://www.gao.gov/assets/710/708097.pdf","false","23126"
"23101","School Reopening Planning: Federal, Association, and State Considerations","Association of State and Territorial Health Officials","2020-07-14T00:00:00.000","PDF","The examples in this three-page document provide guidance and recommendations from national associations, state action plans, and other resources that can be used to inform future recommendations and policy decisions for determining the feasibility and practicality for schools to reopen in light of the COVID-19 pandemic.","https://www.astho.org/COVID-19/School-Reopening-Planning/",,"Guideline/Assessment Tool",,"false","23101"
"23037","Coronavirus (COVID-19) Pandemic: Personal Protective Equipment Preservation Best Practices","U.S. Department of Health and Human Services","2020-07-14T00:00:00.000","PDF","This four-page fact sheet, published with the Federal Emergency Management Agency, summarizes best practices for national implementation to sustain personal protective equipment (PPE) while ensuring the protection of healthcare personnel (HCP) and first responders during the coronavirus (COVID-19) pandemic response. It provides recommendations on how to reduce, reuse, and repurpose PPE.","https://files.asprtracie.hhs.gov/documents/fema-fact-sheet-ppe-preservation-best-practices-update---14-july-2020.pdf",,"Fact Sheet",,"false","23037"
"13073","Pediatric Surge Pocket Guide","Los Angeles County Health Services","2009-06-01T00:00:00.000","PDF","This 138-page document provides clinical checklists, guides, and just-in-time references to manage a surge of pediatric patients. Information sections are Normal Values, Triage and Assessment, Treatment and Medications, Equipment, Decontamination, Mental Health, and Pediatric Safe Areas.","http://www.calhospitalprepare.org/sites/main/files/file-attachments/peds_surge_pocket_guide.pdf",,"Guideline/Assessment Tool",,"false","13073"
"21533","Outpatient Assessment and Management for Pregnant Women With Suspected or Confirmed Novel Coronavirus (COVID-19)","American College of Obstetricians and Gynecologists","2020-07-14T00:00:00.000","PDF","The American College of Obstetricians and Gynecologists and the Society for Maternal-Fetal Medicine have developed this one-page algorithm, updated on July 14, 2020, to aid practitioners in assessing and managing pregnant women with suspected or confirmed COVID-19.","https://www.acog.org/-/media/project/acog/acogorg/files/pdfs/clinical-guidance/practice-advisory/covid-19-algorithm.pdf",,"Guideline/Assessment Tool","Link to document in Spanish: https://www.acog.org/-/media/project/acog/acogorg/files/pdfs/clinical-guidance/practice-advisory/covid-19-algorithm-spanish-4302020.pdf","false","21533"
"23288","Rapid Gender Analysis: COVID-19 in the United States","CARE International","2020-07-13T00:00:00.000","PDF","This 33-page rapid gender analysis offers policy and institutional recommendations for COVID-19 responses in the United States to meet the needs of the most vulnerable and affected communities in the face of systemic race, gender, and class-based oppression. By applying this tool to the specific American context, it aims to enable CARE and others to create better responses to the pandemic that meet the needs of all people.","http://careevaluations.org/evaluation/rapid-gender-analysis-covid-19-in-the-united-states/","Kalyanpur, Anusha; Thomas, Dannielle; Wu, Diana; Tashjian, Laura; Sifuentes, May","Report","Direct link to document: http://careevaluations.org/wp-content/uploads/7.8.2020-USA-RGA.pdf","false","23288"
"23285","Quick Links to COVID-19 Community Mitigation Strategies and Tools","Centers for Disease Control and Prevention","2020-07-13T00:00:00.000","PDF","This three-page resource is a reference for states, tribes, territories, and localities as they consider which actions to take to mitigate community transmission of COVID-19 in the United States. It includes links to mitigation guidance for specific sectors, as well as tools that communities and facilities can use to assess areas for improvement and to operationalize community mitigation guidance.","https://www.cdc.gov/coronavirus/2019-ncov/downloads/php/open-america/community-mitigation-quicklinks.pdf",,"Guideline/Assessment Tool",,"false","23285"
"23086","Caught in the COVID-19 Storm: Women’s, Children’s and Adolescents’ Health in the Context of UHC (Universal Health Coverage) and the SDGs (Sustainable Development Goals)","United Nations","2020-07-13T00:00:00.000","Video or Multimedia","This web page provides information and links for the launch of the United Nations Secretary-General Independent Accountability Panel (IAP) for Every Woman, Every Child  2020 Report at a high-level political forum side event on July 13, 2020. The 76-page report reviews the status of key Every Woman, Every Child indicators and the implications of COVID-19 on women’s, children’s, and adolescents’ health and rights. It presents country scorecards, analyses of critical challenges and factors for success, and highlights from country case studies.","https://iapewec.org/reports/annual-reports/iap-2020-report/",,"Report","Link to video of launch: https://www.everywomaneverychild.org/launch-of-the-2020-report-of-the-un-secretary-generals-independent-accountability-panel-iap-for-every-woman-every-child/Link to full report: https://iapewec.org/wp-content/uploads/2020/07/IAP-2020-Report-3.pdfLink to annexes: https://iapewec.org/wp-content/uploads/2020/07/IAP-2020-Report-Development-Methods-Annexes.pdfExecutive Summary is available in Arabic, Chinese, French, Russian, and Spanish.","false","23086"
"23061","Weighing Up the Risks: School Closure and Reopening Under COVID-19 — When, Why, and What Impacts?","Alliance for Child Protection in Humanitarian Action","2020-07-13T00:00:00.000","PDF","This 15-page paper, co-developed with the Inter-agency for Network for Education in Emergencies (INEE), is meant to help decision-makers frame a holistic analysis of school closure on the well-being of children and young people, and to consider the safe reopening of schools during the COVID-19 pandemic. It provides a balanced analysis to inform decisions based on holistic child well-being as to when and why to reopen schools.","https://www.alliancecpha.org/en/COVID19andschools",,"Report","Direct link to document: https://www.alliancecpha.org/en/system/tdf/library/attachments/cpha-eie_policy_paper_v1.1_en_lowres.pdf?file=1&type=node&id=39405Document in available in Arabic, French, Portuguese, and Spanish.","false","23061"
"23056","Impact of the Novel Coronavirus (COVID-19) on Patients with Cancer","Stanford University","2020-07-13T00:00:00.000","PDF","The purpose of this study is to understand the spread of the COVID-19 and the impact on patients with cancer. Specifically, we want to understand how COVID-19 has impacted patient's lives and their cancer care. The objective is to enhance our knowledge of the evolving COVID-19 pandemic among patients with cancer. The data collected in this survey will help to understand how cancer care is being affected for patients with cancer and potential ways to mitigate this impact.Population: Adults OnlyLength: 74 QuestionsTime to Complete: 5-10 minutesMode of Administration: Face-to-faceOnline (e.g., computer-assisted interview)Pen and PaperTelephoneAdministered by: Lay InterviewerProfessional InterviewerSelf AdministeredSpecialist/Doctor/ExpertTrained Lay Examiner/InterviewerLanguage(s): English, Spanish, VietnameseImpact of the novel Coronavirus (COVID-19) on Patients with Cancer: Full Survey https://www.phenxtoolkit.org/toolkit_content/PDF/Impact.of.COVID19.on.Patients.with.Cancer.pdfOverall Cancer Care: Health Care; Chronic Health Conditions https://www.phenxtoolkit.org/toolkit_content/PDF/Stanford_COVID19_on_Patients_with_Cancer_Overall_Care.pdfCare Delays or Interruptions (due to COVID-19 pandemic): Health Care https://www.phenxtoolkit.org/toolkit_content/PDF/Stanford_COVID19_on_Patients_with_Cancer_Care_Delays.pdfChallenges Due to COVID-19 Pandemic: Overall Impact; Sources of information about COVID-19 https://www.phenxtoolkit.org/toolkit_content/PDF/Stanford_COVID19_on_Patients_with_Cancer_Challenges.pdfNovel Coronavirus Testing: Status; Diagnosis https://www.phenxtoolkit.org/toolkit_content/PDF/Stanford_COVID19_on_Patients_with_Cancer_Testing.pdfDemographics: Personal Demographics; Health History https://www.phenxtoolkit.org/toolkit_content/PDF/Stanford_COVID19_on_Patients_with_Cancer_Demographic.pdf","https://www.nlm.nih.gov/dr2/Impact_of_COVID19_on_Patients_with_Cancer.pdf",,"Guideline/Assessment Tool","Free/Publicly AvailableProgrammed online survey link: https://stanforduniversity.qualtrics.com/jfe/form/SV_ctKS6ZSMYdEYoXXAvailable Formats: PDFContact Information: Manali I. Patel, MD, MPH, MS Email: manalip@stanford.eduStanford University School of Medicine","true","23056"
"23054","Fact Sheet for Healthcare Providers: Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette","U.S. Food and Drug Administration","2020-07-13T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Sienna-Clarity COVIBLOCK COVID-19 IgG/IgM Rapid Test Cassette. This test is authorized for the detection of antibodies to SARS-CoV-2 in human serum, plasma (dipotassium EDTA, sodium citrate, sodium heparin) and venous whole blood (dipotassium EDTA, sodium citrate, sodium heparin).","https://www.fda.gov/media/140080/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140081/downloadLink to Letter of Authorization: https://www.fda.gov/media/140079/downloadLink to Instructions for Use: https://www.fda.gov/media/140082/download","false","23054"
"23053","Fact Sheet for Healthcare Providers: PowerChek 2019-nCoV Real-time PCR Kit  – KogeneBiotech Co., Ltd.","U.S. Food and Drug Administration","2020-07-13T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the PowerChek 2019-nCoV Real-time PCR Kit. The PowerChek 2019-nCoV Real-time PCR Kit is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140067/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140068/downloadLink to Letter of Authorization: https://www.fda.gov/media/140066/downloadLink to Instructions for Use: https://www.fda.gov/media/140069/download","false","23053"
"23052","Fact Sheet for Healthcare Providers: PhoenixDx SARS-CoV-2 Multiplex – Trax Management Services Inc.","U.S. Food and Drug Administration","2020-07-13T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the PhoenixDx SARS-CoV-2 Multiplex. The PhoenixDx SARS-CoV-2 Multiplex is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140071/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140072/downloadLink to Letter of Authorization: https://www.fda.gov/media/140070/downloadLink to Instructions for Use: https://www.fda.gov/media/140073/download","false","23052"
"23051","Fact Sheet for Healthcare Providers: Compass Laboratory Services SARS-CoV2 Assay -  Compass Laboratory Services, LLC","U.S. Food and Drug Administration","2020-07-13T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Compass Laboratory Services SARS-CoV2 Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Compass Laboratory Services SARS-CoV2 Assay is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider or self-collected using a home collection kit specified in the test’s labeling.","https://www.fda.gov/media/140076/download",,"Guideline/Assessment Tool","Fact Sheet for Patients: https://www.fda.gov/media/140077/downloadLink to Letter of Authorization: https://www.fda.gov/media/140074/downloadLink to EUA Summary: https://www.fda.gov/media/140078/download","false","23051"
"23005","Global COVID-19 Clinical Platform with Pregnancy Module – CRF-P","World Health Organization","2020-07-13T00:00:00.000","PDF","This 13-page Pregnancy Module Case Report Form (CRF-P) should be completed for pregnant women or recently pregnant women who delivered within 21 days from onset of COVID-19 symptoms. Data may be collected retrospectively if the patient data are obtained after the admission date.In response to the COVID-19 pandemic, the World Health Organization (WHO) has launched a global COVID-19 anonymized clinical data platform (the “COVID-19 Data Platform”) to enable State Parties to the International Health Regulations (IHR) (2005) to share with WHO anonymized clinical data related to patients with suspected or confirmed infections with SARS-CoV-2 (collectively “anonymized COVID-19 data”). The anonymized COVID-19 data received by WHO will remain the property of the contributing Entity and will be used by WHO for purposes of verification, assessment and assistance pursuant to the IHR (2005), including to inform the public health and clinical operation response in connection with the COVID-19 outbreak. To help achieve these objectives, WHO has established an independent Clinical Advisory Group to advise WHO on global reporting and analysis of the anonymized clinical COVID-19 data. State Parties and other entities are invited to contact WHO to obtain more information about how to contribute anonymized clinical COVID-19 data to the WHO Data Platform. To preserve the security and confidentiality of the anonymized COVID-19 data, State Parties and other entities are respectfully requested to take all necessary measures to protect their respective log-in credentials and passwords to the COVID-19 Data Platform.The anonymized COVID-19 data will be stored in the WHO COVID-19 Data Platform, which is a secured, access-limited, password protected electronic platform. WHO will (i) protect the confidentiality and prevent the unauthorized disclosure of the anonymized COVID-19 data; (ii) implement and maintain appropriate technical and organizational security measures to protect the security of the anonymized COVID-19 data and the COVID-19 Data Platform. In accordance with Article 11(4) of the IHR (2005), WHO will not make the anonymized COVID-19 data generally available to other State Parties or entities until such time as any of the conditions set forth in paragraph 2 of Article 11 are first met, and following consultation with affected countries/entities. Pursuant to that same Article 11, WHO will not make the anonymized COVID-19 data available to the public, unless and until the anonymized COVID-19 data have already been made available to State Parties, and provided that other information about the COVID-19 epidemic has already become publicly available and there is a need for the dissemination of authoritative and independent information. To contribute data to the WHO COVID-19 Data Platform or to receive more information, please contact: COVID_ClinPlatform@who.int.The CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected retrospectively if the patient data are obtained after the admission date. The data collection period is defined as the period from hospital admission to discharge, transfer, death, or continued hospitalization without possibility of continued data collection. This CRF-P should be completed for pregnant women or recently pregnant women who delivered within 21 days from onset of symptoms. If COVID symptoms started more than 21 days after the end of the pregnancy, please complete the Rapid Core CRF only.The Pregnancy CRF has 3 sections: Module 1: to be completed on the first day of admission to the health centre. Module 2: to be completed daily during hospital stay for as many days as resources allow. Continue to follow-up patients who transfer between wards. Module 3: to be completed at discharge or death.Population: Pregnant or Lactating Women; High Risk/Special/Unique PopulationsLength: 33 itemsMode of Administration: Pen and PaperAdministered by: Specialist/Doctor/ExpertLanguage(s): EnglishWHO Global COVID-19 Clinical Platform: Pregnancy Case Report Form (CRF): Full questionnaire https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF.pdfHospital Admission Case Record Form: General Symptoms; Diagnosis; Personal Demographics https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF_Admission.pdfDaily Case Record Form: General Symptoms; Diagnosis https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF_Daily.pdfTreatment and Outcome Case Record Form: Treatment; Outcomes https://www.phenxtoolkit.org/toolkit_content/PDF/WHO_Pregnancy_CRF_Treatment.pdf","https://www.who.int/publications/i/item/WHO-2019-nCoV-Pregnancy_CRF-2020.5",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1287196/retrieve Free/Publicly AvailableContact: World Health Organization (WHO), COVID_ClinPlatform@who.int","true","23005"
"23004","Global COVID-19 Clinical Platform: Rapid Core Case Report Form (CRF)","World Health Organization","2020-07-13T00:00:00.000","PDF","The eight-page, three-module COVID-19 Rapid Core Case Report Form (CRF) is designed to collect data obtained through examination, interview, and review of hospital notes. Data may be collected prospectively or retrospectively.In response to the COVID-19 pandemic, the World Health Organization (WHO) has launched a global COVID-19 anonymized clinical data platform (the “COVID-19 Data Platform”) to enable State Parties to the International Health Regulations (IHR) (2005) to share with WHO anonymized clinical data related to patients with suspected or confirmed infections with SARS-CoV-2 (collectively “anonymized COVID-19 data”). The anonymized COVID-19 data received by WHO will remain the property of the contributing Entity and will be used by WHO for purposes of verification, assessment and assistance pursuant to the IHR (2005), including to inform the public health and clinical operation response in connection with the COVID-19 outbreak. To help achieve these objectives, WHO has established an independent Clinical Advisory Group to advise WHO on global reporting and analysis of the anonymized clinical COVID-19 data. State Parties and other entities are invited to contact WHO to obtain more information about how to contribute anonymized clinical COVID-19 data to the WHO Data Platform. To preserve the security and confidentiality of the anonymized COVID-19 data, State Parties and other entities are respectfully requested to take all necessary measures to protect their respective log-in credentials and passwords to the COVID-19 Data Platform. The anonymized COVID-19 data will be stored in the WHO COVID-19 Data Platform, which is a secured, access-limited, password protected electronic platform. WHO will (i) protect the confidentiality and prevent the unauthorized disclosure of the anonymized COVID-19 data; (ii) implement and maintain appropriate technical and organizational security measures to protect the security of the anonymized COVID-19 data and the COVID-19 Data Platform. In accordance with Article 11(4) of the IHR (2005), WHO will not make the anonymized COVID-19 data generally available to other State Parties or entities until such time as any of the conditions set forth in paragraph 2 of Article 11 are first met, and following consultation with affected countries/entities. Pursuant to that same Article 11, WHO will not make the anonymized COVID-19 data available to the public, unless and until the anonymized COVID-19 data have already been made available to State Parties, and provided that other information about the COVID-19 epidemic has already become publicly available and there is a need for the dissemination of authoritative and independent information. To contribute data to the WHO COVID-19 Data Platform or to receive more information, please contact: COVID_ClinPlatform@who.int.The Rapid Core CRF is designed to collect data obtained through examination, interview and review of hospital notes. Data may be collected prospectively or retrospectively. The data collection period is defined as the period from hospital admission to discharge, transfer, death, or continued hospitalization without possibility of continued data collection.This CRF has 3 modules: Module 1: to be completed on the first day of admission to the health centre. Module 2: to be completed daily during hospital stay for as many days as resources allow. Continue to follow-up patients who transfer between wards. Module 3: to be completed at discharge or death.Population: All/AnyoneLength: 19 itemsMode of Administration: Pen and PaperAdministered by: Specialist/Doctor/ExpertLanguage(s): English","https://www.who.int/publications/i/item/WHO-2019-nCoV-Clinical_CRF-2020.4",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1287200/retrieve Free/Publicly AvailableContact: World Health Organization (WHO), COVID_ClinPlatform@who.int","true","23004"
"23002","Eurasian Avian-Like A(H1N1) Swine Influenza Viruses","European Union, European Centre for Disease Prevention and Control","2020-07-13T00:00:00.000","PDF","This nine-page report discusses study findings that raise concern about the pandemic potential of swine influenza viruses, which are already able to replicate successfully in human tissue and transmit through droplets between ferrets, being a model for human-to-human transmission. It provides information about other related risk assessments and studies.","https://www.ecdc.europa.eu/en/publications-data/threat-assessment-brief-eurasian-avian-ah1n1-swine-influenza-viruses",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/Eurasian-avian-like-A-H1N1-swine-influenza-viruses.pdf","false","23002"
"23001","Zoonotic Influenza: Annual Epidemiological Report for 2019","European Union, European Centre for Disease Prevention and Control","2020-07-13T00:00:00.000","PDF","This four-page report on zoonotic influenza cases is based on data for 2019 retrieved on January 31, 2020. No human cases of avian influenza were reported in the European Union/European Economic Area. Sporadic human cases of avian influenza A(H5N6) and A(H9N2) were reported.","https://www.ecdc.europa.eu/en/publications-data/zoonotic-influenza-annual-epidemiological-report-2019",,"Report","Direct link to document: https://www.ecdc.europa.eu/sites/default/files/documents/AER_for_2019-zoonotic-influenza.pdf","false","23001"
"23091","Key Considerations for Transferring Patients to Relief Healthcare Facilities When Responding to Community Transmission of COVID-19 in the United States","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-12T00:00:00.000","Text","This guidance is for state and local emergency medical planners and all healthcare facilities, especially facilities in rural areas, during the COVID-19 pandemic. It outlines considerations around the transfer of patients, staff, and supplies between healthcare facilities to optimize patient care, balance resources, and minimize use of crisis care standards. One strategy is to identify relief healthcare facilities and either establish a federal, state, or regional Medical Operation Coordination Cell (MOCC) or coordinate with an existing MOCC. This guidance offers considerations for jurisdictions around patient safety and relief healthcare facility operations.","https://www.cdc.gov/coronavirus/2019-ncov/hcp/relief-healthcare-facilities.html",,"Guideline/Assessment Tool",,"false","23091"
"21207","COVID-19: Simple Answers to Top Questions","Association of State and Territorial Health Officials","2020-07-12T00:00:00.000","PDF","This 128-page document, updated on July 12, 2020, provides dozens of top questions about COVID-19 answered with detailed message maps, which are risk communication tools used to help organize complex information and make it easier to express current knowledge. Each question has a short and long answer.","https://www.astho.org/COVID-19/Q-and-A/","Covello, Vincent; Hyer, Randall","Guideline/Assessment Tool",,"false","21207"
"23063","Countering Stigmatization in the Context of COVID-19","United Nations Office for the Coordination of Humanitarian Affairs, Inter-Agency Standing Committee","2020-07-11T00:00:00.000","PDF","This six-page paper focuses on the issue of stigmatization as a common underlying dynamic, heightened as a result of COVID-19, which is creating and exacerbating risks of violence, coercion, and deliberate deprivation of vulnerable people.","https://interagencystandingcommittee.org/operational-response/countering-stigma-c19-final-11-june-2020",,"Report","Direct link to document: https://interagencystandingcommittee.org/system/files/2020-07/Countering%20Stigma%20in%20C19%20%20Final%2011%20June%202020.pdf","false","23063"
"23579","Convalescent Plasma or Hyperimmune Immunoglobulin for People with COVID-19: A Living Systematic Review","Cochrane Library","2020-07-10T00:00:00.000","Text","The purpose of this report is to continually assess, as more evidence becomes available, whether convalescent plasma or hyperimmune immunoglobulin transfusion is effective and safe in treatment of people with COVID-19.","https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub2/full","Monsef, Ina; Piechotta, Vanessa; Chai, Khai Li; Valk, Sarah; Doree, Carolyn","Report","Link to report in Arabic: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub2/full/fa#CD013600-abs-0008Link to report in French: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub2/full/fr#CD013600-abs-0010Link to report in Portuguese: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub2/full/pt#CD013600-abs-0004Link to report in Spanish: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD013600.pub2/full/es#CD013600-abs-0012","false","23579"
"23318","COVID-19 Contact Tracing in Indian Country","National Indian Health Board","2020-07-10T00:00:00.000","Video or Multimedia","This one-hour, 11-minute webinar explores how contact tracing is being carried out in Indian Country during the COVID-19 pandemic, and how case investigation and contact tracing are core methods used by Tribal, local, and state health departments for disease control and preventing the spread of COVID-19.","https://www.youtube.com/watch?v=IIHPCGOmw9k&feature=youtu.be","Dixit, Amy; Parshall, Carolyn; Sehn, Hannah","Instructional/Training Material","Links to presentation slides: https://www.nihb.org/covid-19/wp-content/uploads/2020/07/NIHB-Contact-Tracing-Webinar-Slides-07.10.2020_COPE.pdf;https://www.nihb.org/covid-19/wp-content/uploads/2020/07/NIHB-Webinar_AASTEC-Contact-Tracing.pdf","false","23318"
"23234","Guidance on Maintaining a Safe and Adequate Blood Supply During the Coronavirus Disease 2019 (‎‎COVID-19)‎‎ Pandemic and on the Collection of COVID-19 Convalescent Plasma","World Health Organization","2020-07-10T00:00:00.000","PDF","This six-page document provides interim guidance on the management of the blood supply in response to the pandemic outbreak of coronavirus disease (COVID-19), including recommendations on collection of COVID-19 convalescent plasma.","https://apps.who.int/iris/handle/10665/333182",,"Guideline/Assessment Tool","Direct link to document: https://apps.who.int/iris/bitstream/handle/10665/333182/WHO-2019-nCoV-BloodSupply-2020.2-eng.pdf?sequence=1&isAllowed=y","false","23234"
"23055","Fact Sheet for Healthcare Providers: WANTAI SARS-CoV-2 Ab Rapid Test - Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.","U.S. Food and Drug Administration","2020-07-10T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the WANTAI SARS-CoV-2 Ab Rapid Test. The WANTAI SARS-CoV-2 Ab Rapid Test is authorized for the detection of total antibodies to SARS-CoV-2 inhuman serum, plasma (EDTA, lithium heparin, and sodium citrate) and venous whole blood.","https://www.fda.gov/media/140028/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Recipients: https://www.fda.gov/media/140037/downloadLink to Letter of Authorization: https://www.fda.gov/media/140035/downloadLink to Instructions for Use: https://www.fda.gov/media/140030/download","false","23055"
"23021","Guidance for Health Departments about COVID-19 Testing in the Community","Centers for Disease Control and Prevention, Office of Infectious Diseases","2020-07-10T00:00:00.000","Text","This COVID-19 testing guidance covers Testing Overview; Testing in Communities, Schools and Workplaces; Performing Broad-Based Testing; Testing in Healthcare Settings; and Testing Animals.","https://www.cdc.gov/coronavirus/2019-ncov/php/open-america/testing.html",,"Guideline/Assessment Tool",,"false","23021"
"23012","Coronavirus (COVID-19) Testing Plans by State and Jurisdiction","U.S. Department of Health and Human Services","2020-07-10T00:00:00.000","Text","This web page contains state testing plans that are part of the government response to the COVID-19 pandemic. These plans set specific targets for COVID-19 testing in each jurisdiction.","https://www.hhs.gov/coronavirus/testing-plans/index.html",,"Web Page",,"false","23012"
"23003","WHO Mass Gathering COVID-19 Risk Assessment Tool: Generic Events","World Health Organization","2020-07-10T00:00:00.000","PDF","This risk assessment spreadsheet tool for generic events has been updated to reflect new WHO guidance and new evidence on both COVID-19 and mass gatherings, as well as feedback from end-users. The Decision Tree is now built into the tool, and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; and 6. Risk Communication.","https://www.who.int/publications/i/item/10665-333185",,"Guideline/Assessment Tool","Direct link to spreadsheet: https://apps.who.int/iris/rest/bitstreams/1287134/retrieve","false","23003"
"22998","Fact Sheet for Healthcare Providers: Emergency Use of gammaCore Sapphire CV During the COVID-19 Pandemic","U.S. Food and Drug Administration","2020-07-10T00:00:00.000","PDF","This four-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the gammaCore Sapphire CV during the coronavirus disease 2019 (COVID-19) pandemic. The gammaCore Sapphire CV is intended for acute use at home or in healthcare settings to treat adult patients with known or suspected COVID-19 who are experiencing exacerbation of asthma-related dyspnea and reduced airflow, and for whom approved drug therapies are not tolerated or provide insufficient symptom relief as assessed by their healthcare provider, using non-invasive vagus nerve stimulation (VNS) on either side of the patient’s neck during the COVID-19 pandemic.","https://www.fda.gov/media/139968/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/139969/downloadLink to Letter of Authorization: https://www.fda.gov/media/139967/downloadLink to Instructions for Use: https://www.fda.gov/media/139970/download","false","22998"
"22990","Fact Sheet for Healthcare Providers: BMC-CReM COVID-19 Test","U.S. Food and Drug Administration","2020-07-10T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the BMC-CReM COVID-19 Test that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/140008/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/140026/downloadLink to Letter of Authorization: https://www.fda.gov/media/140024/downloadLink to EUA Summary: https://www.fda.gov/media/140007/download","false","22990"
"22985","Pandemic Response: Confronting the Unequal Impacts of COVID-19","U.S. House of Representatives, Committee on Homeland Security","2020-07-10T00:00:00.000","Video or Multimedia","This one-hour, 51-minute Congressional hearing provides an opportunity to examine the federal response to the COVID-19 pandemic, what must be done to confront the disproportionate impacts of the pandemic in minority and disadvantaged communities, and how the federal government can do more to include communities of color and the economically disadvantaged in its preparation, response, and recovery efforts for COVID-19 and other emergencies.","https://homeland.house.gov/activities/hearings/pandemic-response-confronting-the-unequal-impacts-of-covid-19","Payne, Donald; Thompson, Bennie; Wen, Leana; Benjamin, Georges; Willis, Chauncia","Hearing/Testimony",,"false","22985"
"22974","Guidance for Authorities and Organizers of Sports Events Planning Mass Gatherings During the Current COVID-19 Pandemic","World Health Organization","2020-07-10T00:00:00.000","Text","This risk assessment spreadsheet tool for sports events has been updated to reflect new WHO guidance and new evidence on both COVID-19 and mass gatherings, as well as feedback from end-users. The Decision Tree is now built into the tool, and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; and 6. Risk Communication.","https://www.who.int/publications/i/item/10665-333187",,"Guideline/Assessment Tool","Direct link to tool: https://apps.who.int/iris/rest/bitstreams/1287018/retrieve","false","22974"
"22973","Guidance for the Use of the WHO Mass Gathering Risk Assessment Tools for Religious Gatherings in the Context of COVID-19","World Health Organization","2020-07-10T00:00:00.000","Text","This risk assessment spreadsheet tool for religious gatherings has been updated to reflect new WHO guidance and new evidence on both COVID-19 and mass gatherings, as well as feedback from end-users. The Decision Tree is now built into the tool, and a new tab dedicated to Risk Communication has been added. The expanded tool now includes six tabs: 1. Instructions; 2. Decision Tree; 3. Risk Evaluation; 4. Risk Mitigation; 5. Decision Matrix; and 6. Risk Communication.","https://www.who.int/publications/i/item/10665-333186",,"Guideline/Assessment Tool","Direct link to tool: https://apps.who.int/iris/rest/bitstreams/1287016/retrieve","false","22973"
"22562","Counterfeit Respirators/Misrepresentation of NIOSH-Approval","National Institute for Occupational Safety and Health [Centers for Disease Control and Prevention]","2020-07-10T00:00:00.000","Text","This web page, updated on July 10, 2020, details how to identify a NIOSH-approved respirator, and lists counterfeit respirators and claims. When NIOSH becomes aware of counterfeit respirators or those misrepresenting NIOSH approval on the market, it will post them here to alert users, purchasers, and manufacturers.","https://www.cdc.gov/niosh/npptl/usernotices/counterfeitResp.html",,"Guideline/Assessment Tool",,"false","22562"
"23849","Long Term Care Facilities (Skilled Nursing Facilities and/or Nursing Facilities): CMS Flexibilities to Fight COVID-19","Centers for Medicare & Medicaid Services","2020-07-09T00:00:00.000","PDF","This 11-page document details temporary regulatory waivers and new rules for long-term care facilities to equip the American healthcare system with maximum flexibility to respond to the COVID-19 pandemic. These temporary changes apply immediately across the entire U.S. healthcare system for the duration of the emergency declaration.","https://www.cms.gov/files/document/covid-long-term-care-facilities.pdf",,"Guideline/Assessment Tool",,"false","23849"
"23480","Emergency Services Sector Active Shooter Guide","U.S. Department of Homeland Security","2020-07-09T00:00:00.000","PDF","This two-page guide highlights resources and planning considerations that will enhance emergency services organizations’ ability to develop or improve community planning and preparedness for active shooter incidents.","https://www.cisa.gov/publication/emergency-services-sector-active-shooter-guide",,"Guideline/Assessment Tool","Direct link to document: https://www.cisa.gov/sites/default/files/publications/ESS_Active_Shooter_Guide.pdf","false","23480"
"23011","COVID-19: Digital Contact Tracing and Privacy Law","Congressional Research Service [Library of Congress]","2020-07-09T00:00:00.000","PDF","This six-page report discusses the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule’s application to digital contact tracing during the COVID-19 pandemic, the interaction of the HIPAA Privacy Rule with mobile application contact tracing, and other federal laws that regulate data privacy.","https://crsreports.congress.gov/product/pdf/LSB/LSB10511","Holmes, Eric; Linebaugh, Chris","Report",,"false","23011"
"23000","ADA (Americans with Disabilities Act) National Network Learning Session: California Emergency Plans for Wildfire Season in a COVID-19 Environment","ADA [Americans with Disabilities Act] National Network","2020-07-09T00:00:00.000","Video or Multimedia","This one-hour, 28-minute presentation focuses on plans for fire season and specifically addresses California's efforts regarding practicing integrated emergency communication, transportation/evacuation, and sheltering in a COVID-19 environment. Learning objectives include understanding effective techniques on how to achieve key emergency preparedness goals during the COVID-19 pandemic.","https://www.adapresentations.org/webinar.php?id=163","Antablian, J.R.; May, Bryan; Taylor, Vance","Instructional/Training Material","Link to recording: https://us02web.zoom.us/rec/play/6Z15duqr_Do3HYCc4gSDBKJxW47oLqysgXAb-vsNzhq3VyYHMFagYLVHZQP371TSvSVZRpSRdKcJGIY?continueMode=true&_x_zm_rtaid=0iHMi61gTy-31mDKTX_DZw.1594739394767.5b7938012c810adf61e891cb2d414cc3&_x_zm_rhtaid=307Link to presentation slides: https://www.adapresentations.org/doc/7_9_20/California's%20Emergency%20Plans%20for%20Wildfire%20Season%20in%20a%20COVID19%20Environment.pdfLink to transcript: https://www.adapresentations.org/doc/7_9_20/Transcript%2007-09-20.pdf","false","23000"
"22992","Fact Sheet for Healthcare Providers: Real-Q 2019-nCoV Detection Kit – BioSewoom, Inc.","U.S. Food and Drug Administration","2020-07-09T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the Real-Q 2019-nCoV Detection Kit. The Real-Q 2019-nCoV Detection Kit is authorized for use with respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/139939/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/139940/downloadLink to Letter of Authorization: https://www.fda.gov/media/139938/downloadLink to Instructions for Use: https://www.fda.gov/media/139941/download","false","22992"
"22991","Fact Sheet for Healthcare Providers: SARS-CoV-2 RNA DETECTR Assay","U.S. Food and Drug Administration","2020-07-09T00:00:00.000","PDF","This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of a Molecular LDT COVID-19 Authorized Test called the SARS-CoV-2 RNA DETECTR Assay that has been issued an Emergency Use Authorization (EUA) by the FDA. The Molecular LDT COVID-19 Authorized Test is authorized for use on certain respiratory specimens collected from individuals suspected of COVID-19 by their healthcare provider.","https://www.fda.gov/media/139935/download",,"Guideline/Assessment Tool","Link to Fact Sheet for Patients: https://www.fda.gov/media/139936/downloadLink to Letter of Authorization: https://www.fda.gov/media/139934/downloadLink to EUA Summary: https://www.fda.gov/media/139937/download","false","22991"
"22960","Public’s Role in COVID-19 Vaccination","Center for Health Security [Johns Hopkins University, Bloomberg School of Public Health]","2020-07-09T00:00:00.000","PDF","This 47-page report considers human factors in relation to future vaccines against the novel coronavirus (SARS-CoV-2), drawing on insights from design thinking and the social, behavioral, and communication sciences. It provides recommendations—directed to both U.S. policymakers and practitioners, as well as nontraditional partners new to public health’s mission of vaccination—on how to advance public understanding of, access to, and acceptance of vaccines that protect against COVID-19.","https://www.centerforhealthsecurity.org/our-work/publications/the-publics-role-in-covid-19-vaccination","Schoch-Spana, Monica; Brunson, Emiily; Long, Rex; Ravi, Sanjana; Ruth, Ali","Report","Direct link to document: https://www.centerforhealthsecurity.org/our-work/pubs_archive/pubs-pdfs/2020/200709-The-Publics-Role-in-COVID-19-Vaccination.pdf","false","22960"
"22948","Transmission of SARS-CoV-2: Implications for Infection Prevention Precautions","World Health Organization","2020-07-09T00:00:00.000","PDF","This 10-page document is an update to the scientific brief published on March 29, 2020, entitled “Modes of transmission of virus causing COVID-19: Implications for infection  prevention and control (IPC) precaution recommendations,”  and includes new scientific evidence available on transmission of SARS-CoV-2, the virus that causes COVID-19. Airborne transmission of the virus can occur in healthcare settings where specific medical procedures, called aerosol generating procedures, generate very small droplets called aerosols. Some outbreak reports related to indoor crowded spaces have suggested the possibility of aerosol transmission, combined with droplet transmission, for example, during choir practice, in restaurants, or in fitness classes.","https://www.who.int/publications/i/item/modes-of-transmission-of-virus-causing-covid-19-implications-for-ipc-precaution-recommendations",,"Report","Direct link to document: https://apps.who.int/iris/rest/bitstreams/1286634/retrieveLink to Q&A: How is COVID-19 transmitted?: https://www.who.int/news-room/q-a-detail/q-a-how-is-covid-19-transmitted","false","22948"
"21539","Interim Guide on the Production of Ethanol for Use in Alcohol-Based Hand Sanitizers","Government of Canada","2020-07-09T00:00:00.000","Text","This web page, updated on July 9, 2020, provides information on the use of ethanol as an ingredient in alcohol-based hand sanitizers sold in Canada, and provides further guidance on the quality requirements for ethanol to be used in the production of hand sanitizers.","https://www.canada.ca/en/health-canada/services/drugs-health-products/disinfectants/covid-19/interim-guide-ethanol-hand-sanitizers.html",,"Guideline/Assessment Tool",,"false","21539"
"19333","NIMS Senior Leader Toolkit","Federal Emergency Management Agency [Department of Homeland Security]","2020-07-09T00:00:00.000","Text","The purpose of this toolkit, updated in July 2020, is to help elected officials, other senior executives, and department heads understand their responsibilities in the initial response to an incident. Two reference guides are organized into overarching priorities that apply to every incident, essential responsibilities, what to expect/action steps, and public messaging examples. Priorities include ensuring the safety and security of first responders, support personnel, and the general population. The toolkit also includes a PowerPoint presentation.","https://www.fema.gov/sites/default/files/2020-07/fema_nims_senior-leader-toolkit-2019.zip",,"Guideline/Assessment Tool","Files are provided in a zip file.","false","19333"
"24131","COVID-19 Testing in Long-Term Care Facilities","National Governors Association","2020-07-08T00:00:00.000","Text","This brief provides considerations for developing a strategy for COVID-19 testing in long-term care facilities, a review of state actions to date, and a map of state activity.","https://www.nga.org/memos/covid-19-testing-long-term-care-facilities/",,"Guideline/Assessment Tool","Link to brief in a PDF file: https://www.nga.org/wp-content/uploads/2020/07/COVID-19-Testing-in-Long-Term-Care-Facilities-7-8.pdf","false","24131"
